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Preface 
 
 
In 1998, we organized the first specialized meeting in the field of signal transduction and gene 
expression in Luxembourg. This type of meeting was originally thought to teach doctoral 
students of the molecular and cellular biology master training program of the University 
of Nancy I (France). 
 
Since then, more than 5000 fundamental, clinical and industrial researchers were 
gathering in Luxembourg for eight different meetings in order to discuss therapeutic 
applications in the field of signal transduction, transcription and translation related to novel 
therapeutic applications. These meetings allow new insights into this rapidly moving field. 
Novel antibodies against receptors, protein kinase inhibitors, antisense oligonucleotides and 
siRNA targeting both signal transduction and gene expression will certainly enhance 
therapeutic approaches for the next century. 
 
For the 2010 edition of meeting, with more than 400 participants, I am convinced that this 
meeting will be a great success. 
 
Welcome to Luxembourg! 
Marc Diederich 
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General Information 
 
Meeting Venue 
All meeting sessions are held at the New Congress Center Kirchberg 
4, Place de l’Europe 
L-1499 Luxembourg-Kirchberg 
Onsite Phone: +352 4302 57567 
Onsite Fax: + 352 4302 57568 
 
This new building is hidden located behind the Philharmonie Concert Hall (left side) and is in 
fact integrated into the basis of the white Tower building (see map with photos for details). 
 
Registration will take place at the registration desk open daily (9h00-19h00). 
 
Coffee breaks will be served in the exhibit area daily (See general program for details). 
 
Lunch 
For the participants that pre-paid lunch, lunch is served from 13h00 - 15h00. Additional 
tickets are NOT available at the registration desk. 
 
Exhibits are open daily from January 27th to 30th, 2010. 
The Exhibit opens on Wednesday January 27
th
 (Coffee break 10h30) and ends on Friday 
January 29
st
, 2010 after the afternoon coffee break. 
 
Posters 
All posters will be up from Wednesday January 27th until Friday January 29th: 
 
Wednesday January 27th 14h00 – 16h00: All posters 
Thursday January 28th 14h00 – 16h00: Posters with even numbers 
Friday January 29th 14h00 – 16h00: Posters with odd numbers 
 
On Friday January 29th 16h00, all poster presenters are requested to recover their 
posters (the boards will be taken away). 
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Welcome reception offered by the City of Luxembourg (expo area) 
On Wednesday January 27, 2010 from 19h30-20h30 at the expo surface. 
 
Gala Dinner 
The Gala Dinner will take place at the Hôtel Le Royal 12, boulevard Royal L-2449 
Luxembourg Tel: + 352 24 16 16-1, Fax: + 352 22 59 48 on Thursday, January 28th starting 
at 20h30. Additional tickets are NOT available at the registration desk. 
 
Transportation 
Our bus shuttles will bring the participants from the hotels to the meeting center in the 
morning and back to the hotels or city center in the evening. Please note that the busses leave 
from your hotel depending on the distance to the meeting center (Check timetable for details). 
The busses are red, orange and yellow and are from the bus company "Demy Cars". 
 
Taxis can be called from the registration desk. 
 
How to reach the congress center? 
- By taxi: 
 from the airport (Luxembourg - Findel) in about 15 minutes. 
 from the railroad station (about 15 minutes) 
- By bus:  take bus line number 16  (every 20 minutes from the city center) 
- By car: 
 From France: Highway A4 from Metz, take Highway A1 (E44) direction Trier 
Plateau de Kirchberg Aéroport, choose exit number "8", orient towards "Quartier Europeen 
Sud Luxembourg-Centre" 
 From Belgium: Highway A411 from Brussels, take Highway A6 (E44) 
direction Trier Plateau de Kirchberg Aéroport, choose exit number "8", orient towards 
"Quartier Europeen Sud Luxembourg Centre" 
 From Germany: Highway A6 (E44) from Trier, direction Luxembourg, choose 
exit number "8", orient towards "Quartier Europeen Sud Luxembourg Centre". 
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Exhibition 
 
1. & 2.  BD Biosciences    
3.   Prophac    
4.    Merck Chemicals Ltd.    
5 & 6  AXXORA Europe    
7. & 8.   Enzo Life Sciences AG  
9.    Promega Benelux    
10.    Portland Press Limited    
11. & 12.  Leica Microsystems    
13.   Polyplus-transfection   
14.   AMS Biotechnology   
15.   Sigma 
16.    InvivoGen 
17.   BIOKE / CST 
18.    Jackson ImmunoResearch   
19.   Active Motif    
20.   Olympus Belgium    
21.   GENTAUR   
22.    R&D Systems   
23.    Eurogentec   
24.    Bio-Connect    
25.    Bio-Rad    
26.    Promocell GmbH 
27. & 28.  GREINER BIO-ONE    
29. & 30.  PerkinElmer Bio-discovery    
31. & 32.   tebu-bio    
33.    Berthold   
34.    Millipore   
35. & 36.  VWR International 
37.    Westburg 
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Many thanks to all exhibitors 
Please visit our Expo ! 
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Wednesday January 27th, 2010 
 
8h00 – 19h00: Registration 
 
Keynote session: 
Chair: Marc Diederich (LBMCC, Luxembourg) 
 
9h30 – 10h30: Jurg Tschopp (University of Lausanne, Lausanne, Switzerland): The 
inflammasomes: Guardians of our body 
 
10h30 – 11h00: Coffee break 
 
Session 1: Regulation of cell signaling pathways I 
Chair: Young-Joon Surh  (Seoul National University, Korea) 
 
11h00 – 11h30: Young-Joon Surh (Seoul National University, Korea): Redox regulation of 
pro-inflammatory and anti-inflammatory signaling 
11h30 – 12h00: Massimo Locati (Fondazione Humanitas per la Ricerca, Rozzano, Italy): 
Signaling and adaptive responses via atypical chemokine receptor D6 
12h00 – 12h30: Matthias Gaestel (Hannover Medical School, Germany): The role of 
MAPKAP kinases MK2 and MK3 in inflammation and beyond 
12h30 – 13h00: Thad Stappenbeck (Washington University, St Louis, USA): Role of 
epithelial growth factors in the maintenance of colonic homeostasis 
 
13h00 – 16h00: Lunch, workshops and posters 
Workshops: 
14h00 – 15h00: Becton Dickinson 
15h00 – 16h00: Promega 
Posters: 
14h00 – 16h00: Poster session 
(free viewing) 
 
Session 2: Regulation of cell signaling pathways II 
Chair: Hye-Kyung Na (Sungshin Women's University, Seoul, Korea) 
 
16h00 – 16h30: Véronique Baud (Institut Cochin-INSERM U567, Paris, France): Novel 
roles of the alternative NF-kappaB pathway 
16h30 – 17h00: Rudi Beyaert (Ghent University - Department for Biomedical Molecular 
Biology, Belgium): The NF-kB inhibitor A20 as a peacekeeper in inflammation and immunity 
17h00 – 17h30: Hye-Kyung Na (Sungshin Women's University, Seoul, Korea): Role of 
IkappaB kinase in 4-Hydroxyestradiol-induced migration and transformation of human 
mammary epithelial cells 
17h30 – 18h00: Wouter de Jonge (Academic Medical Center, Amsterdam, The 
Netherlands): Acetylcholine modulates innate immune cell activation via Jak/Stat and NF-kB 
signaling pathways 
18h00 – 18h20: Roberto Gambari (Ferrara University, Italy): Decoy PNA-DNA-PNA 
chimeras targeting NF-kB transcription factors inhibit IL-8 gene expression in cystic fibrosis 
IB3-1 infected with Pseudomonas aeruginosa 
18h20 – 18h40: Emmanuel Dejardin (GIGA-Research, University of Liège, Belgium): 
TNFL–Induced p100 processing (TIPP) relies on the internalization of the cognate TNFR 
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18h40 - 19h00: Hyeyoung Kim (Yonsei University, Seoul, Korea): Effect of lipid-associated 
membrane proteins from Mycoplasma pneumoniae on IL-8 expression in glutamine-deficient 
human alveolar epithelial A549 cells 
 
19h00 – 19h30: Official talks and inauguration 
19h30 – 20h30: Reception offered by the City of Luxembourg 
20h30 – 21h00: Shuttles leave to the hotels from the meeting center 
 
 
Thursday January 28th, 2010 
 
Shuttle bus from the hotels to the meeting center (see map for details) 
 
8h00 – 19h00: Registration 
 
Session 3: Inflammatory mediators 
Chair: Bharat B. Aggarwal (M. D. Anderson Cancer Center, USA) 
 
8h30 – 9h00: Bharat B. Aggarwal (M. D. Anderson Cancer Center, USA): Targeting 
Inflammatory Pathways for Prevention and Treatment of Cancer 
9h00 – 9h30: Sankar Ghosh (Columbia University, New York, USA): Regulation of 
inflammatory signaling by TNF receptor 
9h30 – 10h00: Edward A. Dennis (University of California, USA): TLR4 Initiated 
Phospholipase A2 Signaling via Pro- and Anti- Inflammatory Eicosanoids 
10h00 – 10h30: Zigang Dong (Homel Institute, University of Minnesota, USA): Prevention 
of skin cancer: from basic research to clinical trials 
 
10h30 – 11h00: Coffee break 
 
Session 4: Epigenetic and transcriptional control in inflammatory diseases 
Chair: Jonathan Turner (Institute of Immunology, Luxembourg) 
 
11h00 – 11h30: Ajay Goel (Baylor University Medical Center, Dallas, USA): Epigenetic 
Changes by Dietary Agents 
11h30 – 12h00: Guy Haegeman (University of Ghent, Belgium): Impact of chromatin on 
inflammatory gene expression 
12h00 – 12h20: Jonathan Turner (Institute of Immunology, Luxembourg): Methylation of 
the (anti-inflammatory) glucocorticoid receptor promoter 
12h20 – 12h40: Oliver H. Krämer (Friedrich-Schiller-University Jena, Germany): Crosstalk 
between stimulated NF-!B and the tumor suppressor p53 
12h40 – 13h00: Alexander Remels (Maastricht University, the Netherlands): TNF-" impairs 
regulation of skeletal muscle oxidative capacity through activation of NF-kB 
 
13h00 – 15h00: Lunch, Workshops and Posters 
Workshops: 
13h00 – 14h00: IBA 
14h00 – 15h00: Polyplus-Transfection 
15h00 – 16h00: AMS Biotechnology 
Posters: 
 
14h00 – 16h00: Poster session 
(All posters with even numbers: 2, 4, 6) 
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Session 5: Virus infections and innate immunity 
Chair: Jacques Piette (Université de Liège, Belgium) 
 
16h00 – 16h30: Jacques Piette (Université de Liège, Belgium): Varicella-zoster virus 
interferes with innate immune signaling pathways 
16h30 – 17h00: Andrew Bowie (Trinity College Dublin, Ireland): Novel regulators of pattern 
recognition receptor signaling 
17h00 – 17h30: Christian Münz (University of Zürich, Switzerland): Priming of protective 
and tumor specific T cell responses in mice with human immune system component 
17h30 – 18h00: Johannes Bode (University of Düsseldorf, Germany): Role of the interplay 
of MK2 and MK3 for IRF3 dependent effects of LPS 
18h00 – 18h30: Yong Sang Song (Seoul National University, Korea): Human papillomavirus 
16 E5 oncoprotein as an inducer of inflammatory cell signaling 
18h30 – 19h00: Stephen J. Galli (Stanford University, USA): Mast cells as negative 
regulators of innate and adaptive immune responses 
 
19h00: Shuttles leave to the hotels from the meeting center 
 
 
Friday January 29th, 2010 
 
Shuttle bus from the hotels to the meeting center (see map for details) 
 
8h00 – 19h00: Registration 
 
Session 6: Chronic Inflammatory pathologies – Part I 
Chair: Kapil Mehta (M.D. Anderson Cancer Center, Houston, USA) 
 
8h30 – 9h00: Seth Masters (National Institutes of Arthritis and Musculoskeletal and Skin 
Diseases, USA): New additions and mechanistic insight into the spectrum of auto-
inflammatory disease 
9h00 – 9h30: Decio L. Eizirik (Université Libre de Bruxelles, Belgium): Signal transduction 
of inflammation-mediated beta-cell apoptosis in type 1 diabetes 
9h30 – 10h00: Sushovan Guha (M.D. Anderson Cancer Center, Houston, USA): G protein-
coupled receptor mediated signaling pathways in pancreatic cancer 
10h00 – 10h30: Kapil Mehta (M.D. Anderson Cancer Center, Houston, USA): Tissue 
transglutaminase (TG2): a proinflammatory protein promotes cell survival and invasive 
signaling in cancer cells 
 
10h30 – 11h00: Coffee break 
 
Session 7: Chronic Inflammatory pathologies – Part II 
Chair: Seth Masters (National Institutes of Arthritis and Musculoskeletal and Skin Diseases, 
USA) 
 
11h00 – 11h30: Sunil Krishnan (M.D. Anderson Cancer Center, Houston, USA): Targeting 
Inflammatory Pathways for Radiosensitization of Cancer 
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11h30 – 11h50: Franck Morceau (LBMCC, Luxembourg): TNF alpha and anemia 
11h50 – 12h10: Ma!gorzata Rogali"ska (Medical University of Vienna, Austria): 
Usefulness of differential scanning calorimetry for evaluation of treatment efficacy and 
development of personalized therapy of chronic lymphocytic leukemia 
12h10 – 12h30: Jenny E. Gumperz (University of Wisconsin School of Medicine and Public 
Health, USA): Recognition of Lyso-phosphatidylcholine by Human Natural Killer T 
Lymphocytes 
12h30 – 12h50: George Hajishengallis (University of Louisville, USA): Complement 
pathways involved in periodontal inflammation 
12h50 – 13h10: Salahaddin Mahmudi-Azer (University of Calgary, Alberta, Canada): 
Redefining Eosinophil Crystalloid Granules as a Potential New Functional Unit in 
Extracellular Inflammatory Events 
13h10 – 13h30: Alfonso Pompella (Dept. of Experimental Pathology, University of Pisa, 
Italy): A safe procedure! for measurment of S-nitrosoglutathione, the central metabolite in S-
nitrosothiols formation and bioactivity 
 
13h30 – 16h00: Lunch, workshops and posters 
Workshops: 
14h00 – 15h00: Bio-Rad 
15h00 – 16h00: GE Healthcare 
Posters: 
14h00 – 16h00: Poster session 
(All posters with odd numbers: 1, 3, 5) 
 
Session 8: Regulation of cell signaling pathways III 
Chair: Ivana Scovassi (IGM-CNR, Pavia, Italy) 
 
16h00 – 16h30: Varsha Gandhi (M.D. Anderson Cancer Center, Houston, TX, USA): 
Targeting Bcl-2 Family Survival Proteins 
16h30 – 17h00: Peter Friedl (Radboud University Nijmegen Medical Centre, The 
Netherlands): Killing of cancer cells by CTL 
17h00 – 17h30: Ivana Scovassi (IGM-CNR, Pavia, Italy): PARP inhibitors: new tools to 
protect from inflammation 
17h30 – 17h50: Claudia Cerella (LBMCC, Luxembourg): Anti-apoptotic effect of COX2 
inhibitors 
17h50 – 18h10: Alicia Torriglia (INSERM U 872, Paris, France): Glucocorticoides induce 
cell death in the retina 
18h10 – 18h30: Béatrice Charreau (Université de Nantes, France): Inflammation 
Dysregulates Notch Signaling in Endothelial Cells: Implication of Notch2 and Notch4 to 
endothelial dysfunction 
18h30 – 18h50: Thomas Luft (German Cancer Research Center, Heidelberg, Germany): The 
second signal in antigen-presenting cells: Complementary JAK1 directs pro- and anti-
inflammatory cytokine production induced by CD40L 
18h50 – 19h10: Iris Behrmann (Life Sciences Research Unit, University of Luxembourg): 
Hypoxia-inducible factor 1a is upregulated by Oncostatin M and participates in Oncostatin M 
signalling 
 
19h15: Shuttles leave to the hotels from the meeting center 
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Saturday January 30th, 2010 
 
Shuttle bus from the hotels to the meeting center (see map for details) 
 
8h00 – 13h00: Registration 
 
Session 9: Natural compounds and inflammation cell signalling I 
Chair: Norbert Latruffe (University of Burgundy, France) 
 
8h30 – 9h00: Lina Ghibelli (University of Rome Tor Vergata, Italy): Novel signaling 
pathways induced by melatonin in leukocytes: inflammatory implications and 
pharmacological perspectives. 
9h00 – 9h30: De-Xing Hou (Kagoshima University, Japan): Flavonoids as anti-inflammatory 
compounds: targeting signaling and molecules. 
9h30 - 9h50: Norbert Latruffe (INSERM U 866; University of Burgundy, France): 
Responses of cell targets to resveratrol; involvement of common or separated mechanisms? 
9h50 – 10h10: Francesco Peri (University of Milano Bicocca, Italy): A chemical genetic 
approach to the study of the TLR4 pathway: new chemical entities targeting selectively the 
CD14 and MD-2 receptors 
10h10 – 10h30: Flavia Radogna (University of Rome Tor Vergata, Italy): Interference 
between nitric oxide synthase and lipoxygenase pathways leads to reciprocal abrogation of the 
effects of melatonin and magnetic fields in leukocytes 
 
10h30 – 11h00: Coffee break 
 
Session 10: Natural compounds and inflammation cell signalling II 
Chair: Józefa W#sierska-G$dek 
 
11h00 – 11h20: Assam El-Osta (Baker IDI Heart and Diabetes Institute, Melbourne, 
Australia): The legacy of hyperglycemia is associated with persistent gene-activating 
epigenetic marks on the NFkB-p65 gene 
11h20 – 11h40: Marc Schumacher (LBMCC, Luxembourg): Marine compounds as anti-
inflammatory and anti-cancer agents 
11h40 – 12h00: Veera R. Konda (KinDex Therapeutics, USA): Substituted 1,3-
cyclopentadiones analogues differentially inhibit inflammation in vitro and collagen-induced 
arthritis in mice  
 
12h00 – 12h20: Józefa W#sierska-G$dek (Medical University of Vienna, Austria): Impact 
of selective CDK inhibitors on functional status of cellular factors promoting survival of 
cancer cells 
12h20 – 12h40: Dietmar Fuchs (University Clinics, Innsbruck, Austria): In vitro testing for 
anti-inflammatory properties of compounds employing peripheral blood mononuclear cells 
freshly isolated from healthy donors 
12h40 – 13h00: Stephan Immenschuh (Hannover Medical School, Germany): Inhibition 
and genetic deficiency of p38 MAPK induces the anti-inflammatory heme oxygenase-1 gene 
via the redox-regulated transcription factor Nrf2 in macrophages 
 
13h00 – 14h00: Lunch and end of the meeting 
14h00: Shuttles leave to the hotels from the meeting center 
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(in chronological order) 
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The inflammasomes: Guardians of our body? 
 
Jurg Tschopp  
 
Department of Biochemistry, University of Lausanne, Switzerland 
 
The NOD-like receptors (NLR) are a family of intracellular sensors of microbial motifs and 
'danger signals' that have emerged as being crucial components of the innate immune 
responses and inflammation. Several NLRs (NALPs and IPAF) form a caspase-1-activating 
multiprotein complex, termed inflammasome that processes proinflammatory cytokines 
including IL-1beta. Amongst the various inflammasomes, the NALP3 inflammasome is 
particularly qualified to sense a plethora of diverse molecules, ranging from bacterial 
muramyldipeptide to monosodium urate crystals. The important role of the NALP3 
inflammasome is emphasized by the identification of mutations in the NALP3 gene that are 
associated with a susceptibility to inflammatory disorders. These and other issues related to 
the inflammasome will be presented. 
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Redox Regulation of Pro-inflammatory and Anti-inflammatory Signaling 
 
Young-Joon Surh 
 
WCU Department of Biopharmaceutical Sciences & Molecular Medicine and National 
Research Laboratory of Molecular Carcinogenesis & Chemoprevention, College of 
Pharmacy, Seoul National University, Seoul 151-742, Korea (surh@plaza.snu.ac.kr) 
 
The implication of inflammatory cell/tissue damage in pathophysiology of human metabolic disorders 
is under intense investigation both at the research level and in clinical practice. Numerous studies have 
been reported with the global biochemical profiling technologies, such as DNA microarray, 
proteomics, metabolomics, lipidomics, etc., to identify and characterize a series of critical 
molecules/changes in the inflammatory signaling. It is by gaining this type of mechanistic 
understanding of a disease that researchers will unlock the keys to discovering new diagnostics and 
therapeutic strategies for the management of inflammation-associated metabolic disorders. One of the 
key molecules involved in mediating inflammation signaling is NF-"B. Accumulating data support the 
cross-talk between NF-"B and other redox-sensitive transcription factors. Nuclear factor E2-related 
factor-2 (Nrf2) plays a crucial role in regulating phase-2 detoxifying/antioxidant gene induction. This 
transcription factor is sequestered in the cytoplasm as an inactive complex with the inhibitory protein 
Keap1. Upon activation, Nrf2 binds to antioxidant responsive element (ARE) sites, leading to the 
coordinated up-regulation of down-stream target genes that boost cellular antioxidant potential. Recent 
studies have revealed that Nrf2 also has an anti-inflammatory function and hence represents an 
important therapeutic target for the inflammatory disorders. Many dietary phytonutrients can induce 
ARE-driven antioxidant/phase-2 detoxifying gene expression, thereby fortifying cellular defence 
against oxidative insult. Cysteine thiols present in various transcription factors and their regulators 
function as redox sensors in fine-tuning of transcriptional regulation of many genes essential for 
maintaining cellular homeostasis. Thus, oxidation or covalent modification of thiol groups present in 
the above redox-sensitive transcription factors and their regulating molecules can provide a unique 
strategy for molecular target-based chemoprevention and cytoprotection.   
References 
1. Kim, J., Cha, Y.-N. and Surh, Y.-J. A protective role of nuclear factor erythroid 2-related factor-2 
(Nrf2) in inflammatory disorders.  Mutat. Res., in press. 
2. Kundu, J.K. and Surh, Y.-J. (2008) Inflammation: Gearing the journey to cancer. Mutat. Res.-
Review, 659: 15-30 
3. Surh, Y.-J. and Na, H.-K. (2008) NF-kappaB and Nrf2 as prime molecular targets for 
chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. 
Genes and Nutrition, 2: 313-317. 
4. Na, H.-K. and Surh, Y.-J. (2006) Transcriptional regulation via cysteine thiol modification: a novel 
molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog., 45: 368-380. 
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Signalling and adaptive responses via atypical chemokine receptor D6 
 
Massimo Locati 1,2, Elena M Borroni 1,2, Benedetta Savino 1,2, Stefania Vetrano 2, Paul 
Proost 3, Sofie Struyf 3, Silvio Danese 2, Raffaella Bonecchi 1,2, Alberto Mantovani 1,2. 
 
1 Dept. Translational Medicine, University of Milan, Italy; 2 IRCCS Istituto Clinico 
Humanitas, Rozzano, Italy; 3 Lab. Molecular Immunology, Rega Institute, Leuven, 
Belgium. 
 
Chemokines play a major role in the induction of an appropriate immune response by 
coordinating leukocyte recruitment. The control of the chemokine system relies on several 
mechanisms, including chemokine processing by proteases and their degradation by 
chemokine decoy receptors. D6 is a chemokine decoy receptor which recognizes and 
degrades most inflammatory chemokines agonist at CCR1 to CCR5. CCL14 is a homeostatic 
chemokine present at high concentrations in the serum with a weak agonist activity on CCR1, 
converted by plasmin and UPA-mediated processing in the potent CCR1/CCR3/CCR5 agonist 
CCL14
(9–74)
 under inflammatory conditions. CCL14
(9–74)
 is further processed and inactivated 
by dipeptidyl peptidase IV/CD26 that generates CCL14
(11–74)
. D6 efficiently binds CCL14 and 
all its truncated isoforms, but only CCL14
(9–74)
 induces adaptive up-regulation of D6 
expression on the cell membrane and is rapidly and efficiently degraded, while degradation of 
the biologically inactive isoforms CCL14
(1–74)
 and CCL14
(11–74)
 is very inefficient. Analysis of 
a panel of truncated CC chemokine isoforms revealed that D6-mediated chemokine 
degradation does not correlate with binding affinity, and is positively correlated with D6 
adaptive up-regulation and that a proline residue in position 2 of D6 ligands is dispensable for 
binding but crucial for D6 adaptive up-regulation and efficient degradation. In the SDS model 
of experimental colitis, D6
-/-
 mice show significantly higher levels of several pro-
inflammatory chemokines and are impaired in the ability to resolve colitis. By bone marrow 
chimeric mice showed that the contribution of D6 relies on the stromal/lymphatic 
compartment, with no involvement of D6 on hemopoietic cells. Finally, after administration 
of the carcinogen azoxymethane, D6
-/-
 mice show increased susceptibility to develop colitis-
associated cancer in the distal segment of the colon. Thus, D6 requires an agonist-dependent 
adaptive up-regulation to efficiently degrade its ligands, cooperates with proteases in the 
control of inflammatory chemokines, and being expressed on lymphatic vessels plays a key 
role in the control of intestinal inflammation and inflammation-associated colon cancer. 
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The role of MAPKAP kinases MK2 and MK3 in inflammation and beyond 
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Downstream of mitogen-activated protein kinases (MAPKs), three structurally related 
MAPK-activated protein kinases (MAPKAPKs or MKs) — MK2, MK3 and MK5 — signal 
to diverse cellular targets. Although there is no known common function for all three MKs, 
these kinases are involved in regulation of gene expression at the transcriptional and post-
transcriptional level, control cytoskeletal architecture and cell-cycle progression, and are 
implicated in inflammation and cancer.  
MK2 and MK3 are phosphorylated and activated by p38MAPK-alpha/beta and, in turn 
phosphorylate various substrates involved in diverse cellular processes. In addition to 
forwarding of the p38-signal by MK2/3, protein complex formation between MK2/3 and 
p38 mutually stabilizes these enzymes and affects p38 signaling in general. Among the 
substrates of MK2/3, there are mRNA-AU-rich-element (ARE)-binding proteins, such as 
tristetraprolin (TTP), which regulate mRNA-stability and translation in a phosphorylation-
dependent manner. Phosphorylation by MK2 stabilizes TTP and ARE-mRNAs by their 
exclusion from a default degradation pathway. MK2/3 also contribute to the de novo 
synthesis of TTP and of further immediate early genes by stimulating SRF-dependent 
transcription. Apart from this, MK2/3 bind to polycomb repressive complex and are 
involved chromatin remodeling necessary for stem cell renewal. 
Both p38 MAPK-alpha and MK2 are elements of TLR- and cytokine-signaling and are 
therefore preferential target molecules to treat chronic inflammation involved in asthma, 
rheumatoid arthritis, inflammatory bowl disease, atherosclerosis, Alzheimer’s disease, 
ischemic heart and brain diseases as well as cancer by orally available small molecules. 
Inhibitors against p38 MAPK have been tested in animal models and in the clinics, block 
acute and chronic inflammation efficiently, but show side effects such as liver toxicity and 
skin rash which might result from “on target”-effects. Thus, targets downstream to p38 
MAPK-alpha, such as MK2, become more interesting for anti-inflammatory therapy.  
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Growth factor-dependent control of Ptgs2 expression in colonic mesenchymal stem cells 
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For colonic homeostasis, the mucosal immune system must be regulated to control improper 
response to a large and diverse population of indigenous microbes. This process requires 
multiple inhibitory pathways. We hypothesized that prostaglandin-endoperoxide synthase 2 
(Ptgs2, also known as Cox-2) and its downstream products play a role in this process because 
of the well-recognized role of this pathway in the response to injury that occurs in a variety of 
systems. We previously found that a partially defined population of colonic stromal cells 
constitutively expressed high levels of Ptgs2 and that the location of these cells was mediated 
by Myd88 signaling. We have now found that these colonic stromal cells were mesenchymal 
stem cells (MSCs). These colonic MSCs expressed high Ptgs2 levels not through interaction 
with bacterial products, but instead as a consequence of mRNA stabilization downstream of 
fibroblast growth factor 9 (Fgf9), a growth factor that is constitutively expressed by the 
intestinal epithelium. This stabilization was mediated partially through a mechanism 
involving endogenous CUG binding protein 2 (CUGbp2). These studies suggest that Fgf9 is 
an important factor in the regulation of Ptgs2 in colonic MSCs and may be a factor involved 
in its constitutive expression in vivo. 
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Abstract non vailable at time of printing 
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The NF-kB inhibitor A20 as a peacekeeper in inflammation and immunity 
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NF-"B dependent gene expression plays a key role in immunity, and inappropriate NF-"B 
activity has been linked with many autoimmune and inflammatory diseases. Multiple 
mechanisms normally ensure the proper termination of NF-"B activation. In this context, the 
intracellular ubiquitin-editing protein A20 (also known as TNFAIP3) is a key player in the 
negative feedback regulation of NF-"B signaling in response to multiple stimuli. A20 also 
regulates tumor necrosis factor (TNF)-induced apoptosis. Recent genome wide association 
studies indicate human A20/TNFAIP3 as a susceptibility locus for common inflammatory 
diseases such as Crohn’s disease and rheumatoid arthritis, suggesting that A20 deficiency 
might contribute to the development and progression of human autoimmune and 
inflammatory diseases. Understanding the mechanism of action, regulation, and biological 
function of A20 in different tissues and cell types is therefore of great importance. A20 is 
believed to exert its NF-kB inhibitory function by acting as a de-ubiquitinating enzyme. We 
and others have shown that specific A20-binding proteins can target A20 to ubiquitinated 
substrates in the NF-kB signalling pathway. A20 can be further regulated by phosphorylation 
and MALT1 paracaspase mediated cleavage. To understand the physiological function of A20 
in specific cell types we have also generated multiple cell and tissue specific A20 knockout 
mice. Recent in vitro and in vivo experiments illustrating the mechanism of action of A20 and 
its role in different immunopathologies will be presented during the meeting. 
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There are multiple lines of evidence suggesting estrogen as a prime risk factor for the 
development of human breast cancer.  Estrogen is converted by cytochrome P450 1B1 to 4-
hydroxyestradiol (4-OHE2), a putative carcinogenic metabolite of estrogen.  This catechol 
estrogen metabolite is oxidized further to produce a reactive quinone via semiquinone.  
Redox-cycling between 4-OHE2 and its quinoid generates reactive oxygen species (ROS). 
ROS not only cause oxidative DNA damage but also promote neoplastic transformation of 
initiated cells.  Therefore, we hypothesized that 4-OHE2 can induce neoplastic transformation 
in human mammary epithelial (MCF10A) cells via ROS generation which may activate the 
NF-!B signaling pathway.  4-OHE2 induced anchorage-independent colony formation in 
MCF-10A cells.  MCF-10A cells treated with 4-OHE2 exhibited increased accumulation of 
intracellular ROS.  The antioxidant N-acetyl-L-cysteine (NAC) inhibited the neoplastic 
transformation induced by 4-OHE2.  ROS overproduced by 4-OHE2 increased the nuclear 
translocation of NF-!B and its DNA binding through induction of I!B kinase-" (IKK") and 
IKK# activities.  The inhibition of the IKK activities with Bay 11-7082 significantly reduced 
the anchorage-independent growth induced by 4-OHE2.  In addition to blocking the colony 
formation induced by 4-OHE2, Bay 11-7082 suppressed migration of MCF-10A cells in a 
dose dependent manner.  The 4-OHE2-induced activation of ERK and Akt resulted in 
enhanced IKK activities and phosphorylation of I!B", thereby inducing NF-!B activation as 
well as the anchorage-independent growth of MCF-10A cells.  In conclusion, ROS 
concomitantly overproduced during redox cycling of 4-OHE2 activates IKK signaling which 
may contribute to neoplastic transformation of MCF-10A cells. 
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Acetylcholine modulates innate immune cell activation via Jak/Stat and NF-kB signaling 
pathways 
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Inflammatory cell activation and resolution of inflammation is tightly regulated by 
comprehensive anti-inflammatory mechanisms that can be harnessed for the treatment of 
infectious and inflammatory disorders. Previous studies indicate that the vagal nerve, 
involved in control of heart rate, hormone secretion, and gastrointestinal motility, is also an 
immunomodulator. In experimental models of inflammatory diseases, vagal nerve stimulation 
attenuates the production of proinflammatory cytokines and inhibits the inflammatory process 
in several models of inflammatory disease, such as sepsis, ileus, pancreatitis, and colitis. 
Acetylcholine, the principal neurotransmitter of the vagal nerve, controls immune cell 
functions via activation of nicotinic acetylcholine receptors that are expressed on several 
myeloid immune cell types such as tissue macrophages and dendritic cells. Acetylcholine 
released by efferent vagal signaling has been shown to modulate Jak-Stat3 and 4 signaling 
and down regulate macrophage NF-kB activation and inflammatory cytokine production. In 
addition, acetylcholine inhibits dendritic cell APC function. From a pharmacological 
perspective, nicotinic agonists are more efficient than acetylcholine at inhibiting 
inflammatory signaling and the production of proinflammatory cytokines. This “nicotinic 
anti-inflammatory pathway” may have clinical implications as treatment with nicotinic 
agonists can modulate the production of proinflammatory cytokines from immune cells. I will 
review the recent advances in cholinergic modulation of cellular immune cell activation and 
function and the signaling pathways involved. These data support the design of more specific 
receptor-selective nicotinic agonists that can incline anti-inflammatory effects while eluding 
neurotoxicity. 
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expression in cystic fibrosis IB3-1 infected with Pseudomonas aeruginosa 
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There is a growing interest in developing therapies against CF in order to reduce the excessive 
inflammatory response in the airways of CF patients. This inflammatory process is 
characterized by production and release of cytokines and chemokines, among which 
interleukin 8 (IL-8) represent one of the most important. Since transcription factor NF-kB 
plays a critical role in IL-8 expression, the transcription factor decoy (TFD) strategy might be 
of interest. TFD is based on biomolecules mimicking the target sites of transcription factors 
(TFs) and able to interfere with TF activity when delivered to target cells. In this respect 
PNA-DNA-PNA chimeras, based on peptide-nucleic acids (PNAs), are molecules of great 
interest for several points of view: (a) unlike PNAs, they can be complexed with liposomes 
and microspheres; (b) unlike ODNs, they are resistant to DNAses, serum and cytoplasmic 
extracts; (c) unlike PNA/PNA and PNA/DNA hybrids, they are potent decoy molecules. By 
using electrophoretic mobility shift assay and RT-PCR analysis we have demonstrated that 
the PDP/PDP chimera is a strong inhibitor of IL-8 gene expression in P.aeruginosa infected 
IB3-1 cells even in the absence of protection with lipofectamine. Moreover, unlike ODN-
based decoys, PDP/PDP chimeras are fully resistant to serum and cytoplasmic extracts. This 
information is of great impact for the development of stable decoy molecules to be used in 
non-viral gene therapy as inhibitors of IL-8 pro-inflammatory activity.  
 
Supported by Italian Cystic Fibrosis Research Foundation by SPINNER (CAPS-IT Project), 
COCHISE UE Project, Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), 
Telethon (contract GGP07257). 
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TNFL–Induced p100 processing (TIPP) relies on the internalization of the cognate TNFR  
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Several members of the TNFR family can activate distinct NF-kappaB complexes through the 
classical and the alternative pathway.  However, how a single receptor engages both pathways is 
still poorly understood.  In this study, we further characterized the mechanism by which TNFR 
induce the activation of the alternative NF-kappaB pathway.  We undertook to identify the 
cytosolic region of LTbetaR that mediates the activation of p100 processing. We identified a 
region encompassing amino acid 345 to 359, which does not display any known structural 
features. However, cell imaging and biochemical studies revealed that this region played a dual 
role by controlling LTbetaR trafficking and TRAF recruitment.  Using si RNA and 
pharmacological approaches we demonstrated that LTbetaR-induced p100 processing relied on an 
internalization route that is dynamin and microtubules dependent but clathrin independent.  We 
also identified a new atypical TRAF binding site involved in the recruitment of TRAF-2 and -3.  
This region allows to alleviating the inhibitory function of the complex TRAF2/3-c-IAP1/2 
associated to NIK.  In vivo, we found that the maturation of mesenteric stromal VCAM-1low 
ICAM-1low MadCAM-1- cells into VCAM-1high ICAM-1high MadCAM-1+ organizer cells 
correlated to an activation of RelB and a down-regulation of cell surface LTbetaR.  The dynamin-
dependent internalization of TNFR is a conserved mechanism required for the induction of the 
alternative pathway since dynasore prevented Lymphotoxin-, CD40L-, Tweak- and BAFF-
induced p100 processing while the classical NF-kappaB was unaffected.  Thus, our data shed light 
on a new biological function of intracellular trafficking for building an adapted NF-kappaB-
mediated immune response. 
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Mycoplasma pneumoniae is one of the most frequent causes of respiratory disease. Lipid-
associated membrane proteins (LAMP) from M. pneumoniae activated inflammatory 
signalings through toll-like receptor 2 in human monocytic THP-1 cells. Glutamine is an 
essential amino acid during inflammatory conditions and its deficiency occurs during the 
periods of critical illness. Interleukin-8 (IL-8) is a neutrophil chemotactic and activating 
peptide and contributes to the pulmonary inflammation. IL-8 expression is mediated with 
Janus kinase (JAK)/Signal Transducers of Activated Transcription (STAT) pathway in 
various cells. The present study aims to investigate whether LAMP induces IL-8 expression 
with the activation of JAK/STAT, and whether glutamine deficiency aggravates LAMP-
induced IL-8 induction in the human alveolar epithelial A549 cells. As a result, LAMP 
increased IL-8 expression in A549 cells in a time-dependent manner, which was augmented in 
the absence of glutamine. The activation of JAK2/STAT3 was observed in LAMP-stimulated 
cells. The effect of LAMP on JAK/STAT activation was potentiated in the cells cultured in 
the absence of glutamine. Glutamine supplementation inhibited JAK/STAT activation in the 
cells treated with LAMP and cultured in the absence of glutamine. The JAK2 inhibitor, 
AG490 inhibited LAMP-induced activation of JAK/STAT3 and IL-8 expression in A549 
cells. In conclusion, LAMP of M. pneumoniae induced IL-8 expression mediated by 
JAK2/STAT3 activation in A549 cells. Glutamine deficiency augments LAMP-induced 
signaling for IL-8 expression in A549 cells. Glutamine supplementation may be beneficial for 
preventing and/or development of pulmonary inflammation.  
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Chronic infections, obesity, alcohol, tobacco, radiation, environmental pollutants, and high-
calorie diet have been recognized as major risk factors for the most common types of cancers. 
All these risk factors are linked to cancer through inflammation. While acute inflammation 
that persists for short-term mediates host defense against infections, chronic inflammation that 
lasts for long-term can predispose the host to various chronic illnesses, including cancer. 
Linkage between cancer and inflammation is indicated by numerous lines of evidence; first, 
transcription factors NF-"B and STAT3, two major pathways for inflammation, are activated 
by most cancer risk factors; second, an inflammatory condition precedes most cancers; third, 
NF-"B and STAT3 are constitutively active in most cancers; fourth, hypoxia and acidic 
conditions found in solid tumors activate NF-"B; fifth, chemotherapeutic agents and gamma 
irradiation activate NF-"B and lead to chemoresistance and radioresistance; sixth, most gene 
products linked to inflammation, survival, proliferation, invasion, angiogenesis, and 
metastasis are regulated by NF-"B and STAT3; seventh, suppression of NF-"B and STAT3 
inhibits the proliferation and invasion of tumors; and eighth, most chemopreventive agents 
mediate their effects through inhibition of NF-"B and STAT3 activation pathways. Thus 
suppression of these proinflammatory pathways may provide opportunities for both 
prevention and treatment of cancer. We will discuss the potential of nutraceuticals derived 
from spices and from traditional Indian and Chinese medicine in suppression of inflammatory 
pathways and their role in prevention and therapy of cancer. 
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Tumor necrosis factor receptor 1 (TNFR1) has the capacity to activate both cellular survival 
and death pathways.  Forced overexpression of TNFR1 induces cell death and it has been 
unclear how signaling capability is maintained while preventing spontaneous apoptosis.  We 
have found that TNFR1 is subject to rapid ongoing turnover thereby tightly regulating 
receptor protein levels.  Constitutive trafficking of TNFR1 leads to lysosomal degradation 
through a mechanism that is distinct from ligand-induced receptor downregulation.  Ligand-
engagement however leads to shuttling of the receptor to a signaling endosome that provides a 
platform for recruitment and assembly of signaling complexes. Therefore TNF receptor 1 can 
switch between two fates, ligand-independent constitutive degradation, or ligand-dependent 
receptor downregulation that accompanies signal-transduction. 
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As part of the LIPID MAPS Consortium (www.lipidmaps.com) [Schmelzer et al. (2007) Lipidomics 
Methods in Enzymology, 432, 169-181], we have developed a robust and comprehensive approach to 
lipidomic analysis [Raetz et al. (2006) J. Lipid Research, 47, 1097-111] of hundreds of fatty acids and 
eicosanoids, including their numerous metabolites arising from an array of cyclooxygenases, 
lipoxygenases, cytochrome P450s and non-enzymatic oxidation producing isoprostanes, as well as 
combinations thereof [Buczynski et al.(2009) J. Lipid Res. 50, 1015-1038]. The LC/MS approach to 
eicosanoid analysis [Deems et al. (2007) Lipidomics Methods in Enzymology, 432, 59-82] and GC/MS 
approach to fatty acid analysis [Quehenberger et al. (2008) Prostaglandins Leukotrienes and Essential 
Fatty Acids, 79, 123-129] have been used to discover novel lipids such as the family of 
dihomoprostaglandins [Harkewicz et al. (2007) J. Biol. Chem., 282, 2899-2910]. We can now apply 
these techniques generally in the context of an overall omics analysis of macrophages [Dennis,E.A. 
(2009) Proc.Natl.Acad.Sci.U.S.A,. 106, 2089-2090] integrating transcriptomics, proteomics, and 
metabolomics of lipid metabolites. We will discuss the application of lipodomic analysis to characterize 
cellular lipid signaling in agonist stimulated RAW264.7 murine macrophages and thioglycolate elicited 
and bone marrow derived primary macrophages which activates phospholipase A2 [Burke,J. and Dennis 
E.A., (2009) J Lipid Res. 50 Suppl, S237-S242]. Numerous eicosanoids produced through COX and 5-
LO were detected either intracellularly or in the media following stimulation with various agonists 
including Toll-like receptors (TLR), G protein-coupled receptors, purinergic receptors and combinations 
thereof. Synergy between Ca2+ release and TLR pathways was detected and discovered to be 
independent of NF-kB induced protein synthesis using lipidomics analysis and help to explain 
macrophage priming and synergy [Buczynski et al. (2007) J. Biol. Chem., 282, 22834-22847]. New data 
describing novel synergy between TLR4 and purinergic receptor signaling in primary macrophages will 
be described. We will also illustrate the application of lipidomics analysis to the analysis of lipid 
signaling in tissues with an example of joint tissues from mice suffering Lyme Disease caused by 
Borrelia burgdorferi [Blaho et al. (2009) J. Biol. Chem., 284, 21599-21612] in which a comprehensive 
lipidomics analysis of the metabolites produced demonstrates the profile of both pro-inflammatory and 
anti-inflammatory (resolving) signaling lipid molecules. New data on KO mice and pharmacological 
intervention demonstrating crosstalk between the COX and LOX cascade will be presented. Supported 
by LIPID MAPS Glue Grant U54 GM069338, R01 GM020501, and R01 GM064611 from NIH. 
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Skin cancer is the most common cancer in the world.  Incidence rates of skin cancer, 
especially non-melanoma skin cancer (NMSC) are increasing rapidly.  The major etiological 
factor of human skin cancer is exposure to sunlight.  We have carefully studied the solar 
ultraviolet A and B (UVA and UVB)-induced signal transduction pathways and their role in 
UV-induced skin carcinogenesis.  We have found that CB1/2, protein kinase C, and EGFR are 
directly activated by UV irradiation.  The absence of the CB1/2, protein kinase C, or EGFR 
result in decreased signals downstream of these receptors.  More importantly, genetic removal 
of the CB1/2 receptors in mice results in a dramatic resistance to UVB-induced inflammation 
and a significant decrease in UVB-induced skin cancer. The transient receptor potential 
channel vanilloid subfamily 1 (TRPV1) is expressed highly in neuronal tissues, but is also 
expressed in the epidermis, dermal blood vessels, human keratinocytes and other tissues.  The 
absence of TRPV1 in mice results in a striking increase in skin carcinogenesis. UV light 
strongly activates many protein kinases, including the MAP kinases JNK1/2, p38 and 
ERK1/2.  JNK1 deficient mice develop more UV-induced tumors than JNK wildtype mice or 
JNK2 deficient mice.  UVA or UVB induces activation of AP-1, p70S6 kinases and COX-2.  
Blocking these signals with small molecule inhibitors also decreased UV-induced skin 
carcinogenesis.  By using these approaches, we have discovered many chemopreventive 
agents such as EGCG, myricetin, quercetin, [6]-gingerol, and resveratrol for preventing UV- 
induced skin carcinogenesis. In collaboration with Drs. David Alberts and Tim Bowden, we 
have continually put these chemoprevention agents into clinical trials.  The agents act on 
specific molecular targets and pathways associated with skin carcinogenesis.  Because most 
of these agents are natural compounds isolated from fruits and vegetables, and target- or 
pathway-specific, we believe that these agents can more effectively prevent human skin 
cancer with fewer side effects.  
  
The work was supported by The Hormel Foundation, Pediatrics Pharmaceuticals (Iselin, N.J.),  
and NIH grants CA077646, CA027502, CA111356, CA111536, CA120388, R34CA081064, 
and ES 016548. 
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Epigenetics is the study of the regulation of gene activity that is not dependent on nucleotide 
sequence; this may include heritable changes in gene activity and expression but also long-term 
alterations in the transcriptional potential of a cell that are not heritable. These features are potentially 
reversible and may affect genomic stability and expression of genes. Three types of epigenetic 
changes that we currently best understand include, alterations in the levels of DNA methylation, 
histone modifications and micro RNAs (miRNAs). In recent years, epigenetics researchers have made 
great strides in understanding the many molecular sequences and patterns that determine which genes 
can be turned on and off. This work has made it increasingly clear that in addition to genetic changes, 
the epigenome is just as critical as the DNA to healthy human development. Unlike irreversible 
genetic changes, epigenetic changes are thought to possibly be reversible by the environment, diet or 
pharmacological intervention and alter susceptibility to multiple diseases, including human cancers. 
However, very limited experimental evidence currently exists that addresses the molecular 
mechanisms involved in diet-induced epigenetic alterations in in-vitro or pre-clinical studies. 
Epigenetic events have also emerged as key mechanisms in cancer development, and a better 
understanding of these mechanisms is fundamental to our ability to successfully diagnose, treat, and 
prevent cancer. The growing interest in cancer epigenetics stems from several factors. First, epigenetic 
changes are implicated virtually at every step of tumor development and progression. Second, 
epigenetic changes including DNA hypermethylation are an early event in tumor development, and 
may precede development of the genetic hallmarks of cancer. Third, a key distinguishing feature of 
epigenetic changes in contrast to genetic changes is that these are reversible; therefore, aberrant DNA 
methylation, histone acetylation and methylation provide an exciting opportunity for the development 
of novel strategies for cancer prevention. Fourth, recent studies have recognized that a cross-talk exists 
between various epigenetic processes. It is now known that DNA methylation and histone 
modification processes may cooperate to regulate gene expression. Similarly, expression of miRNAs 
may be regulated by DNA methylation. Collectively, this means that dietary intervention of even a 
single epigenetic process is likely to influence other epigenetic processes in a positive manner. In light 
of this, there is a substantial interest in the development of safe and effective inhibitors of DNA 
methyl transferases (DNMT), an enzyme that catalyzes the transfer of methyl groups to cytosines at 
CpG sequences during DNA methylation-induced silencing of genes. Similar efforts are underway to 
develop histone deacetylase (HDAC) inhibitors that can prevent de-acetylation of lysine residues in 
histone tails that represent the ‘active marks’ for chromatin and unrestricted gene expression. Given 
the increasing evidence that epigenetic changes induced by environment, lifestyle and diet may play a 
major role in oncogenic transformation and cancer development, and it is suggested that over two-
thirds of the cancer incidence can be accounted for by the environmental and dietary factors alone. 
Among all these factors, diet is probably the most important environmental factor which may 
influence carcinogenesis because diet is readily modifiable and have the potential to modulate multiple 
epigenetic processes. Polyphenols in food plants are a versatile group of phytochemicals with many 
potentially beneficial activities in terms of disease prevention. Dietary polyphenols (bioflavanoids) 
have antioxidant and anti-inflammatory properties that might explain their beneficial effects. 
However, the actual therapeutic potential of these compounds ma not have been completely realized 
due to lack of understanding on the effects of these agents on epigenetic modifications. Recent, but 
limited evidence indicates that some of the polyphenols, including curcumin (from turmeric), 
genestein (from soy), EGCG (from green tea), diallyl disulfide (from garlic), sulforaphane (from 
broccoli) and resveratrol (from grapes) may induce epigenetic changes in various cancer cell lines. In 
this presentation, some of these studies on the role of the dietary polyphenols on epigenetic alterations 
will be described, which will provide a strong scientific foundation for preclinical and human clinical 
intervention studies in future. 
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Interleukin-6 (IL6) is a pluri-potent cytokine, the expression of which needs to be tightly 
regulated in order to keep the organism in a balanced and homeostatic condition. Indeed, 
dysregulation of IL6 leads to a variety of affections, like chronic inflammation, autoimmune 
and cardiovascular diseases, cancer progression, osteoporosis, etc. The IL6 gene promoter 
contains a plethora of transcription factor-binding sites, among which NF-kB is the most 
important factor for induction of the gene by infammatory stimuli, like e.g. TNF. NF-kB is in 
majority a cytoplasmic protein complex (composed of a p50 and a p65 subunit), which upon 
inflammatory stimulation migrates to the nucleus and occupies its position on a variety of 
gene promoters. In previous work, we have shown that, in addition to this cytoplasmic 
activation step, the transcriptional potency of NF-kB is codetermined by the activated MAP 
kinase pathway, more particularly by the nuclear kinase MSK1, that phosphorylates the p65 
subunit at Ser 276 (to generate a fully transcription-competent enhanceosome), as well as the 
Histon-3 tails at Ser 10 (which is the onset of chromatin relaxation). Not only the local (i.e. 
the gene-specific) induced chromatin relaxation, but also the entire nucleosomal arrangement 
along the chromatin fiber is determinative for the (cell-specific) levels of gene expression 
within a given cell type. Indeed, upon comparison of the IL6 gene promoter status in two 
different breast cancer cell lines, i.e. the low IL6-expressing cell type MCF-7 and the 
aggressive tumor cell line MDA-MB-231 that shows abundant IL6 expression, we found that, 
upon DNaseI digestion and restriction enzyme accessibility assays, high IL6 expression 
correlates with an increased number of hypersensitive sites, and a higher accessibility of 
transcription factors, nuclear cofactors and polymerase II to the IL6 gene promoter. Finally, 
we could ‘revert’ this open chromatin configuration and the complementary abundant IL6 
expression by means of a natural compound, i.e. Withaferin A. 
 34 
Methylation of the (anti-inflammatory) glucocorticoid receptor promoter 
 
Jonathan D. Turner1,2, Simone R. Alt1,2, Lei Cao1,2, Salomon C Leija1, Claude P. 
Muller1,2 
 
1. Laboratory of Immunology, Laboratoire Nationale de Sante / CRP-Santé, 20A rue 
Auguste Lumiere, L-1011 Luxembourg, Grand duchy of Luxembourg 
2. Graduate School of Psychobiology, University of Trier, 54290 Trier, Germany 
 
Glucocorticoids (GC) are key endogenous anti-inflammatory mediators, acting through their 
associated receptor, the glucocorticoid receptor (GR, NR3C1). Tissue specific GC actions are 
dependent on local GR levels. GR levels are transcriptionally controlled through the highly 
variable 5’ gene region. This region codes for 11 alternative untranslated first exons. Seven of 
these exons are located within a CpG island immediately upstream of exon 2. We have shown 
that the 7 regions we have proposed as promoters are active in a dual luciferase reporter gene 
system, and that patch promoter methylation completely silences them. Investigation of the 
128 CpG dinucleotides contained within the 5 promoters known to be active in PBMCs in 26 
donors revealed stochastic and individual methylation patterns, however, the majority of CpG 
dinucleotides were methylated at levels >25% in at least one donor. The majority of 
evolutionarily conserved, and proven active transcription factor binding sites within these 
promoters contain methylatable CpG sites, suggesting that methylation orchestrates 
alternative first exon usage, silencing, and controlling tissue specific expression. The 
heterogeneity of methylation observed may reflect epigenetic mechanisms of GR fine tuning, 
programmed by early life environment and events. Glucocorticoid levels are controlled by an 
autocrine loop, and hippocampal GR levels play a key role in controlling this loop, and it has 
previously been proposed that epigenetic regulation of hippocampal GR levels is important. 
In a series of 6 post mortem human brains, we were able to show that there is no detectable 
hippocampal methylation. This would suggest that epigenetic control of the GR is limited to 
peripheral glucocorticoid target tissues, rather than central tissues controlling GC levels. 
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NF-!B and p53 critically determine cancer development and progression. Defining the 
crosstalk between these transcription factors can expand our knowledge on molecular 
mechanisms of tumorigenesis. We show that induction of replicational stress activates NF-!B 
p65 and triggers its interaction with p53 in the nucleus. Experiments with knock-out cells 
demonstrate that p65 and p53 are both required for enhanced NF-!B activity during S-phase 
checkpoint activation involving ATM and CHK1. Accordingly, the pro-inflammatory 
cytokine TNF-" also triggers formation of a transcriptionally active complex containing 
nuclear p65 and p53 on !B response elements. Albeit p53 appears not required for NF-!B 
activation in the cytosol, TNF-induced binding of p65 to chromatin and NF-!B-dependent 
gene expression remarkably require p53. Hence, p53 expression unexpectedly controls 
nuclear functions of NF-!B p65 activated by atypical and classical stimuli. Remarkably, data 
from gain- and loss-of function approaches argue that anti-apoptotic NF-!B p65 activity is 
constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations 
suggest explanations for the outstanding question why p53 mutations rather than p53 
deletions arise in tumors of various origins. 
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Skeletal muscle structure and function are known to deteriorate in individuals with chronic 
diseases such as COPD. A plethora of abnormalities have been described including a fiber 
type shift from type I (oxidative) to type II (glycolytic) fibers and decreased activity of 
enzymes involved in substrate oxidation, illustrative of the loss of muscle oxidative capacity 
in this disorder. Other common denominators of this chronic disease are enhanced circulatory 
levels of inflammatory mediators (e.g. TNF-") and loss of muscle mass. Inflammation, in 
particular the cytokine TNF-", has been linked to muscle atrophy. The impact of local 
inflammation on muscle oxidative metabolism however is unknown. Therefore, we aimed to 
identify the impact of TNF-"-induced inflammatory signaling on muscle oxidative capacity 
and elucidate underlying mechanisms. An in vitro model of adult skeletal muscle revealed 
that cellular respiration rates are diminished upon chronic TNF-" stimulation in a NF-!B 
dependent manner. Oxidative phosphorylation (OXPHOS) protein content, myosin heavy 
chain (MyHC)-I, but not -II, protein levels as well as mRNA transcript levels were also 
decreased under chronic inflammatory conditions. Moreover, chronic TNF-" stimulation 
resulted in decreased mRNA expression levels of major regulators of muscle oxidative 
capacity including peroxisome proliferator-activated receptor alpha (PPAR-") and its co-
activator molecule PGC-1" as well as the mitochondrial transcription factor A (Tfam). 
Additionally, PPAR transcriptional activity levels as well as promoter activation of master 
regulators of mitochondrial biogenesis (Tfam and NRF-1) decreased dramatically in response 
to chronic TNF-" stimulation in a NF-!B dependent manner. In conclusion, we have for the 
first time linked inflammatory signaling and muscle oxidative capacity and elucidated a cell 
signaling mechanism to explain this link. 
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The varicella zoster virus (VZV) is a human alpha-Herpesvirus responsible for two diseases. 
It causes varicella (chicken pox), establishes latency in sensory ganglia and may reactivate to 
cause herpes zoster (shingles) in the host. Although Herpesvirus immune evasion has been 
known for many years, the precise mechanisms by which VZV could interfere with two main 
signaling pathways, i.e. NF-kB and IRF have not been studied yet. The down-regulation of 
the ICAM-1 expression in the center of a varicella lesion despite the presence of pro-
inflammatory cytokines such as TNFa was the first observation suggesting a possible 
interference with the NF-kB pathway. Indeed, ICAM-1 gene transcription is regulated via NF-
kB and we have shown in vitro that in VZV- infected cell cultures ICAM-1 gene transcription 
induced by TNFa is inhibited. Analysis of NF-!B activation showed that despite the virus-
induced nuclear translocation of p65, p52 and c-Rel, p50 did not translocate in response to 
TNF". Unexpectedly, these nuclear subunits were unable to bind the proximal NF-!B site of 
the icam-1 promoter, despite an increased acetylation of the promoter in response to TNF". 
Interestingly, VZV induced nuclear accumulation of the NF-!B inhibitor p100 that could 
partly explain the inhibition of ICAM-1 gene transcription. VZV was also shown capable of 
interfering with IRF3 activation. In VZV-infected cells, the hyper-phosphorylated forms of 
IRF3 detected in the nucleus do not form active dimers, are not transcriptionally active and 
thereby do not lead to the release of interferon (IFN)-b in the supernatant. The hyper-
phosphorylation of IRF3 is not occurring in its C-terminal part and is not involving the 
classical TKB-1/IKKe complex. By using viral kinase-deficient mutants of VZV, an active 
dimeric form of IRF3 can be recovered in the nucleus of infected cells demonstrating that 
VZV-encoded viral kinases could participate to the viral interference with the IRF pathways. 
These results showed that by targeting NF-kB and IRF3 signalling pathways, VZV could 
obviously interfere with the innate immune response and likely gain several advantages for its 
replication. 
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The innate immune system recognises viral infection by making use of pattern recognition 
receptors (PRRs), which initiate signalling cascades that control transcription factor 
activation. For example, Toll-Like Receptors (TLRs) and RIG-I-like receptors (RLRs) 
recognise various viral components and stimulate the activation of transcription factors such 
as NFkappaB. Since PRR signalling pathways have a key role in controlling not only innate 
immunity and pathogen-induced inflammation but probably also sterile inflammation induced 
by endogenous danger signals, understanding how these signalling pathways operate is an 
important goal. Many viruses, having co-evolved with their host, encode proteins that block 
or subvert these inflammatory signalling cascades. Large DNA viruses, such as vaccinia virus 
(VACV), encode a particularly ample repertoire of immunomodulatory proteins. We have 
been investigating and exploiting the strategies used by VACV to inhibit and manipulate host 
PRR responses. This is important for a number of reasons. First, this is contributing to our 
understanding of viral pathogenesis. Second, understanding how viruses manipulate and 
inhibit PRR detection pathways has led to further insights into how these host pathways 
function. Third, some of the identified host targets of viral proteins might turn out to be new 
drug targets for treating a range of diseases. Finally, the viral proteins themselves, or 
derivatives of them, may have therapeutic use in suppressing inappropriate PRR signalling, 
since viral proteins have been optimised during evolution to optimally inhibit their targets, 
which is analogous to a naturally occurring drug development programme. We have identified 
both novel VACV inhibitors of PRR signalling, and also novel components of host innate 
immunity, which will be discussed. 
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Many pathogens that cause human disease infect only humans. In order to identify the 
mechanisms of immune protection against these pathogens and also to evaluate promising 
vaccine candidates, a small animal model would be desirable. We demonstrate here that 
primary T cell responses in mice with reconstituted human immune system components 
control infection with the oncogenic and persistent Epstein Barr virus (EBV). These cytotoxic 
and IFN-gamma producing T cell responses were HLA restricted and specific for EBV 
derived peptides. In HLA-A2 transgenic animals and similar to human EBV carriers, T cell 
responses against lytic EBV antigens dominated over recognition of latent EBV antigens. T 
cell depletion resulted in elevated viral loads and emergence of EBV associated 
lymphoproliferative disease. Both loss of CD4
+
 and CD8
+
 T cells abolished immune control. 
Therefore this mouse model recapitulates features of symptomatic primary EBV infection, 
and generates T cell mediated immune control that resists oncogenic transformation. 
 40 
Role of the interplay of MK2 and MK3 for IRF3 dependent effects of LPS 
 
Christian Ehlting1, Natalia Ronkina2, Konrad Bode', Karl Lang1, Alexey Kotlyarov2, Matthias 
Gaestel2, Dieter Häussinger1, Johannes G. Bode1#  
 
1Department of Gastroenterology, Hepatology and Infectiology, Universityhospital of the Heinrich-
Heine- University Düsseldorf, Düsseldorf, Germany. 2 Department of Biochemistry, Medical School 
Hannover, Hannover, Germany. ' Department of Medical Microbiology and Hygiene, Ruprecht-
Karls University, Heidelberg, Germany. #Johannes.Bode@med.uni-duesseldorf.de 
 
Apart from being essential constituents of the innate immune response against virus type I interferons are 
also released from macrophages in response to lipopolysaccharide (LPS). This LPS-induced production 
of type I IFN has been proposed to mediate LPS-induced IL-10 release and subsequent IL-10-induced 
activation of signal- transducer and activator of transcription (STAT) 3 in macrophages. As a key 
molecule of IL-10 signaling STAT3 activation is considered to be crucial for negative regulation of pro-
inflammatory mediator release in macrophages and neutrophils. In the present study evidence is 
provided that activation of the mitogen-activated protein kinase activated protein kinase (MK) 2 plays a 
key role for regulation of LPS-induced synthesis of IFN- beta and IL-27 and is also essential for delayed 
activation of STAT3. Thereby, the data suggest that in macrophages LPS-induced STAT3 activation 
requires expression of type I IFN and, in the absence of MK2, does not implicitly depend on IL-10 
release. Studies in macrophages deficient for MK2, MK3 or for both MK2 and MK3 further reveal that 
MK2 not directly mediates IFN-beta gene expression but rather deters MK3 from impeding IRF3 
expression as well as LPS-induced activation of IRF3 and nuclear translocation of the NF- kappaB 
subunit p65, which both are well known to be important for regulation of IFN-beta and IL-27 gene 
expression. This is in contrast to the regulation of LPS-induced expression of IL-10 or IL-6 as 
demonstrated in this study or the recently reported regulation of TNF" biosynthesis and stabilization of 
p38MAPK protein levels, which indeed are shown to be MK2-dependent but were MK3 is demonstrated 
to cooperate with MK2. Using IFN" receptor I deficient macrophages the present study further 
corroborates that type I IFNs are required for LPS-induced activation of STAT3 and further points to a 
key role of the p38MAPK/MK2 pathway and the interrelationship of MK2 and MK3 in orchestrating the 
inflammatory macrophage response and its termination. This in particular since activation of p38MAPK 
also mediates up-regulation of suppressor of cytokine signalling (SOCS)3, an endogenous inhibitor of 
Jak/STAT-signalling that prevents STAT3 from being untimely activated by LPS-induced factors, that 
also mediate STAT3 activation, such as IL-6, which in contrast to IL-10-mediated STAT3 activation is 
known to be sensitive towards SOCS3. This p38MAPK-dependent regulation of LPS-induced SOCS3 
expression also involves activation of MK2 as demonstrated in macrophages deficient for MK2 or MK2 
and MK3, were LPS-induced SOCS3 expression is almost completely abrogated. 
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Over the past decade, a series of studies have suggested that the cyclooxygenase-2 (COX-2) 
plays an important role in carcinogenesis and cancer progression in various malignancies, 
including cervical cancer. Human papillomavirus (HPV) E6 and E7 oncoproteins, which play 
key roles in cervical carcinogenesis by modulating tumor suppressors, were recently 
demonstrated to stimulate COX-2 transcription. However, the effect of HPV E5 oncoprotein 
on COX-2 expression has not been clearly understood. First, we investigated the effect of 
HPV 16 E5 on COX-2 expression. Our results revealed that transfection of cells (HaCaT, 
C33A, HEK 293 cells) with HPV 16 E5 induced significantly higher expression of COX-2 
mRNA/protein and PGE2. This effect was mediated by the activation of EGFR-signaling 
pathway, which, in turn, increased COX-2 promoter activity with NF-kB and AP-1 as critical 
transcription factors. In addition, we further evaluated the effect of HPV 16 E5 on the 
expression of prostaglandin E2 (PGE2) receptors. E5-expressing C33A cervical cells showed 
significantly increased levels of EP4 mRNA and protein. Also, EP4 protein expression was 
increased in human cervical cancer tissues. We found that EGFR, COX-2, PGE2, EP2 and 
EP4, protein kinase A (PKA), CREB and CRE are involved in the induction of EP4 receptor 
protein by HPV 16 E5. Activation of EP4 by E5 increased anchorage-independent colony 
formation and VEGF expression, both of which are required for tumor growth, angiogenesis 
and metastasis. These results suggest that HPV 16 E5-associated inflammatory signaling 
pathways, including NF-kB and EP4 receptor, may be alternative chemopreventive and 
therapeutic targets for cervical cancer in the light of recent side effects associated with the use 
of COX-2 inhibitors. 
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Mast cells are most commonly thought of as cells which can markedly amplify the local or 
systemic manifestations of IgE-associated immune responses, such as in the context of 
anaphylaxis, atopic asthma or other allergic disorders. Mast cells also can enhance the features of 
many innate immune responses, such as those which eliminate certain bacterial pathogens. In 
settings such as these, mast cells can be regarded as positive regulators of innate or adaptive 
immune responses. Recently, it has become apparent that mast cells also can perform roles well 
beyond that of being an “amplifier” of inflammation in innate or adaptive immunity. One of these 
newly recognized functions is to diminish the toxicity and mortality associated with either high 
concentrations of endogenous peptides (e.g., endothelin-1 or neurotensin) or exposure to the 
venom of certain poisonous snakes or the honey bee. In these settings, mast cells limit morbidity 
and death at least in part by providing proteases that degrade the endogenous peptides or 
components of the venom. Such innate functions of the mast cell may represent an ancient and 
still important function of this lineage. In addition, mast cells can limit the magnitude and/or 
promote the resolution of certain innate or acquired (or “adaptive”) immune responses by 
representing a source of interleukin-10 and other products which can mediate a potentially wide 
variety of anti-inflammatory or immunosuppressive effects. Such negative immunoregulatory 
functions can prevent these innate or adaptive immune responses from severely damaging the 
affected skin. Accordingly, a new picture of the function of mast cells is emerging — these cells 
have the potential to turn innate or adaptive immune responses off, as well as to turn them on. In 
this presentation, I will briefly describe mouse models used to analyse mast-cell function in vivo 
and to identify immunomodulatory roles for mast cells during specific immune responses. Based 
on this evidence, I will discuss three hypotheses: that the potential to perform negative, as well as 
positive, immunomodulatory functions is a basic property of the mast-cell lineage; that mast cells 
can enhance and/or later help to limit certain innate and acquired immune responses; and that the 
extent to which mast cells actually perform such positive or negative immunomodulatory 
functions during specific immune responses in vivo is highly dependent on the individual 
biological setting. 
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Although the innate immune system is absolutely required to fight infection and maintain 
homeostasis, it can cause autoinflammatory disease when inappropriately activated by genetic 
mutation, or exogenous and endogenous components. Recently we discovered a new 
autoinflammatory disease caused by mutations affecting the IL-1 receptor antogonist (IL-
1RA). Normally this cytokine blocks the action of IL-1, a potent pro-inflammatory signal. 
Patients without functional IL-1Ra suffer from potentially lethal systemic inflammation with 
significant skin and bone pathology. Fortunately recombinant IL-1Ra (anakinra) can be 
administered and resolves all disease manifestations. Anakinra has also been observed to 
ameliorate type 2 diabetes (T2D), suggesting that IL-1 is an important inflammatory mediator 
of this disease. While it has been long known that pancreatic beta cells rapidly die upon 
encountering even low levels of IL-1, the mechanism by which IL-1 is generated in T2D is 
not clear. We have now identified several endogenous factors that are associated with T2D 
and can regulate the Nlrp3 (Nalp3) inflammasome to activate and secrete IL-1b. A major role 
for the innate immune system during infection is to promote a successful adaptive immune 
response. Once this is established however, inhibitory signals need to be sent back to the 
innate immune cells so as to limit potentially damaging inflammation. Although T-cells can 
inhibit the inflammasome by direct cell contact with innate immune cells, the role of a 
dominant T-cell cytokine, IFNg, is highly controversial. We can now reconcile the conflicting 
data by showing that IFNg does inhibit IL-1b production, but that this is only transient. This 
leads us to establish a new mechanism by which IFNg provides an anti-inflammatory signal in 
several models of inflammatory disease that depend on IL-1 and Th17 cells. Therefore our 
results highlight the importance of IL-1 in chronic inflammatory pathologies, and new 
mechanisms by which its release can be inhibited by the adaptive immune system, or 
triggered in autoinflammatory disease. 
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Pancreatic beta cells die by apoptosis in early type 1 diabetes mellitus (T1DM). Recent 
observations by our group suggest that beta cell apoptosis depends on the parallel and/or 
sequential up- and down-regulation of hundreds of genes. By performing microarray analysis 
and detailed promoter studies in primary rat beta cells and in human islets exposed for different 
time points to the cytokines interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a) and 
interferon-g (IFN-g) we observed that beta cells respond to damage by triggering several genes 
involved in defense/repair and endoplasmic reticulum stress, by decreasing their most 
differentiated functions and their capacity for growth and regeneration, and by inducing 
expression of diverse cytokines and chemokines. Several of these effects of cytokines are 
regulated by the transcription factors NF-kB and STAT-1, and by blocking NF-kB or STAT-1 
we prevented cytokine-induced beta cell death. Subsequent experiments, combining NF-kB or 
STAT-1 blocking and microarray analysis, suggested that both transcription factors function as 
“master switches” of respectively IL-1b and IFN-g effects on beta cells, controlling networks of 
transcription factors and effector genes that trigger apoptosis and inflammation. Other 
transcription factors, such as JunB, function as “protective regulators”, decreasing expression of 
pro-apoptotic genes and modulating endoplasmic reticulum stress and mitochondrial pathways of 
cell death. Downstream activation of beta cell death depends on mitochondrial pathways 
regulated, by a large extent, by DP5/Hrk and another Bcl-2 family member presently under 
study. By combining functional studies with microarray and proteomic analysis, performed with 
or without targeted perturbations of the system, it will be eventually possible to fully map the 
interacting networks of genes and proteins leading to beta-cell death and amplification of the 
immune assault.  
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Gastrointestinal peptides including mammalian bombesin-like peptides, cholecystokinin, gastrin, 
and neurotensin (NT) stimulate DNA synthesis and cell proliferation in cultured cells and are 
implicated as growth factors in a number of fundamental processes including development, 
inflammation, tissue regeneration, and neoplastic transformation. These agonists bind to G 
protein-coupled receptors (GPCRs) that promote G"q-mediated activation of # isoforms of 
phospholipase C to produce two second messengers: Inositol (1,4,5) trisphosphate {Ins (1, 4, 5) 
P3} that mobilizes Ca
2+ from internal stores, and diacylglycerol that activates the classic and new 
isoforms of the protein kinase C (PKC) family. PKCs play a critical part in transducing GPCR-
induced signals into activation of protein kinase cascades. Protein kinase D (PKD), a 
serine/threonine protein kinase with distinct structural and enzymological properties, is activated 
by phosphorylation in living cells through a new PKC-dependent signal transduction pathway. 
GPCR agonists including NT induce a rapid and striking activation of PKD by PKC. These results 
indicate that PKD functions downstream from PKCs and identify a new phosphorylation cascade 
that is activated by gastrointestinal peptide agonists. The growth-promoting effects of 
neuropeptides and the elucidation of the signaling pathways that mediate their effects assume an 
added importance because these agonists and their receptors are increasingly implicated in 
sustaining the proliferation of clinically aggressive solid tumors including those from lung, 
pancreas, and colon. Neuropeptides and growth factors promote activation of PKD in multiple 
neoplasias including pancreatic cancer (PaCa). We showed that GPCRs stimulated PKD-
dependent mitogenic signaling pathways in PaCa. PKD significantly induced resistance to CD95-
dependent apoptosis in PaCa and promoted PaCa cell proliferation. PKD also plays a potential 
role in cancer cell invasion and motility. PKD is activated by VEGF in endothelial cells and is 
necessary for tumor-associated angiogenesis. PKD activation also initiates NF-!B signaling 
pathway, triggering cell survival responses. We will demonstrate for the first time in vivo efficacy 
of an orally administered small-molecule inhibitor of PKD with no observed toxicity in animal 
models of PaCa. This presentation will summarize PKD-dependent signaling pathways in PaCa 
both in vitro and in vivo with implications for novel therapeutic indications. 
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Drug resistance and metastasis pose major impediment in successful treatment of cancer. 
Therefore, identification of cancer-coded genes whose expression contributes to these 
phenotypes may yield immediate clinical benefits. TGM2 is one such gene whose expression 
is upregulated in several cancer cell types.  
TGM2 codes a functionally complex protein (tissue transglutaminase or TG2), which has both 
intracellular and extracellular functions. A positive correlation between chemoresistance and 
metastatic potential of certain cancers with TG2 expression has been demonstrated. TG2 
expression has been shown to exert anti-apoptotic effects on cells while siRNA-mediated 
downregulation of TG2 or treatment with TG2 inhibitors sensitized these cells to drug-
induced apoptosis. These results imply that aberrant expression of TG2 in cancer cells 
promotes drug resistance and metastatic phenotype.  
Working on the mechanisms by which TG2 promotes drug resistance and metastasis, we 
found that TG2 expression
 
is associated with constitutive activation of cell survival signaling 
in FAK/Akt axis. In addition, TG2 expression resulted in NF-"B activation -the transcription 
factor known to regulate genes involved in cell survival and invasion. 
Based on these results, we reasoned that interruption of TG2-mediated signaling could be 
therapeutically beneficial for treating chemoresistant and metastatic tumors. Indeed, 
downregulation of endogenous TG2 by liposomal-siRNA was effective in blocking the 
growth of orthotopically growing tumors. Notably, downregulation of TG2 by liposomal-
siRNA significantly enhanced the therapeutic efficacy of drugs and inhibited metastatic 
spread of tumors to distant sites. Evidence using cancer cell lines, orthotopically growing 
tumors and genetically engineered mouse models will be discussed to support the biological 
and therapeutic significance of TG2 in drug resistant and metastatic tumors. 
 
Key words – chemoresistance, metastasis, siRNA  
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Although radiation therapy is an integral component of treatment of patients with many different types 
of cancer, inherent and/or acquired resistance to the cytotoxic effects of radiation therapy is 
increasingly recognized as a significant impediment to effective cancer treatment. Inherent resistance 
is mediated by constitutive expression of oncogenic, proliferative and anti-apoptotic proteins/pathways 
whereas inducible resistance refers to transient induction of proteins/pathways following exposure to 
radiation. We and others have reported that the transcription factor NF-kB, a central molecular 
mediator of inflammatory signaling, is potently activated transiently and in a dose-dependent manner 
in cancer cells following radiation therapy. This inducible NF-kB protects cells from subsequent 
fractions of radiation by transcriptionally regulating a wide spectrum of pro-survival genes regulating 
inflammation, anti-apoptosis, invasion and angiogenesis pathways. In colorectal cancer cells, we have 
targeted this radiation-inducible resistance mediated by NF-kB using curcumin, a natural product 
derived from the dietary spice turmeric. Treatment of colorectal cancer cells in vitro and in vivo with 
radiation in the presence of curcumin inhibits inducible NF-kB signaling and increases the efficacy of 
treatment by modulating proliferation, invasion, and metastasis. Not only is curcumin 
pharmacologically safe, it may also mitigate some of the side-effects of radiation. For instance, 
emerging evidence suggests that fatigue experienced during radiation therapy is mediated by 
activation of a proinflammatory cytokine network that includes IL-1#, TNF-# and IL-6. Temporal 
patterns of increase in soluble TNF-R1 serum levels correlate with the development of treatment-
related symptoms in rectal cancer patients. Also, treatment-related fatigue levels independently predict 
response to treatment suggesting a correlation between tumor burden and symptom burden. Although 
additional data is need to conclusively link radiation-induced inflammation and proinflammatory 
cytokines to central nervous system signals that generate fatigue and symptom burden, much of the 
available evidence points to a prominent role played by proinflammatory cytokines in acute side-
effects of radiation. Together with inhibition of radiation resistance in tumor cells, targeting 
inflammatory pathways may widen the therapeutic window of treatment by reducing side-effects. 
Lastly, patient survival and quality-of-life are influenced by radiation-induced chronic injury to 
normal tissues and vasculature. Uncontrolled and chronic radiation-induced inflammatory signaling 
and oxidative stress have been implicated in tissue atrophy, fibrosis, and necrosis. Anti-inflammatory 
therapies have the potential to prevent or mitigate radiation-induced chronic normal tissue injury.  
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Anemia of cancer and chronic inflammatory diseases is a frequent complication affecting 
quality of life. For cancer patients it represents a particularly bad prognostic. Low level of 
erythropoietin is considered as one of the causes of anemia in these pathologies. The 
deficiency in erythropoietin production results from pro-inflammatory cytokines effect. 
However, few data is available concerning molecular mechanisms involved in cytokine-
mediated anemia. The pro-inflammatory cytokine tumor necrosis factor # (TNF#) was 
particularly linked to inflammation and cancer related anemia. Our studies revealed molecular 
mechanisms linked to the inhibition of erythroid differentiation by TNF#. We showed that the 
inhibition of Erythopoietin (Epo)-mediated differentiation by TNF" lead to a downregulation 
of hemoglobin synthesis and was correlated to a modulation of key erythroid transcription 
factors. Thus, a reverse of the transcription factor GATA-1/GATA-2 balance normally 
present during erythropoiesis, as well as a downregulation of the cofactor of GATA-1, friend 
of GATA-1 (FOG-1) was observed after TNF# treatment of K562, HEL and TF-1 cell lines. 
Moreover, we showed a reduction of GATA-1/FOG-1 interaction due to a reduced 
transcription of GATA-1 and a proteasome dependent FOG-1 degradation after TNF# 
treatment. These changes lead to an inhibition of erythroid gene expression including Epo 
receptor (EpoR), #- and $-globin, Erythroid-associated factor (ERAF), hydroxymethylbilane 
synthetase (HMBS), and glycophorin A (GPA). Furthermore, the inhibitory effect of TNF# 
has been studied on CD34+ hematopoietic stem cells collected from cord blood. Cells were 
cultured and differentiated in the presence of hrEpo and experimental results confirmed that 
TNF# affects GATA-1 activity in these cells. Overall, these data contributed to a better 
understanding of pro-inflammatory cytokine-dependent anemia, by giving first hints about 
key erythroid transcription factor modulations after TNF# treatment.  
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Chronic lymphocytic leukemia (CLL) is the most frequent type of leukemia in Europe and North 
America among elderly people. The etiology of this disease is still not known. This heterogeneous 
disease characterized by a strong accumulation of mainly resting B lymphocytes in peripheral blood is 
caused by disruption of mechanisms controlling homeostasis between production and destruction of 
B-cells. The strong between patient’s diversity in the disease progression, response to anticancer 
therapy, and outcome is a main difficulty in elaboration of efficacious treatment. Therefore, it is 
important to develop personalized therapeutic protocols based on the individual patient’s specific traits 
and sensitivity to medication. For this purpose, we describe in this study a combination of a few 
techniques (flow cytometry, cell viability test, differential scanning calorimetry (DSC), and 
immunoblotting) useful for a rapid monitoring of the efficacy of treatment of leukemic cells. CLL 
samples were ex vivo exposed to purine analogs combined with mafosfamide i.e. CM (cladribine + 
mafosfamide), FM (fludarabine + mafosfamide), and additionally to R-roscovitine, an inhibitor of 
cyclin-dependent kinases, with the objective of triggering apoptosis. The changes in chromatin 
complex induced upon treatments were detected by DSC, a simple thermal technique. A significant 
decrease or even loss of transition at 95±3°C in thermal scans of nuclear fraction preparations 
occurred in drug-treated cells. The extent of thermal changes differed between three medications. 
Furthermore, weak or absence of changes in thermal profiles was observed in nuclei originating from 
CLL cells resistant to the treatment. Remarkably, the changes in thermal profiles coincided with a 
marked decrease of the number of viable cells, DNA fragmentation, and changes in cellular levels as 
well as functional status of apoptosis-related proteins (caspase-9, caspase-3, PARP-1, and Bcl-2). Our 
results evidence the advantage of DSC in the evaluation of the treatment efficacy and indicate that its 
application could facilitate the choice of the most effective therapy for individual patients under ex 
vivo conditions. Considering the fact that this method is non-invasive, it could be also applied for 
direct and rapid evaluation of the clinical response. 
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NKT cells are innate T lymphocytes that have been shown to contribute to anti-tumor responses, 
and to have potent immuno-regulatory properties.  NKT cells can be specifically activated by 
CD1d-mediated presentation of certain foreign microbial lipids, but it is also clear that recognition 
of self antigens presented by CD1d molecules on myeloid-lineage cells is an important 
physiological route of NKT cell activation.  However, the molecular identity of specific auto-
antigens that stimulate human NKT cells has remained unclear.  Here, we have analyzed the 
ability of human NKT cells to recognize lipid species that were identified as ligands bound to 
secreted human CD1d molecules.  The most clearly antigenic species was lyso-
phosphatidylcholine (LPC).  LPC recognition was dose-dependent and required presentation by 
CD1d.  Di-acylated phosphatidylcholine and lyso-phosphoglycerols differing in the chemistry of 
the head group stimulated only weak responses from human NKT cells, although lyso-
sphingomyelin, which shares the choline head group of LPC, was also recognized.  Thus, NKT 
cell responses appeared specific for cholinated lyso-phospholipids.  Antigen presenting cells 
pulsed with LPC were capable of stimulating increased cytokine responses by NKT cell clones 
and by freshly isolated peripheral blood lymphocytes.  Inhibition of phospholipase A2 (PLA2) 
enzymes associated with human peripheral blood monocytes resulted in markedly reduced 
activation of NKT cells, suggesting that PLA2 activity provides a source of the LPC that is 
presented by CD1d molecules.  These results suggests that NKT cells are attuned to highly 
conserved lipid signaling pathways that are fundamental to normal physiological processes and 
are markedly up-regulated during inflammation. 
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Periodontal disease arises from excessive host inflammatory responses to subgingival 
pathogenic bacteria, such as Porphyromonas gingivalis. In addition to leading to 
inflammatory destruction of the tooth-supporting tissues, severe periodontitis exerts a 
systemic impact on health and the patients run increased risk for atherosclerotic heart disease 
and diabetes.  The complement system plays a major role in host defense against pathogens 
but has also been implicated in inflammatory pathology.  Our studies indicate that the 
interaction of P. gingivalis with complement and leukocytes leads to amplification of 
inflammatory responses (e.g., increased leukocyte oxidative burst and proinflammatory 
cytokines) but paradoxically also to inhibition of P. gingivalis killing by neutrophils and 
macrophages. The latter involves a P. gingivalis-instigated crosstalk between the complement 
C5a receptor (C5aR; CD88) and Toll-like receptor 2 which impairs nitric oxide-dependent 
killing of this pathogen, which is exquisitely resistant to the oxidative burst.  Our studies with 
specific C5aR antagonists and comparative studies in wild-type and C5aR-deficient mice 
indicate that the pharmacological blockade of the C5aR can be beneficial in periodontitis 
through inhibition of destructive inflammation and by facilitating the killing of P. gingivalis. 
 52 
Redefining Eosinophil Crystalloid Granules as a Potential New Functional Unit in 
Extracellular Inflammatory Events  
 
Salahaddin Mahmudi-Azer MD/PhD*, Peter F Weller MD†, Ann M Dvorak PhD†, 
Redwan Moqbel PhD‡ , Peter D Paré MD§ 
 
* From Department of Medicine, University of Calgary, Alberta, Canada, 
sazer@shaw.ca †  Harvard Thorndike Laboratory and Charles A. Dana Research 
Institute, Departments of Medicine and Pathology, Beth Israel Deaconess Medical 
Center, Harvard Medical School, Boston, MA 02215, USA, ‡ , Department of 
Immunology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, 
Canada. § The James Hogg iCAPTURE Centre, St. Paul’s Hospital, Dept. of Medicine, 
University of British Columbia, Canada. 
 
Eosinophils are major effector cells in allergic inflammatory response. They are known to 
synthesize, store, and release a wide range
 
of pro-inflammatory mediators. Eosinophils
 
contain different populations of mediator-storage organelles,
 
including small secretory 
vesicles as well as crystalloid granules. In cytolysis, eosinophil cell membrane
 
loses its 
integrity and crystalloid granules are released to extracellular
 
space. Potential function of 
crystalloid granules in extracellular space as it relates to inflammatory events remains widely 
unknown. We hypothesized that eosinophil crystalloid granules are equipped to function 
independently in extracellular space. Our findings indicate that both DNA and RNA localize 
to human and rabbit eosinophil crystalloid granules and that RNA seems to be synthesized in 
intra-granular space further suggesting the presence of functional transcription machinery 
inside the granules. Furthermore, we show here that crystalloid granules express functional 
membrane receptors for a cytokine, IFN-gamma, as well as G protein-coupled membrane 
receptors for a chemokine, eotaxin. Our findings indicate that these receptors function by 
activating signal-transducing pathways within granules leading to mediator release from 
granules to extra-granular space in a cell free environment. Taken together our findings define 
a new potential role for eosinophil crystalloid granules as independent extracellular functional 
units in inflammatory events and may reveal a novel target in modulating the inflammatory 
events. 
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S-Nitrosoglutathione (GSNO) plays an important role in the transport and metabolism of 
nitric oxide (NO), and seems to be involved in many patho-physiological processes. Research 
and evaluation of GSNO in human diseases has long been hindered by the lack of analytical 
procedures provided with adequate sensitivity, specificity and reproducibility. All three 
requirements are now satisfied at the highest level by our patented protocol. The procedure is 
based on the innovative, unprecedented concept of using the commercial enzyme gamma-
glutamyltransferase (GGT) coupled to the fast decomposition of its product CysGlyNO 
(CGNO) by copper ion (ancillary reaction), which give oxidized CysGly and NO.  NO then is 
reacted with 4,5-diaminofluorescein (DAF-2) giving the triazole derivate, detectable by 
spectrofluorimetry (ex = 480 nm, em = 515 nm) or in black microplates (ex = 485±15 nm, em 
= 535±25 nm).  The limit of quantitation (LOQc) of GSNO in PBS is 20 nM, the precision 
(CV) 5.5% at 300 nM concentration level, and the dynamic linear range 5-300 nmol/L, 
depending on the DAF-2 concentration. The method is environmental-safe (no mercury), and 
achieves detection limits two orders of magnitude lower than direct UV detection.  These 
features make it suitable for investigating GSNO pathophysiology in vitro and in vivo, in 
experimental conditions encompassing animal, microbiology as well as plant studies. 
 
!PATENT PENDING – COMMERCIALIZED THROUGH OXFORD BIOMEDICAL RESEARCH INC. 
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It has been now recognized and established that balance between anti-and pro-apoptotic 
proteins result in survival or death of cancer cells.  Additionally, several studies have 
demonstrated that most cancer cell types express high levels of anti-apoptotic proteins.  
Among the anti-apoptotic proteins, Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and A1/Bfl-1 are the main 
members.  The anti-apoptotic proteins are inhibitors of Bax/Bak, either by direct binding to 
Bax/Bak or by counteracting the effects of Bax/Bak on the mitochondria.   Among other pro-
apoptotic proteins are members with BH3-only proteins with pro-apoptotic function.  
Overexpression of anti-apoptotic family proteins is a common feature in cancer and has been 
established for leukemia such as chronic lymphocytic leukemia (CLL).  In addition, 
microenvironment-mediated signaling further enhances expression of these proteins (1).  
Because anti-apoptotic proteins bind to pro-apoptotic proteins through BH3 domain, efforts 
have been made to disrupt this interaction resulting in liberation of pro-apoptotic proteins and 
induction of cell death.  Collectively these drugs are known as Bcl-2 antagonists or BH3 
mimetics.  These small molecule Bcl-2 antagonists are a new class of agents and include old 
drugs such as gossypol (2), its analogs (3) and new agent such as ABT-737 (4, 5).  Using 
chronic lymphocytic leukemia as a model system, we elucidate mechanism of action of these 
BH3-mimetics and their current and future role as cancer therapeutics. 
1.  Gandhi, V., et al. Blood, 112:5538-5540, 2008 
2.  Balakrishnan, K., et al.  Blood, 112:1971-1980, 2008 
3.  Balakrishnan, K., et al.  Blood, 113:149-153, 2009 
4.  Oltersdorf, T., et al. Nature 435:677-681, 2005 
5.  Del Gaizo Moore, V., et al. J Clin Invest. 117: 112-121, 2007  
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Immunological control of progressive tumors activation and expansion of tumor specific 
cytotoxic T lymphocytes (CTL) followed by an efficient effector phase in the tumor 
microenvironment. We established a real-time 3D matrix-based model of CTL function that 
allows the observation of active migration, interaction, dissociation and serial killing of CTL 
with target cells over up to 24 hours. Individual CTL-target cell contacts were variable in 
duration (min to hours), comprised a madian lag-phase of 90 min until apoptosis of the target 
cell and were followed by CTL detachment and sequential killing of several target cells. 
Using this model, we presently address  whether factors present in the tumor 
microenvironment interfere or enhance of anti-tumor CTL response and serial killing. 
CXCL12, a chemokine known produced by tumor cells, enhanced CTL migration, shortened 
interaction times with target cells and reduced the killing efficiency on a per-contact-basis 
which lead to near-! 
complete abrogation of target cell killing at low CTL to target cell ratio. This effect was 
reversed by a CXCR4 antagonist, suggesting enhancing serial killing by targeting the 
CXCR4/CCL12 axis may improve anti-tumor imunotherapy. 
 56 
PARP inhibitors: new tools to protect from inflammation 
 
Vincenzo Giansanti, Francesca Donà, Micol Tillhon and A. Ivana Scovassi. 
 
Istituto di Genetica Molecolare CNR, Via Abbiategrasso 207, I-27100 Pavia, Italy. 
E-mail: scovassi@igm.cnr.it 
 
Poly(ADP-ribosylation) is a post-translational modification of proteins which plays a crucial 
role in basic cellular processes, including DNA repair and replication, transcription and cell 
death. The biochemical reaction of poly(ADP-ribosylation) consists of the conversion of ß-
NAD
+
 into ADP-ribose, and the further formation of polymers of variable length and structure 
bound to nuclear protein acceptors. Polymer synthesis and degradation are performed 
respectively by poly(ADP-ribose) polymerase (PARP) and poly(ADP-ribose) glycohydrolase 
(PARG) enzymes. Although poly(ADP-ribosylation) is considered as an emergency reaction 
to DNA damage, high levels of PARP activation cause NAD depletion and consequent 
necrosis, thus having a pathogenetic role in many diseases. As for chemical compounds able 
to inhibit poly(ADP-ribosylation), since the use of nicotinamide and benzamide, potent 
derivatives have been developed and new molecules have been tested. Pharmacological 
inhibition of PARP enzymes proved to reverse the noxious effects of ROS, thus exerting a 
protective role towards a number of pathological conditions. Remarkably, pharmacological 
inactivation of poly(ADP-ribosylation) represents a novel therapeutic strategy to limit 
inflammation. 
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The cyclooxygenases (COXs) are a family of enzymes catalysing the rate-limiting 
step in prostaglandin biosynthesis. COX-2, the inducible isoform up-regulated during 
inflammation, was found constitutively expressed in different adherent tumors, where a poor 
prognosis have been associated. Consequently, the use of preferential/selective COX-2 
inhibitors, alone or in combination with traditional chemotherapeutic agents, is currently 
under investigation for different cancer models, with the purpose to improve the efficiency of 
anti-cancer therapies.  
In this study, we analyzed a possible role of COX-2 in survival/apoptosis on 
hematological cancer models. We selected the COX-2-positive acute myeloid leukemia U937 
vs. the low level COX-2 expressing chronic myeloid leukemia K562 and investigated the 
effects of the two specific COX-2 inhibitors nimesulide and NS-398. We show that COX-2 
inhibitors strongly prevent apoptosis induced by a panel of chemotherapeutic agents in U937 
but not in K562 cells. Similarly, the selective COX-2 inhibitor celecoxib affects apoptosis 
only in U937 cells. Apoptosis prevention correlates with an up-regulation of the multidrug 
resistance protein MRP-1 and an increased drug efflux, as revealed by rhodamine 1,2,3 and 
doxorubicin efflux assays. Concomitantly, the up-regulation of the most abundant isoform of 
glutathione-S-transferase (GST-PI) is detected upon the treatment with the COX-2 inhibitors. 
Altogether, this suggests the over-expression of chemoresistance-mediating proteins as 
mediators of different converging anti-apoptotic mechanisms. Accordingly, COX-2 inhibitors 
do not affect apoptosis induced by physiological stimuli, as FAS or TNF, that do not require 
cell internalization. Similarly, they have no effects on apoptosis induced by hydrogen 
peroxide, which is not targeted by multidrug resistance channels and is  known to be 
unaffected by GST over-expression. 
Our findings show a novel paradoxical anti-apoptotic effect of COX-2 inhibitors on 
hematopoietic COX-2-positive cancer cells. This recommends cautions in the use of anti-
inflammatory agents as chemoadjuvant as well as in counteracting side adverse effects of 
chemotherapy during the treatment of such tumors. 
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Glucocorticoids are commonly used in the treatment of ocular pathologies associated with 
inflammation, vascular leakage, vessels abnormalities, and ocular neovascularization. 
Intravitreous injections of Triamcinolone Acetonide (TA) are used for the treatment of 
macular oedema, resulting in a dramatic macular thickness reduction, inconsistently 
correlated with long-term functional recovery. For the treatment of choroidal 
neovascularizations associated with Age-related Macular Degeneration (AMD) for instance, 
TA decreases the vascular leakage on the short-term, although  its long-term effect on visual 
acuity gain remains controversial. We showed that  glucocorticoids induce a specific and 
dose-dependent reduction in retinal cell viability, affecting essentially cells from the 
pigmented epithelium (RPE) and Müller glial cells (RMG). Caspase-dependent or 
independent apoptosis pathways were not detected in vivo or in vitro but cytoplasmic 
vacuolization was observed in both circumstances. Further analysis indicated that these cells 
die by an alternative cell death pathway called paraptosis. 
We also show, for the first time, that glucocorticoids exert direct toxic effect on endothelial 
cells through caspase-independent mechanisms. When used in animal models of 
neovascularitation  TA induces endothelial cell death and decreases the amount of neovessels.  
These results have important implications on the therapeutic potential and safety use of 
glucocorticoids in human eyes. They also show the importance of considering cells death 
pathways other than caspases in the evaluation of these items. 
 59 
Inflammation Dysregulates Notch Signaling in Endothelial Cells: Implication of Notch2 
and Notch4 to endothelial dysfunction 
 
Quillard T., Devallière J., Coulon F., Chatelais M., Romagnoli M., Barillé S., Charreau B. 
 
INSERM, UMR643 and UMR892, ITERT, Université de Nantes, F44000 France.  
 
Although implicated in vascular morphogenesis and remodeling, regulation of the Notch 
pathway in vascular endothelial cells (EC) upon inflammation remains unclear. Here, we show 
that TNF drives specific regulation of the Notch pathway in vascular EC and smooth muscle 
cells leading to an induction of Notch2 and Dll1 and a decrease in Notch3 and -4 expression. 
Using two readouts we demonstrated a basal Notch/CBF1 activity in quiescent EC that 
decreases in response to TNF. Changes in Notch pathway were both cytokine and cell type 
specific. Notch transcriptional regulation was selectively mediated by at least the NF"B, JNK 
and the PI3K pathways. Next, we investigated the regulatory crosstalk between TNF signaling 
and Notch receptors and activity in cultured ECs and in transplant arteriosclerosis (TA). 
Decrease in Notch4 was consistently observed in TA and in ECs in response to TNF, TGF# and 
IL10, pointing out a functional relevance of Notch signaling in inflammatory processes. Notch4 
and Hes1 knockdown enhances VCAM-1 expression and promotes EC apoptosis indicating that 
Notch4 functions were mediated by Hes1. Silencing Notch4 or Hes1 also drastically inhibits 
repair of endothelial injury suggesting that Notch4 and basal Notch activity are required to 
maintain EC quiescence and for optimal survival and repair. Thus, impaired Notch4 expression 
caused by inflammation in cardiac allograft vessels promotes EC dysfunction and TA (1).  
Little is known about the role of Notch2 expressed on endothelium. Here we show that a major 
consequence of Notch2 activation in ECs is the induction of a caspase-dependent apoptosis. We 
established the direct contribution of Notch2 signaling in the transcriptional regulation of 
several pro- and anti-apoptotic molecules. Both forced Notch2NICD expression and Notch2 
silencing demonstrate interplay between Notch2 signaling and survivin expression in the 
control of EC apoptosis. Thus, dysregulated Notch2 signaling by TNF sensitizes ECs to 
apoptosis and survivin acts as effector of Notch signaling (2). Overall, we show that, in ECs, 
TNF drives a phenotypic switch where Notch4 is replaced by Notch2. Functionally, Notch2 
signaling favors cell death while Notch4 activation was shown to be protective. (1)Quillard T. 
et al. by Arteriosclerosis, Thrombosis, and Vascular Biology 2008, Dec;28(12):2258-65. (2) 
Quillard T., et al. PLos ONE 2009 4(12): e8244.  
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Aberrant expression of CD40 ligand (CD40L) represents a strong endogenous danger signal 
associated with chronic inflammatory disease. However, CD40 activation alone is unable to 
induce interleukin (IL)-12p70 secretion, whereas IL-6, IL-12p40, TNF-a and IL-10 are 
produced. We demonstrate that cytokine-induced Janus kinase (JAK)-1 is unique in mediating 
a complementary pro-inflammatory signal for the production of IL-12p70 whilst at the same 
time inhibiting IL-10 secretion in human APCs.  
CD40- and JAK/STAT signals recruit complementary pathways: CD40 signals involve RelA 
and cRel for the induction of IL-12p70 and RelA for IL-10. In contrast, RelB inhibited IL-
12p70 production. JAK1 complemented CD40-induced NF-kB signals by phosphorylating 
STAT-1 and inducing IRF-1 and IRF-8 expression. siRNA inhibition of any of these 
signalling molecules (JAK1, STAT1, IRF1 and IRF8) abrogated IL-12p70 production. JAK1-
dependent inhibition of IL-10 transcription was mediated either by STAT-1 directly binding 
the IL-10 promoter or by IRF-8 that binds to inhibitory IFN-g-activated sequence 
(GAS/ISRE)-sites of the IL-10 promoter. 
Our results demonstrate that specific inhibition of the “second signal” JAK1 will shift the 
balance of CD40-induced cytokine panels from IL-12p70 towards IL-10 in human APCs. 
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The interleukin-6-type cytokine oncostatin M (OSM) acts via the Jak/STAT pathway as well 
as via activation of MAP kinases and is known to critically regulate processes like liver 
development and regeneration, hematopoiesis, and angiogenesis which are also determined by 
hypoxia with the hypoxia-inducible transcription factor-1a (HIF1a) as a key component. Here 
we show that treatment of hepatocytes and hepatoma cells with OSM leads to an increased 
protein level of HIF1a under normoxic and hypoxic conditions. Further, the OSM-dependent 
HIF1a increase is mediated via Jak/STAT3- and the MEK/Erk1/2-pathway. OSM-mediated 
HIF1a upregulation did not result from an increase in HIF1a protein stability but from 
increased transcription from the HIF1a gene. In addition, we show that the OSM-induced 
HIF1a gene transcription and the resulting enhanced HIF1a protein levels are important for 
the OSM-dependent VEGF- and PAI1-gene induction associated with a number of diseases. 
In conclusion, HIF1a levels significantly increase after treatment of hepatocytes and 
hepatoma cells with OSM and HIF1a contributes to OSM downstream signalling events, 
pointing at a crosstalk between cytokine and hypoxia signalling in processes like liver 
development and regeneration. 
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Melatonin, the neuro-hormone implicated in the control of sleep, has recently attracted much 
interest as a regulator of immune/inflammatory response, after the discovery that leukocytes 
possess the machinery required to produce and to respond to melatonin. Melatonin is a 
modified triptophane with potent biological activity, exerted by stimulation of specific plasma 
membrane (MT1/MT2) receptors, by lower affinity intracellular enzymatic targets (quinone 
reductase, calmodulin), or through its strong antioxidant ability. Intriguingly, melatonin also 
promotes intracellular ROS in a fast (<1min) and transient (up to 5-6 hrs) way on a set of 
normal or tumor leukocytes. ROS production is independent from MT1/MT2 receptor 
interaction. In the search for the mechanism responsible for the pro-radical effect, we found 
that melatonin-induced ROS are produced by lipoxygenase (LOX), which is activated in a 
rapid, strong and transient way. LOX activation is accompanied by strong liberation of AA; 
inhibition of Ca2+-independent, but not Ca2+-dependent, phospholipase A2 (PLA2), prevents 
both melatonin-induced arachidonic acid and ROS production, whereas LOX inhibition only 
prevents ROS, indicating that PLA2 is upstream with respect to LOX, as occurs in many 
signaling pathways. Chlorpromazine, an inhibitor of melatonin-calmodulin interaction, 
inhibits both ROS and arachidonic acid production, thus possibly placing calmodulin at the 
origin of a melatonin-induced pro-radical pathway. Interestingly, it is known that Ca2+-
independent PLA2 binds to calmodulin: our results are compatible with PLA2 being liberated 
by melatonin from a steady-state calmodulin sequestration, thus initiating an arachidonate 
signal transduction. These results delineate a novel molecular pathway through which 
melatonin may participate to the inflammatory response. 
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Flavonoids as anti-inflammatory compounds: Targeting signaling and molecules 
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Phytochemical flavonoids have shown anti-inflammatory activity in vitro and in vivo. One of 
the important mechanisms is an inhibition of eicosanoid generating enzymes including 
phospholipase A2, cyclooxygenases, and lipoxygenases, thereby reducing the concentrations 
of prostanoids and leukotrienes. Recent studies have shown that certain flavonoids, especially 
flavone derivatives, modulate proinflammatory gene expression such as cyclooxygenase-2, 
inducible nitric oxide synthase, and several pivotal cytokines. Flavonoids have been 
considered to be reasonable candidates for new anti-inflammatory drugs due to these action 
mechanisms and significant in vivo activity. Although there are many cellular signaling 
pathways modulating inflammation processes, protein kinases play crucial roles in the 
regulation of multiple cell signaling pathways and inflammation. The inhibition of protein 
kinases has emerged as important targets for inflammation prevention and therapy. 
Accumulated data revealed that flavonoids exert anti-inflammatory effects through acting at 
protein kinase signaling pathways, more than as conventional hydrogen-donating 
antioxidants. Recent studies show that flavonoids can directly bind to some protein kinases 
including Akt/protein kinase B (Akt/PKB), Janus kinase (JAK), mitogen-activated protein 
kinase kinase 1 (MEK1), phosphoinositide 3-kinase (PI3K), and then alter their 
phosphorylation state to regulate multiple cell signaling pathways in inflammation processes. 
In this representation, the interactions of flavonoids and protein kinases, especially their direct 
binding and molecular modeling, will be reported. Moreover, the binding sites, selectivity, 
and the impact on cellular signaling and anti-inflammation of flavonoid-protein kinase 
interactions will be discussed. 
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Responses of cell targets to resveratrol ; involvement of common or separated 
mechanisms ? 
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Resveratrol is produced in hudge amount in vine in response to biotic or a-biotic stresses by 
activating plant defense signaling pathway leading to an anti-oxidative protection and a 
blockade of fungi infection. Similarily, in human resveratrol interferes with many 
physiological fonctions and pathological processes like ageing, infection, inflammation, 
proliferation, neurological processes or circulation.. In front of this diversity of effects is there 
any common signaling pathway affected by resveratrol ? The current knowledge brings 
resveratrol to light as a direct free radical scanvenger molecule, as an indirect anti-oxidant or 
pro-oxidant activating process of regenerating glutathione enzymes or as a ligand-activating 
receptor based on pharmacological mechanisms. While resveratrol inhibits NFKB 
transcription factor and consequently abolishes oxidative stress. In contrast it activates NRF2 
by promoting its nucleus transclocation leading to gene activation of defense enzymes. On the 
other hand resveratrol stimulates NO production a vasorelaxant molecule by activating 
NitrOxideSynthase. Linked to inflammation, resveratrol inhibits COX2 responsible of 
proinflammatory arachidonate derived molecule PGE2 production. Il also inhibits secretion of 
IL6, IL8. Towards cell proliferation, resveratrol activates cell death receptor through their 
recruitement in lipid membrane microdomains while it phosphorylates CDK1. However, 
some resveratrol analogues stop mitosis by blocking tubulin at the cochicin binding site The 
presentation will presnt new data in order to clarify on the involvement of common or 
separated mechanisms in responses of cell to resveratrol. In connection to anti-oxidation, 
apoptosis and inflammation.  
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targeting selectively the CD14 and MD-2 receptors. 
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In this communication we present the discovery and the biological characterization of new 
chemical entities derived from natural sugars targeting selectively the extracellular receptors 
of the Toll-like Receptor 4 (TLR4) inflammatory pathway. The main focus of an NIH-
founded collaboration between the Universities of Milano (Italy) and Iowa (USA) is to gain 
information on the molecular basis of the TLR4 pathway using small molecules capable to 
interact selectively with the extracellular receptors LBP, CD14, MD-2 and TLR4. Positively 
charged monosaccharides with lipid chains have been developed by our group, that inhibit 
lipopolysaccharide (LPS) and lipid A-induced cytokine production in innate immunity cells. 
These molecules are also active in vivo in contrasting septic shock and other syndromes, such 
as neuropathic pain, caused by TLR4 activation. Biochemical studies indicated that these 
monosaccharides inhibit the TLR4 pathway by selectively antagonizing the endotoxin binding 
to the CD14 receptor.  
The discovery of new lipodisaccharides containing negatively charged sulfate groups, active 
as mild agonists of TLR4, will be also described. These molecules selectively target the MD-2 
receptor and are promising leads for the development of non-toxic vaccine adjuvant.  
All molecules presented, besides being hit or lead compounds for the development of anti-
sepsis ad anti-inflammatory agents, and immunotherapeutics, are also unique tools for 
investigating the structural and functional biology of the TLR4 pathway with the chemical 
genetic approach.  
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Magnetic fields (MF), both as static or alternate (50Hz) fields, in the range of 0.6-66 mT, or 
0.08-0.4mT, respectively, elicit deep effect in leukocytes, especially when activated, leading 
to a strong reduction of apoptosis due to stimulatioin of a non-capacitative Ca2+ entry 
through plasma membrane, which promotes a pro-survival pathway. We found that this 
pathway involve production of NO, and is abrogated in the presence of NO synthase (NOS) 
inhibitors. Melatonin, the neuro-hormone involved in sleep control, and that is recently 
attracting much interest as a controller of leukocyte behaviour and inflammation, also reduce 
apoptosis induced by a variety of stimuli in leukocytes, by a mechanism involving activation 
of 5-lipoxygenase (LOX), whose product 5-HETE mediates the inactivation of the pro-
apoptotic protein Bax. Surprisingly, when melatonin and MF are applied together to 
leucocytes induced to apoptosis, their anti-apoptotic effects do not synergize or sum, but are 
abrogated. LOX inhibition recovers MF anti-apoptotic effect, whereas NOS inhibition 
recovers melatonin anti-apoptotic effect, suggesting that LOX and NOS act as reciprocal 
inhibitors, acting at a downstream step. Interference between melatonin and MF effects are 
reported, since it is known that MF inhibit melatonin synthesis; the reciprocal effect instead is 
reported here for the first time, and provide an interesting field of investigation aimed at 
avoiding risk of MF exposure. Interference between LOX and NOS may help to dissect fine 
tuned regulation of the inflammatory response in terms of timing and mechanism of leukocyte 
recruitment, function and demise. 
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It is know clearly evident that metabolic memory, whereby diabetic complications continue to 
develop and progress even in individuals who have returned to improved glycemic control 
after a period of transient hyperglycemia, could have long lasting effects. We present primary 
findings that transient hyperglycemia causes profound transcriptional changes in aortic 
endothelial cells. We have specifically hypothesized that ambient hyperglycemia caused 
gene-activating events of the NFkB-p65 promoter that were mediated by changes in 
epigenetic information (1). In this follow-up study we have identified two histone specific 
writing and erasing enzymes involved in the underlying regulation of gene expression during 
transient hyperglycemia and subsequent return to normoglycemia. Experimental evidence 
indicates that previous hyperglycemia is associated with persistent upregulation of NFkB-p65 
gene expression, which leads to NFkB activation, and upregulation of NFkB dependent 
proteins such as MCP-1, which are implicated in diabetes - associated vascular injury.  Gene 
expression is associated with specific increases in H3K4m1 but not H3K4m2 and H3K4m3 
on the promoter region of the NFkB-p65 gene (2). In human endothelial cells we show that 
the histone methyltransferase Set7 specifically mono-methylates H3K4 and is recruited as a 
gene co-activator. Furthermore, glucose induced changes in H3K4m1 are related to the 
recruitment of this specific H3K4 methylase. Knockdown of Set7 in endothelial cells 
prevented glucose induced p65 upregulation via its ability to inhibit H3K4m1. We 
hypothesize that these molecular events represent an integrated response of the epigenome 
that lead to changes in expression of genes and proteins that regulate critical roles in the 
development and progression of vascular complications in diabetes.  It is postulated that 
further understanding of these glucose induced epigenetic events and the identification of key 
enzymes involved could transform our understanding of the pathways implicated in diabetic 
vascular injury providing new strategies to reduce the burden of diabetic complications. 
 
1. El-Osta et al., Journal of Experimental Medicine 2008;205:2409-2417 
2. Brasacchio et al., Diabetes 2009;58:1229-1236 
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The number of identified natural compounds from marine sources has progressively increased 
especially in the field of anticancer research. The over-expressed activation of NF-"B is 
closely linked to cancer development and inflammatory diseases. In order to find new NF-"B 
inhibitors, isolation, purification and characterization of marine compounds extracted of 
various sponges have been carried out. Bioactivity results show that isolated compounds had 
an apoptotic effect on chronic myelogenous leukemia cells, inhibited both TNF#-induced NF-
"B-DNA binding as well as TNF#-induced IkB# degradation and nuclear translocation of 
p50/p65. Interestingly, natural products inhibited IKK$ kinase as well as the 26S proteasome 
proteolytic activity. The biochemical effect of astaxanthin, chalcones, cembratrienes, 
diterpenes, heteronemin, jasplakinolide, flavolactones, naphthopyrones and stellettin will be 
elucidated in this presentation.[1-3] 
 
[1] Schumacher M, Cerella C, Eifes S, Chateauvieux S, Morceau F, Jaspars M, et al. 
Heteronemin, a spongean sesterterpene, inhibits TNFalpha-induced NF-kappaB 
activation through proteasome inhibition and induces apoptotic cell death. Biochem 
Pharmacol 2010;79:610-22. 
[2] Folmer F, Jaspars M, Solano G, Cristofanon S, Henry E, Tabudravu J, et al. The 
inhibition of TNF-alpha-induced NF-kappaB activation by marine natural products. 
Biochem Pharmacol 2009;78:592-606. 
[3] Rateb ME, Houssen WE, Schumacher M, Harrison WT, Diederich M, Ebel R, et al. 
Bioactive diterpene derivatives from the marine sponge Spongionella sp. J Nat Prod 
2009;72:1471-6. 
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We previously discovered that META060 (tetrahydro-iso-alpha acids, a defined 
mixture of 3 chemically distinct substituted 1,3-cyclopentadiones; TH1, R=isopropyl; TH4, 
R= sec-butyl; TH5, R=isobutyl) mixture was a multi-target kinase inhibitor which reduced 
NF-kB signaling and inflammatory biomarkers in macrophages (Inflamm Res 2009; 58:1-6). 
To identify the efficacy of the individual analogues, we separated them using countercurrent 
chromatography and compared their efficacy to inhibit inflammation in lipopolysaccharide 
(LPS) activated RAW264.7 macrophages. We found that TH4 and TH5 showed similar 
efficacy, which was greater than that of TH1 in nitric oxide (NO) inhibition. To assess the 
effects on inflammatory signal transduction pathways, we analyzed TH1, TH4, and TH5 
against several human protein kinases in cell-free enzyme assays. All three inhibited kinases 
involved in inflammatory signal transduction, including SyK, BTK, GSK3beta, and PI3K. 
TH4 and TH5 showed a lower IC50 than TH1 on some kinase targets. These kinases are 
involved in Fc receptors and B cell receptor signaling, and are therapeutic targets in asthma, 
allergy and rheumatoid arthritis. Further studied focused on TH1 and TH5; both inhibited IL-
1 beta activated PGE2, cytokines, chemokines and matrix metalloproteinases in synovial 
fibroblasts/chondrocytes isolated from human rheumatoid arthritis subject. To determine the 
therapeutic potential of TH1 and TH5 in vivo, they were tested in the collagen-induced 
arthritis model. DBA/J mice were immunized with bovine type II collagen for 3 weeks. Mice 
demonstrating the onset of inflammation were randomized and therapy initiated. The joint 
swelling was measured for the next 2 weeks and joint damage was analyzed histologically to 
determine the extent of the disease. Both TH1 and TH5 dose-dependently reduced the arthritis 
index and joint degradation, with TH5 being more efficacious than TH1. These molecules 
may be of great value as an efficacious and safer alternative to treat chronic inflammation.  
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A fine-tuned balance between pro-survival and apoptosis-promoting factors determines the 
clonal expansion of transformed cells as well as their susceptibility to therapy. In most cases, 
tumor cells divide rapidly due to the shortening of the cell cycle. Progression of the 
mammalian cell cycle is driven by transient activation of complexes consisting of cyclins and 
cyclin dependent kinases (CDKs). The escape from the proper control of the cell cycle by up-
regulation of cyclins or aberrant activation of CDKs as well as by inactivation of cellular 
inhibitors of CDKs (CKI) leads to acceleration of cell divisions and malignant transformation. 
For these reasons the regulators of cell cycle have been considered as very promising 
therapeutic targets in human malignancies. It has been recognized that deficits in cellular 
CKIs, as frequently observed in cancers, could be compensated by synthetic compounds and 
provided a rationale for development of pharmacological inhibitors of CDKs. Tri-substituted 
purine derivatives such as roscovitine (ROSC) and olomoucine II (OLO), are selective CKI 
and affect CDKs involved in the regulation of both: cell cycle progression and transcriptional 
control. The inhibition of CDK7 and CDK9 has a serious impact on the activity of RNA Pol 
II. Unphosphorylated CTD is not able to recruit co-factors required for transcriptional 
elongation resulting in a global transcriptional block. Interestingly, the cellular RNA Pol II is 
also necessary for transcriptional regulation of virally encoded proteins. We observed that 
ROSC and OLOII inhibit CDK7 and RNA Pol II in HPV+-ve cancer cells resulting in the 
repression of virally-encoded oncoproteins promoting cell survival. Interestingly, both 
inhibitors affected the functional status of other cellular factors like NF-!B. In view of 
(several modes of action the distinct small molecule CDK inhibitors are predestinated for 
therapy of virus-associated cancers. 
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Inflammation is crucially involved in a variety of diseases like autoimmune syndromes, cardiovascular 
and neurodegenerative disorders, cancer, sepsis and allograft rejection. Accordingly, 
immunosuppressive and anti-inflammatory medication is important to treat and prevent such 
disorders. Useful drugs usually exert most important effects on the T-cell/macrophage interplay. 
Thereby, Th1-type cytokine interferon- gamma (IFNg) is a most important pro-inflammatory 
mediator. For development and characterization of new anti-inflammatory drugs we investigate effects 
of compounds and biologicals on human peripheral blood mononuclear cells (PBMC) freshly isolated 
from whole blood from healthy donors and stimulated with mitogens. PBMC are stimulated with 10 
µg/ml concentration of mitogen phytohaemagglutinin which was found optimal to detect potential 
suppressive effects. After incubation for 48h, supernatants are collected and measurement of neopterin 
formation by, e.g., ELISA and/or tryptophan degradation by HPLC is used as a convenient read-out, 
both biochemical effects are induced by IFNg. The test system reveals very reproducible results even 
between assays using blood of different donors. The combined study of effects on PBMC, a mixture 
of T-cells and macrophages, provides insight into signalling cascades especially those initiated by T-
cells. Monitoring biochemical effects like neopterin formation and tryptophan degradation appears to 
reveal more stable results in quantitative terms than monitoring cytokine production. Moreover, this 
strategy monitors the net effect of compounds on various pro- and anti-inflammatory cascades which 
are initiated during stimulated immune response in vitro and in vivo. Finally, both the read-out 
systems seem especially suited to test for anti-inflammatory effects of compounds, because enhanced 
production of neopterin and accelerated tryptophan degradation was found earlier to be closely related 
to the pathogenesis of various diseases in which inflammatory processes are involved such as 
cardiovascular diseases and neurodegenerative disorders, but also autoimmunity and cancer. Using 
this approach we demonstrated a dose-dependent effect to slow down activation cascades of PBMC 
for compounds like aspririn, resveratrol and vitamins C and E and also of specific plant extracts with 
supposed anti-inflammatory activity. 
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Heme oxygenase (HO)-1 is the inducible isoform of the first and rate-limiting enzyme of heme 
degradation. It has been shown in HO-1 knock out mice and in human genetic HO-1 deficiency 
that this enzyme has potent anti-inflammatory and immunomodulatory functions which have been 
ascribed to its products carbon monoxide and bilirubin. Although HO-1 has previously been 
shown to be induced by various stimuli via activation of the p38 MAPK signaling pathway, the 
role of this protein kinase for HO-1 gene regulation is largely unknown. In the present study it is 
demonstrated that pharmacological inhibitors of p38 and siRNA-dependent knock down of p38" 
induced HO-1 expression in monocytic cells. Moreover, basal HO-1 gene expression levels were 
markedly higher in untreated murine embryonic fibroblasts (MEF) from p38"-/- mice as compared 
to that from wild type mice. Transfection studies with luciferase reporter gene constructs indicate 
that increased HO-1 gene expression via inhibition of p38 was mediated by the transcription 
factor NF-E2-related factor-2 (Nrf2), which is a central regulator of the cellular oxidative stress 
response. Accordingly, inhibitors of p38 induced binding of nuclear proteins to a Nrf2 target 
sequence of the HO-1 promoter, but did not affect HO-1 protein expression and promoter activity 
in Nrf2-/- MEF. Genetic deficiency of p38 led to enhanced phosphorylation of ERK and increased 
cellular accumulation of reactive oxygen species (ROS). In addition, pharmacological blockage of 
ERK and scavenging of ROS with N-acetylcysteine reduced HO-1 gene expression in p38-/- MEF, 
respectively. Taken together, it is demonstrated that pharmacological inhibition and genetic 
deficiency of p38 induce HO-1 gene expression via a Nrf2-dependent mechanism in monocytic 
cells and MEF. These findings not only give new insights into the complex signaling events of 
HO-1 regulation during the inflammatory response, but may also help to develop novel 
therapeutic approaches for the treatment of inflammatory diseases.  
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optimized reagent system:  The BD Phosflow T Cell Activation Kit 
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Phosphorylation and dephosphorylation of intracellular proteins drives most cellular 
processes including cell growth and differentiation, cell proliferation, cell survival, and 
apoptosis.  Many currently available tools for studying phosphorylated proteins, such as 
Western blot, require that populations of cells be lysed to gain access to intracellular protein 
targets. To study protein phosphorylation within cell subsets derived from heterogeneous cell 
populations, such as whole blood, requires cell sorting and/or purification of cell populations-
of-interest prior to analysis of protein phosphorylation.  This process can be time consuming 
and negatively impact experimental results. By combining BD Phosflow optimized reagents, 
cell surface markers, and routine multiparametric flow cytometry techniques, investigators 
can study intracellular protein phosphorylation in cell subsets without the need for physical 
cell sorting.  The BD Phosflow T Cell Activation kit is an optimized reagent system that 
includes a T-cell-specific multicolor cocktail, and several phosphoprotein-specific 
monoclonal antibodies directed to targets in the JAK-STAT and MAP Kinase pathways.  
These pathways are involved in cytokine, growth factor and antigen-specific T cell signaling.  
This kit enables the study intracellular signaling of CD4+, CD8+, and other lymphocyte 
subsets from whole blood in a rapid and simple technique that can be used in the study of 
immune cell interactions, drug discovery, and the monitoring of disease processes. 
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HaloTag Technology: A Proteomics tool for Understanding Protein Function in a 
Biochemical and Cellular Environment – with a twist of NF-%B signaling pathway. 
 
Presenter: Dr. Marie Stahl, Product Manager - Proteomics and Cellular Analysis 
 
Company name: Promega Benelux BV 
 
Promega has developed the HaloTag technology, which is based on the covalent binding of a 
protein fusion tag (HaloTag) to specific synthetic ligands. The ligands can carry different 
fluorescent dyes enabling protein labeling or are attached to solid support for protein 
immobilization. The specific and covalent nature of capture allows efficient washing and 
removal of non-specific interactions without loss of specific interactions. 
To demonstrate the power of this technology for analysis of protein function, Promega has 
used several different model systems. Using NF-!B signaling pathway as model system, we 
will show how using HaloTag enables simultaneous analysis of protein migration and 
interactions with other proteins and DNA. 
 
 
More information: 
http://www.promega.com/halotag 
 
Contact: 
benelux@promega.com  
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Streptamers are reversible MHC I-multimers for antigen-specific staining and isolation of 
CD8
+ 
T-cells. With biotin Streptamer reagents can be completely dissociated from the stained 
cells, providing quasi untouched, fully functional antigen-specific cells. Especially therapeutic 
applications of Streptamer-isolated T-cells benefit twofold from the absence of isolation 
reagents. First, the effector function of CD8
+
 T-cells remains uncompromised when staining, 
isolation and dissociation is performed at 4°C and second, reversibly Streptamer-isolated cells 
have significant regulatory advantages for adoptive T-cell therapy. After validation of these 
MHC I-Streptamer advantages within a clinical trial targeting CMV-infections after stem cell 
transplantations, we have extended the reversible Streptamer approach to Fab-Streptamers, 
which can address any cell surface marker. Fab antibody fragments are genetically engineered 
to provide complete reversibility. Thus, Fab-Streptamers provide similar advantages 
compared to MHC I-Streptamers but extend the range of accessible target cells to virtually all 
therapeutically relevant cells including regulatory T-cells, stem cells and natural killer cells. 
Therefore, the combination of MHC I- and Fab-Strep-tamers provide a versatile technology 
platform for a rapid and economic access to clinical trials with a broad range of 
therapeutically relevant cells. An overview of the Streptamer technology will be presented 
and potential therapeutic applications will be discussed. Apoptosis plays a major role in the 
pathogenesis of cancer, autoimmune and neurological diseases. Due to a novel trimerization 
module, the T4 Foldon, conformational stabilization of the FasL-Strep homotrimer enables 
efficient and highly reproducible induction of apoptosis in human and murine cells without 
chemical crosslinking.  FasL-Strep is also ideally suited for high-throughput screening and 
quantitative determination of anti-apoptotic agents.  
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Understanding and performing DNA and siRNA transfection  
 
Géraldine Guérin-Peyrou, Scientific and Technical Support Specialist  
 
Polyplus-Transfection 
ggp@polyplus-transfection.com 
 
Transfection is widely used as a tool in research. It consists in introducing nucleic acids into 
mammalian cells. If inadequate, transfection can become a limiting step for any project. Thus 
it is critical to understand the mechanism of transfection to choose the most appropriate 
method. This tutorial will present the various transfection mechanisms as well as currently 
available methods and reagents for DNA and siRNA transfection. We will explain why some 
methods are more effective at transporting and releasing DNA and mRNA while others are 
better for siRNA. In addition the critical parameters for transfection and their optimisation 
will be described. Our goal is to give a solid basis in transfection in order to obtain the best 
results in the shortest timeframe. 
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Oris™ Cell Migration Assays from amsbio: An Innovative Platform For Studying Cell 
Migration & Invasion 
 
Alex Sim 
 
AMS Biotechnology (amsbio), AlexS@amsbio.com 
 
amsbio is proud to offer the Oris™ product line: an innovative line of 96- well, cell exclusion 
zone assays for performing cell migration and cell invasion experiments. The Oris™ assays 
utilize cell seeding stoppers to create a circular Detection Zone in the center of each well into 
which cell movement can occur. Data can be generated using multiple fluorescent stains and 
quantified using fluorescence microplate readers, inverted microscopes, or imaging 
instruments. The Oris™ assay platform allows various Extracellular Matrix coatings for cell 
migration, and has also been adapted for the study of cellular invasion within 3-dimensional 
extracellular matrices. Data demonstrating the robustness and versatility of the Oris™ assays 
and their advantages over other motility assay platforms will be presented. 
  
The presentation will be the platform for the European launch of the NEW Oris™ Pro Cell 
Migration Assay; which features a dissolving, non-toxic biocompatible gel to create an 
annular monolayer of cells with a cell-free, central Detection Zone into which cell migration 
can occur. This format is specifically aimed at high throughput applications as it enables the 
use of automated liquid handling. 
  
By allowing unlimited real time access to wells from cell seeding to data readout the 
presentation will demonstrate the capture and quantification of cell migration results using 
inverted microscopes and high content screening (HCS) and high content imaging (HCI) 
instruments. 
 
Working across the European market since 1987, amsbio (formerly AMS Biotechnology (Europe) 
Ltd) is a global supplier of research products and custom services for biological & pharmaceutical 
research. We offer antibodies, peptides, DNA, RNA, proteins, tissue blocks, arrays, slides, assay kits, 
cell culture consumables, glycobiology reagents, apoptosis and DNA damage kits & reagents, cell 
migration / invasion assays and zymolyase.  
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Getting the Best Data from your Multiplex Immunoassays!  
 
Dennis Buurman, Bioplex Specialist 
 
Bio-Rad Laboratories - TechSupport.Belgium@bio-rad.com 
Dennis_Buurman@bio-rad.com 
 
Multiplex immunoassays with Luminex xMAP technology allows researchers to measure up 
to 100 biomarkers simultaneously and dramatically increase the amount of information 
obtained from irreplaceable or volume-limited samples such as mouse or rat serum.  Major 
applications include cytokine profiling in health and disease conditions.  
But more complexity and more raw data bring new challenges!!   
High quality results are required that allow you to make good decisions on the direction of 
your research and that will stand close scrutiny for publication…. but first time!  No-one 
wants to waste precious samples or valuable assays kits. 
Bio-Rad Laboratories have been pioneers in the development of the Bio-Plex system 
including the recent introduction of more-robust magnetic bead assays and magnetic washing 
workflows.  Come along and share in what we’ve learned over the years.  
  • The factors that most influence multiplex immunoassay workflows 
  • The importance of routine calibration and validation 
  • Critical parameters for successful data analysis 
  • Hints and tips from the experts that will improve your results 
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Innovative 2D DIGE technoloy for differential protein expression : examples in 
inflammation research. 
 
Leon Kraakman, Product specialist 2D DIGE 
 
GE Healthcare Europe 
 
2D DIGE is an innovative technology to compare the expression of proteins between control 
and disease state to identify proteins involved in the onset of the disease. 2D electrophoresis is 
a gel-based technology where proteins are separated based on pI value and size resulting in 
very high resolution separation of about 2000 proteins per gel. 2D DIGE is an innovative 
approach by pre-labelling the proteins with fluorescent dyes making it possible to perform 
multiplexed analysis comparing in one gel control and disease samples. 2D DIGE is unique as 
it can exclude technical variation and inherent biological variation by working with an 
internal standard and multiple biological replicates. More then 1500 publications have 
referred to the 2D DIGE technology. Examples of applications in inflammation research will 
be given. 
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!Oris™ Technology                                                                                   Oris™
Advantages
Increased Productivity
Less Handling
Realise reduced assay handling time.
Automation-Friendly Design
Reproducible Results
Real-Time Analysis
OrisTM Pro 
Biocompatible Gel 
Dissolves to Create 
Detection Zone 
Allow Cells to 
Migrate into 
Detection Zone
Image Cells in 
Detection Zone via 
Microscopy and 
HCS/HCI Instruments
Seed & Adhere 
Cells Around    
OrisTM Pro 
Biocompatible Gel
Treat cells with mulitple fluorescent probes, 
labels, or colourimetric stains for use with 
microscopes, HCS and HCI instruments.
Utilise automated liquid handling equipment 
for fast set-up of high throughput.
Achieve well-to-well CV's <12% and generate 
robust Z’ factors suitable for compound screening.
Unlimited access to cells, cell morphology and 
cell movements throughout your experiment.
Accelerate Your Cell Migration Research
Oris™ Pro Cell Migration Assay
HUVECs were seeded onto an OrisTM Pro Collagen I 
plate.  A dose-response titration was performed 
using the actin polymerization inhibitor, Cytochalasin 
D.  Cells were treated for 18 hours, fixed, and stained 
for F-actin. 
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The new Thermo Scientific Pierce Fast Transfer System 
reduces protein transfer time from gel to membrane to 
only 10 minutes. The system consists of two parts, the 
Pierce® Fast Semi-Dry Transfer Buffer and the Pierce Fast 
Semi-Dry Blotter.
t Fast – transfer protein from gel to membrane in 7-10 
minutes
tSensitive – same transfer efficiency as other semi-
dry or wet-transfer units 
tEconomical – no need to purchase and dispose of 
costly  consumables
tRobust – transfer up to 4 gels at one time
tVersatile – use homemade or pre-cast gels
Visit www.thermo.com/perbio
Moving science forward
!"#$$%&'#()(*+,--...( (/0$%0$%...$%123
PerkinElmer puts faster, easier inflammation assays within reach. 
AlphaLISA® is a homogeneous alternative to conventional  
ELISA, enabling you to eliminate tedious wash steps without  
sacrificing high sensitivity or wide dynamic range. And with our expanding line of AlphaLISA 
kits for research on cancer, inflammation and other disease areas, we’re bringing this highly 
efficient Alpha Technology to more labs than ever before. Learn more about our Alpha 
Technology assays, and all the ways we can give you a hand with your research.  
www.perkinelmer.com/nowashELISA
PerkinElmer • Imperiastraat 8, Bus 1 • 1930 Zaventem • Belgium • Phone: 0800 40858 • Email: benelux@perkinelmer.com 
For a complete listing of our global offices, visit www.perkinelmer.com/ContactUs
VISIT US AT 
INFLAMMATION 2010
BOOTH 29
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MORE AND MORE 
RESEARCHERS ARE SAYING
GOOD-BYE 
TO WASH STEPS
AlphaLISA immunoassay 
kits are available for 
research in several  
key therapeutic areas 
including:
*New Kits!
INFLAMMATION
CCL2 / MCP1*
COMP
CRP*
G-CSF
GM-CSF
IFNg
IL1a*
IL1b
IL2
IL3
IL6
IL8
IL10
IL12 (p70)*
IL13*
IL17
IL18*
TNFa
400162A_03_AlphaLISA_Immunology_A5_Ad.indd   1 1/8/10   12:32 PM

 A heart for cancer sick children 
 
Together we can make difference in the lives of children 
and their families living with childhood cancer 
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Luxembourg, 
January 26th to 29th, 2011 
Luxembourg 
Integrated cellular pathology - 
Systems biology of human 
disease 
Contact : Marc Diederich 
Laboratoire de Biologie Moléculaire 
et Cellulaire du Cancer (LBMCC) 
Hôpital Kirchberg 
9, rue Edward Steichen 
L-2540 Luxembourg 
Fax: + 352 2468-4060 
Email: marc.diederich@lbmcc.lu 
Please register at: 
http://www.transduction-meeting.lu 
Luxembourg, 
January 25th to 28th, 2012 
Luxembourg 
Natural compounds - 
Regulators of cell signaling 
pathways and novel therapeutic 
tools 
Contact : Marc Diederich 
Laboratoire de Biologie Moléculaire 
et Cellulaire du Cancer (LBMCC) 
Hôpital Kirchberg 
9, rue Edward Steichen 
L-2540 Luxembourg 
Fax: + 352 2468-4060 
Email: marc.diederich@lbmcc.lu 
Please register at: 
http://www.transduction-meeting.lu 
We thank our sponsors: 
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Poster Presentations 
 
All posters will be up from Wednesday January 27th until Friday January 29th: 
 
Wednesday January 27th 14h00 – 16h00: All posters 
Thursday January 28th 14h00 – 16h00: Posters with even numbers (2, 4, 6…) 
Friday January 29th 14h00 – 16h00: Posters with odd numbers (1, 3, 5…) 
 
On Friday January 29th 16h00, all poster presenters are requested to recover their 
posters (the boards will be taken away). 
 
 
Posters are classified by session  
& then in alphabetical order (of the first author) 
 
Session I: Regulation of Cell Signaling Pathways in Inflammation 
Session II: Inflammatory Mediators 
Session III: Anti-inflammatory Compounds 
Session IV: Virus Infections and Innate Immunity 
Session V: Chronic Inflammatory Pathologies 
Session VI: Inflammation and Cancer 
Session VII: Cell death and Inflammation 
 
 
NB: sessions were reorganized based on the number of submissions 
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Session I: Regulation of Cell Signaling Pathways in 
Inflammation 
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Session I     Poster I, 1 
 
Apoptotic cell-derived S1P contributes to arginase II expression in murine macrophages 
by activating ERK5/CREB 
 
Vera Barra1, Andreas von Knethen1, Andreas Weigert1 and Bernhard Brüne1 
 
1Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 
Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. 
E-mail: barra@zbc.kgu.de 
 
Apoptotic cell (AC)-derived factors alter the physiology of macrophages towards a regulatory 
phenotype that is characterized by an attenuated pro-inflammatory cytokine profile and 
reduced nitric oxide (NO) production. Impaired NO formation in response to ACs or AC-
conditioned medium (CM) is facilitated by arginase II (ARG II) expression, which competes 
with inducible NO synthase for the common substrate L-arginine. Here we investigated the 
signaling pathway that allowed CM to up-regulate ARG II in RAW264.7 macrophages. A 
sphingolipid, further identified as sphingosine-1-phosphate (S1P), was involved. S1P signaled 
through S1P2, since the antagonist JTE013 and siRNA knockdown of S1P2 prevented ARG II 
up-regulation. Further, inhibition and knockdown of extracellular signal-regulated kinase 5 
(ERK5) attenuated CM-mediated ARG II protein induction. Exploring ERK5-dependent 
transcriptional regulation, promoter deletion and luciferase reporter analysis of the murine 
ARG II promoter (mpARG II) suggested a cyclic adenosine monophosphate (cAMP) 
responsive element binding protein (CREB) to be implicated. This was confirmed by EMSA 
analysis and decoy-oligonucleotides scavenging CREB in RAW264.7 macrophages, thereby 
preventing it from binding to the promoter of its target genes and thus, blocking ARG II 
expression. We conclude that AC-derived S1P shapes an anti-inflammatory macrophage 
phenotype. Along this line, S1P contributes to ARG II induction via binding to S1P2, thereby 
activating ERK5 and subsequently CREB. 
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Permanent inhibition of catalase (CAT) activity in peripheral white mononuclear cells (PWMC) 
of naïve Crohn´s Disease (CD) patients depends on a down regulation of CAT-gene expression. 
   
Belen Beltran1,3,  Marisa Iborra2 , Francisco Rausell1, Ines Moret2, Enrique Busó4, Guillermo 
Bastida1,3, María García-Eliz3 , Julio Ponce1,3, Pilar Nos1, 3 
 
1. Gastroenterology Department. Hospital Universitari la Fe-CIBERehd. Valencia. Spain. 2. 
Instituto de Investigación Sanitaria la Fe. Valencia. Spain. 3. Gastroenterology Department. 
Hospital Universitari la Fe. Valencia. Spain. 4. Unidad Central de Investigación de la Facultad 
de Medicina. Universitat de València. Spain 
 
Background: Oxidative stress (OxS) in PWMC depends on an increased production of H2O2. Although 
some H2O2 scavenger enzymes activity have been shown to be increased in CD, we reported that CAT 
enzyme is permanently inhibited in CD 1). The cause for such a CAT inhibition and its possible implications 
in cellular processes have never been reported and /or studied. In cancer cell lines, CAT enzyme has been 
shown to be more implicated in regulating cellular processes than in detoxifying H2O2. Aim: To analyze the 
quantity of CAT protein, its genetic expression and/or its regulation, in order to characterize the cause of the 
permanent inhibition of CAT activity in CD patients. Other genes related to OxS and genes previously 
reported to be differentially expressed in CD have been also analysed. Methods: Blood samples from healthy 
subjects (n=12, mean age 28,33 ± 4,2) and from patients at first flare of CD, before initiating any specific 
medication (n=12, mean age 30,17 ± 8,3) were obtained. PWMC were isolated by Ficoll-Histopaque 
centrifugation. The quantity of CAT protein was studied by western blotting (WB). Total RNA from 
leukocyte population was extracted according to manufacturer’s protocol (LeukoLOCK™ Total RNA 
Isolation System; Ambion). mRNA expression was measured by Sequenom´s MassARRAY® quantitative 
gene expression (QGE) analysis application (Sequenom TM). The genes analysed were: CAT, SOD1, SOD2, 
NOS2A, STAT1, NFKB1, PKCg, PKCzeta, PSKH1, PPID, ABCB1, ASK, FASR, FASLG, TERT, IL-2, 
IL23R. Results: WB results showed diminished levels of CAT in active and inactive CD patients compared 
to controls. RNA CAT expression levels in active CD patients were lower than healthy subjects (12.12 ± 
10.23 vs 41.53 ± 25.86, data in aM). Other genes differentially expressed in CD are: SOD1, SOD2, STAT1, 
PSKH1 and PKCg. Conclusion: The inhibition of CAT activity depends on a down regulation of the RNA 
expression of Cat-gene which correlates with a low concentration of CAT protein. Despite SOD1 and SOD2 
are increased in CD, CAT does not contribute to H2O2 detoxification. The inhibition of PKC%, a CAT activity 
modulator,  may contribute to the final CAT activity. The increased expression of STAT1 highlights the 
importance of IFN-% in CD and its possible correlation with OxS regulation. The increased PSKH1 identifies 
the trafficking and processing of pre-mRNA as a target for CD pathogenia. 
1) Beltrán B et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune 
cells of naïve and treated Crohn’s Disease. Inflamm Bowel Dis. 2009 Jul 27 (ahead of print). 
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Glucocorticoids are potent modulators of LPS-induced Interferon signalling in 
macrophages  
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anja.billing@LNS.ETAT.LU 
 
Lipopolysaccharide (LPS), the main cell wall component of gram-negative bacteria, is 
recognized by toll-like receptor 4 (TLR). TLR4 signalling is MyD88-dependent or –
independent leading mainly to the activation of NF-kappaB or interferon regulatory factor 3 
(IRF3), respectively.  Glucocorticoids, as the end products of the hypothalamic-pituitary-
adrenal (HPA) axis, are the most important endogenous inhibitors of inflammation. Synthetic 
GC are potent immunosuppressants, but the therapeutical efficiency in endotoxemia, sepsis, 
and septic shock is controversial. Here we investigated the effects of cortisol on LPS-
activated monocyte-derived THP-1 macrophages by two dimensional difference in gel 
electrophoresis (2D DIGE) combined with matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) mass spectrometry. Proteomic data was complemented by qRT-PCR, 
immunoblotting, and in-silico pathway/promoter analysis. We found 47 proteins to be 
modulated: 20 by cortisol, 11 by lipopolysaccharide (LPS), and 16 by cortisol and LPS. We 
identified new cortisol-sensitive proteins (HCLS1, MGN, and MX1) and new LPS-induced 
cortisol-suppressed variants of MX1, SYWC and IFIT3. The combined results of proteomics 
and mRNA expression studies clearly identified the LPS-activated IFN pathway as a complex 
and prominent target of the immune suppressive activity of cortisol. Suppression of the IFN 
pathway in sepsis may well be one of the key therapeutic activities of high dose of cortisol in 
this condition.  
 
1. Billing AM, Fack F, Renaut J et al. Proteomic analysis of the cortisol-mediated stress 
response in THP-1 monocytes using DIGE technology. J Mass Spectrom 2007; 42: 
1433-1444. 
2. Busse M, Traeger T, Potschke C et al. Detrimental role for CD4+ T lymphocytes in 
murine diffuse peritonitis due to inhibition of local bacterial elimination. Gut 2008; 
57: 188-95. 
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NADPH oxidase - mediated production of reactive oxygen species induces inflammation 
and apoptosis in Helicobacter pylori-infected gastric epithelial cells 
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Reactive oxygen species (ROS) are considered as an important regulator in the pathogenesis 
of Helicobacter pylori (H. pylori)-induced gastric ulceration and carcinogenesis. Apoptosis 
and inflammation linked to oxidative stress has been implicated in gastric cell injury. NADPH 
oxidase is a major source of reactive oxygen species (ROS) in phagocytic and non-phagocytic 
cells. Chemokine monocyte chemoattractant protein-1 (MCP-1) was relatively highly 
expressed in gastric epithelial cells infected with H. pylori in Korean isolates (HP99). The 
purpose of the present study is to investigate whether NADP oxidase mediates apoptosis and 
MCP-1 expression in H. pylori-infected in gastric epithelial AGS cells. AGS cells were 
cultured with H. pylori (HP99) at a ratio of 300:1. Apoptotic cell death was determined by 
cell viability, DNA fragmentation, and the levels of apoptotic protein Bax and p53 as well as 
anti-apoptotic protein Bcl-2. Expression of MCP-1 was determined in H. pylori-treated AGS 
cells as inflammatory index. As a result, inhibition of NADPH oxidase using a NADPH 
oxidase inhibitor, diphenyleneiodonium (DPI), suppressed H. pylori-induced apoptotic cell 
death and MCP-1 expression in parallel with the decrease in the levels of hydrogen peroxice 
in the medium. DPI inhibited H. pylori-induced decrease in anti-apoptotic Bcl-2 and increase 
in pro-apoptotic Bax in AGS cells. These results suggest that the activation of NADPH 
oxidase may induce apoptosis and MCP-1 expression which may be mediated by ROS in 
gastric epithelial cells.  
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Inhibitory mechanism of &-lipoic acid on cytokine expression in human gastric epithelial 
cells  
 
Jihyun Choi, Joo Weon Lim, and Hyeyoung Kim 
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Helicobacter pylori (H. pylori), gram negative bacteria, induces the expression of 
proinflammatory cytokines including IL-8 in gastric epithelial cells. NF-!B and JAK/STAT 
have been associated with the expression of proinflammatory genes. "-lipoic acid is a well 
known antioxidant, and shows anti-inflammatory effect. The present study aims to investigate 
whether "-lipoic acid inhibits signaling molecules such as JAK/STAT and NF-!B in H. 
pylori-stimulated gastric epithelial AGS cells. The results show that H. pylori induces the 
expression of IL-8 and activation of NF-!B and JAK/STAT, which was suppressed by 
treatment of "-lipoic acid in AGS cells. In conclusion, "-lipoic acid may inhibit the 
expression of pro-inflammatory cytokine by suppressing the activation of NF-!B and 
JAK/STAT in gastric epithelial cells.  
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Long non-coding Heg RNA, TLR7, IFN-gamma and inhibition of autoantibodies.  
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The aim of the present study was to elucidate the mechanism of action of lnc Heg RNA.  
Heg is a long non-coding RNA transcript (GenBank EU 137727) in blood mononuclear 
cells. Heg is negatively correlated with TSH receptor autoantibodies (TRAk) in patients 
with early, untreated Graves’ disease and with CD14 mRNA in treated patients and in 
controls. Heg correlated positively with IFN-gamma (at least in normal subjects) and with 
TLR7 mRNA. The relationship between TRAk and Heg was increased by including Cdk1 
mRNA (an index of cell cycle activity) in the analysis (TRAk vs. the ratio Heg/Cdk1, r = % 
0.82, p<0.001). Cdk1 was positively related to TRAk. In treated patients both TRAk and 
Cdk1 decreased. 
Increasing cytoplasmatic concentrations of Heg (exogenous Heg) decreased CD14 mRNA 
and increased TLR7 and IFN-gamma mRNA. IFN type 1 was not expressed during basal 
conditions but increased more than 100 fold with addition of exogenous Heg RNA. These 
responses were not specific in the sense that a fragment of the anti-sense Nucks mRNA also 
decreased CD14 mRNA and increased IFN mRNA. Thus the effect of exogenous Heg RNA 
was not dependent on the exact sequence. This finding suggests that endogenous Heg RNA 
may be an index of long non-coding RNA molecules, which escapes degradation in the 
nucleus. Heg may interact with TLR7 in the cytoplasma or in the endolysosome and 
increase the transcription rate of IFN-gamma mRNA and decrease CD14 mRNA 
(apoptosis?). Small increments in Heg in the cytoplasma by administration of exogenous 
Heg (fragment or stabilzed) may inhibit autoimmune function. We are currently testing if 
exogenous Heg can be applied to inhibit early experimental autoimmune disease.  
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Cross-talk of androgen receptor with Akt and beta-catenin in prostate cancer?  
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Patients with advanced prostate cancer initially benefit from androgen-ablation therapy, which leads to 
temporary tumor remission due to apoptosis of androgen-sensitive tumor cells. However, recurrence 
of androgen-independent tumor is inevitable for most patients and renders the conventional hormone 
therapy ineffective. In androgen target cells, androgen receptor (AR) is predominantly localized in the 
cytoplasmic fraction in the absence of ligand while it translocates to the nucleus in the presence of the 
endogenous androgens and activates transcription of AR-responsive genes. Regulation of its function 
involves cross-talk with the other signaling pathways (PI3K/Akt), transcription factors and 
coregulatory proteins e.g. beta-catenin which plays a critical role in tumorigenesis. It’s proposed that 
PI3K/Akt plays role in regulating AR activity through phosphorylation of AR at Ser(P)-213/210 but 
we observed that in differentiated prostate post-surgical tissues, only a small percentage of cells are 
positive for AR Ser(P)-213, which suggests that phosphorylation is not prevalent. Akt also 
phosphorylates beta-catenin at Ser(P)-552/675 induces bet-catenin accumulation in the nucleus and 
increases its transcriptional activity. Our results suggest that in prostate cancer cells AR plays the most 
important regulatory function. In addition interaction between AR and Akt in beta-catenin signaling 
pathway may directly contribute to cancer progression in effect of loss of androgen dependence. 
Silencing of AR with siRNA in LNCaP cell line significantly reduced proliferation (50-80%), nuclear 
beta-catenin, beta-catenin Ser(P)-675, activity of MMPs and in parallel significantly increased 
expression of E-cadherin and cell cycle inhibitors p21 and p27. Our data suggest that loss of E-
cadherin can elevate the nuclear levels of beta-catenin in prostate cancer cells, which may directly 
contribute to invasiveness and more malignant tumor phenotype by augmenting AR activity during 
prostate cancer progression. Prolonged silencing of AR (over 72 hrs) in LNCaP cells results in 
increasing proliferation as well as expression of nuclear beta-catenin with appearance of beta-catenin 
Ser(P)-552/675. We noticed activation of the PI3K/Akt pathway, which has a survival role in prostate 
cancer by protecting cells from apoptosis. Silencing of Akt significantly reduced nuclear beta-catenin 
Ser(P)-675. We propose that Akt replaces AR role and contributes to the development of androgen-
independent cancer progression. Activated PI3K/Akt can stabilize beta-catenin through inhibition of 
GSK-3 by its phosphorylation at Ser11 and Ser9 and/or direct phosphorylation of beta-catenin Ser(P)-
675 resulting in its nuclear accumulation.  This work was supported by MNiSzW grants: 
K/ZDS/001003 and K/ZDS/000455 - Jagiellonian University Medical Collage, Krakow – Poland.  
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Neurosphere-derived astrocytes as a model to study astrocyte behaviour during neuro-
inflammation 
 
Sebastien Gabel, Luc Grandbarbe, Tony Heurtaux, Eleonora Morga, Paul Heuschling. 
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Brain inflammation, currently described in several neurodegenerative diseases like Alzheimer’s 
disease (AD), has been recognized as a complex phenomenon with numerous related aspects. 
Although, microglial cells are considered as the main actors of the neuro-inflammation, several 
studies have recently highlighted the importance of astrocytes during these inflammatory events. 
Primary rodent astroglial-enriched cultures are the most popular model to study astroglial biology 
in vitro. From the original methods a great number of minor modifications have been incorporated 
into these protocols by different laboratories. These protocols result in cultures in which the 
astrocyte is the predominant cell type, but astrocytes never reach 100% of cells in these 
preparations. The proportion of microglial cells and the role they play in astroglial cultures are 
often underestimated. In this work, we clarify this complexity, by using novel approaches to 
prepare pure astrocyte cultures entirely devoid of microglia. The production of pure astrocyte 
cultures is based on promoting neural stem cell (NSC) differentiation into astrocytes. In the 
current study we obtained pure astrocyte cultures by growing NSC in the presence of 10% of 
serum, which promotes NSC differentiation into astrocytes. Microglia free astrocyte cultures 
obtained from primary mixed glial cell cultures, which are needed to validate the model of 
neurosphere derived astrocytes, are obtained by using the CD11b MicroBeads magnetic 
separation technique on mixed glial cells. From the CD11b column we isolate microglia by 
positive selection and astrocytes by depleting microglia. Microglial isolates by positive selection 
are >99% pure and free of astrocytes, while astrocytes collected by negative selection are 95–97% 
pure and completely devoid of microglia. Here, we show that neurosphere derived astrocytes and 
microglia free astrocyte culture, present the same behaviour in inflammatory conditions. Pure 
astrocytes are activated by TNF-#, IL1-$ and IFN-%, but do not respond to Lipopolysaccharide 
(LPS). In addition, we observe that inflammation induces an induction of SOX2, EGFR and 
CD133 expression on astrocytes. 
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Genes involved in endothelial NO production are regulated by NKX2-3 in inflammatory bowel 
disease 
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The homeodomain transcription factor NKX2-3 is expressed in the smooth muscle and in microvascular 
endothelial cells within the lamina propria and submucosa of the intestine. Recently, NKX2-3 has been 
associated with inflammatory bowel disease (IBD), and its mRNA and protein expression levels have been 
found to be up-regulated in Crohn’s disease (CD) patients. In this study, we used cDNA microarrays in a 
NKX2-3 knockdown B cell line and identified NKX2-3 regulated genes to be involved in endothelial NO 
production. High-density cDNA microarrays (Illumina Human HT12 v3 Beadchip) representing over 
25,000 genes with >48,000 probes were used to determine genome-wide gene expression changes in 
siRNA-mediated NKX2-3 knockdown B cell line generated from a CD patient. Ingenuity Pathway 
Analysis (IPA) was used to identify gene networks. mRNA expression levels of argininosuccinate 
synthetase (ASS1), endothelial nitric oxide synthase (eNOS) and endothelin (EDN1) in comparison to 
GAPDH were examined by quantitative real-time RT-PCR using cDNA generated from 23 matched pairs 
of diseased and adjacent non-diseased intestinal tissue from 21 IBD patients (2 patients with 2 pairs from 
different locations). cDNA microarray analysis was conducted with NKX2-3 knockdown and control cells. 
Pathway analysis indicated that the most functional gene network impacted by NKX2-3 knockdown 
involved genes associated with NO production in endothelial cells, including KLF2, ASS1, and EDN1. The 
production of NO has been shown to regulate anti-inflammatory immune responses. ASS1 is involved in 
arginine synthesis from citrulline, while eNOS uses arginine as substrate for the synthesis of NO. EDN1 is 
a potent vasoconstrictor kept in delicate balance by NO. In 23 matched pairs of intestinal tissue from IBD 
patients, mRNA expression of ASS1 was found to be significantly increased by 13% in diseased vs. non-
diseased samples (p < 0.05). On the other hand, we detected a significant down-regulation of mRNA 
expression levels for eNOS (10%) and EDN1 (24%) in diseased vs. non-diseased intestinal tissue (p < 0.05 
each). Our results indicate a potential decrease in NO production in IBD as shown by down-regulation of 
eNOS and EDN1. Consistent with recent observations of elevated arginine levels in IBD, we found ASS1, 
the key enzyme in arginine synthesis, to be up-regulated in IBD. However, the role of high arginine levels 
in NO production is currently unclear. We speculate that the diminished generation of NO might be 
regulated by NKX2-3 in IBD and contributes to disruption of vascular homeostasis by imbalanced 
inflammatory responses. 
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NF-kB and beta-catenin pathway is essential for migration and invasion in human 
melanoma.  
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Malignant transformation in melanoma is characterized by a phenotype “switch” from E- to N-
cadherin, which is also associated with invasiveness and progression of the tumor and is a major 
hallmark of Epithelial-Mesenchymal Transition (EMT). In carcinoma cells, EMT can be associated 
with tumor growth, invasion and metastasis. EMT can be promoted by various intrinsic signals (e.g. 
gene mutations) as well extrinsic (e.g. extracellular matrix proteins or growth factors). Cross-talk 
mechanism between growth factors and integrins, involves the integrin linked kinase (ILK), a 
serine-threonine protein kinase, which regulates many cellular processes, including growth, 
proliferation, survival, differentiation, migration, invasion and angiogenesis. ILK exerts control over 
a diverse set of downstream effectors, in particular, activates Akt by its phosphorylation at Ser 473 
and inactivates glycogen synthase kinase 3 (GSK3) by its phosphorylation at Ser 9 in various cell 
types. One of their major roles is to regulate beta-catenin transcriptional activity. In addition Akt 
and GSK-3 has been reported to activates the NF-kB subunit p65, increasing the binding of the NF-
kB complex to DNA or inactivates the NF-kB signaling, respectively. These results indicate that 
ILK/AKT/GSK-3 directly mediates not only beta-catenin but also NF-kB activation. The 
transcription factors, nuclear factor kappa B and beta-catenin were also found to contribute to EMT 
in a range of human cancers. We were able to show that silencing of ILK gene expression by siRNA 
process significantly inhibits N-cadherin expression. In addition NF-kB (p65) nuclear translocation 
and beta-catenin  activation are completely abolished upon ILK silencing in melanoma cells. 
Studies were carried out on human melanoma cell lines. Secretion of matrix metalloproteinases was 
studied by zymography, and the invasive potential by using Boyden chambers. Expression of cell 
signaling proteins, was analyzed using Western Blot, siRNA transfection was done for ILK 
(Ambion). Our results indicate that, ILK signaling is essential for the induction and maintenance of 
EMT and inhibition of ILK may be a useful strategy for control of tumor invasion and metastasis 
not only in melanoma.  
This work is supported by: MNiSW through Jagiellonian University Medical College 
K/ZDS/000455 and K/ZDS/001003 
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Androgen regulation of motility in fibroblasts. 
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Steroids influence cell growth, inflammation, wound healing, cardiovascular health, bone 
integrity, immunity and other processes. Much evidence from our and other laboratories 
shows that steroids rapidly activate various signaling effectors in target cells. This occurs 
through a direct interaction of classical steroid receptors with Src, the p85-regulatory subunit 
of PI3K and other signaling components. Activation of these pathways fosters cell cycle, 
prevents apoptosis and leads to cytoskeleton changes in reproductive as well as non 
reproductive cells.  
The role of signaling activation in steroid action has been corroborated by findings showing 
that mouse embryo NIH3T3 fibroblasts express very low amount of classical androgen 
receptor (AR) that rapidly activates Rac1 upon stimulation with physiologic androgen 
concentration. Such an activation leads to cytoskeletal changes and cell motility of fibroblasts. 
The upstream events responsible for androgen induced Rac1 activation have been analyzed. 
Collected data indicate that rapid, non-genomic androgen action promotes cell spreading and 
invasiveness. 
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NF-kappaB activation by DNA double-strand breaks is MDC1 and 53BP1 dependent. 
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Cancer therapies such as ionizing irradiation (IR) and DNA topoisomerase I and II inhibitors, 
rely on the genotoxic effect of DNA double-strand breaks (DSB) to eradicate tumors. ATM 
kinase, rapidly activated by DSB, orchestrates different aspects of the DNA Damage 
Response: cell cycle arrest, DSB repair and transcription factors activation. Both NF-kappaB 
and p53 are activated by DSB, both modify the balance between pro- and anti-apoptotic 
signals and thereof affect cell survival and the outcome of the cancer treatment.         
In this work, the importance of MDC1 protein (Mediator DNA damage checkpoint 1) and of 
the nuclear foci in the DNA damage signalling to NF-kappaB is studied. As expected, MDC1 
reduction by siRNAs resulted in a smaller number of nuclear foci after IR and Camptothecin 
treatments. We observed that reduced MDC1 level leads to a reduction of NF-kappaB nuclear 
translocation after both treatments. NF-kappaB transactivation potential was assessed with 
two reporter systems; either a transiently transfected kappaB-Luc reporter plasmid or a stably 
integrated kappaB-GFP reporter. In both cases, we noticed a large reduction of the 
transcriptionnal activity in cells treated with siRNA-MDC1. The reduction was however less 
important than the one observed in cells treated with an siRNA-ATM. Mefs WT and KO for 
MDC1 were tested for NF-kappaB activation by IR and Camptothecin.  However, as Mefs 
WT did not activate NF-kappaB following DNA damage we could not use this model. SiRNA 
for 53BP1, a protein that is recruited later in the nuclear foci, also reduces drastically NF-
kappaB activation after DNA damaging treatments.  
In summary, our data indicate that the disruption of nuclear foci amplification and maturation 
by siRNA-MDC1/53BP1 has an impact on NF-kappaB activation after both IR and 
Camptothecin treatments contrarily to the disruption of NBS/Mre/Rad50 complex that affects 
only IR signalling.  
 
Financial supports: PAI 6/18, Centre anti-cancéreux de l’ULg, FRS-FNRS.  
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Head kidney leukocytes isolated from Atlantic salmons fed either a diet based on fish oil (FO) 
or soy bean oil (VO) were used in order to evaluate if different lipid sources could contribute 
to cellular activation of salmon innate immune system. A specific inhibitor of p38 MAPK, 
SB202190, was used to investigate the effect of lipopolysaccharide (LPS) signalling in the 
head kidney leukocytes. The results show that LPS signals through the p38 MAPK pathway 
and up regulate IL-1!, TNF-", Cox2 expression in leukocytes isolated from fish fed either 
diet. The p38 MAPK inhibitor, SB202190, reduced the LPS induced expression of these 
genes in both dietary groups. In LPS stimulated leukocytes isolated from VO fed fish, 
SB202190 showed a dose dependent inhibitory effect on IL-1!, TNF-" and Cox2 expression, 
which was not observed in leukocytes isolated from FO fed fish. Furthermore, there was a 
stronger mean induction of Cox2 in LPS stimulated leukocytes isolated from the VO group 
compared to LPS stimulated leukocytes isolated from the FO group. This may indicate that 
Cox2 expression can be modulated by dietary fatty acids which may have consequences for 
the fish’s ability to handle infections and stress. LPS stimulation of salmon head kidney 
leukocytes increased the induction of CD83, a dendrite cell marker, but significantly inhibited 
the expression of p38MAPK itself, indicating a p38 MAPK feedback loop. The inhibitor 
SB202190 alone reduced hsp27 expression and increased CD83 expression in salmon head 
kidney leukocytes, indicating that signalling through p38 MAPK is ligand dependent and 
affect gene expression differently.  
 
Key words: Atlantic salmon head kidney leukocytes, cellular activation, p38 MAPK, IL-1#, 
TNF-", Cox2, hsp27, hsp70, CD83 
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Cholecystokinin (CCK) analogue cerulein causes pathophysiological, morphological, and 
biochemical events similar to those shown in human pancreatitis. Redox-sensitive 
transcription factor NF-!B has a critical role in the pathogenesis of cerulein-induced acute 
pancreatitis by regulating the expression of pro-inflammatory genes in the pancreas. 
Lycopene and omega-3 fatty acid docosahexaenoic acid (DHA) have anti-inflammatory effect 
in various cells. In the present study, we examine the effects of lycopene and DHA on NF-!B 
activation and IL-6 expression in cerulein-treated pancreatic acinar cells. The cerulein 
induced IL-6 expression and NF-!B activation, which were inhibited by lycopene and DHA 
in pancreatic acinar cells. In conclusion, lycopene and omega-3 fatty acids may be beneficial 
for prevention or treatment of pancreatic inflammation by inhibiting expression of 
inflammatory cytokine and suppressing NF-!B activation in pancreatic acinar cells.  
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There has been considerable accumulation of evidence supporting that exhaustive exercise causes 
oxidative stress, which may lead to various disorders as well as inflammation. However, it is 
considered that regular exercise can attenuate oxidative stress and inflammation. In the present 
study, we investigated the effects of one-bout exhaustive exercise and long-term regular exercise 
on oxidative stress and inflammatory responses in human peripheral blood mononuclear cells 
(PBMCs). In the first experiment, twenty volunteers who participated in the guided exercise 
program were subjected to progressive exercise until they were exhausted on the treadmill 
followed by resting conditions. Isolated human PBMCs were collected immediately following 
exercise and after 1 h recovery. One-bout exhaustive exercise induced expression of glutamate-
cysteine ligase catalytic subunit (GCLC), interleukin 1# (IL-1#), and cyclooxgenase 2 (COX-2) as 
well as nuclear factor kappa B (NF-!B) DNA binding activity and phosphorylation of both IKK" 
and I!B" in PBMCs. Initial induction of the above oxidative signaling and pro-inflammatory 
response fully returned to the basal level during 1 h of recovery. In a follow-up experiment, 
twenty men who participated in the exercise training of different two intensities (40% and 80% of 
VO2max) for 4 times per week for 12 weeks were randomly allocated to low- and high-intensity 
exercise groups (n=10; each group). After 12 weeks, the expression of IL-1#, p-IKK", and p-I!B" 
in  the high-intensity exercise group was significantly decreased in comparison with control and 
low-intensity exercise groups. On the other hand, there were not significant differences in NF-!B 
DNA binding activity and COX-2 expression among all groups, and the levels of glutathione and 
GCLC in high-intensity exercise group were statistically higher than those in the control group. 
Taking all these findings into account, although the one-bout exhaustive exercise transiently 
induced NF-!B signaling and subsequent inflammatory response, regular exercise may potentiate 
cellular antioxidant and anti-inflammatory capabilities. 
 98 
Session I     Poster I, 16 
 
15-Deoxy-"12,14-prostaglandin J2 inhibits STAT3 signaling and induces apoptosis in 
human mammary cancer cells 
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Constitutive activation of the signal transducers and activators of transcription 3 (STAT3) 
occurs frequently in many cancerous and transformed cells. Activated STAT3 contributes to 
its oncogenic potential by inducing cell proliferation and inhibiting apoptosis. We explore the 
possibility that 15-deoxy-$12,14-prostaglandin J2 (15d-PGJ2) could exert an anti-tumorigenic 
effect by targeting STAT3 in Ras-transformed human mammary epithelial (MCF-10A) cells. 
When MCF-10A-Ras cells were treated with 15d-PGJ2, they underwent apoptotic death as 
determined by activation of caspases (caspases 3 and 9) and cleavage of poly(ADP-
ribose)polymerase (PARP). 15d-PGJ2 inhibited translocation to the nucleus, DNA binding 
and dimerization of STAT3. In contrast to 15d-PGJ2, 9,10-dihydro-15d-PGJ2, a non-
electrophilic analog of 15d-PGJ2, failed to inhibit STAT3 activation. Moreover, we found that 
biotinylated 15d-PGJ2 directly bound to STAT3 protein. Taken together, these results suggest 
that 15d-PGJ2 has an anti-tumor activity through inhibition of STAT3 in Ras-transformed 
cells. 
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Hydrogen peroxide-induced IL-8 expression is mediated by STAT3 activation in gastric 
epithelial AGS cells  
 
Youngha Kim, Joo Weon Lim and Hyeyoung Kim 
 
Department of Food and Nutrition, Brain Korea 21 Project, College of Human Ecology, 
Yonsei University, Seoul 120-749, Korea 
E-mail: kim626@yonsei.ac.kr 
 
Reactive oxygen species (ROS) are involved in the pathogenesis of gastric inflammation. IL-8 
is a potent mediator of the inflammatory response by activating and recruiting neutrophils to 
the site of infection. ROS activates STAT3 and induces IL-8 expression in various cells. The 
present study aims to investigate whether hydrogen peroxide directly turns on the 
transcription of IL-8 in gastric epithelial AGS cells and whether STAT3 activation mediates 
IL-8 expression in AGS cells exposed to hydrogen peroxide. As a result, hydrogen peroxide 
induced the expression of IL-8 and the phosphorylation of STAT3 in a time-dependent 
manner. The expression of IL-8 was dose-dependently inhibited by treatment of antioxidant 
N-acetyl-L-cysteine (NAC) in AGS cells. In conclusion, hydrogen peroxide-induced IL-8 
expression is mediated by STAT3 activation in gastric epithelial cells.  
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Effect of N-acetylcysteine on Down Syndrome Candidate Region-1 Protein-mediated 
cytokine expression  
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The Down syndrome candidate region-1 gene (DSCR1) is situated close to the Down 
Syndrome Critical Region (DSCR1), which contains genes responsible for many features of 
Down Syndrome. DSCR1 modulates IL-1 receptor- mediated signaling pathways to IL-8 
expression in HEK (Human Embryonic Kidney) 293 cells. IL-8 expression is induced by 
oxidant-sensitive transcription factor NF-!B. In the present study, we investigated the effect 
of antioxidant N-acetyl-L-cysteine (NAC) on DSCR1-mediated IL-8 expression in HEK 293 
cells. As a result, transfection of DSCR1 gene to HEK293 cells induced IL-8 expression in 
the cells, which was augmented by treatment of IL-1#. NAC significantly inhibited IL-8 
expression in the IL-1#–treated cells regardless of transfection of DSCR1. In conclusion, 
antioxidant NAC may be beneficial for prevention or treatment of the disease associated with 
DSCR1 gene.  
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TGF-beta and IL-10-mediated resolution of inflammatory reaction is delayed in MMP-
9-deficient mice  
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Metalloproteinase 9 (MMP-9, gelatinase B) belongs to Zn
2+
-endopeptidases of the matrix 
metalloproteinase (MMP) family and its substrates include components of basement 
membranes and extracellular matrix (e.g. collagens). Therefore the role of MMP-9 in 
inflammation is generally associated with the onset of the reaction and migration of 
leukocytes into the inflammatory focus. Indeed, we have shown that in the MMP-9-deficient 
mice less neutrophils accumulated in peritoneum during early (6 h) zymosan peritonitis. 
However, we detected that during late peritonitis (24 h) there were more neutrophils in 
peritoneum of the MMP-9-deficient mice then the wild-type mice and this was due to their 
impaired apoptosis and compensatory activity of other protease(s). The aim of the current 
study was to verify if also other anti-inflammatory mechanisms are MMP-9-dependent. For 
this acute zymosan peritonitis was induced in MMP-9-deficient and wild-type mice and 
expression (on gene and protein levels; RQ-PCR/ELISA) of anti-inflammatory TGF-$ and 
IL-10 was verified during the peak (6 h) and the termination phase of the reaction (24 h). In 
contrast to the wild-type controls, in the MMP-9 knockouts the expression of both mediators 
was significantly attenuated at 6 h while it was significantly augmented at 24 h. Thus the 
same phenomenon was observed as in the case of neutrophil accumulation. Therefore overall 
the data suggest that the genetic lack of MMP-9 limits early infiltration of neutrophils but it is 
not driven by anti-inflammatory mediators. However, the late neutrophil influx paralleled 
with the high expression of TGF-$/IL-10 which indicates that the anti-inflammatory response 
is delayed in MMP-9-deficient mice. 
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NOD2 Interactome. 
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The mammalian innate immune system has evolved to detect pathogens-associated molecular 
patterns (PAMPS).  Recognition of PAMPS involves membrane-spanning proteins like the 
Toll-like receptors (TLR) and cytosolic proteins such as the recently identified NOD-like 
receptors (NLR).  This family is comprised 23 members with important functions in immune 
sensing in humans, as highlighted by severe inflammatory disorders linked to polymorphisms 
in some NLR members. Best studied are mutations in Nod2 that are linked to Crohn’disease 
(CD) and Blau syndrome.  Nod2 was shown to sense the bacterial peptidoglycan subunit 
muramyl-dipeptide (MDP) and to subsequently mediate inflammatory responses in cells by 
activating the NF-kappa B and MAPKs signalling pathways. This project is consisting in the 
identification of new Nod2 partners and in the evaluation of their role in the Nod2 signalling 
pathways. We chose two strategies to select new Nod2 interactants.  First, we performed a 
yeast two hybrid assay using the human ORFeome 15.1 and the protein Nod2 WT or mutated 
(deletion or CD mutants) as bait.  The second proteomic strategy consisted in the purification 
of Nod2-containing complexes in stably Nod2-expressing cells after MDP treatment or 
infection by Listeria monocytogenes followed by Nod2 partners identification by mass 
spectrometry. Through the proteomic approach, we obtained several potentially interesting 
partners: cytoskeleton proteins, scaffold proteins, proteins shuttling between the cytosol and 
nucleus and interfering with transcription, membrane receptor as well as bacterial proteins 
from L. monocytogenes. By these two complementary approaches, we hope to bring new 
insights concerning the molecular mechanisms underlying the loss of function of CD mutants 
and the MDP recognition.  This work could open onto new NOD2-dependent host defense 
mechanisms and/or new strategies used by L. monocytogenes to escape from the host immune 
response. 
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Glutamine deficiency induces IL-8 expression in gastric epithelial AGS cells 
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Glutamine is a conditionally essential amino acid in the state of illness or injury. It regulates 
the expressions of many genes related to metabolism and signal transduction, and shows anti-
inflammatory effects in various cells. Glutamine deficiency induces the expression of pro-
inflammatory chemokines including IL!8 through activation of nuclear factor-kappa B (NF-
"B) in some cells. Glutamine provides a precursor for the synthesis of glutathione (GSH), the 
major endogenous antioxidant, which protects cells from oxidative injury. In the present 
study, we investigated the inflammatory signaling induced by glutamine deficiency in relation 
to IL-8 expression in gastric epithelial AGS cells. As a result, glutamine deficiency induced 
IL-8 expression by activating mitogen-activated protein kinases and redox sensitive 
transcription factors NF-"B and AP-1 in AGS cells. Glutamine deficiency-induced IL-8 
expression was suppressed by GSH. In conclusion, glutamine deficiency may induce IL!8 
expression which is mediated with the activation of MAPK, NF-"B and AP-1 in gastric 
epithelial cells. 
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Isoangustone A blunted high glucose-triggered renal inflammation and fibrosis through 
disrupting NF-kappaB signaling 
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Development of diabetic nephropathy is associated with hypereglycemia-linked renal 
inflammation. Increased levels of some proinflammatory factors such as intercellular 
adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) have been 
found in diabetic patients with nephropathy. The present study was to test whether 
Isoangustone A (IsoA), a phenolic compound found in licorice, can inhibit proinflammatory 
factors promoted by high ambient glucose (HG) in human mesangial cells (HRMC) through 
blocking nuclear translocation of NF-kappaB. Serum starved HRMC were cultured in media 
containing 5.5 mM glucose plus 27.5 mM mannitol as an osmotic control or 33 mM glucose 
for 3 days in the presence of 1-20 micromole IsoA. Exposure of HRMC to HG caused a 
marked increase in ICAM-1 expression, which was dose-dependently suppressed by IsoA. In 
addition, IsoA appeared to retard HG-triggered MCP-1 mRNA upregulation. Such effects 
were mediated most likely through disturbing NF-kB signaling. Furthermore, exposure of 
cells to HG caused marked increases in collagen secretion and CTGF expression, which was 
dose-dependently reversed by IsoA at the transcriptional levels. IsoA boosted HG-plummeted 
type matrix metalloproteinase-1 (MT-1 MMP) expression and dampened HG-elevated tissue 
inhibitor of MMP-2 (TIMP-2) expression, facilitating the degradation of mesangial matrix. 
The results demonstrate that the bioactive IsoA diminished mesangial inflammation and 
matrix accumulation in response to ambient HG through retarding NF-kappaB signaling 
transduction. Therefore, IsoA may be a potential therapeutic agent for diabetes-associated 
renal inflammation and fibrosis. This work was supported by the Korea Research Foundation 
Grant funded by the Korean Government (MEST)” (The Regional Research Universities 
Program/Medical & Bio-Materials Research Center) 
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Signaling Pathways involved in the Poly-L-arginine - induced IL-6 and IL-8 Release in 
Cultured Human Bronchial Epithelial Cells, 16HBE14o- 
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Eosinophil-derived cationic proteins, particularly major basic protein (MBP), are implicated 
in the pathogenesis of bronchial asthma. It is established that MBP actions could be mimicked 
by synthetic poly cations poly-L-arginine. Previous data of our lab confirmed that poly-L-
arginine may contribute to neutrophilic airway inflammation by inducing the release of pro-
inflammatory cytokines IL-6 and IL-8, which are known to modulate the recruitment, 
activation and survival of neutrophils!in a  human bronchial epithelial cell (16HBE14o-) 
model.  
The mitogen-activated protein (MAP) kinase family and NF!B signaling pathways are central 
in mediating certain cytokines expression. In this study, we examined the involvement of 
MAP kinases and NF!B pathways in poly-L-arginine induced release of IL-6 and IL-8 in 
16HBE14o- cells. Co-incubation studies showed that SB202190, a specific inhibitor of p38 
MAP kinase and BAY 11-7085, an inhibitor of NF!B pathways, dramatically reduced poly-L-
arginine - stimulated IL-6 and IL-8 production. However, PD98059, inhibitor of extracellular-
signal-regulated kinase [ERK] pathway, did not alter IL-6 or IL-8 levels in poly-L-arginine - 
stimulated cells. Activation of P38 MAPK pathway was further confirmed by Western 
blotting, which showed that phosphorylated P38 MAPK was elevated in poly-L-arginine 
treated cells. Immunofluorescent assay demonstrated translocation of NF!B from the cell 
cytoplasm to the nucleus and confirmed NF!B activation.  
These data indicate a role for P38 pathways and NF!B pathways in poly-L-arginine induced 
release of IL-6 and IL-8 in human bronchial epithelial cells. These mechanisms may be 
potential pharmacotherapeutical targets for inhibition of the MBP mediated airway 
inflammation. 
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Role of protease activated receptor-2 on Helicobacter pylori-induced IL-8 expression and 
apoptosis in gastric epithelial cells  
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Hallmarks of Helicobacter pylori (H. pylori)-induced gastric injury are inflammation and 
apoptosis. Protease activated receptor-2 (PAR-2), a novel family of G protein-coupled 
receptors, is activated by serine proteases such as trypsin and tryptase. PAR-2 is present in 
gastric epithelial cells and activated by Helicobacter pylori (H. pylori) infection. Previously, 
we demonstrated the presence of trypsinogen 1 and 2 which may be converted and activated 
to trypsin in H. pylori-infected gastric epithelial AGS cells. The present study aims to the role 
of PAR-2 in H. pylori-induced expression of pro-inflammatory cytokine IL-8 and apoptosis in 
gastric epithelial AGS cells. As a result, H. pylori induced both activation and expression of 
PAR-2 in AGS cells. IL-8 expression and apoptosis (determined by DNA fragmentation and 
cell viability) were induced by H. pylori in AGS cells, which were inhibited by transfection 
with antisense (AS) oligonucleotide (ODN) for PAR-2. H. pylori induced activation of 
mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinases 
(ERKs), p38 kinase, and c-Jun NH2-terminal protein kinases (JNKs). H. pylori-induced 
MAPKs were suppressed in the cells transfected with AS ODN for PAR-2. In conclusion, the 
activation of MAPKs, IL-8 expression and apoptotic cell death are mediated by the activation 
of PAR-2 in H. pylori-infected gastric epithelial cells. Inhibition of PAR-2 may be beneficial 
for the treatment and prevention of gastric damage caused by H. pylori infection. 
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Identification of disease-associated DNA methylation in intestinal tissues from patients with 
inflammatory bowel disease  
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Inflammatory bowel disease (IBD) is a complex disease with a wide variety of clinical presentations. Crohn’s 
disease (CD) and ulcerative colitis (UC) are the major subtypes of IBD. Overwhelming evidence supports the 
theory that IBD is caused by genetic predisposition of multiple genes and an abnormal interaction with 
environmental factors. With genome-wide association studies, currently more than 32 genes/loci have been 
identified for IBD susceptibility genes. However, the risk conferred by all the genetic risk factors discovered 
so far can only account for approximately 20% of the genetic risk. This suggests that other factors, including 
possible epigenetic factors, are involved in IBD pathogenesis. In this study, we have explored the role of 
DNA methylation in IBD pathogenesis. Fifty-four intestinal tissues (26 diseased and 26 matched normal) 
from 26 IBD patients (9 CD and 17 UC) used in this study were collected at the time of surgery and then 
classified by a pathologist as diseased and paired with normal tissue for each IBD patient. Genomic DNA was 
isolated and unmethylated C in the genome was converted to T by bisulfite treatment. The converted genomic 
DNA was used for methylation profiling using GoldenGateTM BeadArray (1505 CpG sites of 807 genes). The 
microarray data were then validated by the PCR based-RFLP method. After initial identification of a training 
set (14 non-diseased and 14 diseased CpG sites) and subsequent validation with a testing set (12 non-diseased 
and 12 diseased CpG sites), we identified 7 CpG sites that are differentially methylated in intestinal tissues of 
IBD patients (p<0.05, mean # value difference across the samples 0.05-0.19). These CpG sites included 
AATK_P709_R, BGN_P333_R, GABRA5_P862_R, MAPK10_E26_F, SERPINA5_P156_F, STAT5A_P704_R, and 
TNFRSF1A_P678_F. Of these methylated genes, STAT5A, SERPINA5, and BGN are of particular interest. 
We further studied DNA methylation in CD and UC patients. We observed that 25 methylated CpG sites 
exhibited significantly differential methylated in diseased intestinal tissues of CD patients (p<0.02 and $ value 
difference >0.1), and 13 methylated CpG sites exhibited significant differential methylated in UC patients 
(p<0.02 and $ value difference >0.1). These results indicate that IBD-associated DNA methylation is disease 
subtype-specific. We used IPA pathway analysis to examine the pathways and gene networks in which these 
IBD-associated genes are involved. The genes that were preferentially methylated in CD patients highlight an 
interesting network of 4 CD associated methylation genes, FGF2, NOTCH4, S100A4, and SPARC, and a 
glucocorticoid receptor (NR3C1)-related gene network for several genes preferentially methylated genes in 
UC patients.  
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IKK#  is required for maintaining skin homeostasis and preventing skin tumor development 
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IKK# is required for the formation of the embryonic epidermis. Loss of IKK# prevents 
keratinocytes from terminal differentiation and promotes keratinocyte proliferation in vivo and in 
vitro. Furthermore, downregulation, altered localization, mutations, and/or loss of heterozygosity 
(LOH) of Ikk" have been reported in squamous cell carcinoma (SCC) of the skin, lungs, 
esophagus, and head and neck in humans, highlighting the importance of IKK# in human cancers. 
It has long been known that excessive mitotic activity due to H-Ras can block keratinocyte 
differentiation and cause skin cancer. It is not clear whether there are any innate surveillants that 
are able to ensure that keratinocytes undergo terminal differentiation, preventing the disease. 
IKK# induces keratinocyte terminal differentiation and its reduction promotes skin tumor 
development. However, its intrinsic function in skin cancer is unknown. Thus, our lab generated 
Ikk" conditional knockout mice, deleted IKK# in keratinocytes in mice by using keratinocyte 
specific Cre mice, and then examined the effect of IKK# loss on skin development and 
maintenance, and skin tumorigenesis. We found that mice with IKK# deletion in keratinocytes 
developed a thickened epidermis and spontaneous squamous cell-like carcinomas. Inactivation of 
epidermal growth factor receptor (EGFR) or reintroduction of IKK# inhibited excessive mitosis, 
induced terminal differentiation, and prevented skin cancer through repressing an EGFR-driven 
autocrine loop. We also identified that IKK# repressed expression of several EGFR ligands at 
their transcription level, thereby inhibiting the pathway of EGFR and Ras. Thus, IKK# serves as 
an innate surveillant. These findings shed light on therapeutic targets for preventing IKK#-related 
skin cancer development. We are currently investigating how inflammation effects IKK# defect-
mediated skin tumor development. 
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Objective: Adhesion molecule integrin beta4 (ITGB4) play an important role in constitutive 
adhesion of airway epithelium. The preliminary study of our group found that loss of 
expression of ITGB4 and typical Th2 inflammation bias has been observed in the asthmatic 
airways. The airway epithelial cells have been demonstrated as a kind of accessory antigen 
presentation cells (APC) to activate T cells which may play an important role in the 
development of allergic airway inflammation of asthma. The purpose of this study is to find 
the connection of decreased expression of ITGB4 with adaptive immune response of airway 
epithelial cells. 
Method: We silence ITGB4 expression in bronchial epithelial cells by small interference 
RNA and studied effects on antigen presentation ability. T cells proliferation and cytokine 
production were also investigated after co-culturing with ITGB4 silence epithelial cells. 
Result: Small interference RNA silencing of ITGB4 resulted in impaired antigen presentation 
ability. ITGB4 silent epithelial cells inhibited Th1 cells activation, proliferation and secretion 
of Th1 cytokine IFN-gamma, while secretion of Th2 cytokine was unaffected. 
Conclusion: Down regulation of ITGB4 expression on airway epithelial cells may impair the 
antigen presentation ability and inhibits the Th1 inflammation response in allergic asthma. 
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Alzheimer’s Disease (AD) is a neurodegenerative disorder. AD is characterized by the 
formation of extracellular senile plaques generated by the aggregation of the #-amyloïd (A#) 
peptide. The presence of these aggregates causes chronic microglial activation, which induces 
an inflammatory state and a subsequent neuronal loss in AD patients. The oligomeric A# 
conformation (olA#) is known to be the most neurotoxic peptide form. Moreover, we have 
recently shown that this form is also the most potent inflammatory activator. Microglia are the 
resident tissue-macrophages of the brain. It is known that activated macrophages can 
differentiate towards a continuous spectrum of phenotypes of which the two extreme states 
are M1 for the pro-inflammatory state and M2 for the anti-inflammatory state. Our team and 
others have described these two phenotypes in microglial cells. Moreover, we have shown 
that olA# induces the pro-inflammatory M1 state. The Liver X Receptors (LXRs) are 
members of the nuclear receptor family. Two isoforms of LXR exist: LXR" and LXR#. LXRs 
are known to regulate inflammatory responses. In fact, activation of LXRs by specific 
agonists is able to repress pro-inflammatory gene expression in activated microglia. The aim 
of this project is to study whether activated LXR is able to shift microglia from an olA#-
induced M1 state towards the anti-inflammatory M2 state. 
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Mediators pre-stored in neutrophil azurophilic granules are central to the acute inflammatory 
response and tissue degradation and damage through their proteolytic activity. Different 
granule populations mobilize and release their content via distinct and hierarchical molecular 
mechanisms. The molecular mechanisms by which mediators pre-stored in azurophilic 
granules are mobilized and released to the extracellular space remain largely unknown. We 
used a number of complementary techniques including; confocal laser scanning microscopy, 
subcellular fractionation, flow cytometric analyses, Western blot analyses and electron 
microscopy to examine the ultrastructural and molecular nature of mediator release in 
neutrophil azurophilic granules. We found that following IL-8 activation, neutrophil 
azurophilic granules undergo piecemeal degranulation (selective mediator release) leading to 
altered granule content. Piecemeal degranulation of azurophilic granules is characterized by 
budding of small secretory vesicles and consequent reduction in granule density. Furthermore, 
budding of small secretory vesicles and selective mediator mobilization and release from 
azurophilic granules is associated with reduced localization of CD63, Hck and $-arrestin-1 to 
granule membranes and also cell surface upregulation of these molecules. Our study is first to 
identify piecemeal degranulation as a potential underlying mechanism of mediator release 
from neutrophil azurophilic granules and supports the involvement of CD63, Hck, and $-
arrestin-1 in this process.   
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Inflammatory response involves transcriptional regulation of nuclear receptors that play 
important functions in mediating lipid and drug metabolism in the kidney and liver. For 
example, expression of liver X receptor (LXR) and liver X receptor response element 
(LXRE)-driven transcription of several LXR target genes were reported to be regulated by 
inflammatory agents such as cytokines. And an orphan nuclear constitutive androstane 
receptor (CAR) that modulate phenobarbital response element (PBRU) of cytochrome P450 
genes is also involved during inflammation. This study reports modulatory actions of estrogen 
in transactivations of SXR-mediated LXRE and CAR-mediated PBRU in HepG2 cells. 
HepG2 cells were transiently transfected with either (LXRE)3-tk-luciferase reporter or 
PBRU2C1luciferase reporter plasmids. When cells were expressed exogenously with estrogen 
receptor (hER-alpha) and steroid and xenobiotic receptor (SXR), treatment with rifampicin 
and corticosterone promoted SXR-mediated transactivation of LXRE reporter gene 13-fold 
and 30-fold respectively, as compared with ethanol or 17-beta-estradiol treatment. However, 
combined treatment with estrogen plus rifampicin or corticosterone resulted in less than 50% 
in mean values of transactivation by rifampicin and corticosterone alone. These results may 
suggest that ligand-bound SXR can transactivate LXRE and estrogen has repressive effects 
via ER. The CAR-mediated PBRU transactivation was not influenced by Mox-estrol in the 
absence of transfected hER-alpha, but transfection with hER-alpha slightly stimulated CAR-
mediated PBRU2C1luciferase both in the absence and in the presence of the CAR agonist, 
TCPOBOP. More interestingly, the potentiation by estrogen receptor was significantly 
repressed by Mox-estrol in the agonist-bound CAR transactivation of PBRU. Thus, estrogen 
may play modulatory roles in transactivation of LXRE and PBRU of nuclear receptor target 
genes. 
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Notch Inhibition in Astrocytes: Implication for Inflammation and Microarray Analysis 
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mike.moro@uni.lu. 2 Microarray Center/CRP-Santé, 84 rue Val Fleurie, L-1926 
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In the injured CNS, astrocytes appear as a key component of reactive gliosis. Reactive 
astrocytosis is defined as a hypertrophy and often hyperplasia of these cells that is associated 
with an increased synthesis of GFAP and cytokines. The Notch pathway is implicated in 
many aspects of the CNS development and functions. More recently, the Notch pathway has 
been identified to be involved in inflammatory events of the CNS. In an attempt to understand 
the implication of this pathway on astrocytes, we have characterized the Jagged-Notch-Hes 
pathway under inflammatory conditions. LPS exposure induced an upregulation of Jagged1 
expression on astrocytes. To address the role of Jagged1 in the modulation of inflammation, 
we used a siRNA mediated silencing of Jagged1 (siRNA J1). siRNA J1 repressed the mRNA 
expression of genes known as hallmarks of the gliosis. On activated astrocytes, the inhibition 
of Jagged1 had anti-inflammatory effects and resulted in a decrease of LPS-induced 
proinflammatory cytokines as well as the iNOS expression. Moreover, Jagged1 inhibition 
modulated the NF-"B and JAK/STAT pathways. In the current study, Agilent whole rat 
genome oligonucleotide microarrays (41000K) were used to examine alterations in gene 
expression of astrocytes treated with siRNA J1. DNA microarray data filtration by intensity 
signal, x-fold change and p-value, revealed 3978 genes varying for the comparison ctr/siRNA 
J1 and 3577 genes for LPS/LPS+siRNA J1. Several clusters of genes involved in various 
cellular processes such as immune response, cell signaling, cell adhesion and many others 
were altered by the inhibition of the Notch pathway. Previous results showing a modulation of 
the NF-"B and JAK/STAT pathways could be confirmed in the microarray study. 
Interestingly, other pathways showed important variations due to Jagged1 inhibition (ex: IGF-
1 -, EGF -, chemokine - signaling), highlighting possible crosstalks between these signaling 
pathways and the Notch pathway.  
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Induction of atherogenic changes in vascular endothelial cells by radiation: role of the 
receptor for advanced glycation endproducts 
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Exposure to ionizing radiation is a prominent factor associated with increased cardiovascular 
morbidity and mortality. The aim of this study was to assess acute effects of moderate dose 
X-ray radiation (2 to 10 Gy) on atherogenic parameters in arterial (HAEC) and microvascular 
(HDMEC) endothelial cells. Three days after irradiation, activation of NF-kB, functional 
expression of the receptor for advanced glycation endproducts (RAGE), production of 
cytokines (TNFalpha, IL-6, MCP-1), leukocyte adhesion, and endothelial cell injury 
(thrombomodulin (TM)) was assessed in all cells compared to sham-irradiated controls. 
Irradiation of EC resulted in a dose-dependent augmentation of all parameters studied. When 
irradiated EC were treated with RAGE ligands (glycated LDL, recombinant human S100 
calcium binding proteins/calgranulins, cell debris from irradiated leukocytes), both production 
of cytokines and leukocyte adhesion was further upregulated. Moreover, a dose-dependent 
induction of EC injury (TM deficiency) could be observed after treatment with RAGE 
ligands. The effects modulated by RAGE were attenuated in the presence of molar excess of 
soluble RAGE (sRAGE). Taken together, the data suggest that after exposure to ionizing 
radiation the concerted action of autocrine and paracrine activation loops and, furthermore, 
multiligand ligation of the pattern recognition receptor RAGE contributes to a highly 
inflammatory and atherogenic state in vascular endothelial cells. 
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Molecular and functional links between the IKK complex, proteasomes and the CSN 
signalosome 
 
Johannes A. Schmid , Hannah Neumeier and Lukas Orel. 
 
Center for Biomolecular Medicine and Pharmacology, Dept. of Vascular Biology, 
Medical University Vienna, Austria. Email: Johannes.Schmid@meduniwien.ac.at 
 
A variety of signaling pathways regulating inflammation, cell development and cell survival 
require NF-kappa B transcription factors, which are normally inactive due to binding to 
inhibitors, such as I-kappa B alpha. The canonical activation pathway of NF-kappa B is 
initiated by phosphorylation of the inhibitor by an I-kappa B kinase (IKK) complex triggering 
ubiquitination of I-kappa B alpha by SCF-type E3-ligase complexes and rapid degradation by 
26S-proteasomes. The ubiquitination machinery is regulated by the COP9 signalosome 
(CSN), a complex of eight proteins homologous to 19S proteasome regulator subunits. We 
show that IKK-complexes interact with a functional super-complex consisting of SCF, CSN 
and 26S-proteasomes, providing an explanation for the rapid signaling-induced degradation of 
I-kappa B alpha. We found that IKK’s phosphorylate not only I-kappa B alpha, but also the 
CSN-subunit Csn5/JAB1 and that this subunit serves as negative regulator of basal NF-kappa 
B activity (Orel et al., 2009). The inhibitory effect requires a functional Csn5-MPN+ 
metalloprotease domain, which is responsible for cleaving ubiquitin-like Nedd8-
modifications. Upon activation of cells with TNF-alpha, CSN dissociates from IKK’s 
allowing full and rapid activation of the NF-kappa B pathway by the concerted action of 
interacting protein complexes. Furthermore, we have evidence that IKK molecules 
phosphorylate subunits of 26S proteasomes and influence proteasomal activity. All together 
our observations imply multifaceted mutual regulatory processes between protein complexes 
involved in NF-kappa activation, ubiquitination and proteasomal degradation. 
 
Ref: Orel L., Neumeier H., Hochrainer K., Binder B.R. and Schmid J.A. Crosstalk between 
the NF-kappaB activating IKK-complex and the CSN signalosome. J. Cell. Mol. Med. (2009) 
in press; published online July 28
th
 2009. 
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The role of TAK1 signaling in epithelial cells in maintaining intestinal homeostasis 
 
Katrin Schumann1, Andrea Hoffmann2, Astrid Westendorf1 
 
1 Mucosal Immunity Group, Institute of Medical Microbiology, University Hospital 
Essen 
2 Department of Trauma Surgery, Hannover Medical School, Hannover 
 
Disruption of the intestinal barrier results in overproduction of proinflammatory mediators, 
which are associated with inflammatory bowel disease. Given that TGF-#-activated kinase 1 
(TAK1) is an upstream signaling molecule of the NF-!B-pathway, it is suspected that TAK1 
might regulate epithelial growth, differentiation and apoptosis. To investigate the impact of 
TAK1 in the intestinal epithelium, we generated two transgenic mouse lines which 
overexpress functional active TAK1 (TAK1wt) or the inactive dominant negative variant of 
TAK1 (TAK1dn) specific in intestinal epithelial cells (IECs). RT-PCR and western blot 
analysis of sorted IECs exhibited the specific upregulation of TAK1wt and TAK1dn 
expression on RNA and protein level. In addition, gene expression analysis of IECs isolated 
from TAK1wt and TAK1dn demonstrated distinct expression profiles in comparison to non 
transgenic IECs. However, under normal conditions no spontaneously intestinal inflammation 
was observed. In future experiments we set out to investigate the role of TAK1 in acute and 
chronic colitis as well as in intestinal infections. 
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Association of NF-kB and Bax expression with apoptosis in varicose veins of aging 
women 
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The aetiology and pathophysiology of varicose vein disorders still remain  unclear.  NF-kB is 
implicated in multiple physiological and pathological processes, including cell proliferation 
and differentiation, inflammatory and immune response, cell survival and apoptosis. Thus 
changes in NF-kB expression, apoptosis and apoptosis associated proteins in veins of patients 
may contribute to an increased risk of varicosities. The aim of the study was to investigate the 
expression of NF-kB and Bcl-2 associated protein x (Bax) together with apoptosis (Ao) of 
endothelial cells (EC) and smooth muscle cells (SMC) in varicose veins of aging women. 
Women (n=30) undergoing the excision of varicose veins were divided into 3 groups: 
younger than 35 years (I), 35-50 years (II), older than 50 years (III). Apoptosis was 
determined using TUNEL method, NF-kB and Bax expressions were investigated 
immunohistochemically. Apoptotic cell percentages were counted in the EC and in SMC.  
Remarkable changes took place in the varicose veins of group II, in which NF-kB expression 
had the lowest level in all layers of the vein wall. Especially low NF-kB level was found in 
the media. NF-kB level rose again in all layers of the vein wall in group III. In group I NF-kB 
level was significantly higher in the adventitia. In group II Bax level, on the contrary, 
increased in all layers of the vein wall and  the most intensive expression of Bax was found in 
the media. The percentage of apoptotic EC of varicose veins increased in groups II and III, 
but the percentage of apoptotic SMC was higher in group II. 
In conclusion, the results demonstrate that changes of NF-kB and Bax expressions in the wall 
of varicose veins were different in middle-aged women, but were approximately at the same 
level in young and older women. EC and SMC apoptosis increased with advancing age.  
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Expression of CD44 on lymphocytes during experimental inflammatory response of 
bovine mammary gland 
 
Petr Slama 
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CD44 is a proteoglycan that is expressed by most cell types (leukocytes, fibroblasts, neurons 
and myeloid cells). CD44 plays a role in leukocyte trafficking to extra lymphoid sites of 
inflammation or as a non-specific accessory adhesion molecule
1
. The aim of this study was to 
inquire development over time of the surface expression of CD44 on lymphocytes during an 
inflammatory response of bovine mammary gland induced by lipopolysaccharide (LPS) and 
muramyl dipeptide (MDP). Intramammary application of LPS and MDP resulted in a 
significant increase in the proportion of CD44-positive lymphocytes after 24 hours. During 
resolution of inflammatory response, there was observed a decrease in the proportion of 
CD44-positive lymphocytes. The results suggest that the cell surface receptor CD44 play an 
important role in inflammatory response of bovine mammary gland to bacteria and their 
toxins and components. 
 
References: 
1
Harp JA, Waters TE, Goff JP, Bannerman DD, Paape MJ. Expression of lymphocyte homing 
and adhesion molecules during intramammary infection of cows with Serratia marcescens or 
Streptococcus uberis: Correlation with bacterial colonization and clinical signs. Veterinary 
Immunology and Immunopathology 2006, 109: 13-21.  
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The human paracaspase MALT1 is regulated by an intracellular serpin 
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Department of Molecular Biomedical Research, VIB, Technologiepark 927, Ghent, 
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Belgium. 
 
MALT1 is a caspase-like cysteine dependent protease that plays a key role in immunity and 
inflammation. Antigen receptor activation on T and B cells has recently been shown to induce 
the MALT1-mediated cleavage and inactivation of the ubiquitin-editing protein A20 (also 
known as TNFAIP3), which is known to have anti-inflammatory as well as tumor suppressor 
activities. Inhibition of MALT1 paracaspase activity therefore offers interesting potential in 
the treatment of autoimmune diseases or certain tumors. 
To understand the molecular mechanisms that regulate MALT1 protease activity, we focused 
on their potential regulation by serpins. Serpins are serine- and cysteine- dependent protease 
inhibitors, and inhibition of caspases or metacaspases by specific serpins has already been 
demonstrated before. For example, the Cowpox virus serpin CrmA is an efficient inhibitor of 
caspase-1 and 8, and AtSerpin1 inhibits Arabidopsis metacaspase-9. 
A screening of human intracellular (B-clade) serpins with a cleavage site fitting the substrate 
preference of MALT1 revealed a single serpin with MALT1 inhibitory potential. The serpin 
forms reduction-sensitive high-molecular weight complexes with proteolytically active 
MALT1 and inhibits MALT1-induced NF-kB activation and A20 cleavage. These data 
provide novel insight in the molecular regulation of MALT1. 
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Increased inflammatory response in diabetic placenta may depend on histamine 
concentration and expression of bradykinin receptors.    
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Wigury 61, 02-091 Warsaw, Poland. E-mail: Dszukiewicz@hotmail.com 
 
BACKGROUND: Increased histamine content and bradykinin levels were reported within 
diabetic placenta. Both compounds are well known mediators of the inflammatory reactions. 
Bradykinin induces mast cell degranulation, leading to increase in the local histamine 
concentration. Bradykinin B1 receptor shows strong involvement in the inflammatory 
response, whereas the B2 receptor mediates most of the effects induced by kinins. The aim of 
this study was to examine comparatively correlation between placental histamine 
concentration and placental bradykinin receptors B1 and B2 expression in diabetes class C 
versus normal pregnancy. MATERIAL AND METHODS: Sixteen diabetic placentae were 
compared with 16 normal placentae (Group I and II, respectively). Histamine concentrations 
in placental cuts were estimated fluorimetrically. Expression of B1 and B2 was examined in 
immunostained paraffin sections by quantitative morphometry in the areas matched in mean 
vascular density. RESULTS: Histamine concentration in Group I was significantly increased 
compared to Group II (387 ±25.3 versus 239 ±14.3 ng/g of wet weight ±SEM). Mean 
expression of the B1 was augmented in diabetes and reached 289.8% of the value for Group II 
(p<0.05). The differences in mean expression of B2 receptors were non significant. 
CONCLUSION: Increased amounts of histamine in placental tissue in diabetes producing 
pro-inflammatory conditions may change vascular properties to the some degree by influence 
on bradykinin receptors expression and vice versa (i.e. bradykinin may affect action of 
histamine). Pro-inflammatory reactions mediated via B1 should be expected rather, than 
changed vasomotor reactivity related to B2. Angiogenic properties of histamine and kinins 
should also be considered. 
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MageD2, a newly identified ATM substrate, regulates the DNA damage induced 
transcriptional response 
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Cellular responses to DNA damage are crucial for maintaining cell homeostasis and 
preventing the development of cancer. Of the many types of DNA damage that exist, the most 
dangerous is DNA double strand break (DSB). Ataxia Telangiectasia mutated (ATM) is a 
serine-threonine kinase, present in the nucleus that is activated by DNA double-strand breaks 
(DSBs). This kinase phosphorylates a number of proteins (including p53, Chk2, BRCA1,…) 
involved in cell cycle checkpoint control (G1/S, intra-S and G2/M), apoptosis, transcription 
responses and DNA repair.  
In order to identify new ATM partners, we have performed a yeast 2 hybrid experiment with 
two ATM fragments and a HeLa cDNA library. We have identified 18 proteins and one was 
selected to verify its interaction with ATM in an eukaryotic environment and investigate its 
potential role in DSB cellular response. 
MageD2 is a member of the MAGE (Melanoma Antigen) genes family and is expressed in 
various normal adult human tissues. This protein has a MAGE homology domain and a 
hydrophobic domain. The functions of the MAGE genes are partially unknown but it would 
seem that the MAGE genes are important for cell survival, cell cycle progression and 
apoptosis. 
According to the known ATM target consensus sequence “SQ”, we have identified four ATM 
putative phosphorylated sites within the primary structure of mage D2. In vitro kinase assays 
have allowed us to establish that mageD2 is a novel substrate of ATM kinase, and that 3 
serines are phosphorylated. The importance of these phosphorylations in the DNA Damage 
Signaling Pathway is investigated.  
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Cigarette smoke and alpha,beta-unsaturated aldehydes elicit VEGF release through the 
p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts 
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The angiogenic factor vascular endothelial growth factor (VEGF) is elevated in the sputum of 
chronic obstructive pulmonary disease (COPD) smokers as well as in the asymptomatic 
smokers and correlate with smoking pack years. Consistent with this notion is our observation 
that inhalation of cigarette smoke for 3 days elevated VEGF in broncho-alveolar lavage fluid 
(BALF) of mice. In order to investigate the mechanism through which cigarette smoke elicits 
VEGF release we challenged cultured human airway smooth muscle cells (ASMC) and 
normal human lung fibroblasts (NHLF) with aqueous cigarette smoke extract (CSE). VEGF 
release was characteristically elevated by sub-toxic concentrations of CSE in both ASMC and 
NHLF, in a concentration-dependent fashion. In both ASMC and NHLF cultures, CSE-
evoked VEGF release was mimicked by acrolein, crotonaldehyde and 4-hydroxy-2-nonenal 
(4-HNE) at concentration range of 10-100 uM, and fully prevented by a scavenger of 
alpha,beta-unsaturated aldehydes, N-acetylcysteine (NAC, 0.3 mM). CSE-evoked VEGF 
release was accompanied by a rapid and lasting p38 MAPK and ERK1/2 phosphorylation in 
ASMC which was blocked by NAC and mimicked by acrolein. VEGF release elicited by both 
acrolein and CSE was abolished by pharmacological inhibition of p38 MAPK signaling but 
not by selective inhibitors of ERK1/2 or PI3K. Taken together, our data indicate that 
alpha,beta-unsaturated aldehydes of endogenous (4-HNE) or exogenous (smoke) origin, 
evoke VEGF release from pulmonary resident cells via p38 phosphorylation pathway. Given 
the pivotal role of VEGF as angiogenic factor, our results shed light on the mechanisms 
through which cigarette smoke can initiate vascular remodeling in the lung. 
 
Key words : COPD, Airway smooth muscle cells, fibroblasts, VEGF, p38, acrolein. 
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Adhesion molecules play vital roles in airway hyperresponsiveness or airway inflammation. 
Our previous study indicated an alpha-catenin-related protein, catenin alpha-like 1 
(CTNNAL1) was downregulated in asthma patients and animal model. We also observed that 
the expression of CTNNAL1 was increased with the acute ozone stress. CTNNAL1 
contribute to the wound repair and proliferation of human bronchial epithelial cells (BECs). In 
the present study, we determined molecular mechanisms of CTNNAL1 regulation in human 
BECs. 8 oligonucleotide probes corresponding to various regions of the CTNNAL1 promoter 
were used in EMSA (electrophoretic mobilityshift assays). 5 were found to have an enhanced 
mobility shift with extracts from BECs. On the basis of the assay of mutated probes and 
antibody supershift, they were verified as LEF-1, AP-2" and CREB. Next, ChIP (chromatin 
immunoprecipitation) assay was used to observe the interaction between these transcription 
factors and CTNNAL1 promoter. Only AP-2" and LEF-1 show the binding on CTNNAL1 
promoter. By site-directed mutagenesis of putative transcription-factor-binding sites within 
pGL3/FR/luc, we observed a reduction in human CTNNAL1 promoter activity of mutants of 
both AP-2" and LEF-1 sites. The time courses of AP-2" and LEF-1 activation, followed by 
CTNNAL1 expression were also examined. It was shown that ozone stress can activate the 
AP-2" and LEF-1 within one hour, ozone-inducible CTNNAL1 expression and AP-2" and 
LEF-1 binding activity correlated during a-16 hour time course. Our data suggest that a robust 
transcriptional CTNNAL1 up-regulation occurs during acute ozone-induced stress and is 
mediated at least in part by ozone-induced recruitment of LEF-1 and AP-2" to the human 
CTNNAL1 promoter. 
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Helicobacter pylori-infected gastric epithelial AGS cells 
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Monocyte chemoattractant protein (MCP-1) plays an important role in the recruitment of 
monocytes to the site of tissue injury. We previously demonstrated that Helicobacter pylori 
(H. pylori) in Korean isolates induces the expression of cyclooxygenase-2 (COX-2) and 
MCP-1 which is mediated by the activation of AP-1 and NF-kB in gastric epithelial AGS 
cells. Prostaglandin E2 (PGE2) is a product of COX-2 in various cells. The present study aims 
to investigate the role of PGE2 on H. pylori -induced MCP-1 expression in AGS cells. As a 
result, H. pylori induced expression of MCP-1. Treatment of PGE2 enhanced the H. pylori-
induced MCP-1 expression. The expression of MCP-1 up-regulated by H. pylori and PGE2 
was inhibited by H-89, an inhibitor of protein kinase A (PKA). The results indicate that PGE2 
modulates H. pylori-induced MCP-1 expression in a PKA-dependent manner. DNA-binding 
activity for cAMP response element binding protein (CREB), which is reported to be 
mediated by protein kinase A, was increased by H. pylori and PGE2. Furthermore, PGE2 
augmented H. pylori-induced activation of AP-1 and NF-kB in AGS cells. In conclusion, PGE 
mediates inflammatory signaling including NF-kB, AP-1 and CREB and induction of MCP-1 
in a PKA-dependent manner in H. pylori-infected gastric epithelial cells.  
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Selective regulation of nuclear orphan receptors 4A by adenosine receptor  
subtypes in activated mast cells   
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Nuclear orphan receptors 4A (NR4A) belong to the superfamily of hormone receptors and 
comprise NR4A1 (Nur77), NR4A2 (Nurr1) and NR4A3 (NOR-1). These early responsive 
genes have been associated to transcriptional activation of multiple genes involved in 
inflammation, apoptosis and cell cycle control. In this study, we established a link between 
NR4As and adenosine, a paradoxical inflammatory molecule that can contribute to 
persistence of inflammation or mediate inflammatory shutdown.  Transcriptomics screening 
of the human mast cell-line HMC-1 revealed a sharp induction of transcriptionally active 
NR4A2 and NR4A3 by the adenosine analogue NECA. A2AAR silencing exaggerated this 
effect, suggesting that upregulation of these factors is mediated by other AR subtypes (A2B 
and A3) and that A2AAR activation counteracts NR4A2 and NR4A3 induction. A similar 
effect was observed by the concomitant treatment with NECA and the A2AAR selective 
antagonist SCH-58261. Interestingly, upregulation of these factors correlated with ERK1/2 
phosphorylation (but not with CREB activation) and could be partially reverted by PKC or 
MEK1/2 inhibition. Furthermore, selective A2AAR activation with CGS-21680 decreased 
both PMA/ionomycin-induced ERK1/2 phosphorylation and upregulation of functional 
nuclear orphan receptors 4A.  Taken together, these results establish a novel 
PKC/ERK/nuclear orphan receptors 4A axis for adenosinergic signalling in mast cells, which 
can be modulated by A2AAR activation, not only in the context of adenosine but of other 
mast cell activating stimuli as well. 
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Lipoic acid prevents wound healing inhibition induced by dietary n-3 fatty acids in rats 
 
Andres Arend and Marina Aunapuu 
 
Department of Anatomy, University of Tartu, Biomedicum, Ravila 19, Tartu 50411, 
Estonia. andres.arend@ut.ee 
 
Applying rat liver wound healing model we have previously shown the suppressive effect of a 
n-3 PUFA-rich diet on the wound healing process, where the proliferetion of the connective 
tissue was suppressed together with increased level of lipid peroxidation, the peroxidizability 
of lipids and decreased content of 2-series prostaglandins (PGs). It is known that any injury of 
tissue is followed by a normal inflammatory response and several products of lipid 
peroxidation, as chemo-attractants, are able to disturb the normal migration of neutrophils and 
monocytes as well the proliferation of fibroblasts. As lipoic acid (LA) when provided 
exogenously in pharmacological doses, may serve as an antioxidant the present study was 
performed to test the influence of LA on the n-3 PUFA-induced inhibition of connective 
tissue proliferation in the rat liver wound. The experiments were performed on male albino 
Wistar rats. The first group of animals served as a control-group kept on the standard diet low 
in unsaturated fatty acids. The second group of animals was on a diet where 10% of sunflower 
oil was added to the standard pellets. The third group of rats was fed with standard pellets 
with 10% addition of cod liver oil (containing over 25% of n-3 PUFAs). The animals were 
fed with above-mentioned diets for 8 weeks. Then, 10 days before the operation, 0.1% of 
lipoic acid (DL-6,8-thioctic acid) was added to all diets and feeding was continued for six 
days postoperatively. The test model used was a liver thermic wound of a standard size. LA 
prevented the suppression of connective tissue proliferation in the healing wound induced by 
n–3 PUFAs, avoided the increase in peroxidation of lipids, reduced peroxidizability of lipids 
and modulated the decrease in PGE2 and PGF2alpha content. LA also improved glutathione 
redox status (GSSG/GSH) both in the liver tissue and in the liver wound. It seems that the 
elevation of the level of reduced glutathione (GSH) in liver might have an impact on the 
protective effect of LA. It can be concluded that the protective effect of LA on the 
suppression of wound healing induced by n–3 PUFAs includes the prevention of increased 
lipid peroxidation and the maintenance of a suitable spectrum and/or level of 2-series PGs. 
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TNF-alpha induced release of pro-inflammatory proteins by cystic fibrosis IB3-1 cells 
encapsulated in alginate microbeads 
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The inflammatory processes activated in cystic fibrosis are complex and need the 
development of specific systems to possibly study the mechanism of bacterial activation of 
cystic fibrosis cells, as well as the effect of the secreted chemokines on target cell 
populations. To this aim, we have developed an ionic alginate microencapsulation procedure 
for the entrapment and manipulation of IB3-1 cystic fibrosis cells. This microencapsulation 
procedure does not alter viability and the secretomic profile of encapsulated IB3-1 cells. 
Most of the analyzed proteins (members of the interleukin family, chemokines, growth 
factors and soluble forms of adhesion molecules), using Bio-plex technology, were secreted 
both by the free and encapsulated cells, even if in a different extent. In order to determine the 
biotechnological applications of this procedure, encapsulated and free IB3-1 cells were 
treated with TNF-alpha and after 24 hours the culture media from both cell populations were 
collected. As expected, TNF-alpha induced a sharp increase in the secretion of interleukins, 
chemokines and growth factors. Of great interest was the evidence that induction of IL-6 and 
IL-8 occurs also by encapsulated IB3-1 cells. In conclusion, the encapsulation of secreting 
cells in alginate microbeads represents a promising strategy for biotechnology applications in 
tissue engineering and biomedicine. 
 
Funded by SPINNER (CAPS-IT Project), COCHISE UE Project, Fondazione Cariparo 
(Cassa di Risparmio di Padova e Rovigo), Telethon (contract GGP07257). 
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DEVELOPMENT OF NEW ALPHALISA NO-WASH IMMUNOASSAY KITS FOR 
SENSITIVE, RAPID AND EFFICIENT QUANTIFICATION OF CYTOKINES 
  
Véronique Brechler, Lucille Beaudet, Claire Normand, Julie Blouin, Mireille Caron, 
Josée Frappier, Nancy Gauthier, Thomas Lassalle, Jean-Philippe Lévesque-Sergerie, 
Martin Loignon, Nancy MacDonald, Alexandre Marcil, Valérie Paquet, Liliana Pedro, 
Lenka Rihakova, Roberto Rodriguez-Suarez, Marjolaine Roy, Marie-Hélène Venne, 
Francesco Lipari and Stéphane Parent. 
  
PERKINELMER INC. BIO-DISCOVERY, MONTRÉAL, QUÉBEC, CANADA. 
  
Enzyme-linked Immunosorbent Assay (ELISA) is the most widely adopted method for 
detection and quantification of cytokines and other biomarkers. This traditional technology 
offers good selectivity, sensitivity and assay versatility; however, it has certain disadvantages 
such as limited dynamic range and low throughput due to the numerous wash steps. In 
addition, ELISA is not well suited for the use of medium or low affinity antibodies. In 
contrast, chemiluminescent bead-based AlphaLISA® assays do not face these limitations. 
AlphaLISA dynamic range is generally between 3 to 4.5 log units and the absence of wash 
steps allows performing these assays in high throughput mode. Assay development is simple 
and fast, and hands-on time as well as total assay time is significantly reduced. AlphaLISA 
assays are easy to miniaturize and automate enabling both Research and High Throughput 
Screening (HTS) laboratories to efficiently quantify analytes of interest. PerkinElmer has 
developed several AlphaLISA assays for the detection and quantification of cytokines in cell 
culture supernatants and serum samples. Experiments showing Lower Detection Limit (LDL) 
and dynamic range will be presented. The performance of the assays is excellent, including a 
large dynamic range, high sensitivity, accuracy and precision. The overall results confirm the 
user-friendly AlphaLISA technology as a new generation of tools available for 
immunoassays. 
#
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The important role of molecular chaperones (HSPAs/HSP70s) in oral cavity and oral 
inflammatory diseases 
 
Giuseppina Casella (1), Riccardo Polosa (2) 
 
(1) University of Catania, Doctoral of Search in Interceptive Ortognatodontics, 
coordinator Prof. M. Caltabiano, Departiment  of  Specialities Medical-Surgical, Section 
of Odontostomatologic II, Street S. Sofia, 78 – 95124 Catania, mail: g.casella@unict.it 
(2) University of Catania, Institute of Internal Medicine, S. Marta Hospitals, Street 
Gesualdo Clementi, 36 – 90124 Catania, mail: polosa@unict.it  
 
Heat shock proteins of the 70kDa family (HSPAs/HSP70s) are major molecular chaperones 
and cytokines of most cells and microbes, extracellular and interstitial fluids, blood, synovial 
fluids and secretory body fluids like saliva. The induction of human HSPAs plays an 
important role at cellular level under most stress conditions; whereas microbial HSPAs 
improve microbial tolerance to environmental changes, and improve virulence and resistance 
against antimicrobial peptides. Extracellular HSPAs reveal cytoprotective properties and are 
involved in numerous physiological and pathological events, including modulation of 
cytokine release and immunity. Accordingly, HSPAs play a role in the maintenance of pulpal 
health, and the repair of injured dental hard tissues. HSPAs also play a role in stress 
adaptation of periodontal tissues, and in the maintenance of periodontal and mucosal health 
including defense against microbes, prevention of mucosal allergic reactions, and facilitation 
of healing of ulcers and wounds. Despite their advantageous effects maintaining health of 
several oral tissues, HSPAs are likely to play a role in the disadvantageous amplification of 
pulpal inflammatory response to bacteria, and in the formation of several periapical 
inflammatory lesions. HSPAs may also induce gingivitis under certain conditions, and play a 
role in the progression of periodontal bone defects. HSPAs may also play a role in atopic – 
type allergic reactions, autoimmune disorders, and haptenation in certain cases. Based on the 
above data, it can be assumed that HSPAs play an important role in oral defense under 
healthy conditions; however, their role is somewhat “Janus-faced” under pathological 
conditions.    
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Role of CXC chemokines in innate immune response of Teleost fish 
 
Magdalena Chadzinska1, Lieke van der Aa2,3, B.M. Lidy Verburg-van Kemenade2 
 
1Jagiellonian University, Ingardena 6, 30-60, Krakow, Poland, 
magdalena.chadzinska@uj.edu.pl, 2.Wageningen University, the Netherlands, 3.The 
National Institute of Agronomical Research, Jouy en Josas, France 
 
A large array of chemokines is known in mammals, some of which are important 
chemoattractants induced during the pro-inflammatory phase of inflammation. Others are 
constitutively expressed in the lymphoid organs and in the central nervous system, where they 
are crucial for development. To date a fair number of CXC chemokines (CXCL) were 
discovered in Teleost fish, but for the majority orthology with any particular mammalian 
CXCL is difficult to establish. Current discovery of a new carp CXCL (CXCL8) motivated us 
to study the profile of CXCL and CXC receptor (CXCR) expression during the immune 
response of carp (Cyprinus carpio L). Two in vivo models of inflammation were used: 
zymosan-induced peritonitis (Z) and hyperosomotic shock (HI). Gene expression of CXCL 
(CXCL8, CXCa, CXCb) and their receptors (CXCR1, CXCR2) was measured by RQ-PCR. 
Hyperosmotic treatment induced mild disruption of the integrity of the gill epithelia, and was 
related to rapid granulocyte migration. Immediately, after HI treatment substantial up-
regulation of expression of the CXCL8 gene was observed in gills, while only small effects 
were detected for CXCa and CXCb. Expression of CXCR1, but not CXCR2, was up-
regulated in the HI group 3-24 h after treatment. Z-injection induced acute peritonitis, 
manifested by massive influx of phagocytes. Expression of CXCL8, CXCa and CXCR1 was 
quickly and significantly up-regulated in peritoneal leukocytes. Increase of expression of 
CXCb and CXCR2 was recorded in peritoneal leukocytes during the later phase of 
inflammation. The expression profile of CXCs and their receptors in carp leukocytes suggests 
that CXCL8, CXCa and CXCR1 are connected with the acute inflammatory response with 
quick granulocyte migration, while CXCb and CXCR2 are related to the later resolution 
phase. 
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Mobility of 2-oxoglutarate in plant in response to C- and –N metabolim under cadmium 
stress 
 
Chiraz Chaffei-Haouari1,2, Afef Hajjaji-Nasraoui1, Elisa Carrayol2, Mohamed Habib 
Ghorel1 and Houda Gouia1 
 
1Unité de Recherche : Nutrition et Métabolisme Azotés et Protéines de Stress (99UR/09-
20), Département de Biologie, Faculté des Sciences de Tunis. Campus Universitaire El 
Manar I, 1060, Tunis- Tunisie. 
2Unité de Nutrition Azotée des Plantes, INRA, route de Saint Cyr, 78027 Versailles- 
France. 
 
In plant leaf, 2-oxoglutarate is present at relatively low levels when compared to other organic 
acids. It has been shown that 2-oxoglutarate levels depend upon metabolic fluxes related to C- 
and N- metabolism, although it is not known whether 2-oxoglutarate fluctuations reflect a 
change in a given enzymatic activity. Indeed, 2-oxoglutarate levels are dependent on 
inorganic and organic N content and their related metabolism as well as nitrate and sugar 
levels. This has been studied in nitrate accumulation decrease and NR activity decrease in 
tomato leaves that led to an increase in 2-oxoglutarate content under conditions where 
glutamine levels stayed low. In tomato plants, leaf 2-oxoglutarate levels responded to N 
starvation when glutamine levels were low, nitrate was absent, NR activity was reduced, and 
sugar root allocation had increased. Sugar provided to detached tomato leaves induced a 
dramatic rapid increase in 2-oxoglutarate levels without any subsequent change in NR 
activity. Taken together, such data indicate that plant cell 2-oxoglutrate levels can reflect C/N 
status, and therefore this organic acid could play a signalling role in the co-ordination of C 
and N metabolism. 
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+-oxidation modulates metabolic competition between eicosapentaenoic acid and 
arachidonic acid regulating prostaglandin E2 synthesis in rat hepatocyte-Kupffer cells  
 
Zhen-Yu Du1*, Tao Ma2, Synnøve Winterthun1, Karsten Kristiansen2, Livar Frøyland1, 
Lise Madsen1,2 
 
1 National Institute of Nutrition and Seafood Research (NIFES), P.O. Box 2029 Nordnes, 
N-5817 Bergen, Norway; 2 Department of Biology, University of Copenhagen, 2200 
Copenhagen, Denmark; * Correspondence:  zdu@nifes.no 
 
The ability of n-3 PUFA to competitively inhibit the use of arachidonic acid (AA) for 
membrane phospholipids synthesis and prostaglandin E2 (PGE2) production has been well 
demonstrated in single cell models. In the present study, metabolic competition between AA 
and eicosapentaenoic acid (EPA) for PGE2 synthesis in a rat hepatocyte-Kupffer cell 
(HPC/KC) co-culture system was investigated when the cellular oxidation capacity was 
enhanced by exogenous L-carnitine. Here we demonstrate that in absence of L-carnitine, 1) #-
oxidation rates of EPA and AA were comparable in HPC and in KC; 2) AA was preferentially 
incorporated into glycerolipids rather than EPA; 3) addition of EPA significantly decreased 
AA-dependent PGE2 synthesis in HPC and cyclooxygenase-2 (COX-2) expression in co-
cultured HPC/KC. However, the addition of L-carnitine 1) significantly increased #-oxidation 
of EPA in HPC, but only marginally elevated the oxidation of AA in HPC and the oxidation 
of both fatty acids in KC; 2) decreased the esterification, but did not alter the preferential 
incorporation of AA into glycerolipids; 3) alleviated the significant competitive inhibition of 
AA-dependent PGE2 synthesis and COX-2 expression by EPA. Taken together, the results 
strongly suggest that L-carnitine affects competition between AA and EPA in PG synthesis in 
liver cells by enhancing oxidation of EPA in HPC. This implies that the beneficial effects of 
n-3 PUFA, especially EPA, are affected by cellular oxidation capacity.  
 
Keywords: L-carnitine; eicosapentaenoic acid; arachidonic acid; prostaglandin E2; #-
oxidation; hepatocyte-Kupffer cell co-culture 
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Endothelial ICAM-1 protein expression is regulated by cytosolic phospholipase A2a via 
both NFkB and CREB transcription factors 
 
Nurit Hadad,  Liron Tuval, Vered Elgazar-Carmom and Levy Rachel  
 
Infectious Disease and Immunology Laboratory, Clinical Biochemistry Department, 
Faculty of health Sciences, Soroka Medical University Center and Ben-Gurion 
University of the Negev, Beer  Sheva 84105, Israel. 
 
The regulated expression of intercellular adhesion molecule-1 (ICAM-1) plays an important 
role in inflammatory process and in immune responses. The present study aimed to determine 
the in vivo involvement of cytosolic phopholipase A2a (cPLA2a) in ICAM-1 over-expression  
during inflammation and to elucidate cPLA2a specific role in signal events leading to ICAM-1 
upregulation in endothelial cells. Elevated cPLA2a and ICAM-1 protein expression were 
detected in inflamed paws of mice with collagen induced arthritis and in periepdidymal 
adipose tissue from mice fed a high fat diet.  Intravenous  injection of 2 mg/kg oligoantisense 
against cPLA2a (AS) that reduced the elevated  cPLA2a  protein expression  also decreased 
ICAM-1 over-expression suggesting a key role of  cPLA2a in ICAM-1 up-regulation during 
inflammation.  Preincubation of endothelial ECV-304 cells with 1mM AS prevented cPLA2a  
and ICAM-1 up-regulation induced by TNFa and inhibited their adherence to phagocyte like-
PLB cells. NADPH oxidase inhibitors, DPI or apocinine, inhibited cPLA2a activation, 
suggesting that the NADPH oxidase acts upstream to cPLA2a. Attenuating cPLA2a activation 
by AS or DPI prevented the induction of COX2 and the production of PGE2 that were 
essential for ICAM-1 up-regulation by TNFa.    AS or DPI inhibited the  phophorylation of 
both the redox sensitive p65 NFkB on serine 536  and PKA-dependent CREB on serine 133. 
Our results are the first to show that CREB activation is involved in ICAM-1 up-regulation 
and suggest that cPLA2a activated by NADPH oxidase, is required for both NFkB 
phosphorylation by an undefined kinase and CREB activation by PGE2 mediated PKA.  
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Specific enhancement of TLR2 activity in chronically activated astrocytes 
 
Anja Henn, Susanne Kirner, Marcel Leist 
 
Doerenkamp-Zbinden Chair for Alternative in vitro Methods, Department of Biology, 
University of Konstanz; 78457 Konstanz, Germany - AnjaHenn@uni-konstanz.de 
 
Activated glial cells secrete inflammatory factors that have been implicated in several 
neurological diseases. In CNS inflammation, microglia and astrocytes interact with respect to 
the regulation of local innate immune reactions. However, up to now the knowledge about 
microglia-astrocyte interaction under repeated inflammatory stress is relatively scarce. 
Therefore, in this work, we investigated activation of primary astrocytes under sequential 
stimulation conditions. For a first stimulus of primary astrocytes, we used conditioned 
medium of the microglia-like cell line BV-2, which has been activated with LPS. Microglia 
are a major source of cytokines such as IL-1ß and TNF" which are potent activators of 
astrocytes. Alternatively a more defined proinflammatory cytokine mix (CCM) which 
contained TNF", IL-1ß and IFN$ was applied as primary stimulus. In both cases, activated 
astrocytes expressed higher levels of several genes linked to inflammation. In particular, 
expression of some pattern recognition receptors (PRRs) was upregulated significantly. This 
altered phenotype may be important in chronic inflammation and leads to the question 
whether pre-activated astrocytes react in a different way to a secondary stimulus which targets 
PRRs or cytokine receptors. In this work, we focus on Toll-like receptor 2 (TLR2) and its 
ligands as a secondary stimulus. As readouts we used NF-kB activation as receptor-proximal 
signal and cytokine (IL-6) secretion as more distal event. We found reactivity of astrocytes 
towards a secondary stimulus was increased. Pre-stimulated astrocytes reacted more readily to 
a secondary stimulus compared to non-prestimulated cells. This finding might be crucial for 
the understanding of CNS host response under chronic stress conditions and its 
pharmacological modulation. 
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TNF-alpha is involved in the release of the acute phase protein PTX3 in lung co-cultures 
exposed to particulate matter from wood combustion and traffic.  
 
Jan I Herseth 1, 2, Vivi Volden 2, Per E Schwarze 1, Anette Kocbach Bølling 1 
 
1Division of Environmental Medicine, Norwegian Institute of Public Health, P. O. Box 
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2Faculty of Health Sciences, Oslo University College, P.O. Box 4 St. Olavs plass, N- 0130 
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Exposure to ambient particulate matter has been associated with cardiopulmonary morbidity 
and mortality, and inflammation is thought to play a role in the pulmonary and cardiovascular 
effects induced by particles. Long pentraxin 3 (PTX3) is a newly discovered acute phase 
protein produced by cells involved in innate immunity as well as by bronchial and alveolar 
epithelial cells. Through interaction with for instance pathogens, growth factors and the 
complement factor C1q, PTX3 may be involved in tuning of the inflammatory response. It has 
also been suggested as a new marker of innate immunity and inflammation, reflecting tissue 
and vascular bed responses. The pro-inflammatory cytokines IL-1 and TNF-alpha have both 
been found to induce release of PTX3. In this study, we used a contact co-culture of 
monocytic and pneumocytic cell lines to determine the release of PTX3 induced by wood 
smoke particles (WSP) and different types of traffic derived particles (TDP) after 12, 40 and 
64 h of exposure to 40 micrograms/cm
2
. In addition, anti-TNF-alpha and IL-1 receptor 
antagonist were used to investigate the influence of these two pro-inflammatory cytokines on 
the release of PTX3. All particle samples induced a significantly increased release of PTX3 
from the co-culture after 40 and 64 h of exposure, but TDP were generally more potent 
inducers of PTX3. TNF-alpha, but not IL-1, was involved in the release of PTX3 induced by 
WSP, whereas both these cytokines seemed to be involved in the PTX3 release induced by 
TDP. The role of PTX3 in particle induced inflammation has not been studied in any detail, 
and this is the first study investigating the release of PTX3 induced by ambient particulate 
matter in an in vitro model system. Although the role of PTX3 in particle toxicology needs 
further elaboration PTX3 may become an interesting marker for particle-induced 
inflammation. 
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Determination of TNF-& in inflamed radicular cysts 
 
Vladimir Jurisic, Tatjana Terzic, Milan Jurisic 
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TNF-" is pleiotropic cytokine that is considered a primary modifier of inflammatory and 
immune reaction in response to various diseases. It is induce stimulation of osteoclastic bone 
resorption and helps fibroblast to release collagenase and participated also in inflammation. 
Based on these multiple effects we investigated its values in 33 radicular cysts obtained from 
patients with radicular cysts in maxillofacial region. The cysts were surgically enucleated 
under local anaesthesia. After this mucoperiostal flap was raised and cystic fluid was 
aspirated from non-ruptured cysts, than aspirate is immediately centrifuged to remove cells 
and supernatant was stored at -70˚C until use in ELISA assay.  TNF-" was analyzed in respect 
to clinical symptoms, cystic diameter, localization based on radiographic and histological 
examinations. In addition, each section was stained with hematoxylin-eosin and by 
immunohistochemistry using Anti-CD3, anti-CD20 and anti-CD68 monoclonal antibodies to 
access presence of inflammatory cells in pericystic tissues. These results show increase in 
TNF- " concentration in radicular cysts based on several clinical parameters including cysts 
volume, the protein concentration in cystic fluid as well as on histological findings including 
cyst wall thickness, count and subtype of inflammatory cells and degree of vascularization 
analyzed in cyst wall (Spearman correlation, p <0.05). We believe that determination of TNF-
" simultaneous with other clinical parameters can help in classification, earlier and better 
diagnosis of these cysts in routine practice. 
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Glutathione S-transferase polymorphism and the association with cytokine markers in 
Korean smokers  
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Science, Kyung Hee University, Yongin-si, 446-791, Korea 
 
Inflammation is the body's first line of defense against injury or infection or even wider array 
of chronic illnesses. Long-term cigarette smoking is associated with activation of a cascade of 
inflammatory response that leads to tissue injury and dysfunction. Glutathione S-transferases 
(GST) are a family of enzymes that detoxify xenobiotics such as carcinogens present in 
cigarette smoke and has been shown to exert different effect based on the phenotype of this 
enzyme. In this study, we tried to compare the level of cytokines between 48 smokers and 197 
non-smokers and to examine whether these effects are dependent on their differences in GST 
polymorphism. The levels of TNF- " and interleukin (IL-6) were compared and we found that 
smokers had decreased level of TNF-" and increased level of IL-6 (p<0.001). When the 
inflammation markers were tested for relationship with antioxidant nutrient status (total 
radical trapping antioxidant potential, lipid peroxidation, vitamin C level) there were no 
significant relationship except negative association between the level of vitamin C and IL-6 in 
non-smokers. These result were again tested based on their GST genotype (GSTM1, GSTT1), 
but, found no significant differences. We observed that IL-6 inflammation marker is elevated 
in smokers, but, did not find any significant link regarding GST polymorphism. It may be 
possible that we need a bigger sample size for detecting any differences and for drawing a 
clinically significant conclusion.  
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Mono-2-ethylhexylphthalate (MEHP) activates both pro- and anti-inflammatory signals  
 
Anette Kocbach Bølling, Mónica S Korsnes, Jørn A Holme, Rune Becher  
 
Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404 
Nydalen 0403 Oslo, Norway (anette.kocbach@fhi.no, monica.korsnes@fhi.no, 
jorn.holme@fhi.no, rune.becher@fhi.no).  
 
Phthalates are plasticizers that are used in a wide range of commercial products. Since they 
are not chemically bound to the plastic they leak out to the environment, causing human 
exposure through inhalation, diet and skin. Epidemiological studies have associated indoor 
exposure to phthalates with increased incidences and severity of asthma in children and 
adults. Although airway inflammation has been suggested as a possible mechanism for these 
effects, the underlying cellular mechanisms for phthalate-induced effects are still largely 
unknown. 
Since macrophages are known to be involved in the pathogenesis of asthma, we used the 
murine macrophage cell line RAW264.7 to investigate possible signalling pathways activated 
during exposure to mono-2-ethylhexylphthalate (MEHP). Exposure to 0.1-1.0 mM MEHP 
increased the formation of reactive oxygen species (ROS), whereas concentrations from 
0.3mM induced a significant release of TNF-alpha as well as a necrotic cell death. By using 
the p38 specific inhibitor SB202190, we found that the mitogen activated kinase p38 appeared 
to be involved in the release of TNF-alpha. MEHP induced activation of p38 was confirmed 
by Western blotting showing increased levels of phospho-p38 after 30 min exposure to 0.1 
and 0.5 mM MEHP. The levels of phospho-Akt were also increased at this time point, 
suggesting a concomitant activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway. 
This pathway is known to be involved in innate immunity through regulation of cytokine 
production, and PI3K was recently found to limit the TNF-alpha production in monocytes. 
However, the role of the PI3K/Akt pathway in the MEHP-induced release of TNF-alpha 
needs further investigation. 
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Expression of the Luteinizing Hormone receptor in the spongious tissue 
 
Kersti Kokk1, Marianne Kuuslahti3, Tiina Keisala3, Sami Purmonen3, Antti Kaipia2, 
Teuvo Tammela2, Helle-Evi Simovart1, Helen Orro1 and Pasi Pöllänen3,4 
 
1Department of Anatomy, University of Tartu, Tartu, Estonia, E-mail: 
Kersti.Kokk@ut.ee 
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Recent works show that the inflammatory cytokines implication in hypothalamo- hypophyso-
corticosuprarenal and gonad axis have consequence on ACTH, corticoids and LH secretion, 
explaining the gestational disorders. The proportion of men with serum LH > 6.0 U/l and 
serum testosterone > 9.8 nmol/l, i.e. of men with subclinical hypogonadism, increases 
significantly between 40 and 70 years. As the proportion of men with erection disturbances 
increases simultaneously, it is possible that the elevated LH concentrations are involved in the 
generation of the erection disturbances. The precondition for this is the expression of LH 
receptor in the spongious tissue.  In the present study, the expression of the LH receptor in the 
male mouse spongious tissue was studied to see, if LH effects are possible in the spongious 
tissue. Balb/c mice were used as donors of normal penis spongious tissue and testis tissue. 
Immunocytochemistry, Western blotting and quantitative RT-PCR reactions were used for the 
detection oh the LH receptor. Positive immunoreaction for the LH receptor was found in the 
mouse penis spongious tissue using immunocytochemistry. Western blotting experiments 
demonstrated the presence of LH antigen at Mr = 97. 4 and 78 kD. Quantitative RT- PCR 
reactions confirmed the expression of LH receptor in the spongious tissue. Our results suggest 
that LH receptor is expressed in the male spongious tissue of the mice and thus the elevated 
LH levels of the aging men with subclinical hypogonadism may affect the spongious tissue. 
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De novo generation of cytokine-responsive astrocytes from murine embryonic stem cells  
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Astrocytes are the most abundant glial cell type in the brain. They are involved both in the 
maintenance of physiological homeostasis and in inflammatory responses. Research into the 
inflammatory response of these cells would benefit from the availability of astrocytes 
cultures free of other glial contaminants. One approach to obtaining a reliable and 
reproducible cell culture system is differentiation of the cells from embryonic stem cells 
(ESC). We present here a method to generate highly astroglial-enriched cultures from ESC 
and characterise them for inflammatory signalling responses. During the differentiation of 
both, embryonic and neural stem cells, astroglial markers (GFAP, S100b, A2B5, CD44) were 
upregulated while the transient neural markers nestin, NCAM, and bIII-tubulin were 
downregulated in the final cultures. The presence of astroglial markers in about 90% of the 
cells of the culture and the absence of any microglial markers and of the neuronal markers 
NCAM and bIII-Tubulin indicate a specific differentiation process. We demonstrated 
inflammatory signalling capability of our astrocytes by nuclear factor kB translocation into 
the nucleus and an increased release of IL-6 and NO into the supernatant upon stimulation 
with a proinflammatory cytokine mix. ESC-derived astrocytes and neural stem cell-derived 
astrocytes showed the same response pattern as astrocytes isolated from mouse brain. 
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Greatly increased levels of acute phase protein serum amyloid A (SAA) have been reported 
during acute and chronic inflammation. They predict the risk of coronary artery disease and 
even mortality in humans. SAA is an active player in atherogenesis, although its mechanism 
of action is still unclear. In physiological concentrations, SAA plays a protective role in 
bacterial and viral infections. The objectives of this study are to understand the role of SAA in 
human coronary artery endothelial cells (HCAEC) and to determine its cellular localization. 
Our broad hypothesis is that secreted versus intracellular SAA have different functions that 
could lead to either protective or degradatory responses. The mechanism of how SAA works 
lead us to address the presence of SAA candidate cellular receptors. The identification of 
FPRL1/ALX, TANIS, CLA1, RAGE, TLR2 and TLR4 was confirmed in HCAEC and 
HUVEC using RT-PCR. Their mRNA expression was similar in interleukin-1beta or SAA-
stimulated cells as compared to background controls, with the exception of TLR2, which was 
greatly increased in stimulated cells. TLR2 could be one of the major SAA receptors 
responsible for its role in promoting atherosclerosis. Immunofluorescence, cell fractionation 
studies and Western blots indicated prominent intracellular localization of SAA in HCAEC in 
the cytoplasm and in the nuclear fraction. Association of SAA was also found with 
microtubules and the membrane/vesicular fraction. Especially interesting is the fact that 
HCAEC do not secrete SAA in response to proinflammatory stimuli, as is the case for 
hepatocytes. In conclusion, the majority of SAA synthesized in HCAEC stays within the cells 
and could play a variety of different functions based on the compartments it is located in. 
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It has been reported that prostaglandin E2 (PGE2), one of the major products of 
cyclooxygenase-2 (COX-2), promotes cancer progression. 15-Hydroxyprostaglandin 
dehydrogenase (15-PGDH), a key enzyme for degradation of PGE2, was initially found to be 
down-regulated in colon cancer. In the present study, we have found that 15-deoxy-&
12,14
-
prostaglandin J2 (15d-PGJ2), one of the terminal products of COX-2, upregulates 15-PGDH 
expression in human breast cancer (MDA-MB-231) cells. 15d-PGJ2-induced 15-PGDH 
expression correlated with suppression of MDA-MB-231 cell migration. Of the several 
candidates of 15-PGDH regulators, Ets was considered as a major determinant responsible for 
the 15-PGDH-inducing effects of 15d-PGJ2 as assessed by the luciferase assay by use of 
deletion constructs of 15-PGDH promoter. Elk-1, one of the Ets family members, was 
activated by treatment of 15d-PGJ2. Taken together, these findings suggest that 15d-PGJ2 may 
exert an anti-carcinogenic effect by upregulating the expression of 15-PGDH, a putative 
tumor suppressor. 
 144 
Session II     Poster II, 17 
 
Intestinal model of Inflammation in primary cells 
 
S. B. Lobo1, M. Denyer1, F. A. Javid2 
 
1School of Pharmacy, University of Bradford, Bradford, UK (S.Lobo1@bradford.ac.uk; 
(M.Denyer@bradford.ac.uk) 
 2School of Applied Sciences, University of Huddersfield, Huddersfield, UK 
(fajavid@hud.ac.uk) 
 
The gastrointestinal tract contains an enormous mucosal surface, which is continuously exposed 
to antigens hence making it susceptible to an inflammatory response. Such response targets 
potential pathogens by direct activation of the mucosal immune cells, however, in newborns the 
continuous inflammation attacks the intestine which leads to induction of necrotising 
enterocolitis.  The present study aims at developing an “in-vitro” intestinal model of inflammation 
to assist in understanding the complex interplay of pro-inflammatory mediators during the 
immune response in neonates. Segments (1.5cm length) from the ileum were obtained from SD 
rat neonates (1-4 days old) and exposed to 0.25% trypsin/EDTA for 30min. Following trituration 
and subsequent centrifugation for 5min at 450xg, cells were suspended in DMEM-Hepes 
supplemented with 10% FCS, 2.5% Penicillin/Streptomycin, 2.5% L-Glutamine, and 0.2% 
Amphotericin B. Cell suspension were transferred to culture flaks and incubated at 37°C. Once 
confluent, the cell preparation media was replaced by FCS-free media, and treated with 0, 10, 50, 
and 100'g/ml of LPS. IL-8 and nitric oxide (NO) response were subsequently measured. In 
separate studies cell proliferation, cell viability, and cell adhesion were analysed. Additionally, 
the phenotypic properties of the intestinal muscle cells were also investigated via 
immunocytochemistry. Initial studies demonstrated that LPS treatments induced a significant 
increase in the release of IL-8 and NO compared to controls. The effect of LPS treatments on cell 
dynamics demonstrated small changes in cell viability and adhesion, whereas an increase in cell 
proliferation was observed. Immunocytochemistry studies indicated that LPS treatment caused a 
decrease in the expression of actin fibers with impaired distribution compared to controls. In the 
present model key aspects of intestinal inflammation were replicated “in-vitro” including the 
activation of pro-inflammatory mediators, the loss in enteric innervations and subsequent tissue 
hyperplasia. Thus, this model may be used as a tool to investigate the anti-inflammatory 
properties of candidate drugs targeting functional GI diseases. 
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Background: Cytokines are mediators and regulators of inflammatory processes. We 
investigated neuropsychiatric patients with acute inflammation of the CNS (non-bacterial 
meningitis (N-MEN)), assumed chronic low level neuroinflammation (schizophrenic SCH-S 
and affective spectrum disorders PSYCH-A) and tension headache (CEPH) of unknown 
origin. Cytokines determined were proinflammatory cytokine IL-1beta, T cell derived IL-2, 
the proinflammatory IL-8/CXCL8, antiinflammatory IL-10 and IL-17. Purpose: to 
differentiate chronic and acute neuropsychiatric diseases by cytokine profiles and to evaluate 
cytokine levels in the CSF and peripheral blood to characterize the two distinct compartments.  
Methods:   In total 10 N-MEN, 10 CEPH, 15 PSYCH-A and 16 PSYCH-S patients were 
included. Peripheral blood and CSF was taken at the same time. CSF parameters were 
evaluated by conventional methods, cytokines determined on a sensitive commercial 
multiplex immunoassay platform (Mesoscale) by a modified protocol. Statistics: Mann-
Whitney-U-Test and Kruskal-Wallis H-Test. Results: Serum and CSF levels:   Highest levels 
of IL1b, IL-2, IL-8 and IL-17 were observed in the CSF of N-MEN, whereas in serum, levels 
were not or slightly elevated. Significant (p<0.05) tested in CSF for N-MEM versus 
CEPH,PSYCH-A,PSYCH-S for IL-8 and versus PSYCH-A,PSYCH-S for IL-17.  IL-10, CSF 
levels were also highest in N-MEM, and significant also versus CEPH,PSYCH-A,PSYCH-S, 
but IL-10 in serum was even higher than in CSF, although not significant as compared to all 
other patient groups.  We observed in all cytokine (except IL-2) significant differences either 
in serum or in CSF or both between the diseases; but more frequent CSF than in the serum. 
Conclusions: Investigation of cytokine levels in CSF is more sensitive than in serum to detect 
significant differences between neuropsychiatric diseases, establishing the CSF as a distinct 
compartment for cytokines. Cytokine patterns are disease specific and may be used for 
therapy monitoring. Elevated IL-1beta, IL-2 and IL-8 CSF/serum ratios in N-MEM may 
indicate an intrathecal synthesis of these cytokines. 
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and effects of the double point mutation in its putative ubiquitination sites on 
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Bile acids act as signaling molecules and inflammatory agents that modulate nuclear receptors 
and signaling pathways that regulate metabolic homeostasis. Several lines of evidence 
established that small heterodimer partner (SHP) plays an important role in maintaining 
cholesterol homeostasis by bile acid mediated feedback inhibition of cholesterol 7alpha 
hydroxylase (CYP7A1) gene. Recent studies demonstrated that SHP is a target of ubiquitin-
proteosomal degradation with K122 and K123 being major ubiquitination sites. Individual 
mutation on each of these ubiquitination sites (K122R, K123R) altered the repression activity 
of SHP. This study further examined in vitro ubiquitinations of different regions of SHP 
fragments (1-92, 92-160, 160-260) and sumoylation of SHP proteins. When in vitro translated 
GST-SHP-wild type protein was incubated with HA-ubiquitin, high molecular weight forms 
of ubiquitinated GST-SHP were detected. Whereas both 1-92 and 160-260 regions decreased 
in ubiquitinated forms, the 92-160 region of the GST-SHP fragment showed significant 
increase and even higher than SHP wild type in ubiquitination. However, SHP did not show 
any sumoylation although discrete sumoylated bands occurred in liver receptor homolog-1 
(LRH-1), a nuclear receptor protein known to be regulated by sumoylation. This study also 
examined the effects of double point mutation in putative ubiquitination sites of SHP 
(K122/123R) on transactivation of hCYP7A1 gene and GAL4-TATA-luciferase reporter in 
hepatoma cell lines. Whereas K123R mutation increased the repressive activity of SHP on 
hCYP7A1 transactivation in HepG2 cells, double point mutation of K122/123R decreased its 
repression activity of hCYP7A1 transactivation in HepG2 and did not differ from wild type in 
transactivation of GAL4-TATA-luciferase reporter in H1c1c7 cells. These results suggest that 
major ubiquitinations within the 92-160 region of the SHP can be influenced by conformation 
of the protein, and the double point mutation of K122/123R may affect both the stability and 
the activity of SHP in transcriptional modulation. 
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It is accepted that a sexual dimorphism exists in the mammals’ immune function. In fact, evidences suggest 
that while estrogens enhance the immune response, androgens inhibit it and gonadectomy alters this 
response. Exposure to androgens early in life development is essential for masculinization of the male 
phenotype. Male fetuses exposed to anti-androgens during peri-natal life are permanently demasculinized 
in their morphology and physiology. The discovery of androgen-active chemicals in the environment has 
placed increased emphasis on describing the effects of both natural and environmental androgens and anti-
androgens on the physiology of the male individual. Thus, the aim of the present study was explore in the 
male rat the effect of neonatal flutamide (F) treatment, a selective androgen receptor blocker, on peripheral 
TNFa levels during the acute phase response of endotoxemia at adult age. Five day-old male Sprague-
Dawley rats were s.c. treated with a single injection of a small volume of either sterile corn oil alone 
(control animals, C) or containing 1.75 mg F. After weaning, rats were individually housed and kept with 
free access to Purina chow diet and water until experimentation. On the experimental day (age 100 days), 
animals were submitted to ketamine anesthesia and the right jugular vein was exposed, in a room with 
sterile atmosphere. Thereafter, rats were bled before (sample time zero) and at several hours (1-4 h) after 
i.v. injection of 25 micrograms/Kg BW of bacterial lipopolysaccharide (LPS, Sigma-Aldrich; dissolved in a 
small volume of sterile physiological NaCl solution as vehicle). The volume of blood collected at every 
time was immediately replaced by the same volume of red blood cells resuspended in heparinized-sterile 
vehicle. Due to the small blood volume of samples, only plasma tumor necrosis factor alpha (TNFa) 
concentrations were measured (ELISA) in samples taken from C and F rats. Our data indicated that no 
group differences were found in circulating TNFa concentrations when evaluated in samples from the time 
zero (n=9 rats per group). On the other hand, significantly (p<0.05 vs. C values) higher TNFa plasma 
concentrations were found in the F group at 1 h post-LPS. Thereafter, circulating TNFa levels remained 
(samples taken at 2 and 3 h post-LPS) elevated (albeit not significantly) over C values in F rats. Finaly, 
TNFa values on time 4 h post-LPS recovered sample time zero-values in both groups examined. The area 
under the curve of circulating TNFa concentrations during the study resulted significantly (p<0.05) higher 
in F than in C rats. Our study add new data sustaining a suppressive role of endogenous androgens on pro-
inflammatory cytokine release in plasma during acute endotoxemia and, strongly supports a sex steroid 
basis for immunological sexual dimorphism in mammals. 
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Estrogen undergoes oxidative metabolism by CYP1B1 to form 4-hydroxyestradiol (4-OHE2), 
a putative carcinogenic metabolite of estrogen. Further oxidation of this catechol estrogen to  
quinine through redox cycling produces reactive oxygen species (ROS) which can either 
cause DNA damage or stimulate abnormal cell proliferation. Our previous study showed that 
4-OHE2-induced ROS production contributed to neoplastic transformation of human breast 
epithelial (MCF-10A) cells (S.-A. Park et al., Cancer Res., 2009). In this study, 4-OHE2 
increased heme oxygenase-1 (HO-1) expression by activating antioxidant response element 
(ARE)-mediated Nrf2 signaling. By utilizing human HO-1 promoter reporter plasmids and the 
ChIP assay, we have identified that 4-OHE2 transcriptionally activated the upstream ARE-rich 
enhancer region of the human HO-1 promoter. Induction of HO-1 expression by 4-OHE2 was 
attenuated by a pharmacological inhibitor of PI3K/Akt as well as siRNA Nrf2 gene knock 
down. Furthermore, 4-OHE2-induced expression of HO-1 was abolished by the antioxidant N-
acetyl-L-cysteine (NAC) and trolox. Inhibition of HO-1 expression and activity by siRNA 
knock-down of HO-1 gene and chemical inhibition of HO-1 enzymatic activity by zinc 
protoporphyrin IX (ZnPP) abrogated 4-OHE2-induced cell migration. Moreover, ZnPP 
suppressed 4-OHE2-induced matrix metalloproteinase-9 (MMP-9) mRNA expression. A 
recent report has revealed that HO-1 renders tumor cells resistant to photodynamic therapy-
mediated cytotoxicity. Although a role of HO-1 in 4-OHE2-induced hormonal carcinogenesis 
has not been fully clarified yet, the upregulation of this stress-responsive enzyme may provide 
cancer cells with survival advantage. In this context, HO-1 may hence represent a novel target 
for chemoprevention and treatment of breast cancer.  
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PPAR gamma activation diminishes tymic stromal lymphopoietin mRNA level in Caco-2 cells 
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Thymic stromal lymphopoietin (TSLP) – a cytokine secreted constitutively from various epithelia – is 
considered as a very important agent in the crosstalk between epithelial and dentritic cells, driving the 
balance towards the mucosal homeostasis. Peroxisome proliferator-activated receptors $ ligands are 
also believed to calm down inflammation in the gut. The aim of this study was to investigate the 
influence of PPAR$ activation on the production of TSLP in human colon tumour derived Caco-2 
cells. In the high density culture these cells undergo spontaneous differentiation into the intestinal 
enterocytes. Caco-2 cells were cultured in DMEM supplemented with 10% FCS or in Q286 epithelial 
cells serum free medium (PAA, Germany). The cells were seeded on permeable membranes of cell 
culture inserts (LD, 0.4'm) at initial density of 2.5x105 and were differentiated for 6 days. At that time 
the expression of sucrase-isomaltase, a marker of mature enterocytes, increased about 100-fold 
although TSLP and PPAR$ mRNA level were not significantly changed. TSLP and PPAR$ transcripts 
were also present in cells cultured at low density on plates. Since natural ligands of PPAR$ 
(conjugated linoleic acid, CLA) and its partner receptor – RXRa (dietary retinoids) – are components 
of normal diet, enterocytes are constantly exposed to its action. To mimic this physiological situation 
Caco-2 cells were stimulated with natural (conjugated linoleic acid, CLA mixed isomers, 1'M) and 
synthetic (ciglitazone, 1'M) PPAR$ ligands in the presence or absence of 9-cis retinoic acid (9-cis-RA 
1'M).  After 3 or 18 hours the total cellular RNA was isolated and mRNA levels of the selected genes 
were evaluated by RT-PCR. The analysis was performed on cells seeded in low density on plates 
(undifferentiated) and on cells cultured for 6 days on inserts (differentiated cells). The experiments 
demonstrated that only the mixture of PPAR$ ligand and 9-cis-RA reduced the amount of TSLP 
transcripts to almost undetectable level in differentiated cells. This effect was not observed when these 
agents were used separately. In undifferentiated Caco-2 cells cultured on plates in low density 
activation of PPAR$ and its co-receptor did not change the level of TSLP mRNA. Caco-2 cells were 
frequently treated as the model of functional enterocytes. Our results point out the importance of cell 
culture conditions in analysing the regulation of inflammatory gene expression in the in vitro studies.  
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Lymphocyte functions are strongly dependent on cell surface receptor signaling. Recently it 
was shown that alkylating agents in the dose 100 fold lower than cytostatic one are capable to 
disturb signal passage through various cell surface receptors, such as IL-2R, TNFR and Fas. 
Molecular mechanisms of the receptor blockage were investigated on model of TNF 
signaling. We succeeded in demonstration that low concentrations of alkylating agent 
melphalan (Mp) protect murine fibroblastoid cells against TNF-a-induced cytotoxicity. The 
protection did not depend on de novo protein synthesis. Moreover, no increase in NF-kB in 
nuclear extracts of Mp-treated cells was observed. At the same time, 1-hour treatment with 
Mp markedly reduced NF-kB activity in nuclear extracts of the cells challenged with TNF-a. 
These data support the suggestion that specific alkylation of components in the cytoplasm or 
cell membrane by Mp interferes with surface receptor signaling pathway. Among a large 
variety of T cell subsets only regulatory T cells (Tregs) constitutively express high affinity 
receptor for IL-2, the cytokine, which is the factor of their growth and survival. Surplus 
accumulation of Tregs is known to be at the bottom of many morbid conditions among them 
being neuropsychiatric diseases. In particular, Tregs may inhibit Th1 cells, including brain 
autoimmune lymphocytes, controlling the local microglial response. Malfunction of these 
cells leads to the appearance of neurodegenerative foci. The animal model of Treg 
accumulation has been used. BALB/c mice were chronically treated with dexamethasone and 
IL-2. Spatial learning/memory was assessed in the Morris Water Maze Behavioral Test. It 
was shown that the pharmacologically-induced Treg accumulation leads to cognitive and 
behavioral abnormalities, which may be prevented by Mp administration. Indeed, already on 
the 2
nd
 day of training the percentage of Mp-treated mice, which were able to find a 
submerged platform, was significantly higher (p=0.04; Wilcoxon paired test) than in untreated 
animals after Treg induction. In conclusion, disturbance of IL-2 signaling with alkylating 
agents is a new safe method of Treg elimination. 
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There is some evidence that probiotics may be protective against intestinal bowel disease 
diseases, depending on the strain and/or mixture of probiotics, however the underlying 
mechanisms are still largely unknown. A regulation of lamina propria lymphocytes (LPLs) 
function by probiotics in colitis has been indicated, but data are lacking on possible 
involvement of intraepithelial lymphocytes (IELs). The aim of this study was to investigate 
whether a probiotic mixture prevented gut inflammatory disease and the role of both IELs and 
LPLs in such protection, using a murine model of colitis. BALB/c mice received orally a 
mixture of Lactobacillus acidophilus Bar 13 and Bifidobacterium longum Bar 33, daily for 3 
weeks. Colitis was induced by intrarectal administration of trinitrobenzene sulfonic acid 
(TNBS), 48 h before the end of the experimental period. An increase of L. acidophilus and B. 
longum were found in the stools after 1, 2 and 3 weeks of probiotic treatment. The probiotic 
mixture was able to prevent the TNBS induced intestinal inflammation and ulcerations. While 
no differences were observed in LPLs, in IELs a reduction in CD4+, an increase in 
gammadelta T cells, and an expansion of regulatory T cells, both Treg (CD4+CD25+Foxp3+) 
and Tr1 (CD4+IL-10+) cells, were found associated with the protection elicited by the 
probiotics. A significant increase of apoptosis of both CD4+ and CD8+ in IELs was induced 
by the probiotics, whereas no differences were observed in the spleen. In addition, the 
probiotic mixture was able on one side to inhibit the TNF-alpha, MCP-1, IL-12 and IFN-
gamma increase induced by TNBS, and on the other side to up-regulate IL-10 production. Our 
results indicate that the L. acidophilus and B. longum mixture was able to prevent the TNBS 
induced colitis and suggest the importance of the IELs population in such protection. 
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Silicon dioxide (SiO2) is abundant in nature as crystalline quartz particles, and is known to 
cause chronic inflammation and lung fibrosis (silicosis) upon long-term exposure. Lung 
macrophages are known to release the pro-inflammatory cytokine IL-1beta after phagocytosis 
of micrometer-sized crystalline silica particles. The induction of IL-1b release occurs by 
activation of the intracellular NALP3 receptor, a cytoplasmic pattern recognition receptor 
known to recognize crystalline structures. Upon activation, NALP3 assembles a protein 
complex (inflammasome) that activates caspase-1, which in turn cleaves pro-IL-1b to its 
mature form. NALP3-deficient mice have decreased pulmonary inflammation and fibrosis 
after silica challenge, suggesting an important role of NALP3 in silica-induced pathology. 
Due to increasing utilization, a critical question is whether silica particles of nano-size have 
the same pathogenic potential. The mouse macrophage RAW cell line and primary rat lung 
macrophages were primed with LPS for 3 hours, and then exposed to increasing 
concentrations of  nano-sized silica particles (30 nm, 50 nm and 100 nm) and crystalline silica 
(MinUsil; median diameter 5 micrometer) for 6 hours, and then analyzed for IL-1beta release 
by ELISA. A marked dose-dependent IL-1b response was observed for all particles in both 
cell systems. The IL-1b release both by the silica NPs and MinUsil was blocked by 10 
microM of the Capase-1 inhibitor zYVAD-fmk, and by the actin inhibitor cytochalasin D, 
suggesting an uptake-dependent, inflammasome-mediated mechanism. In conclusion, non-
crystalline silica particles of nano-size markedly induce IL-1b release from cultured 
macrophages that may involve an inflammasome mechanism, as previously reported for 
large-sized crystalline silica particles. Further experiments are in progress to confirm NALP3 
engagement by non-crystalline silica NPs. Moreover, to address whether the nano-size alone 
is important for this pathogenic mechanism, other non-crystalline nanoparticles and their 
micro-sized counterparts are now included in this study. 
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Neuroinflammatory processes are etiologically important in neurodegenerative diseases such as Alzheimer’s 
disease (AD). Proinflammatory cytokines promote AD, whereas anti-inflammatory therapeutics may delay 
the onset of the disease. The level of mitochondria-derived reactive oxygen species (mtROS), induced by 
proinflammatory cytokines, is a central pathogenic determinant in AD and several other neurodegenerative 
diseases. MtROS create oxidative damage upon ambient neurons, which is closely associated with neuronal 
damage. Consistently, reduction of mtROS suppresses neuroinflammatory processes. To study basic 
pathogenetic mechanisms in inflammatory neurodegenerative diseases, we have established C. elegans as a 
new model system for analysing the impact of aging and pharmacological intervention on the formation of 
mtROS, structural and functional neurodegeneration, and changes in lifespan. To mimic neuroinflammatory 
processes, we increased mtROS formation by suppression of the C. elegans APE1 ortholog exo-3, a central 
component of the mtDNA repair system. To evaluate reduction of mtROS as a therapeutic option, animals 
were treated with FCCP, an uncoupler of the mitochondrial electron transport chain. Generation of ROS 
increased steadily during aging of wild-type C. elegans (WT), and to a greater extent in exo-3 RNAi-treated 
animals. Sites of ROS generation colocalized with the neuronal system. FCCP significantly reduced ROS 
formation in both groups. Neuronal damage was not detected in WT up to the age of 12 days, whereas exo-3 
RNAi induced structural disintegrity by the age of 6 days. FCCP did not affect neuronal structure in WT and 
clearly reduced neuronal damage in animals treated with exo-3 RNAi. To assess loss of neuronal function, 
different parameters of motility were analyzed. Exo-3 RNAi significantly reduced head and whole animal 
motility. FCCP did not affect WT and significantly increased motility in animals with exo-3 suppression. 
Mean and maximum lifespan were significantly reduced by exo-3 RNAi, whereas FCCP significantly 
increased lifespan in WT and exo-3 RNAi-treated C. elegans. These data demonstrate for the first time that 
levels of mtROS formation are closely linked to structural and functional neurodegeneration and lifespan in 
C. elegans. Accumulation of mtROS may explain the reported association between aging, rising prevalence 
of neurological diseases and persistent neuroinflammatory events. Thus, reduction of mtROS production may 
represent a therapeutic option for the treatment of inflammatory neurodegenerative conditions. 
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2-MBQ (2-methoxy-1,4-benzoquinone) and 2,6-DMBQ (2,6-dimethoxy-1,4-benzoquinone) 
have been known to anti-carcinogenic components in fermented wheat germ. In this study, we 
have examined the effects of 2-MBQ and 2,6-DMBQ on apoptosis through different 
regulation of redox signaling pathway in HT-29 colorectal cancer cells. Our results showed 
that the 2-MBQ and 2,6-DMBQ have the potent anti-carcinogenic effects in HT-29 cell and in 
vivo xenograft models. 2-MBQ and 2,6-DMBQ treatment increased ROS generation which 
was correlated with decrease of cell viability. 2-MBQ and 2,6-DMBQ (10 and 50 µM) 
treatment increased an apoptosis of HT-29 cells. In 2,6-DMBQ treated group (30 µg/g/day) 
tumor volume was reduced by 44% when compared to tumor group in vivo xenograft model. 
To investigate the mechanisms of apoptosis by 2-MBQ and 2,6-DMBQ in HT-29 cells, the 
expression of redox state-apoptosis proteins such as p53, p-ASK1, pro-caspase, cleaved-
PARP and COX-2 were analyzed. The 2-MBQ treatment increased p53 expression 
accompanied with a marked increase in pro-caspase and cleaved-PARP expression, and the 
2,6-DMBQ treatment increased p-ASK1 expression. Both 2-MBQ and 2,6-DMBQ inhibited 
the expression of COX-2. These results suggest that the regulation of redox state may be 
important in anti-carcinogenic effects of 2-MBQ and 2,6-DMBQ through different controlling 
mechanism upon p53 and p-ASK1 expression. Moreover, apoptosis by regulation of redox 
state may be closely related to COX-2.  
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In osteoarthritis, the onset of inflammatory processes has been recently recognised as a 
decisive factor for the degradation of cartilage tissue. Despite the significance of 
glycoproteins for extracellular matrix assembly in cartilage, little is known about the 
regulation of the chondrocyte glycophenotype under inflammatory conditions. The present 
study aimed to assess the impact of pro-inflammatory cytokines interleukin-1ß (IL-1ß) and 
tumor necrosis factor-# (TNF-#) on the glycophenotype of primary human chondrocytes. 
Particular focus was set on the sialylation of chondrocyte glycoprotein N-glycans and O-
glycans. The transcription of 11 sialyltransferase (SiaT) genes was quantified using real-time 
RT-PCR assays, whereas N-glycan and O-glycan analysis was performed using LC-ESI-MS. 
We found that primary human chondrocytes predominantly express "-2,6-specific SiaTs and 
accordingly, "-2,6-linked sialic acid residues in glycoprotein N-glycans. Importantly, a 
considerable shift towards "-2,3-linked sialic acids and "-2,3-specific SiaT mRNA levels 
occurred in primary chondrocytes treated with IL-1ß or TNF-". In general, diminished 
ST6Gal1 and increased ST3Gal4 mRNA levels appear to be responsible for this shift towards 
enhanced "-2,3-sialylation under inflammatory conditions. Similarly, downregulated 
ST6GalNAc3 and increased ST3Gal1 mRNA levels resulted in increased "-2,3-sialylation of 
O-glycans. Given the involvement of sialylated glycoproteins in many biological processes 
including cell-matrix interactions, the presented findings may shed light on their significance 
for cartilage homeostasis and on their function as trigger molecules for cellular signaling 
pathways in osteoarthritis. 
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Role of the PGE2 and EP receptors in the regulation of the mast cell activation induced 
by osmotic changes 
 
Ivonne Torres A.1, Fernando de Mora P.2, Margarita Martín A.1, César Picado1 
 
1Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, 2Departament of 
Pharmacology, Therapeutic and Toxicology of UAB. Barcelona, Spain. E-mail: 
ivonne.torres@campus.uab.cat 
 
Mast cells are known for their critical roles in asthma and others, allergic and inflammatory 
diseases. Their versatility and is attributable to their capability to produce a wide array of 
regulatory and proinflammatory mediators. Exercise produces AHR in some asthma patients. 
The mechanism for exercise-induced bronchoconstriction (EIB) has been suggested to be 
related to an increased airway fluid osmolarity. This may activate mast cells which 
subsequently release mediators that act on bronchial smooth muscle leading to 
bronchoconstriction. In parallel protective substances such as PGE2 are probably also released 
and could explain the observed refractory period in patients with EIB.The aim of this study 
was to characterize the effect of PGE2 in human mast cells under hyperosmolar stimulation. 
Cells from the human mast cells line LAD2 were osmotically stimulated with mannitol. Mast 
cell activity was determined by #-hexosaminidase (#-Hex) release assay Mast cells 
degranulation, cytokine production and PGE2 secretion were measured. LAD2 cells expressed 
EP2/EP3/EP4 receptors. Interestingly, PGE2 inhibited degranulation induced by mannitol in a 
concentration-dependent manner. Using selective EP receptors antagonists we found that 
PGE2 can either potentiate or suppress mannitol-induced degranulation. Osmotic changes 
induced release of PGE2 and cytokine production. PGE2 modulates mannitol-induced 
hyperosmolar stimulation of human mast cells through interaction with EP receptors. The 
concentration of PGE2 may be critical to trigger an activating or inhibitory response in the 
human mast cell line, LAD2. 
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Hippocampal gene network analysis to determine the effects of antioxidant treatment in 
an experimental model of accelerated senescence  
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Advanced Science Institute, RIKEN 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 
Kanagawa 230-0045, Japan, E-mail: asato@gsc.riken.jp (AS), akitamoto@riken.jp 
(AK), ada@gsc.riken.jp (NA), tkojima@riken.jp (TK). 3, The Institute for Creative 
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Senescence-accelerated mouse prone 8 (SAMP8) is widely used as an animal model of 
accelerated aging. The accelerated aging in this model is known to be partially retarded by the 
administration of an antioxidant agent. To clarify the molecular events that occur during 
accelerated aging and the molecular mechanism underlying the effects of antioxidants on the 
aging process, we performed a comprehensive gene expression analysis of the hippocampus 
of SAMP8 mice and normal control animals (SAMR1) with/without the administration of an 
antioxidant agent, i.e., coral calcium hydride (CCH), by using a DNA microarray. A large 
difference in gene expression was observed between the SAMR1 and SAMP8 models. The 
most significant difference was upregulation of genes related to the inflammatory and other 
immune response in SAMP8, although some immune response-related genes were 
downregulated. The difference observed in hippocampal gene expression in the SAMP8 
model by the effect of CCH administration was much less than the difference between the 
SAMR1 and SAMP8 models. An intriguing effect of CCH administration was upregulation of 
the genes related to inflammation. Our result suggests that CCH may be effective to some 
extent as an antioxidant agent and may retard the accelerated senescence observed in SAMP8 
through the regulation of genes related to the inflammatory response. 
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Intracellular Serum Amyloid A is colocalized with E.coli within mouse urothelial cells 
 
Peter Veranic1, Andreja Erman1, Katja Lakota2, Katjusa Mrak-Poljsak2, Blaz Rozman2 
and Snezna Sodin-Semrl2*(ssodin1@yahoo.com) 
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Serum amyloid A (SAA) is an acute phase protein involved in homeostasis of inflammation. 
SAA is necessary in host defense and has beneficial properties in protection against viral and 
bacterial infections. In salmon, E.coli content is correlated with higher SAA. It is also used as 
a sensitive marker during bacterial infection (E.coli) of reindeer. As an acute-phase marker, 
SAA acts similarly in humans and mice, making murine models accessible. This has not been 
the case with the classical inflammatory marker, C-reactive protein (CRP) which is 
inapplicable in mice. Urothelial infections have been especially difficult to treat since latent 
intracellular pools of bacteria remain in urothelial cells, also after treatment with antibiotics, 
and cause episodes of recurrent cystitis without evident re-infections. When SAA is present 
and/or under the appropriate conditions/conformation/interaction, it might downregulate and 
protect from development of recurrent infections. The aim of this study was to understand the 
role of SAA in murine infections of the urothelium with E.coli. Our experiments revealed that 
SAA is highly expressed in urothelial cells of E. coli infected mice versus non-infected mice. 
Especially, there is a high increase in cytoplasmic SAA during infection as compared to the 
nuclear SAA in urothelial cells. We also have evidence that SAA can be colocalized with 
cytoskeletal elements which are supposedly the attachment sites for the clusters of E. coli. We 
propose that SAA can serve as a marker for E.coli urothelial infection where it could also 
perform bactericidal functions. 
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Involvement of Peroxisome Proliferator-Activated Receptor (PPAR) gamma in 
epithelial tolerance against muco-active ribotoxic stress 
 
Hyun Yang and Yuseok Moon 
 
Department of Microbiology and Immunology and Medical Research Institute, Pusan 
National University School of Medicine, Yangsan, 626-813 Korea; Email: 
moon@pnu.edu 
 
Inflammatory bowel diseases (IBD) are aggravated by disrupted epithelial barrier integrity. 
Some muco-active ribotoxic stresses are known to cause IBD-like symptom including 
mucosal intolerance by triggering the production of pro-inflammatory mediators by enhancing 
mRNA stability. Elav-like RNA binding protein 1 (ELAVL1) positively regulates mRNA 
stability of AU-rich elements (ARE)-containing transcripts such as pro-inflammatory 
mediators. We investigated the effects of ribotoxins on ELAVL1 translocation and its 
involvement in the regulation of the pro-inflammatory interleukin-8 (IL-8) mRNA stability. 
Exposure to the muco-active ribotoxins induced nuclear export of both endogenous and 
exogenous ELAVL1 protein in human intestinal epithelial cells. Moreover, ELAVL1 was 
shown to be involved in ribotoxin-induced IL-8 mRNA stabilization. It was also demonstrated 
that ELAVL1 was regulated by peroxisome proliferator-activated receptor gamma (PPAR 
gamma). PPAR gamma retarded DON-triggered cytoplasmic translocation of ELAVL1, 
which led to suppression of IL-8 production. In this study, ELAVL1 was the positive 
regulator for IL-8 production, and regulated by PPAR$ in anti-directional coupled manner. 
ELAVL1 and PPAR gamma were critical mechanistic links between ribotoxic stress and the 
pro-inflammatory cytokine production, and may have a broader functional significance with 
regard to gastrointestinal insults by muco-active ribotoxic stresses. (This work was supported 
by the Korea Research Foundation (KRF) grant funded by the Korea government (MEST) 
(No.2009-0065479)). 
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Antiinflammatory effect of a leguminous lectin isolated from Canavalia maritima seeds 
 
Ana Maria S Assreuy, Nilson V Pinto, Natália VFC Rodrigues, Benildo S Cavada 
 
Laboratório de Fisio-Farmacologia da Inflamação–LAFFIN, Universidade Estadual do 
Ceará, 60740-000 Fortaleza-CE, Brazil. E-mail: anassreuy@gmail.com 
 
Lectins are proteins used in the study of inflammation due to their capability to recognize 
carbohydrate in inflammatory cell membranes. The leguminous lectin isolated from 
Canavalia maritima (ConM) presents vasodilator activity in vivo and in vitro, but little is 
known about its anti-inflammatory effect. Here, it was investigated the ConM anti-
inflammatory activity and its possible systemic toxicity. Protocols were approved by our 
Institutional Ethical Committee (N
o
. 0559924-4). Edema was measured by 
hydroplethysmometry before (zero time) s.c. injection of carragenan (2 mg/paw) or dextran 
(300 µg/paw) into the hind paw of Wistar rats (150-250g) and thereafter (1-4h). Results were 
expressed as area under the time-course curve-AUC. ConM was injected i.v. (0.01; 0.1 and 1 
mg/kg), 30 min before flogistic agents. Participation of the lectin domain was evaluated by 
incubation (30 min, 37°) of ConM with its binding sugar maltose (0.1M). The formalin test 
was performed by s.c. injection of formalin (2.5%, 20ml) into the hind paws of Swiss mice 
(25-30g) and the time that animals spent licking the paws was recorded from 0-5 min 
(neurogenic phase) and from 15-30 min (inflammatory phase). ConM (0.1-10 mg/Kg; i.v.) 
was injected 30 min before formalin. The toxicity was assessed after 7 days of rats treatment 
with ConM (1mg/Kg) analyzing renal and hepatic function (wet weight, creatinine and urea 
dosage, kinetic of serum transaminase activity, heart and spleen wet weight, body mass, 
leukogram and osmotic equilibrium (total protein and albumin/globulin). Results were 
expressed as Mean ± SEM and analyzed by ANOVA followed by Duncan’s test (p<0.05 to 
indicate differences). ConM (1mg/Kg) inhibited the rat paw edema induced by carragenan 
(200.9 ± 12.7) and dextran (240.7 ± 16.0) about 43% (113.9 ± 10.5) and 27% (176.3 ± 12.4), 
respectively. ConM inhibited the late phase of the nociception induced by formalin (210.6± 
17.6s) at 1 (86.0 ± 11.3s, 59%) and 10 mg/Kg (96.7 ± 7.0s, 54%). ConM presented 
antinociceptive and anti-edematogenic actions without apparent toxicity. The anti-
edematogenic effect of ConM seems not to involve the lectin domain. Acknowledgments: 
CNPq, FUNCAP and Gabriela FO Marques-Domingos for technical assistance.  
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Improved blood lipid and antioxidant status in healthy subjects consuming soy- fortified 
rich lycopene tomato juice 
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Background: Both tomato and soy foods are hypothesized to be beneficial for preventing 
cardiovascular disease and cancer. However, no studies have investigated the effects of 
simultaneously consuming soy and tomato. Objective: To investigate changes in blood lipids, 
oxidative stress and inflammatory markers, and metabolism of isoflavones/lycopene in humans 
consuming a novel functional food, soy-germ-fortified tomato juice, rich in isoflavones/carotenoids. 
Design: Healthy subjects (n=18) consumed 300mL soy-germ-fortified juice/d (containing 22mg 
isoflavones and 7.3mg lycopene/100mL) during an 8 wk intervention-trial after a 1wk washout. 
Prior and after washout, and after 4 and 8wks of juice consumption, cholesterol, apolipoproteins A-I 
and B, triacylglycerols, plasma antioxidant capacity, Cu2+-mediated LDL+VLDL-C oxidation, C-
reactive protein and carotenoids were measured in plasma; 8-isoprostaglandin-2", isoflavones and 
metabolites in 24h urine. On day1 after washout, appearance of isoflavones in plasma and urine and 
lycopene in the triacylglycerol-rich lipoprotein-fraction were monitored 10h postprandial after 
consumption of 255mL juice. Results: Consuming the juice for 8wks significantly improved 
resistance of LDL+VLDL-C to oxidation (lag-time increase from 138.5±18.2 to 146.3±14.7min, 
P=0.039), HDL-C (from 47.3±15.8 to 51.7±14.8mg/dL, P<0.001), and the ratio of total-C/HDL-C 
(from 4.25±1.59 to 3.63±1.16, P<0.001); effects were less pronounced after 4wks. The postprandial 
trial indicated that 3.1±2.3% of lycopene was absorbed; 49.3±12.1% of isoflavones ingested were 
recovered within 24h urine pools. Conclusions: These studies show that lycopene and isoflavones 
were readily absorbed from the soy-fortified tomato juice, and that consuming the product for 8wks 
improved markers of blood lipids and antioxidant status in healthy subjects, making this a promising 
combination for future clinical studies. 
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Inhibition of expression of pro-inflammatory genes in cystic fibrosis cells by products 
from Citrus Bergamia Risso 
 
Monica Borgatti1, Alessandra Guerrini2, Irene Mancini1, Damiano Rossi2, Gianni 
Sacchetti2, Roberto Gambari1 
 
1. BioPharmaNet, Department of Biochemistry and Molecular Biology, Ferrara 
University, Via Fossato di Mortara 74, 44100 Ferrara, Italy, e-mail: brgmnc@unife.it; 
2. Department of Biology and Evolution, Agro-technological and Pharmaceutical 
Resources (Agri-Unife), Ferrara University, Ferrara, Italy. 
 
The inflammatory process of  cystic fibrosis (CF) is characterized by production and release 
of cytokines and chemokines, among which interleukin 8 (IL-8) represent one of the most 
important. Accordingly, there is a growing interest in developing therapies against CF in 
order to reduce the excessive inflammatory response in the airways of CF patients. In this 
respect, extracts from medicinal plants have been reported to exhibit anti-inflammatory 
activities in several reports. In this study we report that extracts obtained from bergamot 
(Citrus bergamia Risso) epicarps contain two components (citropten and bergapten) 
displaying an strong inhibitory activity on IL-8 expression. These effects have been 
confirmed both at the mRNA levels and the protein release in the CF cellular model IB3-1 
induced with TNF-#, using RT-PCR and Bio-plex technology respectively. These results 
indicate that bergapten and citropten could be proposed as potential anti-inflammatory 
molecules to reduce lung inflammation in CF patients. 
 
Supported by Italian Cystic Fibrosis Research Foundation by SPINNER (CAPS-IT Project), 
COCHISE UE Project, Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), 
Telethon (contract GGP07257). 
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Microarray-based determination of anti-inflammatory genes targeted by fisetin in 
macrophages 
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3,3',4',7-tetrahydroxyflavone (fisetin) is a common flavonoid that exists in many types of 
plants including fruits, vegetables and medicinal herbs. To evaluate the anti-inflammatory 
function and underlying genes targeted by fisetin, gene expression profiling through DNA 
microarray was performed in mouse macrophages. Among 22,050 oligonucleotides, the 
expression levels of 406 genes were increased by equal or more than 3-fold in 
lipopolysaccharide (LPS) - activated RAW264 cells, 223 gene signals of which were 
attenuated by fisetin (equal or more than 2-fold). Expression levels of 717 genes were 
decreased by equal or more than 3-fold in LPS-activated cells, of which 417 gene expression 
were restored by fisetin (equal or more than 2-fold). Utilizing group analysis, 206 genes 
affected by fisetin were classified into 35 categories relating to biological processes (72), 
molecular functions (98), and signaling pathways (17) with equal or more than 2-fold change. 
The genes were further categorized as “defense, inflammatory response, cytokines activities, 
and receptor activities” and some of them were confirmed by real-time polymerase chain 
reaction. Ingenuity pathway analysis further revealed that fisetin regulated the relevant 
networks of chemokines, interleukins and interferons to exert its anti-inflammatory function. 
Our DNA microarray data, for the first time, revealed the gene expression profiling of fisetin 
in an inflammatory cell model, RAW264.7. These data provide a basis for understanding the 
molecular mechanisms of the anti-inflammatory effects of fisetin. 
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Age-related neurodegenerative diseases including Alzheimer’s disease are related to 
inflammation. Therefore, the great effort has been focused on search for anti-inflammatory 
agents without toxicity. In the present study, the protective effect of black rice against 
amyloid beta 25-35 (A#25-35)-induced memory impairment was investigated under in vivo 
Alzheimer’s model. The memory and cognition abilities were observed by the tests of T-
maze, object recognition and Morris’s water maze. Although impairment of recognition and 
memory was observed by A#, the oral administration of black rice (50 and 100 mg/kg body 
weight/day) for 7 days after treatment of A# showed improvement of cognition and memory. 
Furthermore, A# treatment significantly elevated nitric oxide (NO) formation and lipid 
peroxidation, while the black rice significantly decreased NO formation and lipid 
peroxidation in brain, liver and kidney. In particular, the protective effect against 
inflammation induced by A# was stronger in the brain than other tissue. It suggests that the 
improvement of memory deficit and cognition ability by black rice is closely related to the 
attenuation of A#-induced inflammation.  
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Comparing the anti-inflammatory activity of curcumin alone and in a cocktail of plant 
extracts on cytokine-stimulated cartilage explants 
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Curcumin (diferuloylmethane) is used in traditional medicine for treating inflammatory diseases 
such as arthritis.  This study sought to test the hypothesis that curcumin may be more potent when 
acting synergistically with other plant extracts.  The effects of curcumin alone and in combination 
with other known anti-inflammatory plant extracts, where it represented <20% of the formulation, 
were evaluated.  Curcumin (from Curcuma longa) was dissolved in DMSO.  A self-formulated 
cocktail of plant extracts containing <20% curcumin was dissolved in either DMEM or DMSO.  
Cartilage explants from horses euthanized for purposes other than research were incubated for 5 
days with interleukin(IL)-1beta (10ng/ml-1) and either curcumin (25, 50, 75, 100microM) or the 
cocktail in DMEM or DMSO (0.4, 40, 400micrograms/ml-1).  Curcumin significantly reduced IL-
1beta-stimulated cartilage glycosaminoglycan (GAG) release at 50microM (P<0.05), 75microM 
(P<0.01) and 100'M (P<0.001).  Prostaglandin E2 (PGE2) release was significantly lowered at 
25'M curcumin (P<0.001).  The plant extract cocktail in DMEM significantly increased IL-
1beta-stimulated GAG release from 40micrograms/ml and above (p<0.001) whereas equivalent 
concentrations in DMSO reduced GAG release (p<0.001).  PGE2 release was significantly 
decreased by the cocktail in DMSO (40micrograms/ml; p<0.01) and in DMEM 
(400micrograms/ml; p<0.01).  Micromolar concentrations of curcumin, alone and as part of the 
cocktail, exerted anti-inflammatory effects on the explants.  However, as expected, one of the 
water-soluble cocktail components, bromelain, increased GAG release in DMEM due to its 
established proteolytic activity.  Thus, the mode of action of key functional ingredients in plant 
extracts must be carefully considered before interpreting the results from in vitro models of 
cartilage inflammation. 
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Tumor targeted delivery of pravastatin by liposomes inhibits B16F10 melanoma growth 
in mice 
 
Maria Coimbra, Manuela Banciu, Marcel H.A.M. Fens, Sylvia A. Kuijpers, Lieselotte de 
Smet, Magda Cabaj, Josbert M. Metselaar, Gert Storm, Raymond M. Schiffelers 
 
Division Pharmaceutics, Dept. of Pharmaceutical Sciences, Faculty of Science, Utrecht 
University, Utrecht, The Netherlands, e-mail: R.M.Schiffelers@uu.nl.  
 
Statins have activities that extend beyond their cholesterol-lowering capability. These 
pleiotropic effects result from the altered post-translational modification of GTP-binding 
proteins, which regulate many intracellular pathways. Pre-clinical studies have suggested that 
these altered post-translational modifications could make statins effective anticancer agents.  
However, required doses are higher than those needed to lower cholesterol levels. 
Furthermore, in view of their wide-ranging effects on cellular metabolism, target site-specific 
delivery is preferred. In this study, we investigated tumor-specific delivery of pravastatin 
using long-circulating liposomes. 5 mg/kg liposome-encapsulated pravastatin inhibited 
murine B16F10-melanoma growth over 70% as compared to free pravastatin, which was 
ineffective. At 24 h after injection of the liposomes, 3 microgram of pravastatin could be 
recovered in the tumor, whereas drug levels were below detection limit (i.e. < 20 ng) after 
administration in the free form. Neither treatment affected cholesterol metabolism within the 
time frame of the study.  In vitro studies on the effects of (liposomal) pravastatin on viability 
and proliferation of tumor cells, endothelial cells, and macrophages revealed that 
macrophages were the most sensitive cell type towards (liposomal) pravastatin treatment. 
Measurement of tumor levels of a panel of 24 proteins involved in inflammation and 
angiogenesis showed that liposomal pravastatin treatment effectively inhibited production of 
pro-inflammatory/pro-angiogenic mediators as compared to free drug. Taken together, 
targeted delivery of statins can improve their tumor growth inhibiting activity. This activity 
seems to result primarily from a local inhibition of tumor inflammation and angiogenesis. 
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mesenchymal stem cells in a high-density co-culture microenvironment 
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Osteoarthritis (OA) and rheumatoid arthritis (RA) are characterised by joint inflammation and 
cartilage degradation. Although mesenchymal stem cell (MSC) like progenitors are resident in 
the superficial zone of articular cartilage, damaged tissue does not possess the capacity for 
regeneration. The high levels of pro-inflammatory cytokines present in OA/RA joints may 
impede the chondrogenic differentiation of these progenitors. IL-1# and TNF-" activate the 
transcription factor nuclear factor-!B (NF-!B), which in turn activates proteins involved in 
matrix degradation, inflammation and apoptosis. Curcumin is a phytochemical capable of 
inhibiting the IL-1#-induced activation of NF-!B and the expression of apoptotic and pro-
inflammatory genes in chondrocytes. Here we present evidence to show that although 
curcumin alone does not have chondrogenic effects on MSCs, it inhibits IL-1# induced 
activation of NF-!B, activation of caspase-3 and Cox-2 in MSCs as it does in chondrocytes in 
a time and concentration dependent manner. In contrast, in our high-density co-culture model 
of OA where primary chondrocytes and MSC are stimulated with IL-1#, a 4h pre-treatment 
with curcumin antagonized the adverse effects of IL-1# on the co-culture, thus promoting 
chondrogenesis. In IL-1# stimulated co-cultures, pre-treatment with curcumin significantly 
enhanced the production of collagen type II, cartilage specific proteoglycans (CSPGs) and #1-
integrin and activation of the MAPKinase pathway. Furthermore, activation of caspase-3 and 
Cox-2 were suppressed. In conclusion, curcumin treatment may help establish a 
microenvironment in which the effects of pro-inflammatory cytokines are antagonized, thus 
facilitating chondrogenesis of MSC-like progenitor cells in vivo.  This strategy may support 
the regeneration of articular cartilage. 
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Quercetin protects HepG2 cells against inflammation induced by TNF-# . 
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Quercetin is one of the most common flavonoids found in the diet. It possesses antioxidant, 
antiinflammatory and anticarcinogenic properties, and it may modulate key proteins involved 
in signaling transduction pathways connected to the apoptotic and cell survival/proliferation 
processes (Granado-Serrano et al., J Nutr 2006,136,2715-21; Granado-Serrano et al., J Agric 
Food Chem 2007,55,2020-7 Granado-Serrano et al., 2009, Nutr Cancer, in press). These 
features confer quercetin a great interest in pathological situations associated to oxidative 
stress, suggesting its potential as a chemopreventive agent. The aim of this study was to 
evaluate the effect of quercetin as anti-inflammatory agent in a model of inflammation 
induced by TNF-# in human hepatoma HepG2 cells. In order to establish a model of 
inflammation in cultured cells, the response of the main proteins involved in the modulation 
of the NF-"B pathway (p-I"B, I"B , IKK and NF-"B) to TNF-#, as well as the potential 
regulation of the NF-"B pathway to quercetin were studied. Analyses were carried out pre-
incubating cells with different quercetin concentrations (0-10 %M) for 4 h and later stimulating 
cells with TNF-#. Cell viability and reactive oxygen species (ROS) generation were assayed by 
crystal violet test and by the dichlorofluorescein assay, respectively, and the inflammatory 
process was evaluated by analyzing p-I"B, I"B, IKK and NF-"B levels. Treatment of HepG2 
cells with all tested concentrations of quercetin did not result in any cell damage or change in 
the levels of the NF-"B pathway proteins evaluated. TNF-#, which did not cause any cell 
damage, induced the NF-"B pathway, showing the maximum stimulation after 30 min of 
incubation. Pretreatment for 4 h with 0.5-10 µM quercetin reduced ROS generation when 
compared to control, TNF-# and 0.1 µM quercetin treated cells, which showed similar ROS 
levels among them. Quercetin (5-10 µM) greatly prevented the increase of p-I"B, IKK and 
NF-"B levels and the decrease of I"B values evoked by TNF-# in HepG2 cells. In summary, 
treatment of HepG2 cells in culture with the natural dietary antioxidant quercetin strongly 
protects the cells against a pro-inflammatory insult. 
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The synergistic anti-inflammatory effect of Lycopene, Lutein and Carnosic acid 
combination  
 
Nurit Hadad and Rachel Levy  
 
Infectious Disease and Immunology Laboratory,  Clinical Biochemistry Department,  
Faculty of health Sciences,  Soroka Medical University Center and Ben-Gurion 
University of the Negev, Beer  Sheva 84105, Israel. 
 
Macrophages play an important role in host defense by producing a variety of pro-
inflammatory cytokines such as TNF" as well as other inflammatory mediators including 
PGE2 and nitric oxide (NO), which are synthesized by cyclooxygenase and inducible nitric 
oxide synthase, respectively. These inflammatory mediators are involved in the pathogenesis 
of many inflammation-associated human diseases, thus their attenuation may contribute to 
efficient therapy. The aim of the present research was to study the potency of combinations of 
Lycopene, carnosic acid, lutein and #-carotene, at concentrations that can be achieved in 
blood, to inhibit the release of the inflammatory mediators from macrophages exposed to  
LPS. Preincubation of mouse peritoneal macrophages with Lycopene (1 'M), Carnosic acid 
(2 'M) and Lutein (1 'M) or #-carotene (2 'M) before addition of LPS caused an efficient 
and synergistic inhibition of about 60% of NO and PGE2 production and 40% of TNF" 
secretion. This inhibition was much higher than the additive inhibitory effect of each of the 
phyto-nutrients alone, that had a very low, if any, inhibitory effect. Combinations of the three 
carotenoids, excluding the polyphenol, carnosic acid, were less effective, suggesting that  the 
synergistic effect was achieved by combinations of polyphenol and carotenoids that probably 
act by different  mechanisms. Omitting Lycopene from combination of carotenoids and 
Carnosic acid resulted in lower inhibition compared with its presence, indicating the 
importance of for the process. The effect of these phyto-nutrient combinations is probably due 
to their anti-oxidant effect, since they caused a synergistic inhibition of around 80% in 
superoxide production by macrophages exposed to LPS. Taken together, all of the results 
obtained suggest that combinations of low concentrations of Lycopene,  Carnosic acid Lutein 
and b-Carotene have a very potent  anti-inflammatory effect. 
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Synthesis and Study the Analgesic and Anti-inflammatory Effects of Rigid 6-methoxy 
Benzopyran 3, 4 Dihydroxy Chalcon (DHC) in Mice 
 
Mahmoud Reza Heidari1,2, Alireza Foroumadi 2,3,  Hojat Ghorbani 4,  Ali Asadipour 4, 
Shohreh Shahnavaz4 Mohammad Heidari 4 
 
1-Faculty of Pharmacy, Pharmaceutics, Neuroscience and Physiology Research Centers, 
Kerman University of Medical Sciences, Kerman, Iran, Heidarimr@kmu.ac.ir. 2- 
Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran. 3-
 
Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of 
Medical Sciences, Tehran, Iran, aforoumadi@yahoo.com. 4- Pharmaceutics Research Center, 
Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.  
 
Although, anti-inflammatory and antinociceptive drugs have some useful applications, but 
they have some adverse effects. Therefore researchers are trying to find new anti-
inflammatory compounds with more ideal applications and less adverse effects. In this 
research anti-inflammatory  and antinociceptive effects of rigid derivative of 6-methoxy 
benzopyran 3,4- Dihydroxy chalcone  ( DHC) was evaluated by Formalin, Hot plate and 
Carageenan tests. At first different doses of DHC 25, 50 and 75 mg/kg  were  injected  to 
mice and the analgesic and anti-inflammation effects of it was evaluated by three mentioned 
tests. The result showed that dose of 50mg/kg of DHC induced more significant anti- 
inflammation and antinociception in formalin test. In addition the effect of  DHC was higher 
in the chronic phase, therefore it seems that DHC has better anti- inflammatory effect rather 
than analgesic effect. Doses of  50 and 75 induced some  lethargy in the mice. DHC induced  
analgesia and anti-inflammation in hotplate and carageenan test too. The result showed that 
DHC has a significant anti-inflammatory and antinocicpeptive effect and more effective 
compounds can be synthesized by modification of structure of this derivative.  
Key words: Methoxy Benzopyran 3, 4 Dihydroxy Chalcon, Anti inflammation, Anti 
nociception, Mice.  
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Antinociceptive and anti-inflammatory effects of new rigid 6 Methoxy Benzofurane 3,4- Di-
hydroxychalcone (M-DHC) in mice 
 
Mahmoud Reza Heidari1,2, Alireza Foroumadi 2,3,  Amirhossein Saadati 4,  Mohammad 
Heidari 4 
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Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of 
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Center, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.  
 
Introduction: Study of anti- inflammation and antinociception effects of rigid drivetives from 3,4- 
Dihydroxy chalcone is the revise of this research. In this study the analgesic effect of different 
doses of rigid drivative 3,4- Dihydroxy chalcone, was injected intraperitoneally to mice and the 
analgesic and anti- inflammation effects was evaluated by formalin, Hotplate and Carageenan 
tests. Methods: first Different concentration of 3,4- DHC prepared and injected to mice Doses of 
12.5, 25 and 50 mg/kg of 3,4- DHC evaluated by formalin, Hotplate and carageenan tests. 
Effective dose compared by morphine and Ibuprofen. Results:The result showed that, 3,4- DHC 
with dose of 25mg/kg induced Significant antinociception and anti- inflammation compared with 
control group. In formation test , in additon the effect of 3,4-DHC was higher in the chronic phose 
of formalin test, therefore it seems that 3,4- DHC has better anti- inflammatory effect rather than 
analgesic effect. The results showed that, dose of 25 mg/kg of 3,4 DHC, induces significant 
analgesia in hot plate test in 45 and 60 ominutes the doses of 25 and 50 mg/kg, induced lethargy 
in mice. The analgesic effect of the most effective dose of 3,4 – Dihydroxy chalcone was lower 
than morphine (2.5 mg/kg) in all time in formalin, Hotplate tests. The analgesic effect of DHC 
was higher than Ibuprofen (200mg/kg) in 0-5 minute in formalin test and  in 45 and 60 minutesin 
Hot plate test but in chronic phase of formalin test and one hour after injection carageenan in 
carageenan test was nearly equal 3,4-DHC. Conclusion: The result showed that with madification 
of stractare of the DHC, this drivative has a significant analgesic effect and it could be used for 
more studies to access aclinical use of 3,4- DHC as a drug.  
Key words: 3,4-Dihydroxy chalcone, Anti-inflammation effect, Anti nociception effect, formalin 
test, Hot plate test, carageenan test, Mice.  
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Antinociceptive and anti-inflammatory effect, of new rigid, propoxy benzopyrane-3, 4 Di-
hydroxychalcone (DHC-P) by Hot-plate, Formaline and Plethysmography tests, in mice 
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Introduction: There are many reports indicating the analgesic and anti inflammatory effects of 3,4-
dihydroxy chalcones. In this study antinociceptive and anti-inflammatory effects of rigid derivative 3-
(3,4-dihydroxybenzylidene)-7-propoxy benzopyran-4-one, (DHC-P) were evaluated by Formalin, Hot 
plate and Carageenan tests. Methods: Experimental doses of 50, 75 and 100 mg/kg of DHC-P were 
injected to mice and the analgesic and anti inflammatory effects evaluated by Formalin, Hotplate and 
Carageenan tests. Effective dose compared with Morphine and Ibuprofen. Results: The result showed 
that, DHC-P with dose of 75mg/kg induced significant anti nociception and anti inflammation in 
Formalin and Carageenan tests. The results showed that the dose of 75 mg/kg of DHC-P induces 
significant analgesia in 45 and 60 minutes in hot plate test .The analgesic effect of the most effective 
dose of DHC-P 75mg/kg was lower than morphine (2.5 mg/kg) in all time in Formalin and Hot plate 
tests. The analgesic effect of DHC-P was higher than Ibuprofen (200mg/kg) in 0-5 minute in Formalin 
test and in 45 and 60 minutes in Hot plate test, but in chronic phase of Formalin test was nearly equal 
to Ibuprofen. In Carageenan test, the anti inflammatory effect of DHC-P was higher than Ibuprofen 
(200mg/kg) and morphine (2.5 mg/kg) in the first and third hours. Therefore it seems that DHC-P has 
better anti-inflammatory effect rather than analgesic effect. The doses of  75 and 100 mg/kg, induced 
lethargy in mice. Conclusion: The results showed that the modification of this structure of DHC-P, 
may lead to more effective derivative with significant analgesic effect and it could be used for more 
studies to access a clinical use of 3,4 DHC as a drug. 
Key words: 3-(3,4-dihydroxybenzylidene)-7-propoxy benzopyran-4-one, Anti-inflammation, Anti 
nociception, Mice. 
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Comparison of the Gastric Ulcerogenicity of Analgesic Doses of Percolated Extract of 
A. Occidentale with Indomethacin in Rats 
 
Mahmoud Reza Heidari1,2, Mohammad Heidari 2 , Effat Behravan3,4, Ghasem Fatemi 3, 
Leila Etemad3,4 
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2- Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, 
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3-Pharmaceutics Research Center, Kerman University of Medical Sciences, Kerman, 
Iran.  
4- Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad 
University of Medical Sciences, Mashhad, Iran 
 
In traditional Iranian medicine, the core of the fruit of Anacardium occidentale (cashew nut) 
was used in the treatment of pain. In this research comparison of ulcerogenic effect of 
percolated extract of A. occidentale with indomethacin were investigated. There are five rats 
with (200-250 g) weight in each group. The extract or indomethacin was administrated orally 
with dose of 200, 300, 400 and 800 mg/kg. In control group normal saline was administrated 
with volume of 5 mg/kg. The animals were killed 4h after receiving extract or indomethacin 
or normal saline. The stomachs were removed and 10ml formalin 2% injected in to the 
stomach to fix the inner layer of the gastric wall. The stomachs were incised along the greater 
curvature and lesion in the glandular portion were evaluated, 20 min after formalin exposure. 
The ulcer index was calculated, using the J- Score. The results showed that the oral dose of 
200mg/kg of the extract did not induce any ulcerogenic effect in the rat’ stomach. The dose of 
300, 400 and 800 mg/kg of extract induced lower ulcerogenic effect than the same dose of 
indomethacin (p<0.01). Therefore according to previous study indicating the analgesic effect 
of A. occidentale, it seems that this plant is suitable for more investigation as an analgesic 
compound with low gastro intestinal unwanted effect in clinical use. 
 
Key words: Anacardium occidantale, Gastric ulcerogenicity, Cashew nut, J-Score 
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Investigation of Hypericum Perforatum Extract on Convulsion Induced by Picrotoxin in 
Mice 
 
Mahmoud Reza Heidari1,2, Leila Etemad1,3,  Mohammad Moshiri3, Mohammad Heidari4, 
Effat Behravan1,3 
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Theraputic effect of Hypericum perforatum L. has been known for many years. In this 
investigation, we studied about effects of methanolic extract of this plant against seizure 
induced by picrotoxin in mice. In first phase, the study was performed on four groups of 
animals pretreated with different doses of percolated extract of this plant via Intraperitoneal 
injection. After 20 minutes each animal received picrotoxin for induction of seizure. Latency 
of seizure, Duration of seizure, Death latency and Mortality percent were determined. The 
results showed that the latency of seizure was increased in group that pretreated with dose of 
50 mg/kg (p<0.01). The results showed that the dose of 50 mg/kg of Hypericum perforatum 
L. maybe  have some beneficial effect in seizure induced by picrotoxin. More studies are 
needed in this field. 
 
Keywords: Hypericum perforatum L. , Picrotoxin, Seisure, mice. 
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Evaluation of the Effects of Annacardium Occidentale Extract on Histopathology  and 
Hepato - Renal Function Tests in Rats 
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Introduction: In Iranian traditional medicine, the core of the fruit of Anacardium occidentale 
(A.O) was used for relief of pain. In this research hepatotoxicity and renal toxicity of 
percolated extract of A.O were investigated. 
Methods: Five groups of six rats in each group were used in this experiments. The extract 
was administered orally with doses of 200-400 and 800mg/kg every 24 hours for 7 days. In 
control group, normal saline was administered 5ml/kg. In the end of 7
th
 day, urine, blood and 
tissue specimen were collected for analysis. In second of the experiment, the blood enzymes 
including; Alanin transpherase (ALT), Aspartate transpherase (AST), Alkalin phosphatase 
(ALP), and the serum creatinin (Cr), and the Blood Urea Nitrogen (BUN) and Activity of 
urinary enzymes including; gama- glutamil transpherase (GGT), and lactate dehydrogenase 
(LDH), changes in the kidney weights were determined. In third phase of the experiment, 
histopatological study in kidney and liver were evaluated.  
Results: The results showed, the oral doses  of  200mg/kg (therapeutic analgesic dose) and 
400mg/kg of the extract, did not induce any hepatotoxicity or renal toxicity effects in the rats, 
but the dose of   800mg/kg induced hepatotoxicity and renal toxicity.  
Conclusion; It seems that the A.O is a suitable plant for further investigation for introducing 
as analgesic drug for clinical use. 
     
Key Words: Annacardium Occidental, Hepatotoxicity, Renal toxicity, Rat, Histopathology 
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Protective effect of Isoorientin against oxidative stress, inflammation, and apoptosis of 
high glucose exposed human umbilical vein endothelial cells 
 
Ji Young Hwang1, Ji Sook Han1  
 
1Department of Food Science and Nutrition, Pusan National University, 30 Jangjeon-
dong, Busan, 609-735, Korea  
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Sasa borealis bamboo has been used for making tea in the Far East, and it is known for 
traditional medicine. Antioxidant activity-guided fractionation of buthanol fraction from Sasa 
borealis led to the isolation of Isoorientin which has strong antioxidant activity. The present 
study examined the protective effect of Isoorientin against high glucose induced oxidative 
stress, inflammation, and apoptosis in human umbilical vein endothelial cells (HUVEC). To 
assess the efficacy of Isoorientin, several key markers and activities were measured, including 
cell viability, lipid peroxidation, intracellular reactive oxygen species (ROS) and nitric oxide 
(NO), as well as expressions of inflammatory proteins, inducible nitric oxide synthase 
(iNOS),  cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-kB), and levels of 
Bcl2/Bax protein. Results showed that high glucose treatment induced HUVEC cell death, but 
Isoorientin significantly increased cell viability and effectively suppressed lipid peroxidation, 
ROS generation and NO level from high glucose induced glucotoxicity. In addition, 
Isoorientin significantly reduced iNOS, COX-2, NF-kB and pro-apoptotic Bax protein levels, 
whereas it increased anti-apoptotic Bcl2 protein level. These results suggest that Isoorientin 
has a protective efficacy against several deleterious effects caused by high glucose exposure 
in HUVEC.  
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[6]-Gingerol Rescues BV2 Microglial Cells from $-Amyloid-induced Pro-inflammatory 
Damages and Cell Death 
 
Jung-Hee Jang 
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$-Amyloid (A$) peptide is responsible for the formation of senile plaques, the 
neuropathological hallmarks of Alzheimer’s Disease (AD) and has been reported to induce 
apoptotic cell death in neurons and glia via oxidative and pro-inflammatory pathways. 
Recently, considerable attention has been focused on dietary manipulation of oxidative and 
inflammatory cell death in neurodegenerative disorders including AD. Therefore, in this 
study, we have investigated the neuroprotective effect of [6]-gingerol, a pungent ingredient of 
ginger against A$-induced inflammatory cell death. BV2 microglial cells treated with A$ 
underwent apoptotic cell death as determined by positive in situ terminal end-labeling 
(TUNEL staining), decreased mitochondrial transmembrane potential, and increased ratio of 
proapoptotic Bax to antiapoptotic Bcl-2. [6]-Gingerol pretreatment attenuated A$-induced 
apoptosis in BV2 cells. Moreover, [6]-gingerol effectively inhibited A$-induced cell death by 
suppressing expression of inducible nitric oxide (iNOS) and subsequent production of nitric 
oxide (NO) and peroxtnitrite. A$ treatment caused activation of NF-"B as an upstream 
regulator for iNOS expression, which seemed to be mediated by activation of extracellular 
signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (p38 MAPK). [6]-
Gingerol pretreatment effectively down-regulated DNA binding of NF-"B, phosphorylation 
of p65, the functionally active subunit of NF-"B, and degradation of I"B#, the cytoplasmic 
inhibitor of NF-"B by suppressing upstream kinases. Thses results suggest that [6]-gingerol 
may have preventive and/or therapeutic potential in the management of neuroinflammation 
and cell death in AD. 
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Effect of a novel COX-2 inhibitor on IL-8 expression in Helicobacter pylori-infected 
gastric epithelial AGS cells 
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Helicobacter pylori (H. pylori) infection induces many pathogenic factors including reactive 
oxygen species (ROS) in gastric epithelial cells. ROS is considered as an important regulator 
in pathogenesis of H. pylori associated inflammation in H. pylori-associated gastric diseases. 
Previously we showed that ROS induced the expression of COX-2 and IL-8 by activating 
redox-sensitive transcription factors NF-!B and AP-1 in gastric epithelial AGS cells. In the 
present study, we determined whether a novel synthetic COX-2 inhibitor suppresses the 
expression of IL-8 by inhibiting NF-!B and AP-1 in AGS cells. H. pylori strain of HP99 
(Korean isolates) was used to stimulate gastric epithelial AGS cells with or without treatment 
of a new COX-2 inhibitor. A novel COX-2 inhibitor was kindly provided by Prof. E. S. Lee, 
Yeungnam University, Korea. HP99 induced the expression of IL-8 with the activations of 
NF-!B and AP-1 and degradation of I!B". A new COX-2 inhibitor (2 or 5 %M) inhibited the 
expression of IL-8 dose-dependently and suppressed DNA binding activities of NF-!B and 
AP-1 as well as  degradation of I!B". In conclusion, a novel synthetic COX-2 inhibitor may 
have anti-inflammatory activity by inhibiting the expression of target gens of NF-!B and AP-
1 in H. pylori-stimulated gastric epithelial cells.  
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Effect of Rubus coreanus Miquel added to Bacillus sp.-fermented soymilk on high 
glucose-induced vascular inflammation in human umbilical vein endothelial cells   
 
Hong Eun Ju1 and Ji Sook Han1 
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Vascular inflammation is an important factor which can promote diabetic complications. We 
investigated whether 5% R. coreanus Miquel added to Bacillus sp.-fermented soymilk (RFS), 
which had strong antioxidant activity in previous study, suppresses vascular inflammatory 
process induced by high glucose in human umbilical vein endothelial cells (HUVEC).  
Western blot analysis revealed that incubation of HUVEC with high glucose increased cell 
adhesion molecules (CAMs) expression levels. However, high glucose-induced increase of 
CAMs expression was attenuated by pretreatment with RFS extract (RFSE). The cell 
adhesion between HL-60 monocyte and HUVEC induced by high glucose was also reduced 
by pretreatment with RFSE. Pretreatment with RFSE inhibited high glucose-induced 
intracellular reactive oxygen species (ROS) formation. In addition, RFSE suppressed the 
transcriptional activity of NF-!B increased in high glucose condition. The present data 
suggested that RFSE could suppress high glucose-induced vascular inflammatory process, 
which may be closely related with the inhibition of ROS and NF-!B activation in HUVEC.  
Acknowledgment: This research was financially supported by the Ministry of Education, 
Science Technology (MEST) and Korea Institute for Advancement of Technology (KIAT) 
through the Human Resource Training Project for Regional Innovation. 
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Aging is known to associate with inflammation that accelerates aging process. The anti-aging 
activity and the related inflammatory mechanisms of kimchi during fermentation was 
evaluated using stress-induced premature senescence (SIPS) of WI-38 fibroblasts caused by 
hydrogen peroxide (H2O2), a well-established cellular aging model. The methanol extracts of 
fresh kimchi (pH 5.8), optimally ripened kimchi (Opt-R kimchi, pH 4.1) and over ripened 
kimchi (pH 3.7) fermented at 5! were prepared. H2O2-treated WI-38 cells showed the loss of 
cell viability, the increase of lipid and shortening of the cell lifespan, indicating the induction 
of SIPS. However, treatment with kimchi, especially Opt-R kimchi, attenuated cellular 
oxidative stress through increase in cell viability and inhibition of lipid peroxidation. In 
addition, the lifespan of WI-38 cell was extended, suggesting promising role of kimchi as an 
anti-aging agent. Furthermore, H2O2-treated WI-38 cells significantly increased the age-
related inflammatory gene expression such as nuclear factor kappa B (NF-!B), 
cyclooxygenase-2, inducible NO synthase and Bax. However, the treatment of kimchi exerted 
anti-aging effect through NF-!B-related gene regulation. These results suggest that kimchi, 
especially Opt-R kimchi, may delay the aging process by regulation of inflammatory process.  
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Pine bark extract enzogenol blunted pro-inflammatory tumor necrosis factor-alpha-
induced endothelial cell adhesion and transmigration of human monocytic THP-1 cells 
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The leukocyte recruitment and transmigration across the endothelial barrier into the vessel 
wall are crucial steps in promoting atherosclerosis. Cell adhesion molecules mediate the 
attachment of THP-1 monocytes and facilitate their migration into the subendothelial space, 
thus contributing to accumulation of mononuclear cells in the vascular wall that is one of the 
initial steps in the development of atherosclerosis. Vascular endothelial cells are an important 
target of pro-inflammatory cytokines modulating many genes involved in cell adhesion, 
thrombosis and inflammatory responses. This study examined whether pine bark extract 
enzogenol blunts transendothelial migration of THP-1 monocytes through TNF-alpha-
activated human umbilical vein endothelial cell (HUVEC). The pro-inflammatory TNF-alpha 
markedly induced protein expression of intracellular cell adhesion molecule, vascular cell 
adhesion molecule, and E-selectin with increasing mRNA levels in HUVEC. Nontoxic 
enzogenol at 5-25 microgram/mL attenuated the expression of all three adhesion molecules in 
a dose-dependent fashion. Consistently, enzogenol suppressed the enhanced THP-1 
monocytes adhesion onto TNF-alpha-activated HUVEC. In TNF-alpha-activated HUVEC 
was observed IkB dissociation and NF-kappaB nuclear translocation, which was ameliorated 
by enzogenol. Furthermore, enzogenol hampered the transendothelial migration of THP-1 
monocytes by increasing matrix metalloproteinase-9 activity. These results demonstrate that 
blunting induction of cell adhesion molecules by enzogenol was mediated by their 
interference with the NF-kappaB-dependent transcription pathways. Thus, enzogenol
 
may 
have therapeutic potential targeting inflammatory response-associated atherosclerosis. This 
work was supported by the Korea Research Foundation Grant funded by the Korean 
Government (MEST)” (The Regional Research Universities Program/Medical & Bio-
Materials Research Center) 
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Inflammation is a complex event modulated by various mediators. Nitric oxide (NO) and 
prostaglandins (PGs) are known to be an important mediator of acute inflammation. They are 
synthesized by nitric oxide synthase (NOS) and cyclooxygenases (COX), respectively. In this 
study, we investigated anti-inflammatory effect of soybean germ extract (SGE) in 
lipopolysacharide (LPS)-stimulated HT-29 human colorectal cancer cells. Soybean germ 
extract inhibited in a dose-dependent manner the protein expression levels of inflammatory 
mediators such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in 
LPS-stimulated HT-29 cells. Also, our results showed that the inhibition of iNOS and COX-2 
takes place via a down regulation of NF- !B. In conclusion, our study indicates that soybean 
germ extract (SCE) may be utilized for the development of an anti-inflammatory functional 
food and further studies can be conducted to estimate its effect in vivo animal model and 
clinical study.  
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Hypercholesterolemia plays key roles in the production of oxidative stress in vascular cells 
and stimulates the early stage of the atherosclerosis process. In this study, 4-
[(butylsulfinyl)methyl]-1,2-benzenediol (SMBD), sulfur-containing phenolic antioxidants in 
sea weed, was synthesized and demonstrated to inhibit the Cu
2+
-induced low-density 
lipoprotein oxidation. Rabbits were fed an atherogenic diet containing 0.5% (w/w) cholesterol 
and 10% (w/w) coconut oil for 4 weeks, while SMBD or simvastatin was given as an 
intravenous injection (0.33 mg/kg/day) simultaneously. The SMBD significantly lowered the 
plasma cholesterol, lipid peroxidation and aortic lipid levels compared to the control group. 
Furthermore, when compared with the control group, both the simvastatin and SMBD group 
significantly inhibited the proliferation of aortic intima, resulted in reducing the thickness by 
38% and 36% through retarding the aortic reactive oxygen species (ROS) generation. The 
cyclooxygenase-2 protein levels of these groups were also decreased.  In conclusion, SMBD 
seems to have benefits in the early stage of atherosclerosis through its antioxidant activities, 
especially with retardation of ROS generation.  
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amyloid beta-induced memory impairment through attenuation of inflammation 
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Inflammation has been known to play an important role in the progression of Alzheimer’s 
disease (AD). The present study was focused on the protective effect of 5% purple sweet 
potato added to Bacillus sp.-fermented soymilk (PFSM), which had strong antioxidative 
activity in previous study, from cognition impairment under AD model of ICR mouse induced 
by amyloid beta (A#). To observe the abilities of memory and cognition, T-maze, object 
cognition and Morris water-maze tests were carried out. A# injected groups showed the 
impairments of cognition and memory. However, the oral administration of PFSM extract 
(100 and 200 mg/kg body weight/day for 7 days) improved cognition and memory. 
Furthermore, nitric oxide (NO) formation and lipid peroxidation were significantly elevated 
by A#, whereas the PFSM treatment significantly decreased NO formation and lipid 
peroxidation in brain, liver and kidney. The present study suggests that PFSM significantly 
improves memory deficit and cognition ability induced by A#. The protective effect of PFSM 
against A#-induced impairments of memory and cognition ability is closely related to the 
attenuation of inflammation induced by oxidative stress.  
 
Acknowledgment: This research was financially supported by the Ministry of Education 
Science Technology (MEST) and Korea Institute for Advancement of Technology (KIAT) 
through the Human Resource Training Project for Regional Innovation. 
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isolated from Celastrus regelii 
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Han Yoon Park 
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Background Celastrol, a quinone methide triterpenoid isolated from the Celastraceae 
family, exhibits various biological properties, including chemopreventive, antioxidant, and 
neuroprotective effects. In this study, we showed that celastrol inhibits inflammatory 
reactions in macrophages and protects mice from skin inflammation. 
Materials and methods  Anti-inflammatory effects of celastrol (0-1 µM) were examined 
in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. In order to investigate the 
effects of celastrol (0-50 µg/mice) in vivo, activation of myeloperoxidase (MPO), and 
histological assessment were examined in the 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-
induced mouse ear edema model. 
Results Our in vitro experiments showed that celastrol suppressed not only LPS-
stimulated generation of nitric oxide and prostaglandin E2, but also expression of inducible 
nitric oxide synthase and cyclooxygenase-2 in RAW264.7 cells. Similarly, celastrol inhibited 
LPS-induced production of inflammatory cytokines, including tumor necrosis factor-# and 
interleukin-6. In an animal model, celastrol protected mice from TPA-induced ear edema, 
possibly by inhibiting MPO activity and production of inflammatory cytokines.  
Conclusions Our data suggest that celastrol inhibits the production of inflammatory 
mediators and is a potential target for the treatment of various inflammatory diseases. 
 
This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant 
funded by the Korea government (MOST)(R01-2007-000-20164-0). 
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XH-14 is known as a potent ingredient isolated from Danshen, the dried root of Salvia 
miltiorrhiza Bunge (Lamiaceae), is one of the most commonly used traditional Chinese 
medicines for cardiovascular indications and structurally identified as a benzo[b]furan lignan. 
Many biologically active benzo[b]furan compounds are found in nature. Herein, 2-(4-
hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-6-methoxybenzofuran (5-methoxy-XH-14, 
HC-59) was used in this study. This study tested whether HC-59 can inhibit differentiation of 
adipocytes and expression of pro-inflammatory visfatin and resistin, visceral-fat-specific 
adipokines. The 3T3-L1 preadipocytes were differentiated in DMEM-10% FBS for up to 6 
days in the absence and presence of nontoxic HC-59 between 1 and 25 microM. Oil Red O 
staining and Western blotting analyses revealed that HC-59 at more than 5 microM attenuated 
lipid accumulation and expression of PPAR gamma and C/EBP alpha, indicating that 
submicromolar HC-59 suppressed adipocyte differentiation. In addition, HC-59 dampened 
expression of visfatin and resistin proteins highly elevated in differentiated adipocytes. The 
results demonstrate that compound HC-59 may be a promising agent to disturb adipocyte 
differentiation and obesity-associated inflammation. This work was supported by the Korea 
Research Foundation Grant funded by the Korean Government (MEST)” (The Regional 
Research Universities Program/Medical & Bio-Materials Research Center) 
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Free radical scavenging activities of natural products are important to reduce the oxidative 
stress which subsequently will retard the inflammatory responses in the body. Health 
promoting effects of soymilk (SM) products are well known to people and these beneficial 
effects of SM will increase by fermentation. In this study, free radical scavenging activities of 
SM fermented with Lactobacillus acidophilus or/and Bacillus subtilis were examined. 
Fermentation elevated the radical scavenging activity of SM against DPPH radical, hydroxyl 
radical, nitric oxide radical, superoxide radical, and peroxinitrite radical. But the radical 
scavenging activities of various FSMs were differed. FSM by Bacillus subtilis showed the 
greatest radical scavenging activity against DPPH, hydroxyl and peroxynitrite radicals among 
FSMs. But nitrite and superoxide scavenging activities of FSMs were not differed. IC50 for 
DPPH scavenging activity of FSM with Bacillus subtilis and its total antioxidant activity 
expressed as TEAC were 769.23 ug/mL and 0.55mM, respectively, which were 140 and 
275% higher than un-fermented SM (UFSM). LDL susceptibility to oxidation was retarded by 
60%, compared with UFSM. These results indicate that FSM with Bacillus subtilis, beverage 
type natto, would reduce oxidative stress via scavenging free radicals and increasing 
antioxidant status in the body when we consume it. Further study for FSM against 
inflammation is needed. (This research was financially supported by MEST and KIAT 
through the Human Resource Training Project for Regional Innovation.)  
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Ultradeformable cationic liposome (UCL) has been recently developed to improve 
transdermal delivery of therapeutically active agents. To alleviate disease conditions 
associated with inflammatory skin disease, we formulated UCL containing IL-13 antisense 
oligodeoxynucleotide (ASO) and investigated their physicochemical properties in vitro. When 
applied in vivo model of inflammatory skin disease, IL-13 ASO-UCL complexes dramatically 
suppressed IL-13 production as well as other T helper 2 lymphocyte-secreted cytokines, IL-4, 
IL-5. Therefore, IL-13 ASO-UDL presents the ability to control inflammatory conditions and 
further demonstrated the feasibility as an effective therapeutics for inflammatory skin disease. 
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Curcumin down-regulates HIF-1& through the regulation of AMPK in hypoxia-induced 
HT-29 colon cancer cells  
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Hypoxia inducible factor 1" (HIF-1"), the primary transcriptional regulator has been reported 
to play an important role in modulating tumor growth and angiogenesis in response to oxygen 
deprivation.  In this study, we investigated the possible cross-talk between HIF-1" and AMPK 
(AMP-activated protein kinase), a major signaling molecule for the regulation of energy 
metabolism, often induced by cellular stress such as glucose deprivation and hypoxia utilizing 
HT-29 colon cancer cells treated with curcumin.  The induction of HIF-1" and AMPK was 
observed in cancer cells under CoCl2 induced hypoxic state.  However, curcumin reduced the 
expression of HIF-1", which was increased in cells of hypoxic state with CoCl2.  The 
effective AMPK activator, curcumin abolished the ability of CoCl2 to induce HIF-1" 
expression.  These observations suggest that phytochemical such as curcumin may exert the 
inhibitory effects on HIF-1" in hypoxic tumor cells, and thus control tumor cell growth and 
angiogenesis.  [This work was supported by the Korea Science and Engineering Foundation 
(KOSEF) grant funded by the Korea government (MEST) (NO. R01-2008-000-20131-0)] 
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ATP-gated P2X1 ion channels negatively regulate neutrophil activation: a novel anti-
inflammatory mechanism 
 
Christelle Lecut1, Céline Faccinetto1, Estelle Dortu2, Philippe Delvenne2, Richard J Evans3, 
Vincent Bours1, Cécile Oury1 
 
1GIGA-R, Human Genetics Unit, University of Liège, Liège, Belgium – c.lecut@ulg.ac.be 
2GIGA-R, Department of Pathological Anatomy and Cytology, University of Liège, Belgium 
3Department of Cell Physiology and Pharmacology, University of Leicester, United Kingdom 
 
Extracellular nucleotides, secreted by activated blood platelets and leukocytes or by epithelial and 
endothelial cells submitted to mechanic stress or hypoxia, act as signalling molecules through their 
interaction with P2Y and P2X receptors. Upon tissue damage or infection, a sudden increase of 
extracellular ATP concentration occurs, that is thought to contribute to the inflammatory response. We 
previously showed that ATP-gated P2X1 ion channels are expressed by neutrophils and promote their 
chemotaxis through Rho Kinase activation. In this study, we investigated the role of these channels in 
neutrophil activation both in vitro and in vivo in murine models of sepsis. In vitro studies revealed that 
neutrophils isolated from the bone marrow of P2X1
-/- mice had enhanced respiratory burst activity. 
Reactive oxygen species (ROS) production induced by formylated peptide, PMA or serum-opsonized 
zymosan particles was significantly augmented as compared to that of wild-type neutrophils. A 
hallmark of neutrophil activation is the shedding of L-Selectin (CD62L). P2X1
-/- neutrophils displayed 
significantly lower CD62L expression than wild-type neutrophils, indicative of a basal pre-activated 
state. This observation was confirmed in a model of endotoxemia induced by intraperitoneal injection 
of a sub-lethal dose of lipopolysaccharide (LPS). We showed that plasma myeloperoxidase (MPO) 
concentration, an indicator of neutrophil systemic activation, was increased after LPS treatment in 
wild type mice but reached significantly higher levels in the P2X1
-/- mice. In addition, peripheral P2X1
-
/- neutrophils expressed higher levels of CD11b in response to LPS injection, again reflecting their 
higher activation state. Concomitantly, we observed that the LPS-induced drop in platelet and 
lymphocyte counts were both worsened in the P2X1
-/- mice as compared to their wild type littermates. 
Furthermore, immunohistochemistry and MPO activity assay revealed exaggerated neutrophil 
relocalization into the lungs of P2X1
-/- mice, where these cells formed large aggregates in the capillary 
lumen. Finally, in a model of septic shock induced by intraperitoneal injection of a lethal dose of LPS, 
the P2X1
-/- mice exhibited shorter survival time than wild type mice, most likely as a consequence of 
enhanced neutrophil-mediated organ failure. Taken together, these results suggest that P2X1 ion 
channels negatively regulate neutrophil activation, contributing to limit inflammation in response to 
bacterial challenge. 
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Akt signals in HT-29 colon cancer cells 
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Cancer cells generally show hyper-activated inflammatory molecules, which are related to 
cancer survival and malignancy.  In this study, we have examined the potential of Elaeagnus 
multiflora as a cancer preventive agent through regulating inflammatory signals including 
COX-2 and Akt.  Elaeagnus multiflora has been traditionally used in china, and recently, it 
has reported to exert anti-oxidative effect, anti-inflammatory and anti-cancer effects.  We 
obtained extracts from seed and flesh of Elaeagnus multiflora extracted with 95% ethanol and 
analyzed the effects of COX-2 and Akt activities in HT-29 colon cancer cells.  Our results 
showed that the treatment of seed extracts (200 – 800 µg/ml) for 48 h effectively reduced 
COX-2 and p-Akt expression, and their inhibitory effect was stronger than that of flesh 
extracts.  In addition, these anti-inflammatory effects seemed to be related to cancer cell 
death.  Both of seed and flesh extracts inhibited cell growth and induced apoptosis in HT-29 
cells.  These results suggest that Elaeagnus multiflora may contribute to suppressing cancer 
growth through its anti-inflammatory and anti-proliferative effects, and natural products used 
as oriental medicine have the possibility to control tumor cell growth.  
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AMP-activated protein kinase (AMPK) is a major signaling molecule for the regulation of 
energy metabolism.  Recent studies indicate that AMPK activation regulates several cellular 
processes including cell proliferation, apoptosis and inflammatory responses.  In this study, 
we have examined the effects of quercetin on hypoxia condition-stimulated cancer cell growth 
and regulatory mechanism of AMPK on HIF-1", the transcriptional regulator of response to 
oxygen depletion, in MCF-7 breast cancer cells.  Our results showed that the induction of 
HIF-1" and AMPK was observed in cancer cells under CoCl2–induced hypoxic state.  
Quercetin reduced the expression of HIF-1", which was elevated in hypoxic state with CoCl2.  
However, this inhibitory effect of quercetin on HIF-1" did not seem to be dependent on 
AMPK activity.  Since the inactivation of AMPK by applying AMPK inhibitor, Compound C 
did not affect the ability of quercetin to inhibit HIF-1".  These observations suggest that 
quercetin exerts its anti-cancer effects through regulation HIF-1" and AMPK against hypoxic 
state tumors and may contribute to controlling tumor angiogenesis and metastasis.  [This work 
was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by 
the Korea government (MEST) (NO. R01-2008-000-20131-0)] 
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Most breast cancers have characteristics of over-activated Akt, a major stimulator of cell 
growth and tumor progression.  Thus, suppressing Akt activity can provide an effective way 
for control tumor.  In this study, we have focused on the regulatory effects of AMPK and 
cyclooxygenase-2 (COX-2) on cell survival signal in MCF-7 breast cancer cells using their 
specific inhibitors, Compound C and Celecoxib for AMPK and COX-2, respectively.  Our 
results showed that the inhibition of AMPK by Compound C increased both Akt and COX-2 
levels.  Blocking COX-2 expression by Celecoxib increased AMPK, and surprisingly it 
increased Akt also in MCF-7 cells.  To determine the relationship between Akt and COX-2 
signals, we used the cox-2 negative and positive cells.  In cox-2 positive cells, Celecoxib 
decreased COX-2 level as well as Akt activity, but activated AMPK.  In addition, treatment of 
Celecoxib and LY294002, Akt inhibitor reduced cell growth of MCF-7 cells.  Therefore, 
these results suggest that their might exist mutual regulatory interactions between COX-2 and 
Akt signals in only cancerous applicable cells.  Moreover, AMPK can act as a negative 
regulator of Akt and COX-2 signals and targeting AMPK to control tumor growth can be an 
effective way due to its inhibitory effects of Akt against breast cancers.  [This work was 
supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the 
Korea government (MEST) (NO. R01-2008-000-20131-0)] 
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Objectives: Toll like receptor 4 (TLR4) represents an important mediator of endotoxin-related 
signal transduction. Aim of our study was to evaluate whether TLR4 inhibition after onset of 
experimental endotoxemia is able to improve the intestinal microcirculation, which is crucial in 
the pathogenesis of septic multiple organ failure. 
Materials and Methods: We studied four groups of animals (Lewis rats, n=10 per group): 
healthy controls (CON group), endotoxemic animals (15 mg/kg lipopolysaccharide, LPS group), 
endotoxemic animals treated with TLR4 antagonist (1 mg/kg CRX-526, LPS+CRX group), and 
CRX-526 treated controls (CRX group). Intravital microscopy of the intestinal microcirculation 
was performed following 2 hours of observation in all animals. Blood samples were taken for 
cytokine measurements at the end of the experiments. 
Results: Following two hours of endotoxemia we observed a significant increase of leukocyte 
adhesion in the intestinal submocosal venules (e.g., V1 venules: CON 20.4±6.5 n/mm2, LPS 
237.5±36.2 n/mm2, p<.05). Capillary perfusion of the muscular and mucosal layers of the 
intestinal wall was significantly reduced (e.g., longitudinal muscular layer: CON 112.5±5.9 
cm/cm2, LPS 71.3±11.0 cm/cm2). TLR4 inhibition reduced leukocyte activation (V1 venules: 
104.3±7.8 n/mm2) and improved capillary perfusion (longitudinal muscular layer: 111.0±12.3 
cm/cm2) significantly. Cytokine release was not affected. 
Conclusions: Administration of the TLR4 antagonist CRX-526 improved intestinal 
microcirculation in a post-treatment model of experimental endotoxemia. The TLR4 pathway may 
be a target in clinical Gram-negative sepsis. 
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Antiflammin-1 (AF-1,MQMKKVLDS) is a nonapeptide which has a powerful anti-
inflammatory effect . It acts as its original full length protein-Clara Cell Secretory Protein 
(CCSP) and may display potent clinical application value. Our previous studies indicated that 
Clara Cells on the terminal bronchioles significantly inhibited pulmonary fibrosis induced.by 
bleomycin. In present study, we observed firstly the protective effect of AF-1 against 
pulmonary fibrosis. Mice were subjected to intratracheal administration of bleomycin 
(5mg/kg) to establish the fibrotic model and received AF-1(15mg/kg) by intratracheal 
administration 3 days later. The mRNA expression level of precollagen " and 
precollagen#in lung tissue were quantified by RT-PCR at 14
th
 day and 28
th
 day 
respectively.The bleomycin-induced increase of precollagen " and precollagen#mRNA 
expression were significantly down-regulated by AF-1. The collagen deposition detected by 
Masson staining and the hydroxyproline content was decreased by AF-1. All together, our 
results showed that AF-1 could reduce the degree of lung damage and fibrosis. In conclusion, 
AF-1 has a protective effect on bleomycin-induced lung fibrosis and it might prove useful as 
an add-on therapy for the treatment of fibrotic disorders of lung such as idiopathic pulmonary 
fibrosis, a disease that still represents a major challenge to medical treatment. 
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The glutamate (Glu) is the major excitatory neurotransmitter in the mammalian central 
nervous system. And the basal levels of extracellular glutamate are maintained primarily by 
the exchange of extracellular cystine for intracellular Glu via cystine/glutamate transporter 
(Xc¯) exchange in the nucleus accumbens(NA) in rats. However, the overactivation of NMDA 
receptor-induced by the accumulation of extracellular Glu can cause excitotoxicity. The 
expression of xCT mRNA, the light chain of Xc¯, has been confirmed in the bronchiolar 
epithelium of the lung in lipopolysaccharide (LPS)- induced endotoxemia mice. Our previous 
study has firstly found that NMDA receptor antagonist MK801 can attenuated LPS-induced 
acute lung injury (ALI) in mice. It suggests that endogenous Glu take part in LPS-induced 
ALI mediated by NMDA receptor. However, whether the release of endogenous Glu-induced 
by LPS through Xc¯ is not clear. In present study, we observed firstly that the effect of LPS 
on Glu release from human bronchial epithelial cell line (HBEc). The results showed that the 
expression of Xc¯ mRNA was positive in HBEc. And LPS promotes HBEc to release Glu 
which can be inhibited by Xc¯ inhibitor homocysteic acid (HCA). In conclusions, LPS can 
promote the glutamate release from HBEc by Xc¯. This cell may be the sources of 
endogenous Glu in the pathogenesis of ALI.  
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Vitis coignetiae Pulliat Named Meoru in Korea has been used widely as a remedy for 
inflammatory diseases and various cancers. We previously suggested that anthocyanins from Vitis 
coignetiae Pulliat (AIMs) should have apoptotic effects through suppression of Bcl-2 and anti-
invasive activity through suppression of MMP-2 and MMP-9. We investigated their effects on 
NF-!B-regulated gene products and cellular responses in HeLa human uterine cervical cancer 
cells. AIMs inhibited the proliferation of Hela cells in a dose dependent manner. AIMs inhibited 
the motility of HeLa cells in a wound healing test and gelatin migration test. AIMs also inhibited 
the invasion of HeLa cells in a similar dose-dependent manner as determined through a Matrigel-
coated chamber assay. They also inhibited expression of MMP-2 and MMP-9 which are key 
molecules for cancer invasion. AIMs inhibited the NF-!B activity and the I!B" phosphorylation 
induced by TNF-". AIMs also suppressed the NF-!B-regulated proteins which are related to 
metastasis. Taken together, this study indicates that AIMs have anti-cancer effects on HeLa cells 
through the inhibition of NF-!B activation and downstream proteins. This study suggested that 
AIMs might have anti-cancer effects on human uterine cervical cancer by inhibiting the NF-!B 
activity through the inhibition of I!B" phosphorylation. [This work was supported by a grant of 
the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, 
Republic of Korea (A080164).] 
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Inflammatory cytokines and pro-coagulants in monocytes/macrophages have a key role in 
physiological and pathological inflammatory responses. However, the mediators regulating the 
expression of inflammatory genes committed to restore the normal homeostasis after acute 
inflammation are poorly defined [1]. Recent investigations have revealed the active involvement of 
the phosphoinositide derivatives produced by phospholipase A2 activity: the 
glycerophosphoinositols (GPIs). Immune cells have a potent and regulated phospholipase A2 that 
provides fine modulation of intracellular GPI levels consequent to cell development, differentiation 
and hormone stimulation (i.e. exposure to lipopolysaccharides [LPS], cytokines, and other pro-
inflammatory agents) [2,3]. In this study, we delineate a role of the GPIs as endogenous 
metabolites that are part of a negative feed-back loop that limits pro-inflammatory and pro-
thrombotic responses in human monocytes stimulated with LPS. The pro-coagulant activity of 
LPS-stimulated monocytes is mainly ascribed to tissue factor expression; in addition, LPS induces 
increase in the mRNA levels of tissue factor, cyclooxygenase-2, interleukin-1beta, and tumour 
necrosis factor-alpha. Pre-treatment of monocytes with GPIs before LPS addition resulted in dose-
dependent inhibition of tissue factor activity as well as decrease of mRNA levels of all the analysed 
inflammatory genes. Notably, treatment with the GPIs was consistently associated with decreased 
LPS-induced nuclear translocation of transcription factors, such as NF-kB. The time course of the 
effects of different GPIs on NF-kB nuclear levels were consistent with the different timing for the 
modulation of the mRNA levels of the inflammatory markers. Our study provides new insight into 
the biology of the GPIs, suggesting that these compounds have roles as endogenous anti-
inflammatory mediators for inflammation resolution.  
 
1.Fujiwara N, Kobayashi K. (2005) Curr Drug Targets Inflamm Allergy. 4:281-6. 
2.Corda D, Iurisci C, Berrie CP. (2002) Biological activities and metabolism of the 
lysophosphoinositides and glycerophosphoinositols. Biochim Biophys Acta. 1582:52-69. 
3.Corda D, Zizza P, Varone A, Filippi B M, Mariggiò S. (2009) The glycerophosphoinositols: 
cellular metabolism and biological functions. Cell Mol Life Sci. 66:3449-67. 
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Antinociceptive and anti-inflammatory activities of the essential oil of Lippia gracilis  
 
S. S. Mendesa, R. R. Bomfima, H. C. R. Jesusb, P. B. Alvesb, A. F. Blankc, C. S. Estevama, A. 
R. Antoniollia,  R. D. Castrod, R.C.H. De Vose, S. M. Thomazzia* 
 
Department of aPhysiology, bChemistry and cAgronomic Engineering, Federal University of 
Sergipe, dDepartment of Biofunction, Federal University of Bahia, Brazil, ePlant Research 
International, Wageningen, The Netherlands. 
 
Essential oil (EO) of leaves from the tropical plant L. gracilis (Verbenaceae) has antimicrobial 
activities and is traditionally used to externally treat cutaneous diseases, burns, wounds, and 
ulcers. In this study we evaluated the antinociceptive and anti-inflammatory activities in rats and 
mice and linked these activities with the chemical composition of the EO. The chemical analysis 
of the EO was performed using GC/MS and GC/FID. The antinociceptive activity, induced by 
injection of 1% acetic acid, was investigated using concentrations of 50-200 mg EO (dissolved in 
NaCl + DMSO)/kg in mice, n=6) and with acetylsalicylic acid as a reference. Anti-inflammatory 
activity of the EO was evaluated using the paw edema method in rats (n=6) and the peritonitis 
method in mice (n=6). The paw edema assay was based on diminution by the EO (at 50-200 
mg/kg) of local inflammation induced by carrageenan, using dexamethasone (2 mg/kg) as a 
reference. The paw volume of the rats was measured plesthismographically before and after 
administering carrageenan for up to 4h. In the peritonitis method, drugs or vehicle were 
administered orally. Carrageenan was injected intraperitoneally 1h later, and after a further 4 h 
period the animals were sacrificed and total amounts of leukocytes were estimated using a Coulter 
counter. In all experiments, 0.9% (w/v) NaCl + DMSO was used as the negative control. The 
results of the composition analysis of L. gracilis EO indicated that the terpenoids thymol (35%), 
p-cymene (14%), methyl thymol (12%) and carvacrol (8%) were the major compounds. At least 
thymol and carvacrol are known for their antioxidant and anti-inflammatory effects in vitro. In the 
antinociceptive test, the oral treatment with the EO elicited significant inhibitory activity (P < 
0.05) effect at all concentrations tested. In the anti-inflammatory assay, carrageenan-induced 
edema formation was reduced by EO at both 100 and 200 mg/kg (P < 0.001).  Likewise, EO 
diminished carrageenan-induced leukocyte migration at all concentrations tested (P < 0.01). Our 
results indicate that essential oil of L. gracilis leaves shows both antinociceptive and anti-
inflammatory activities.  
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Curcumin and resveratrol counteract the catabolic effects of lipopolysaccharides (LPS) in 
explant models of canine and porcine cartilage inflammation 
 
Ali Mobasheri1, Stuart M. Williamson2, Jessica A. Reynolds2, Abigail L. Clutterbuck1, 
Melissa D. Royal2 and Mehdi Shakibaei3 
 
1School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, 
LE12 5RD, UK. Email: abigail.clutterbuck@nottingham.ac.uk; 
ali.mobasheri@nottingham.ac.uk 2School of Veterinary Science, University of Liverpool, 
Liverpool L69 3BX, UK. E-mail: s.m.williamson@student.liverpool.ac.uk; 
jessica_reynolds_18@hotmail.com; mdroyal@liverpool.ac.uk; 3Institute of Anatomy, 
Ludwig-Maximilians-University Munich, 80336 Munich, Germany. E-mail: 
mehdi.shakibaei@med.uni-muenchen.de 
 
In this study we established an in vitro model of joint inflammation mimicking the events that 
occur in osteoarthritis (OA) and osteochondritis dissecans (OCD) to investigate whether curcumin 
and resveratrol can counteract lipopolysaccharide (LPS) induced glycosaminoglycan (GAG) 
release.  Cartilage was obtained from canine stifle and porcine hock joints.  Explants were 
incubated in serum-free culture medium and challenged with LPS (0.25'g/ml-1) to mimic joint 
inflammation.  LPS-stimulated samples and controls were co-treated with either curcumin or 
resveratrol, both at 2.5'M for 5 days.  Tissue culture media and the papain digested cartilage 
explants were analysed for GAG content in order to asses the anti-catabolic potential of curcumin 
and resveratrol using the dimethylmethylene blue (DMMB) assay.  There was a significant 
increase in GAG release from LPS-stimulated canine and porcine samples when compared to 
controls (P<0.001).  Co-treatment with curcumin and resveratrol antagonized the degradative 
effects of LPS and inhibited GAG release from the explants.  There was a marked decrease in 
GAG release from LPS-stimulated canine and porcine samples with 2.5µM resveratrol and this 
difference was found to be statistically significant in the canine explants (P<0.05).  Differences 
were also noted between LPS stimulated samples with and without 2.5µM curcumin but these did 
not reach statistical significance.  Curcumin and resveratrol antagonized the catabolic and 
degradative effects of LPS in explant cultures.  However, resveratrol had a more significant anti-
catabolic effect on canine explants.  These plant-derived compounds may have potential as novel 
anti-inflammatory nutraceuticals. 
This work was funded by The Wellcome Trust and BPEX. 
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A pilot study with a modified filter-type device (Cellsorba EX) for leukocytapheresis using ACD-
A as anticoagulant in patients with mild to moderately active ulcerative colitis. LL-37 is 
generated during apheresis session. 
 
Muratov V1, Mandic-Havelka A2, Elvin K1, Öst Å3, Shibata H4, Shizume Y5, Furuya K5, Löfberg R6 
and Lundahl J1 
 
1 Unit of Clinical immunology, Dept. of Clinical immunology and transfusion medicine, Karolinska 
Institutet, Karolinska University Hospital, Stockholm, Sweden. 2 Dept. of Clinical chemistry, 
Karolinska University Hospital, Stockholm, Sweden. 3 Dept. of Clinical pathology, MediLab AB, 
Täby, Sweden. 4 Asahi Kasei Kuraray Medical Co., Ltd. , Tokyo, Japan. 5 Asahi Kasei Medical 
Europe GmbH, Frankfurt, Germany. 6 IBD-Unit, Sophiahemmet, and Karolinska Institutet, 
Stockholm, Sweden. Vladislaw.muratov@karolinska.se, aleksandra.mandic-havelka@karolinska.se, 
kerstin.elvin@karolinska.se, ake.ost@medilab.se, furuya.kb@om.asahi-kasei.co.jp, shizume.yb@om.asahi-
kasei.co.jp, furuya.kb@om.asahi-kasei.co.jp, robert.lofberg@ki.se, joachim.lundahl@karolinska.se  
 
Background: Leukocytapheresis (LCAP) is a non-pharmacological treatment modality for inflammatory 
conditions. CellsorbaTM  is a medical device for LCAP treatment of ulcerative colitis (UC). Cellsorba EX 
Global type has been developed from Cellsorba E to minimize the risks of bradykinin generation and for use 
with ACD-A as anticoagulant. Aims & Methods: To evaluate safety and efficacy of the modified 
CellsorbaTM using ACD-A as anticoagulant in a pilot trial comprising patients with active UC, despite 
receiving 5-ASA. A total of 10 LCAP treatments were administered. Safety assessment focused on clinical 
signs and symptomsbefore, during and after each LCAP session. Hematological variables were assessed 
before and after all sessions, and levels of bradykinin and IL-6 were measured before and during LCAP. 
Efficacy was determined using the Mayo clinical / endoscopicscoring index at start, after 8 and 16 weeks as 
well histological assessment of biopsies taken at 0, 8 and 16 weeks. Additional aim was to evaluate the impact 
of apheresis system lines and filter on selected regulatory molecules. Results: All six subjects completed the 
trial without any serious adverse events. WBC, platelet counts and levels of bradykinin and IL-6 were not 
significantly affected. The median Mayo score decreased from 8.0 to 3.5 at week 8 (and to 2 at week 16 for 
the responders). Two patients were then in remission, and two additional patients were responders. Median 
histological scores decreased from 3.5 at entry to 2.0 at the end of the study in these four patients. LL-37 
increased significantly within the apheresis system lines. Conclusions: LCAP using the modified CellsorbaTM 
EX (Global type) device with ACD-A as anticoagulant for the treatment of active UC was found to be safe 
and well tolerated. The clinical response experienced in this study was promising as 4/6 patients were 
responders, out of which 2 were in remission at week 16. Immunoregulatory molecules can be generated 
within the apheresis apparatus plastic lines.  
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Anti-inflammatory effects of active principle of Korean cabbage kimchi via suppressing 
NF-kappa B and increasing NO production in aorta of apoE KO mice 
 
Jeong Sook Noha, Hyun Ju Kima, Myung Ja Kwona, Hongsuk Suhb, Yeong Ok Songa*, 
 
aDepartment of Food Science and Nutrition, Kimchi Research Institute, Pusan National 
University, Busan 609-735, South Korea, bDepartment of Chemistry and Chemistry 
Institute for Functional Materials, Pusan National University, Busan 609-735, South 
Korea 
goodnoh7@pusan.ac.kr, hjkim03@hotmail.com, mjkown7@hanmail.net, hssuh@pusan.ac.kr, 
yosong@pusan.ac.kr 
  
In atherosclerotic process, inflammatory response and impaired nitric oxide bioavailability in 
aorta are associated with pathogenesis. 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid 
(HDMPPA) demonstrated antioxidant activity in kimchi (Korean fermented vegetable) may 
inhibit expression of pro-inflammatory mediator and adhesion molecules in aorta. Apo E KO 
mice were fed an atherogenic diet with an intraperitoneal injection (10 mg/kg bw/day 
HDMPPA) for 8 weeks. HDMPPA treatment increased NO production accompanied by 
augmenting the expressions of eNOS protein in aortas (p<0.05). The concentration of BH4, 
cofactor of eNOS was elevated by HDMPPA-treatment (control vs HDMPPA; 32.48 vs 40.88 
pmole/mg protein, p<0.01). The inflammatory protein levels of COX-2 and iNOS was 
reduced by 45% and 44%, respectively. Significant decreased in the protein level of ICAM-1 
and VCAM-1 in plasma of HDMPPA group (40% and 17%) was observed. Furthermore, 
HDMPPA increased protein level of IkBa (p<0.01) while that of NF-kB p65 in nucleus 
decreased (p<0.001). HDMPPA inhibited inflammatory response by down-regulating the pro-
inflammatory responses while preserving NO bioavailability in apoE KO mice.  
 204 
Session III     Poster III, 44 
 
Protective Effect of Coptis Chinensis against UVB-induced Pro-inflammatory Responses 
in Human Keratinocytes and NC/Nga Mice 
 
Chan Ik Park 
 
Department of Cosmeceutical Science, Daegu Haany University, 290, Yugok-dong, 
Gyeongsan-si, Geongsangbuk-do, 712-715, Korea 
E-mail : cipark@dhu.ac.kr 
 
Atopic dermatitis (AD) is a complex skin disorder accompanied by severe itching and 
inflammation with frequently repeated episodes. Genetic as well as environmental factors are 
involved in the development and pathogenesis of AD. Recently, ultraviolet B (UVB) radiation 
is regarded as a critical factor aggravating AD-related symptoms. The purpose of this study is 
to search for naturally occurring medicinal herbs which can protect against UVB-induced pro-
inflammatory responses and improve AD-like skin lesions in the in vitro cell culture as well 
as in vivo animal models of AD. Human keratinocytes, HaCaT cells were irradiated with 
UVB in the presence or absence of Coptis Chinensis. Rhizome of Coptis Chinensis referred as 
Hwang-ryun has been widely used in traditional Korean medicine to treat a vast array of 
inflammation-related health problems and medical conditions caused by excessive heat. In 
HaCaT cells, UVB irradiation led to an increased mRNA and protein expression of inducible 
nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and subsequent generation of 
nitric oxide (NO) and prostaglandin E2 (PGE2), which were significantly inhibited by Coptis 
Chinensis pretreatment. In another experiments, topical application of Coptis Chinensis to 
NC/Nga mice suppressed the development of UVB-mediated skin lesions and AD-like 
dermatitis. Moreover, expression of inflammatory enzymes and production of pro-
inflammatory mediators were effectively attenuated by Coptis Chinensis treatment. These 
findings suggest that Coptis Chinensis has preventive and therapeutic potential against UVB-
induced skin damages in AD. 
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Luteolin inhibits iNOS expression via blockade of NF-kappaB and JNK/AP-1 pathways 
in TNF-alpha induced HepG2 cells. 
 
Chung-Mu Park, Jin-Hyuk Shin, Young-Sun Song. 
 
Department of Smart Foods and Drugs, Biohealth Products Research Center, Inje 
University, Gimhae, Gyeongnam, Korea. Email : fdsnsong@inje.ac.kr 
 
Luteolin (3’,4’,5,7-tetrahydroxyflavone), an abundant flavonoid in celery, green pepper, 
parsley, perilla leaf, and dandelion, showed anti-inflammatory activities in previous 
researches. In this study, the inhibitory mechanism of luteolin on tumor necrosis factor 
(TNF)-alpha-induced inflammation was investigated in HepG2 cell line. Luteolin 
significantly suppressed TNF-alpha-stimulated inducible nitric oxide synthase (iNOS) 
expression in a dose dependent manner without cytotoxicity. Activator protein (AP)-1 and 
nuclear factor (NF)-kappa B were also measured due to an important role in inflammation and 
were known to regulate iNOS expression. Luteolin treatment dose-dependently inhibited the 
phosphorylation and nuclear translocation of p65 and c-jun, one subunit of NF-kappaB and 
AP-1. In addition, luteolin suppressed TNF-alpha-induced phosphorylation of c-Jun N-
terminal kinase (JNK) which is attributable for iNOS expression, and this stimulation was 
attenuated by the JNK selective inhibitor, SP600125, in HepG2 cells. These results suggest 
that luteolin attenuates TNF-alpha-stimulated iNOS expression through blockade of NF-
kappaB and JNK/AP-1 pathways in HepG2 cells.  
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Luteolin and chicoric acid synergistically inhibited inflammatory responses via 
inactivation of PI3K-Akt pathway and impairment of NF-kappaB translocation in LPS 
stimulated murine macrophage cell line  
 
Chung-Mu Park, Jin-Hyuk Shin, Young-Sun Song. 
 
Department of Smart Foods and Drugs, Biohealth Products Research Center, Inje 
University, Gimhae, Gyeongnam, Korea. Email : fdsnsong@inje.ac.kr 
 
The synergistic effect of luteolin and chicoric acid, two major constituents of dandelion 
(Taraxacum officinale Weber), was investigated in lipopolysaccharide (LPS)-stimulated 
RAW 264.7 cells. The optimum mixing ratio of luteolin and chicoric acid was 1:2. The anti-
inflammatory activity was compared using mRNA and protein expression levels, which were 
attributable to the suppression of inflammatory mediators, such as inducible nitric oxide 
synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), 
interleukin-1beta (IL-1beta). Cytoprotective enzyme, heme oxygenase (HO)-1, and its 
corresponding transcription factor, nuclear factor (NF)-E2-related factor (Nrf)-2, were 
increased by luteolin and chicoric acid co-treatment. In addition, synergistic effect was further 
examined whether inflammatory response was related to NF-kappaB activation in the 
mitogen-activated protein kinase (MAPK) or phosphoinositide 3-kinase (PI3K)-Akt pathway, 
inflammatory signaling pathways in RAW 264.7 cells. Luteolin and chicoric acid co-
treatment inhibited phosphorylation of IkappaB alpha, p65 and Akt, while gave no effect on 
extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38. 
These results suggest that two phenolic compounds synergistically attenuate LPS-induced 
inflammation via inactivation of PI3K-Akt pathway and impairment of NF-kappaB 
translocation in RAW 264.7 cells.  
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Daidzein suppresses high glucose-induced ICAM-1 and VCAM-1 expression in human 
umbilical vein endothelial cells  
 
Mi Hwa Park1, Jae Won Ju1, Ji Sook Han1  
 
1Department of Food Science and Nutrition, Pusan National University, 30 Jangjeon-
dong, Busan 609-735, Korea  
mf0106@hanmail.net, philo7ju@hanmail.net, hanjs@pusan.ac.kr  
 
Adhesion molecules are produced by endothelial cells following stimulation with various 
inflammatory cytokines. The current studies examined the effect of daidzein, an isoflavone 
and phytoestrogen component of soy, on the expression of adhesion molecules in human 
umbilical vein endothelial cells (HUVEC) stimulated with high glucose. Adhesion of 
monocyte to daidzein treated HUVEC was evaluated by co-culture experiments using 2,7-
bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethylester (BCECF-AM) labeling of 
HL-60 cells. The expression levels of vascular cell adhesion molecule-1 (VCAM-1), 
intracellular cell adhesion molecule-1 (ICAM-1) and nuclear NF-!B were evaluated by 
Western blot. Daidzein significantly inhibited the high glucose-induced increase in HL-60 
monocyte adhesion to HUVEC as well as downregulated protein expression levels of CAMs 
and E-selectin on HUVEC. High glucose-induced ROS production was inhibited by treatment 
of daidzein. Daidzein also reduced nuclear NF-!B protein expression in HUVEC. These 
results suggest that daidzein reduced high glucose-induced CAMs activation by inhibiting 
monocyte adhesion, ROS generation, and NF-!B in HUVEC. 
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Modulation of cancer cell proliferation by cell survival signal Akt and tumor 
suppressive energy sensor AMP-activated kinase in colon cancer cells treated with 
resveratrol 
 
Song Yi Park1, Yun-Kyoung Lee2, Young Min Kim1, Won Sup Lee3 and Ock Jin Park2  
 
1 Department of Biological Sciences, 2 Department of Food and Nutrition, Hannam 
University Daedeok Valley Campus, 461-6 Jeonmin-dong, Yuseong-gu, Daejeon 305-
811, Korea.  E-mail: ojpark@hnu.kr 
3 Department of Internal Medicine, Gyeong-Sang National University Hospital, 90 
Chilam-dong, Jinju, Gyeongsangnam-do 660-702, Korea 
 
It has been well known that resveratrol inhibits the proliferation of various cancer cells. AMP-
activated kinase, a sensor of cellular energy status, has emerged as a potent target for cancer 
prevention and/or treatment.  We have found that the activation of AMPK by resveratrol was 
crucial for the inhibition of growth of HT-29 colon cancer cells.  Resveratrol strongly 
inhibited p-Akt.  We have investigated the possibility of AMPK activation with resveratrol 
was essential to the inhibition of p-Akt.  The inhibitory effect of resveratrol on Akt was not 
observed when AMPK activities were blocked by the treatment with AMPK siRNA at a 
relatively low concentration of resveratrol.  However, at the higher dose of resveratrol, 
without the activation of AMPK resveratrol inhibited phosphorylation of Akt to a certain 
degree.  Therefore, we have concluded that resveratrol could modulate Akt AMPK-
dependently or AMPK-independently.  This suggests that resveratrol has molecular targets 
within the Akt signaling pathways and that the inhibition of Akt along with the activation of 
AMPK may contribute to the unraveling anticancer mechanism exerted by resveratrol.  [This 
work was supported by the Korea Science and Engineering Foundation (KOSEF) grant 
funded by the Korea government (MEST) (NO. R01-2008-000-20131-0)] 
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Identification of anti-inflammatory molecules for cystic fibrosis by virtual screening of a 
furocoumarin database against NF-kB 
Laura Piccagli1, Enrica Fabbri1, Monica Borgatti1, Nicoletta Bianchi1, Valentino 
Bezzerri2, Irene Mancini1, Marco Mori2, Elena Nicolis2, Maria Cristina Dechecchi2, 
Anna Tamanini2, Ilaria Lampronti1, Francesco Dall’Acqua3, Daniela Vevaldi3, Giulio 
Cabrini2, Roberto Gambari1 
 
1. BioPharmaNet, Department of Biochemistry and Molecular Biology, University of Ferrara, 
Ferrara, Via Fossato di Mortara 74, 44100 Italy, e-mail: gam@unife.it; 2. Laboratory of 
Molecular Pathology, Laboratory of Clinical Chemistry and Haematology, University Hospital 
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Persistent recruitment of neutrophils in the bronchi of CF patients contributes to airway tissue damage, 
suggesting the importance of intervening on the expression of the neutrophil chemokine IL-8. Since 
transcription factor NF-kB plays a critical role in IL-8 expression, a virtual screening of database with 
1740 furocoumarin (consisting of a furan ring fused with coumarin) compounds has been utilized to 
select molecules for their ability to inhibit the binding of NF-kB with the consensus sequence 
identified in the promoter of IL-8. Compounds available in a structure searchable database were 
retrieved using a substructure searching (2D) method. VS approach was followed against both NF-kB 
p50 monomer and homodimer. The selection of interesting compounds were based on the docking XP 
GlideScore rank for each target. Among the compounds exhibiting the highest docking ranks in the 
dimeric aggregation of the protein, the compound 7f (a furo(3,2-c)chromen-4one derivative) inhibited: 
(a) the formation of a stable NF-kB p50/DNA complex in EMSA studies; (b) the PAO1-dependent 
transcription of IL-8 in IB3-1 cystic fibrosis cells. In conclusion, compounds identified by a NF-kB 
virtual screening of a furocoumarin database resulted to be useful to identify novel pharmaceutical 
molecules able to inhibit the expression of the pro-inflammatory chemokine IL-8, which could be 
beneficial to control lung inflammation in the lung of CF patients.   
Supported by Italian Cystic Fibrosis Research Foundation (FFC#13/2007) with the contribution of 
“Associazione Veneta Lotta Fibrosi Cistica”. 
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Influence of novel selective cyclooxygenase-2 (COX-2) inhibitors on low density 
lipoprotein oxidation 
 
Jens Pietzsch1,*, Franz-Jacob Pietzsch1, Markus Laube2, Ralf Bergmann1, Frank 
Wuest3, Joerg Steinbach1,2, Torsten Kniess2 
 
1Department of Radiopharmaceutical Biology and 2Department PET Tracers, Institute 
of Radiopharmacy, Research Center Dresden-Rossendorf, P.O. Box 51 01 19, D-01314 
Dresden, Germany; 3Cross Cancer Institute, 11560 University Avenue, Edmonton AB 
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Clinical investigations showed a link between the extended use of rofecoxib, a selective COX-2 
inhibitor (coxib), and increased cardiovascular risk. This has led to general concern over the coxibs' 
cardiovascular safety. Subsequently, rofecoxib has been shown to increase oxidation of low density 
lipoproteins (LDL) and membrane lipids, whereas other coxibs did not, providing a biochemical 
rationale for differences in cardiovascular risk among coxibs. We investigated the independent effects 
of eight COX-2 inhibitors (two cyclopentene-/four indole-based sulfonyl derivatives) and two non-
sulfonyl indomethacin derivatives, which all were synthesized as lead compounds for development of 
novel COX-2 imaging radiotracers, on both human LDL lipid (kinetics of conjugated diene formation 
was followed photometrically) and protein oxidation (formation of %-glutamyl semialdehyde/#-
aminoadipyl semialdehyde in LDL apolipoprotein B-100 was followed by gas chromatography-mass 
spectrometry) compared to celecoxib and quercetin as controls. The presence of indole derivatives (50 
nM to 10 µM) concentration-dependently increased the lag-time for Cu2+- or hemin(Fe3+)-mediated 
formation of conjugated diene in LDL (>10%, p<0.01) and, furthermore, significantly decreased 
transition metal-catalyzed protein oxidation (>18%, p<0.01). Addition of indole-based coxibs to 
human plasma increased the oxygen radical antioxidant capacity (ORAC) by 6-14% (p<0.01). By 
contrast, other coxibs (cyclopentene and indomethacin derivatives) did not show effects on lipid and 
protein oxidation and, even at suprapharmacologic concentrations, had no significant effect on plasma 
ORAC values. A radiotracer-based analysis showed that indole derivatives interact differently with 
LDL subfractions and other lipoprotein particles, than the cyclopentene and indomethacin derivatives, 
respectively, suggesting a physico-chemical basis for observed differences in anti-oxidant activity. 
These findings may provide further insights for evaluation of potential cardiovascular risk of selective 
COX-2 inhibitors. 
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Antiinflamatory activity of Lonchocarpus araripensis lectin in mouse 
 
Alana de F. Pires, Ana Maria S. Assreuy, Márcia M. Marinho, Benildo S. Cavada 
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Anti-inflammatory activities have being demonstrated for leguminous lectins. Here, it was 
investigated the anti-inflammatory effect of a leguminous lectin from Lonchocarpus araripensis (LaL) 
in the models of mice paw edema and peritonitis. Systemic effects and participation of nitric oxide and 
arachidonic acid metabolites were also investigated. Protocols using Swiss mice (25- 30g) were 
approved by our Institutional Ethical Committee (No. 0559924-4). Paw edema was induced s.c. by 
carrageenan (Cg; 300 µg), sodium nitroprusside (10 µmol/Kg), or phospholipase A2 (1µg), measured 
by hydroplethysmometry before (zero time) and thereafter (1-5h) s.c. injection of stimuli and 
expressed as area under the time-course curve (AUC). Vascular permeability (A600nm-µg of Evans 
blue/g of tissue) was evaluated after mice had received Evans blue (25mg/kg; i.v.) 1h before sacrifice 
(2°h of Cg-induced edema). Peritonits was induced by Cg (500 µg; i.p.) for total and differential 
leukocyte counts (cells/µL) 4h after induction. LaL was injected i.v. (0.1-10 mg/kg), 30 min before 
flogistic agents. Toxicity was evaluated after a nine-day treatment with LaL (10mg/Kg) analyzing 
renal and hepatic function, body mass and leukogram. Results were expressed as Mean ± S.E.M 
(ANOVA and Bonferroni´s test; p<0.05). LaL (0.1, 1, 10mg/kg), dose- dependently, inhibited the 
time-course of Cg-paw edema (15.69 ± 1.58) by 32% (10.68 ± 1.37), 52% (7.45 ± 0.36) and 69% 
(4.84 ± 0.41), respectively. LaL at 10mg/Kg also inhibited the increase in vascular permeability 
elicited by Cg (38.7 ± 1.5) about 26% (26.61 ± 1.3). The edema induced both by sodium nitroprusside 
(10.76 ± 1.08) and by PLA2 (12 ± 0.89) was respectively inhibited by LaL (10 mg/Kg) about 83%  
(1.84 ± 0.58) and 48% (6.21 ± 0.86). LaL, dose dependently, reduced about 68% (1168.75 ± 117.9) 
the leukocyte migration evoked by carragenin (3704.17 ± 184.2), with maximal effect at 10mg/Kg, 
mainly due to inhibition (86%) upon neutrophils. L. araripensis lectin inhibited vascular and cellular 
events of inflammation with the apparent involvement of NO and prostanoids showing no signs of 
toxicity. Acknowledgments: CNPq, CAPES, FUNCAP and Gabriela FO Marques-Domingos for 
technical assistance.  
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Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in 
human articular chondrocytes in vitro: potential for treating osteoarthritis 
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Bonington LE12 5RD, United Kingdom 
 
The mitogen-activated protein kinase (MAPK) pathway is stimulated in differentiated 
chondrocytes and is an important signaling cascade for chondrocyte differentiation and 
survival. Pro-inflammatory cytokines such as interleukin 1# (IL-1#) play important roles in 
the pathogenesis of osteoarthritis (OA). In this study we investigated whether curcumin and 
resveratrol together can act synergistically to inhibit the catabolic effects of IL-1#, 
specifically the inhibition of MAPK and subsequent apoptosis in human articular 
chondrocytes. Chondrocytes were either left untreated or treated with 10 ng/ml IL-1$ or 1 'M 
U0126 alone for the indicated time periods or pre-treated with 10 'M curcumin, 10 'M 
resveratrol or 10 'M resveratrol and 10 'M curcumin for 4 hours followed by co-treatment 
with 10 ng/ml IL-1$ or 1 'M U0126 and 10 'M resveratrol, 10 'M curcumin or 10 'M 
resveratrol and 10 'M curcumin for 1, 12, 24 and 48 h. Cultures were evaluated by 
immunoblotting and electron microscopy. Incubation of chondrocytes with IL-1# resulted in 
activation of caspase-3, down regulation of ß1-integrins and the extracellular signal-regulated 
kinase (Erk) and induction of apoptosis. Interestingly, incubation with U0126, a specific 
inhibitor of Erk1/2 blocked these changes. Furthermore, co-treatment of the U0126–
stimulated cells with curcumin and resveratrol blocked activation of the caspase-3 and 
apoptosis suggesting, at least in part, that this process is a MAPK-dependent pathway. Thus, 
these results suggest that the MEK/Erk signal transduction pathway is involved in the 
maintenance of chondrocyte differentiation and survival and this pathway may be activated by 
combining these natural compounds. 
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Replacement enzyme therapy and systemic oxidative stress in patients with exocrine 
pancreatic dysfunction  
 
Galina Shmarina1,2, Alexander Pukhalsky1,2, and Vladimir Alioshkin2  
 
1Research Centre for Medical Genetics, Moscow 115478, 2Gabrichevsky Institute of 
Epidemilogy and Microbilogy, Moscow 125212, Russia. E-mail: 
sakmarariver@yahoo.com 
 
Cystic fibrosis (CF) is inherited disorder caused by mutations in a single gene encoding cystic 
fibrosis conductance regulator (CFTR) protein, resulting in fatal lung disease and exocrine 
pancreatic insufficiency. Dysfunctional CFTR modifies calcium homeostasis, impairs 
transport of glutathione, and induces mitochondrial oxidative stress. The disturbance of the 
redox balance evokes endogenous activation of NF-kB and exaggerates proinflammatory 
signaling in CF cells. In this environment, malabsorption of fatty soluble antioxidants 
secondary to pancreatic insufficiency can affect inflammatory response in CF patients. The 
aim of this study was to compare inflammatory markers in CF patients with different enzyme 
treatment regimens. Nineteen CF patients with pancreatic insufficiency were examined at a 
time of symptomatic exacerbation of their lung disease. Group A (n=11) were regularly 
received currently recommended lipase/protease intake. Group B (n=8) were treated with 
pancreatic enzyme supplements during hospitalization period only. The reasons for irregular 
pancreatic enzyme treatment were social, including parents’ preference as well as infrequent 
follow-up at the CF centres. During exacerbation group B had lower levels of T-cell 
proliferation then group A (p = 0.026). There were no differences in initial plasma 
malondialdehyde (MDA) levels between the groups. Adequate enzyme therapy improved 
lymphocyte functions but increased in systemic oxidative stress in the patients from group B. 
Indeed, their plasma MDA levels were markedly elevated after the treatment (p=0.021).  For 
group B, a significant positive linear association between values of plasma MDA and T 
lymphocyte proliferation has been observed. For group A, neither the same correlation, nor 
changes in MDA levels and lymphocyte proliferation have been found. In conclusion, rapid 
enzyme replacement in malnourished CF patients results in drastic influx of lipid targets for 
peroxidation that introduces a heavy oxidative challenge. Under the circumstances exhausted 
antioxidant defenses are unable to handle the oxidative insult.  
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Flavonoid Dihydroquercetin from Larix sibirica (L.) supresses inflammation processes, 
caused by H1N1 pandemic Influenza Virus Infection in Mice 
 
Anna A. Shtro *†,Vladimir V. Zarubaev†, Angelica A. Garshinina†, Mikhail Y. Eropkin 
†, Nelly A. Kalinina†, Vasily A. Babkin‡, Liudmila A. Ostroukhova‡, Oleg I. Kiselev† 
 
† Influenza Research Institute, St. Petersburg, Russia; ‡ Irkutsk Institute of Chemistry, 
Irkutsk, Russia 
*To whom correspondence should be addressed: Influenza Research Institute, 15/17 
prof. Popova str., 197376 St. Petersburg, Russian Federation, Tel. +7 812 234 6725, Fax 
+7 812 234 5973, Email: shtro@influenza.spb.ru 
 
Despite success with chemotherapy and vaccine prophylaxis, influenza remains a poorly 
controlled infection causing epidemics and pandemics. The aim of this study was to evaluate 
anti-influenza properties of dihydroquercetine (DHQ), the flavonoid from larch (Larix sibirica 
L.), on the model of infection in mice, caused by pandemic H1N1 influenza virus. Animals 
were infected with the influenza virus A/St.Peterburg/5/09 (H1N1)v and treated 
intraperitonially with DHQ on a combined (before and after infecting) schedule. On day 3 p.i. 
level of virus’ replication in lung tissue and mean size of foci of inflammation were evaluated 
by titration in MDCK cells and lung morphology analysis, respectively. No differences in 
virus’ titer was detected between control and DHQ- treated groups of animals. In both cases 
the virus replicated up to approx. 10
5.5
 EID50/(0,2 mg tissue) suggesting that there is no direct 
anti- viral activity of DHQ. However, DHQ has been shown to possess protective activity 
against influenza virus infection leading to a decrease in size of foci of inflammation (from 
approx. 25% of total lung volume in control group to 10% in experimental group). These data 
suggest that DHQ can be considered as an affordable and prospective tool to be used in 
complex prophylaxis and/or treatment of severe influenza. 
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Effects of COX-2 inhibitors on cell proliferation in human hematopoietic cancer cell 
lines 
 
Cyril Sobolewski1, Claudia Cerella1, Sebastien Chateauvieux1, Michael 
Schnekenburger1, Mario Dicato2, and Marc Diederich1 
 
1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 
Luxembourg; 2Department of Hematology-Oncology, Centre Hospitalier Luxembourg 
 
The link between chronic inflammation and cancer involves different cytokines and mediators 
of inflammatory pathways (i.e., reactive oxygen species, cyclooxygenases) and acts at the 
different steps of tumorigenesis. The cyclooxygenases (COX) are a family of enzymes, which 
catalyze the rate-limiting step in prostaglandin biosynthesis. COX-2 is the inducible isoform 
of COX, upregulated during inflammation and overexpressed in various cancers. There is 
evidence about the role of COX-2 in proliferation of colorectal, breast and prostate cancers, 
whereas this role remains to be elucidated in hematopoietic malignancies. In our study, we 
analyzed the role of COX-2 in cell proliferation of a panel of leukemic and lymphoblastic cell 
lines, including cells expressing COX-2 (U937, Jurkat, Hel and Raji) and a cell line (K562) 
expressing low level COX-2. We used two different COX-2 inhibitors: nimesulide and NS-
398. We found that both inhibitors were able to inhibit cell proliferation in all COX-2-positive 
cell lines tested whereas they were completely ineffective in low level COX-2 K562 cells. 
Focusing our investigations on U937 and K562, respectively as a COX-2 positive and a low 
level COX-2 cell model, we show that nimesulide and NS-398 led to an accumulation of the 
cells in the G0/G1 phase of the cell cycle in U937 cells, paralleled by an up-regulation of p27, 
a cyclin-dependent kinase inhibitor involved in the inhibition of G1/S transition. No 
upregulation of p27 was observed on K562. The fact that COX-2 inhibitors affect cell 
proliferation only on COX-2 positive cell lines suggests that this phenomenon may be related 
to the specific COX-2 inhibition. Possible modulation of autophagy, as a possible explanation 
to the effects exerted by COX-2 inhibitors on cell proliferation, was also investigated and 
discussed. 
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Chemopreventive effect of curcumin on the Wingless signaling pathway in prostate 
cancer cells  
 
Teiten M-H1, Gaascht F1, Henry E1,Eifes S1, Cronauer M2, Dicato M1 and Diederich M1 
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Prostate cancer is the third cause of death from cancer in men. Lifestyle, aspects of the diet and 
environmental factors as well as genetic factors (e.g. disregulations of the Wingless (Wnt) 
signaling pathway) promote the malignant transformation of healthy prostatic epithelium. Due to 
the high prevalence and the slow progressive development of prostate cancer, primary prevention 
using non-toxic natural or synthetic compounds appeared as an attractive strategy to eradicate 
prostate cancer. Curcumin (diferuloylmethane), a major component of turmeric plant (Curcuma 
Longa), is mainly characterized for its anti-inflammatory, anti-carcinogenic, anti-proliferative, 
anti-angiogenic and anti-oxidant properties. Based on the fact that curcumin exhibits an inhibitory 
effect on the Wnt signaling pathway in colon cancer and that this pathway is highly implicated in 
prostate cancer progression, we evaluate the potential impact of curcumin on the Wnt pathway in 
prostate cancer cells. We pointed out that whenever curcumin has the same intracytoplasmic 
localization in all of the prostate cancer cells tested, the androgen sensitive cells (22rv1, LNCaP) 
appear more sensitive to curcumin treatment than the androgen independent one (DU145, PC-3). 
We also reported that curcumin has an impact on the proliferation of the androgen 22rv1 sensitive 
cells as it induces a cell cycle arrest in G2/M phase confirmed by a decrease of the mRNA and 
protein level of expression of PCNA (proliferating cell nuclear antigen) and cyclin B1. Curcumin 
was also shown to decrease the Wnt ($-catenin/Tcf-4) transcriptional activity in 22rv1 cells that 
could be explained by a decrease of the level of expression of the nuclear Tcf-4 transcription 
factor after curcumin treatment. This leads to a decrease of the mRNA and protein expression 
level of both c-myc and cyclin D1, two well-known target genes of the Wnt signaling pathway. 
All of these findings suggested that curcumin could be considered as a potential chemopreventive 
agent for early but not for late, metastatic stages of prostate cancer. 
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The Diabetic antigen Glutamic Acid Decarboxylase (GAD 65) in the human peripheral 
blood 
 
G.P. Tilza , J. Dausseta, M. Wiltgenb  
 
a Centre d’Etude du Polymorphysme Humain, Paris, France and Medical University 
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Background: Glutamic Acid Decarboxylase (GAD 65) is a diabetes associated antigen which 
is generally considered to be strictly intracellular. In order to better understand autoimmunity, 
this study demonstrates the appearance of GAD 65 in the peripheral human blood and 
presents implications for diagnosis and therapy of some autoimmune diseases. Method: In an 
experimental set up with fluorescence correlation spectroscopy (FCS), the GAD 65 molecules 
are detected by their interaction with corresponding monoclonal antibodies, labelled with 
dyes. These interactions result in changes of the Brownian motion, measured as fluorescence 
fluctuations. Sera from 153 patients, with Diabetes Mellitus Type 1 and controls, were 
investigated. To enable an imagination of the molecule as model for further discussions we 
present structural visualizations of its hydrophobic properties, leading to possible interactions 
with the cell membrane lipids, and epitope locations. Result: The GAD 65 antigen could be 
measured with the sensitivity of 2.65 microgram/ml in “clean systems”, resulting from 
spiking experiments and human sera. In 8 cases of patient sera the GAD 65 antigen could be 
identified: 4 children with Diabetes Mellitus Type 1 and 4 adults, which were initially used as 
controls, who retrospectively showed signs of autoimmunity. Conclusion: We conclude that 
these findings are of significance for the concept of autoimmunity, whereby in an initial step 
the immune system is primed by the accessibility to GAD 65. Our experimental results may 
also be important for the therapy of Diabetes Mellitus Type 1 and other autoimmune diseases 
by the passive administration of GAD 65-antibodies.  
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Phosphatidylcholine inhibits TNF-&-induced pro-inflammatory signalling and interferes with 
the compartmentation of TNF-R1 and TNF-R2 to sphingolipid/cholesterol enriched 
microdomains (lipid rafts). 
 
Irina Treede, Hannah Schneider, Annika Braun, Thomas Giese, Wolfgang Stremmel, Joachim 
Füllekrug, Gareth Griffiths and Robert Ehehalt 
 
Department of Gastroenterology, INF 410, University hospital Heidelberg, 69120 Heidelberg, 
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Background: Phosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer that is 
reduced in patients suffering from ulcerative colitis [1, 2]. Clinical studies reveal that the therapeutic 
addition of PC to the colonic mucus using slow release preparations is beneficial [3, 4]. The positive 
role of PC in this disease is still elusive, however, we have recently shown that PC has an intrinsic 
anti-inflammatory property [5]. Exogenous PC inhibited membrane-dependent actin assembly and 
TNF-"-induced nuclear NF-!B activation. Methods: We investigated the hypothesis that exogenous 
application of PC has anti-inflammatory properties. PC species with different fatty acid side chains 
were applied to polarized and non-polarized Caco-2 cells treated with TNF-". We analysed NF-!B-
activation via the transient expression of a NF-!B-luciferase reporter system. Pro-inflammatory gene 
transcription was detected with the help of a quantitative (RT)-PCR. We assessed the binding of TNF-
" to its receptor by FACS and analysed lipid rafts by isolating detergent resistant membranes (DRMs). 
Activation of MAP kinases ERK and p38 were analysed by blotting. Results: All PC species tested 
significantly inhibited TNF-"-induced pro-inflammatory signalling. The expression levels of IL-8, 
ICAM-1, IP-10, MCP-1, TNF-" and MMP-1 were reduced after PC pre-treatment for at least two 
hours. The effect was not due to a reduced binding of TNF-" to its receptor or a decreased surface 
expression of TNF-" receptors. PC was also effective when applied to the apical side of polarised 
Caco-2 cultures if cells were stimulated from the basolateral side. Phosphorylation of ERK and p38 
was inhibited and PC changed the compartmentation of the TNF-"-receptors 1 and 2 to DRMs. 
Conclusions:  PC induces a prolonged inhibition of TNF-"-induced pro-inflammatory signalling. This 
inhibition may be caused by a shift of the TNF-" receptors at the surface to lipid rafts. Our results 
provide a molecular foundation for the clinical studies showing a beneficial effect of PC therapy in 
ulcerative colitis. 
1. Braun A et al: Inflamm Bowel Dis 2009, 15: 1705-1720. 2. Ehehalt R et al: Scand J Gastroenterol 
2004, 39: 737-742. 3. Stremmel W et al: Ann Intern Med 2007, 147: 603-610. 4. Stremmel W et al: 
Gut 2005, 54: 966-971. 5. Treede I et al: J Biol Chem 2007, 282: 27155-27164. 
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Leishmania infection control and Ehrlich Tumor inhibition by a neutrophil-mediated 
inflammatory reaction modulated by Chenopodium ambrosioides treatment. 
 
Wanderson S. Pereira, José J. Marques, Paulo V.S. Pereira, Marcia C.G. Maciel, 
Graciomar C. Costa, Lucilene A. Silva, Rosane N.M. Guerra, Flavia R.F. Nascimento 
 
Laboratory of Immunophysiology, Federal University of Maranhao, Sao Luis, MA, Brazil 
 
The leaves of Chenopodium ambrosioides L. (Chenopodiaceae) have been indicated for the 
treatment of tumor diseases. Recently, we showed that the treatment with hydroalcoholic 
crude extract (HCE) from the leaves of C. ambrosioides has a potent anti-tumor and anti-
leishmanial effects, which was evident even when the HCE was given after the tumor 
implantation or after the infection progression. The aim of this study was to investigate the 
effect of the daily treatment with HCE by different routes on the inflammatory reaction 
induced by Ehrlich Tumor cells implantation or by  Leishmania promastigotes inoculation. 
Tumor bearing or Leishmania-infected C3H/HePas mice received HCE (5mg/kg) by 
intraperitoneal route.  The treatment   initiated soon after the inoculation of 5x10
5
 tumor cells 
or 4 weeks after the Leishmania inoculation and it was maintained by 2 weeks. To determine 
the solid tumor growth and the infection progression, the footpad was measured with a digital 
caliper each 2 days or each week in the case of infected mice until the sacrifice of mice, when 
the paw were cutted, weighted and fixed to histopathological analyses. The results showed 
that the treatments increased the thickness of the footpad, but this was not related to an 
increase in the tumor cell number or in the parasite burden, but it was related to an intense 
inflammatory influx to the footpad, since both, the tumor cells and the parasite burden was 
significantly decreased in both cases. In fact, the HCE induced an intense infiltration of 
inflammatory cells, specially neutrophils, suggesting a pro-inflammatory effect of this 
product, what is fundamental to the controlling of tumor developing and Leishmania infection 
progression.  In conclusion, the treatment with Chenopodium ambrosioides reduced both the 
presence of tumor cells and the parasite burden in the site of inoculation, likely because the 
induction of an intense neutrophilic infiltration. Those results can, at least in part, justify the 
popular use of this specie to the treatment of tumor diseases and ulcers caused by Leishmania.   
Keywords: Chenopodium ambrosioides, Chenopodiaceae, Leishmania, Ehrlich tumor, 
Inflammation.  
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A NOVEL ANTI-INFLAMMATORY ROLE FOR ANDROGRAPHOLIDE AND ITS 
DERIVATIVES IN ASTHMA VIA INHIBITION OF THE NUCLEAR FACTOR-"B 
PATHWAY  
 
W.S. Fred Wong 
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Persistent activation of nuclear factor (NF)-"B has been associated with the development of 
asthma. Andrographolide, an active component of a medicinal plant Andrographis paniculata, 
has been shown to inhibit NF-"B activity. We hypothesized that andrographolide may 
attenuate allergic asthma via inhibition of the NF-"B signaling pathway. BALB/c mice 
sensitized and challenged with ovalbumin (OVA) developed airway inflammation and airway 
hyperresponsiveness. Andrographolide dose-dependently inhibited OVA-induced increases in 
total cell count, eosinophil count, and IL-4, IL-5 and IL-13 levels in BAL fluid, and reduced 
serum level of OVA-specific IgE. It attenuated OVA-induced lung tissue eosinophilia and 
airway mucus production, mRNA expression of E-selectin, chitinases, Muc5ac and iNOS in 
lung tissues, and airway hyperresponsiveness to methacholine. In normal human bronchial 
epithelial cells, andrographolide blocked TNF-#-induced phosphorylation of inhibitory "B 
(I"B) kinase-$ (IKK$), and downstream I"B# degradation, p65 subunit of NF-"B 
phosphorylation, and p65 nuclear translocation and DNA-binding activity. Similarly, 
andrographolide blocked p65 nuclear translocation and DNA-binding activity in the nuclear 
extracts from lung tissues of OVA-challenged mice. 14-Deoxy-11,12-
didehydroandrographolide is another major component of A. paniculata, and has shown 
similar anti-inflammatory actions in allergic asthma. Our findings implicate a potential 
therapeutic value of andrographolide and its derivatives for asthma and it may act by 
inhibiting NF-"B pathway at the level of IKK$ activation. (This work was supported by a 
BioMedical Research Council grant BMRC06/1/21/19/443 and Academic Research Grant R-
184-000-130-112) 
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The link between multiple sclerosis, T regulatory cells and Japanese rice 
 
Uri Wormser, Berta Brodsky, Elena Proscura, Avigail Erlanger-Rosengarten and Elena 
Shapira 
 
Institute of Drug Research, School of Pharmacy, Faculty of Medicine, Institute of Life 
Sciences, The Hebrew University, Jerusalem, Israel 
 
The purpose of the present study was to develop a peptide for treatment of multiple sclerosis 
(MS). We have tested the effect of a novel antiinflammatory peptide (KGHYAERVG, termed 
IIIM1) on experimental autoimmune encephalitis (EAE), an animal model of MS. Our findings 
demonstrate significant reduction in neurological score following oral administration of IIIM1, as 
compared to the control groups received the vehicle (saline). Structural studies revealed that the 
entire peptide is required for activity. The peptide caused significant reduction in IL17, interferon 
gamma and IL12 production by isolated splenocytes and concomitant elevation of 
antiinflammatory cytokines. IIIM1 elevated T regulatory cells (Tregs, CD4
+
CD25
+
FoxP3
+
) in 
brain and spleen of EAE mice. Similar proliferative effect was observed in isolated human and 
mouse Tregs in vitro. Stimulation of Tregs by IIIM1 caused production of a new peptide termed 
RA1 present in Oryza Sativa Japonica group. This Japanese rice peptide ameliorated neurological 
symptoms in the EAE model. Similar beneficial effect was observed upon oral administration of 
an extract of Japanese rice. In conclusion, oral treatment with IIIM1 ameliorates EAE symptoms 
via stimulation of Tregs to proliferate and produce RA1 which reduces EAE symptoms. These 
findings may explain the relatively low prevalence of MS in Japan and other Japanese rice-eating 
populations. (This work was supported in part by The Israel Science Foundation grant 747/05).  
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Novel peptides as potential treatment of systemic lupus erythematosus 
 
Uri Wormser, Berta Brodsky, Elena Shapira and Elena Proscura,   
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Sciences, The Hebrew University, Jerusalem, Israel 
 
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a loss of 
immunologic tolerance, production of auto-antibodies and inflammatory damage in multiple 
organs. We have tested the effect of anti-inflammatory peptide, a H2A histone fragment, 
termed IIIM1 on MRL/lpr mice, an animal model of SLE. Oral administration of IIIM1 at 
early stage of disease caused reduction in proteinuria and serum anti-dsDNA antibodies. 
Starting the treatment at advanced stage of disease resulted in prolonged animal survival, 
decreased lymphadenosis and reduced levels of pathogenic or abnormal double negative CD4
-
CD8
-
 cells and B220
+
 cells in lymph nodes and spleen. We discovered that IIIM1 induces the 
production of an additional peptide, a fragment of alpha-1-antitrypsin, termed UBE. 
Relatively low dose (1'g/kg) of UBE reduced proteinuria and hematuria in MRL/lpr mice. 
The beneficial effect of the peptide was corroborated by histological examination. 
Furthermore, a significant reduction in serum IL17, IL12 and anti dsDNA antibodies was 
observed in the UBE-treated mice. Isolated CD4 cells incubated with the peptide showed 
similar cytokine profile. Decreased levels of double negative CD4CD8 and B220
+
 cells were 
determined in lymph organs of UBE-treated animals. The beneficial effects of both UBE and 
IIIM1 suggest these peptides as potential drugs for SLE.  
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Anti-inflammatory effect of fisetin on ovalbumin-induced asthma 
 
Mei-Yao Wu, Shu-Ling Fu 
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Asthma is a chronic inflammatory disease with the characteristics of airway inflammation, 
airway hyperresponsiveness, and mucus production. Activation of NF-kB is highly associated 
with the pathogenesis of asthma. Fisetin, a natural compound commonly found in fruits and 
vegetables, has been shown to inhibit the NF-kB activation in macrophages and epithelial 
cells. In this study, we investigated whether fisetin can attenuate asthma via inhibition of NF-
kB activity using an ovalbumin (OVA)-induced murine asthma model. Our data showed that 
fisetin decreased the total inflammatory cell counts, eosinophil count and lymphocyte count in 
broncholalveolar lavage (BAL) of OVA-challenged mice. Furthermore, fisetin attenuated 
OVA-induced lung inflammation and goblet cell hyperplasia. The expression of eotaxin 
mRNA and Th2-associated cytokines (IL-4 and IL-5) in the lungs of OVA-challenged mice 
was also reduced after fisetin treatment. However, the serum OVA-specific IgE was not 
altered by fisetin. Notably, expression of Th2-predominant transcription factor GATA-3 and 
cytokines (IL-4, IL-5) in splenocytes under OVA stimulation were both suppressed by fisetin. 
Whether fisetin can attenuate airway hyperresponsiveness and NF-kB activation in OVA-
induced asthma mice are currently under investigation. 
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In osteoarthritis (OA), chondrocytes and infiltrating inflammatory cells express 
proinflammatory mediators such as IL-1ß, TNF-", nitric oxide (NO) and prostaglandins that 
contribute to the production of catabolic enzymes (MMPs and ADAMTS). The aim of the 
present study was to evaluate the anti-inflammatory activity of an extract from Caesalpinia 
sappan (CSE) as well as its main constituent brazilin in a cell model of joint inflammation 
comprising human chondrocytes and macrophages. 
Dose-response experiments indicated that concentrations up to 10'g/ml and 20'g/ml CSE did 
not impair viability of THP-1 macrophages and chondrocytes, respectively. CSE and brazilin 
treatments suppressed the up-regulation of IL-1ß, TNF-", COX-2 and MMP-3 mRNA 
induced by IL-1ß in chondrocytes and macrophages. An inhibition of NO production and 
inducible nitric oxide synthase (iNOS) mRNA expression was observed in IL-1ß stimulated 
chondrocytes treated with CSE. Transient transfection was carried out in SW1353 
chondrosarcoma cells and T/C28a2 chondrocytes using LipofectAMINE PLUS. 
Cotransfections of the COX-2 promoter luciferase reporter plasmid together with p50 and p65 
expression vectors enhanced the COX-2 promoter activity 3.4-fold and 3.5-fold in SW1353 
and T/C28a2 cells, respectively. This p50/p65-mediated transactivation of the COX-2 
promoter was dose-dependently down-regulated to basal levels by CSE. 
These results revealed potent anti-inflammatory activities of CSE and brazilin in joint 
inflammation. Potential molecular mechanisms might involve the inhibition of NO production 
via iNOS downregulation as well as the inhibition of p50/p65-mediated COX-2 promoter 
activation.   
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Effects of Anthocyanins Isolated from Vitis coignetiae Pulliat on NF-%B and NF-%B-
regulated Gene Expressions in HT-29 Human Colon Cancer Cells in vitro and in vivo 
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Vitis coignetiae Pulliat has been used as a folk remedy for inflammatory diseases and cancers. We 
previously suggested that anthocyanins from Vitis coignetiae Pulliat (AIMs) should have anti-
cancer activities by inhibiting NF-!B activation. Here, we investigated their effects on NF-!B-
regulated gene products and cellular responses in HT-29 human colon cancer cells, in vitro and in 
vivo. AIMs inhibited the proliferation of HT-29 cells in a dose dependent manner. AIMs inhibited 
the motility of HT-29 cells in a wound healing test and gelatin migration test. AIMs also inhibited 
the invasion of HT-29 cells in a dose-dependent manner as determined through a Matrigel-coated 
chamber assay. AIMs suppressed activation of NF-!B and NF-!B-regulated proteins (MMP-2, 
MMP-9, COX-2, XIAP, ICAM, and VEGF), which are related to metastasis. AIMs inhibited 
tumorigenicity of HT-29 cells in xenograft mouse model. AIMs inhibited the activation NF-!B 
and suppressed the NF-!B -regulated protein levels such as XIAP, COX-2 and ICAM in the HT-
29 cells grown in athymic nude mice. Taken together, this study indicates that AIMs should have 
anti-cancer effects on HT-29 cells through the inhibition of NF-!B activation and downstream 
proteins. This study provides evidence that AIMs might have anti-cancer effects on human colon 
cancer. [This study was supported by a grant from the National R&D Program for Cancer Control, 
Ministry for Health, Welfare & Family Affairs, Republic of Korea. (0820050).] 
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Using immunomodulatory agents to limit a dysregulated host response during severe 
influenza 
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The recent H1N1 influenza pandemic reminded us that the generation of a pandemic vaccine 
takes some months, leaving antivirals as the only available mainstream treatments.  While a 
report noted oseltamivir to be ineffective in treating children with influenza, and there is 
growing resistance to oseltamivir in the field, alternative treatments that target the host 
response rather than the virus are required, particularly in cases of influenza requiring 
hospitalization and intensive care.  In response to literature suggesting a role for statins in 
treating pandemic influenza, our research program has focussed on using mouse models for 
influenza to find the best candidate treatments for severe murine influenza, from a range of 
pharmaceutical and natural sources.  Reports indicate that the Chinese herbs Angelica sinensis 
and Salvia miltiorrhiza decrease serum levels of the pro-inflammatory molecule HMGB1 in a 
mouse model for lethal endotoxaemia, suggesting a potential utility in the treatment of severe 
influenza.  Glycyrrhizin, from Glycyrrhiza spp., would be useful as an influenza treatment, 
both as an antiviral and as an immunomodulatory treatment.  One of the active flavonoids 
from Trifolium pratense, biochanin A, could be used as a “natural” PPAR gamma agonist, as 
recent evidence gathered in our laboratory and others suggests that activation of PPAR 
gamma limits the severity of experimental influenza.  
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The immunogenicity of HIV-1 derived lentiviral vectors is mediated by TLR3 and TLR7 
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Lentiviral vectors are promising vaccine vector candidates, which have been extensively 
tested in pre-clinical models of infectious disease and cancer immunotherapy.  They are 
further used in gene therapy clinical trials, both for the ex vivo modification of cells and for 
direct in vivo injection.  It is therefore critical to understand the mechanism(s) by which such 
vectors might stimulate the immune system.  We evaluated the effect of lentiviral vectors on 
myeloid dendritic cells (DC), the main target of lentiviral transduction following 
subcutaneous immunisation.  Activation of DC cultures was independent of the lentiviral 
pseudotype, but dependent on cell entry and reverse transcription.  In vivo transduced
 
DC also 
displayed a mature phenotype, produced TNF-alfa, and stimulated naive CD8 positive T cells.  
Lentiviral activation of DC was TLR-dependent as it was inhibited in TRIF/MyD88 double 
knock out (KO) DC. TLR3 KO or TLR7 KO DC were less activated, and reverse 
transcription was important for activation of TLR7 KO DC.  Moreover, lentivirally 
transduced DC lacking TLR3 or TLR7 had an impaired capacity to induce antigen-specific 
CD8 positive T cell responses.  In conclusion, we demonstrated TLR-dependent DC 
activation by lentiviral vectors, explaining their immunogenicity. These data allow the 
rational development of strategies to manipulate the host’s immune response to the transgene. 
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VIP reduces TLR3 signalling pathways in rheumatoid arthritis and osteoarthrosis 
fibroblast synoviocytes  
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Vasoactive intestinal peptide (VIP) is a broadly distributed peptide first isolated in intestine 
but described later as a mediator produced in nervous endocrine and immune systems. Its 
anti-inflammatory properties have been proved both “in vivo” in several animal models and 
“in vitro” in human tissues and cells. TLRs are a family of receptors that activates the innate 
immunity in response to bacterial and viral compounds, inducing signals linking innate and 
adaptive immunity. TLR3 is present on intracellular compartments and it is activated by viral 
dsRNA and by its synthetic analogue Poly I:C. After TLR3 engagement, it couples to the 
adaptor TRIF starting a signalling pathway that culminates in activation of different 
transcription factors, NFkappaB and AP-1 which induce the production of inflammatory 
cytokines and IRF3 activation that leads to production of type I IFN. Fibroblast like 
synoviocytes (FLS) of rheumatoid arthritis (RA) and osteoarthrosis (OA) express different 
TLRs. In the present study we show that RA and OA FLS express TLR3. In RA FLS, the 
mRNA expression of TLR3 is higher than in OA FLS. Both FLS were stimulated with Poly 
I:C in the presence or absence of VIP and the IRF3 phosphorylation was measured in the 
nuclear extracts by TransAM. VIP treatment reduces IRF3 phosphorylation induced by Poly 
I:C. Moreover, VIP acts as a negative modulator of the IRF3-signalling by overturning the 
IFN# expression at mRNA level and its production. These results confirm the role of VIP as a 
negative regulator of TLR-signalling and corroborate its potential as therapeutic agent. 
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Relation between Hypertonic saline and Macrophage migration inhibitory factor  
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Immunological suppression is a well-recognized consequence of trauma and hemorrhagic 
shock and contributes to infectious complications, ultimately leading to sepsis and multi-
system organ failure. T cell dysfunction after traumatic stress is characterized by a decrease in 
T cell proliferation. The addition of prostaglandin E2 (PGE2), which depressed immune 
function after hemorrhage and trauma, to T cells decreases T cell proliferation and Hypertonic 
saline (HTS) restores PGE2-induced T cell suppression. Recently, it has become apparent that 
Macrophage migration inhibitory factor (MIF) plays a central role in several immune 
responses including the modulation of several cytokines and T cell activation. By controlling 
immune and inflammatory responses, MIF is thought to play an important role in the 
pathophysiology of septic shock and chronic inflammatory diseases. The role of MIF 
mediating HTS restoration of T cell dysfunction is unknown. Therefore Jurkat cells were 
cultured in RPMI media, final concentration of 2.5 & 106 cell/ml. Cell proliferation was 
suppressed using PGE2 and treated HTS at 20 and 40 mM above isotonicity. MIF 
concentrations of the supernatant will be determined by enzyme-linked immunosorbent assay 
(ELISA) and the cell lysates will be used for Western Blots to determine the expression of 
MIF. PGE2 caused a 15.0% inhibition of Jurkat cell proliferation compared to control. HTS 
reversed PGE2 suppressed Jurkat cell proliferation to normal. MIF concentrations was 
increased in PGE2-suppressed cells compared to controls. Cells treated with HTS had lower 
MIF concentrations and MIF expression then PGE2-suppressed cells and controls. The 
addition of HTS restored PGE2-induced cell suppression similar to control. The role of HTS 
in restoring Jurkat cells proliferstion would be mediated through a MIF pathway.  
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B cells regulate innate immune responses via promoting activation of Natural Killer 
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Belonging to innate immunity, Natural killer (NK) cells constitute of circulating lymphocytes 
which provide a body’s first line of defense against infections and cancers. In a secondary 
lymphoid organ, e.g., spleen or lymph nodes, NK cells co-exist with cells in adaptive 
immunity, T and B cells. Though NK cells are likely to interact with B cells, the functional 
consequence of this interaction remains uncertain. To address this question, we co-cultured 
primary NK cells with freshly isolated B cells from the spleen and investigated the influence 
of B cells on NK cells. Here we show that co-presence of B cells in cultures facilitated NK 
cell expansion, as measured by 3H-thymidine incorporation and CFSE dilution assays, while 
augmented NK cytotoxicity against RMA/S tumor targets. NK cells cultured with B cells 
exhibited higher expression of CD69, B220, CD25 activation markers, and produced more 
Granzyme B, suggesting that B cells drastically facilitated NK cell activation. Given the fact 
that NK cells can exert regulatory role in the pro-inflammatory diseases, such as atopic 
dermatitis and psoriasis, co-presence of B cells can potentiate the role of NK cells via 
promoting their proliferation and cytotoxicity. 
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IKK# is required for the formation of the embryonic epidermis. Loss of IKK# prevents 
keratinocytes from terminal differentiation and promotes keratinocyte proliferation in vivo and in 
vitro. Furthermore, downregulation, altered localization, mutations, and/or loss of heterozygosity 
(LOH) of Ikk" have been reported in squamous cell carcinoma (SCC) of the skin, lungs, 
esophagus, and head and neck in humans, highlighting the importance of IKK# in human cancers. 
It has long been known that excessive mitotic activity due to H-Ras can block keratinocyte 
differentiation and cause skin cancer. It is not clear whether there are any innate surveillants that 
are able to ensure that keratinocytes undergo terminal differentiation, preventing the disease. 
IKK# induces keratinocyte terminal differentiation and its reduction promotes skin tumor 
development. However, its intrinsic function in skin cancer is unknown. Thus, our lab generated 
Ikk" conditional knockout mice, deleted IKK# in keratinocytes in mice by using keratinocyte 
specific Cre mice, and then examined the effect of IKK# loss on skin development and 
maintenance, and skin tumorigenesis. We found that mice with IKK# deletion in keratinocytes 
developed a thickened epidermis and spontaneous squamous cell-like carcinomas. Inactivation of 
epidermal growth factor receptor (EGFR) or reintroduction of IKK# inhibited excessive mitosis, 
induced terminal differentiation, and prevented skin cancer through repressing an EGFR-driven 
autocrine loop. We also identified that IKK# repressed expression of several EGFR ligands at 
their transcription level, thereby inhibiting the pathway of EGFR and Ras. Thus, IKK# serves as 
an innate surveillant. These findings shed light on therapeutic targets for preventing IKK#-related 
skin cancer development. We are currently investigating how inflammation effects IKK# defect-
mediated skin tumor development. 
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cytokine storm in patients after major trauma  
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Introduction. Severe trauma and the systemic inflammatory response syndrome (SIRS) are 
associated with a so-called cytokine storm which is in part due to ATP released from 
damaged tissue. This pathology may lead to highly increased numbers of immature 
phagocytic cells sharing properties of either dendritic cells or macrophages. Clinically, the 
occurrence of this cell type was related to the reactivation of herpes virus infections and 
impaired natural killer (NK-) cell function during sepsis. The aim of this study was the 
comparative analysis of the ultrastructural and functional characteristics of such immature 
antigen presenting cells (APC). Methods. We used high pressure freeze substitution 
transmission electron microscopy (TEM) to study morphological criteria and caspase 
measurements to study ATP related effects and to investigate the susceptibility for cell lysis 
by NK effectors. Herpes virus reactivation was tested by a novel multiplex PCR identifying 
EBV genes characterizing EBV latency states I, II and III. Results. Ultrastructural studies 
identified impressive macroautophagy, impaired phago-lysosome fusion, mitochondrial 
degradation and multivesicular body formation in immature APC cells isolated from blood of 
patients with sepsis following a major SIRS. Caspase 3/7 activation was increased when 
immature APC were coincubated with NK-92 killer effector cells, but caspase 3/7 activation 
was significantly downregulated in the presence of exogeneous ATP. We found evidence for 
EBV latency state II infection in these immature APC cells as well as in whole blood of these 
patients which was most frequently associated with the detection of EBV-specific LMP-1 and 
EBNA 2 genes. Conclusions. The present study illustrates novel aspects of cytokine storm-
associated APC maturation deficiency to explain immune dysfunction against virus 
reactivation in sepsis patients after major trauma. The induction of autophagy is a novel 
morphological criterion associated with ATP specific anti-apoptosis, and EBV infection. 
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Bacterial antigens and cytokines influence Toll-like receptor (TLR)2 expression on mast 
cells 
 
Maciej Wierzbicki, Ewa Brzezi"ska-B!aszczyk and -ukasz Konopka   
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Nowadays it is well established that Toll-like receptors (TLRs) play a critical role in 
development of innate immunity and are involved in adaptive immunity processes. TLRs are 
expressed on both lymphoid and non-lymphoid cells, including mast cells. Taking into 
account the role of mast cells in antibacterial defense, immunological reactions as well as in 
inflammatory process in the present study we examined the influence of some TLR ligands 
and proinflammatory cytokines on mast cell TLR2 expression. Experiments were done in 
vitro on mature tissue rat peritoneal mast cells. We used lipopolysaccharide (LPS) from 
Pseudomonas aeruginosa, lipoarabinomannan (LAM) from saprophytic Mycobacterium 
smegmatis, peptidoglycan (PGN) from Staphylococcus aureus, tumor necrosis factor (TNF), 
interleukin (IL)-6 and chemokine RANTES. Mast cells were incubated with bacterial antigens 
or cytokines for 1, 3, 6, 12 and 24 hours and flow cytometry was employed to determine 
membrane expression of TLR2. We found that TNF and IL-6 did not influence TLR2 
expression on mast cells. LPS and LAM also failed to alter mast cell membrane TLR2 
expression. At the same time, PGN at concentration of 1 mikrog/mL significantly upregulated 
mast cell TLR2 expression after 1- and 3-hour incubation (p < 0.01). RANTES at 
concentrations of 1 pg/mL and 100 pg/mL induced statistically significant downregulation of 
TLR2 expression after 24-hour incubation (p < 0.05 and p < 0.01, respectively). Our results 
indicated that bacterial cell wall component PGN as well as chemokine RANTES, modulate 
mast cell TLR2 expression and thereby might influence TLR2-dependent mast cell activation. 
This work was supported by grants from the Medical University of (ód) (grant 502-12-606 
and 502-12-759) and financial resources for research project (N N401 010236). 
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Low level neuroinflammation in severe psychiatric disorders 
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Immune and inflammatory mechanisms are increasingly detected in subgroups of patients with 
severe psychiatric disorders. We analysed treatment resistant hospitalised affective and 
schizophrenic spectrum disorder patients regarding albumin, IgG, IgA, IgM, oligoclonal IgG and 
specific antibodies in paired cerebrospinal fluid (CSF) and serum samples . Numerical and graphical 
interpretation of CSF protein data was performed by Reibergrams with a new CSF statistics tool for 
nonlinear group analysis with reference to a large control group (n=4100). In 41% of the psychiatric 
patients (n=63) we observed CSF pathologies: 14% displayed intrathecal humoral immune 
responses, 10% slightly increased CSF cell counts (5-8/'L) and 29% had moderate blood-CSF 
barrier dysfunctions, in 24% as the only pathological sign with normal IgG, IgA and IgM 
concentrations in CSF (p=0.9 testing the null hypothesis for intrathecal synthesis with reference to 
Qmean of the reference group). In the group of affective (n=24) spectrum disorders 20% displayed a 
systemic immune reaction as detected by oligoclonal IgG. CSF analysis and interdisciplinary 
clinical approach revealed 6% of psychiatric patients likely to represent a virusspecific, bacterial or 
autoimmune associated disorder with CNS involvement. Elevated CSF neopterin concentration in 
34% of the patients was interpreted as an increased release from astrocytes or from other glia cells. 
The low level immune response and barrier dysfunctions are discussed on the base of a mild 
encephalitis pathomechanism in subgroups of psychiatric patients. CSF analysis is kown a useful 
diagnostic tool for differential diagnosis in neurological disorders, and may become increasingly 
important in psychiatric diseases. Therefore low level neuroinflammation may represent an 
underlying cause as proposed by the Mild Encephalitis Hypothesis in subgroups of severe 
psychiatric disorders. The broad diagnostic spectrum involved is not surprising as the validity of 
psychiatric diagnoses appears limited presently, to be enriched by biological markers close to the 
neurobiological mechanisms. Overlap between present psychiatric diagnostic categories and 
findings has for example also been found regarding genes. Such psychoneuroimmunological 
scenario would be similar to that found in autoimmune disorders in general, that is interaction 
between environment (infectious agents), genes, and immune system. Antiinflammatory, 
antiinfectious and/or immunemodulatory treatments of therapyresistent psychiatric disorders have 
begun. 
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NANOTECHNOLOGY IN LIGATURE-INDUCED PERIODONTITIS: PROTECTIVE 
EFFECT OF A DOXYCYCLINE GEL WITH NANOPARTICULES. 
 
Marco Botelho 
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Objectives: We aimed to investigate the effect of a nanostructured doxycycline gel 8.5% in 
the experimental periodontal disease (EPD) model in rats, using the (AFM) tap mode 
technique. Material and Methods: EPD was induced in twenty-four Wistar rats. Animals 
were treated with a nanospheres doxycycline gel (NDG) topically, immediately after EPD 
induction and 3 times a day for 11days. Controls did not receive any treatment naïve and non-
treated group (NT) and another group received only a vehicle gel (V). In order to investigate 
topographical changes in histological sections, we used a new simple method for sample 
preparation, etching with xylol the sections from paraffin-embedded specimens. Results: 
Comparing the AFM images of periodontal surface, several grooves was present in the 
alveolar bone and other periodontal structures surface of untreated maxillae (NT) and vehicle 
gel group (V), the depths of the grooves was significantly deeper when compared with the 
DOX group (p<0.05).  Conclusions: The doxycycline gel was able to provide periodontal 
surface preservation, with flatter grooves. Periodontal structures were brought into high relief 
confirming to be a simple and cost-effective method for AFM imaging with ultrastructural 
resolution. 
 
Key words: Nanotechnology. Doxycycline. Periodontitis. Atomic force microscopy. 
Nanospheres.  
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Introduction and Aim: Asthma is a chronic inflammatory disease characterized by airway 
inflammation and hyperresponsiveness (AHR) to methacholine. In addition, asthmatic lung 
usually respond to allergen by two distinct phases: an early-phase response (EPR) and a more 
prolonged late-phase response (LPR). The early or late phase responses are not easily 
reproduced in mouse models of asthma. Because AIRmax and AIRmin mice differ in 
mobilization of inflammatory cells we used these mouse strains to study bronchial responses 
and airway allergic inflammation. Methods and Results: AIRmax and AIRmin mice were 
sensitized twice with OVA/Alum on days 0 and 7 and challenged with aerosolized OVA (2% 
in PBS) on days 14 and 21. Immediately after the last OVA challenge mice were placed in 
whole-body plesthysmograh (Buxco apparatus) for LPR determinations. Twenty-four hours 
later, AHR to increases doses of methacholine and airway inflammation were also 
determined. AIRmax but not AIRmin mice developed a clear LPR from 3-6 hours after 
allergen challenge (Penh180min=1,75±0,63 and Penh360min=2,02±0,76). Twenty-four hours after 
OVA challenge, the bronchial response to methacholine in allergic AIRmax mice was 130% 
higher when compared to control mice whereas in AIRmin was only 30% higher than control 
animals. As expected, airway inflammation and type 2 cytokines were more robust in 
AIRMax than in AIRmin mice (AIRmax 108,3x10
5
±7,3 vs AIRmin 6,7x10
5
±1,2), eosinophils 
(AIRmax 88,6x10
5
±7,5 vs AIRmin 1,8x10
5
±0,5), and IL-5 cytokine (AIRmax 267,3±64,1vs 
AIRmin 114±8,6 pg/mL). Conclusion: We conclude that AIRmax animals are of value as a 
model of asthma because these animals develop allergen-induced late phase reaction, airway 
eosinophilia campaigned AHR to metacholine. Financial support: Supported by CNPq and 
FAPESP. 
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Inflammatory bowel diseases, represented mainly by ulcerative colitis and Crohn’s disease are 
thought to result from inappropriate activation of the mucosal immune system driven by 
penetration of normal luminal flora through the intestinal epithelial barrier. This barrier is 
primarily regulated by the apical junctional complex consisting of tight junctions and adherens 
junctions. After resolution of inflammation, mucosal repair involved epithelial cell proliferation 
and migration. Our recent works have demonstrated the critical role of the lipid phosphatase 
activity of the PTEN tumor suppressor in stabilizing adherens junctions, and in reverting EMT 
and invasiveness. PTEN is a multifunctional protein that dephosphorylates the 
phosphoinositides generated by PI3K. Interestingly, PTEN is inactivated by reactive oxygen 
species produced by immune cells, and accumulated under the phosphorylated/inactive form in 
ulcerative colitis. In this context, our study aimed to investigate the implication of PTEN in 
tissue repair during intestinal inflammation. Experimental colitis were induced in Villin-Cre 
PTENflox/flox and wild-type mice using sodium dextran sulfate (DSS). DSS is directly toxic to 
gut epithelial cells and affects the integrity of the mucosal barrier. The intestinal invalidation of 
PTEN was associated with a lower sensitivity to DSS-induced acute inflammation as evidenced 
by the lower incidence of anal bleeding and by the decreased weight loss in Villin-Cre 
PTENflox/flox mice as compared to wild-type mice. At histological level, we evidenced an 
improved intestinal repair in villinCre PTENflox/fox mice as compared to wild-type mice, after 
DSS treatment. These results might be explained by the enhanced proliferative activity of 
intestinal epithelium of PTEN defective mice, and/or an increased in cell motility related to 
EMT. In this context, preliminary results suggest an increased accumulation of snail transcripts 
in the colon of villinCrePTENflox/fox mice. Our results suggest that PTEN might be a valid 
target directed at restoring epithelial barrier function after intestinal injury. 
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Foundation, Howard Hughes Medical Institute, United States  
 
Atypical hemolytic uremic syndrome (aHUS) is characterized by microangiopathic hemolytic 
anemia, thrombocytopenia, and renal failure. Disease-associated polymorphisms in 
complement regulatory genes account for half the patients, but the etiology of the rest remains 
unknown. Thrombomodulin (TM) is a ubiquitously expressed endothelial membrane protein 
with anticoagulant and anti-inflammatory properties. To determine if aHUS is associated with 
TM mutations, we sequenced the TM gene (THBD) of 152 patients with aHUS and 380 
controls. Using purified proteins and cell expression systems we investigated whether TM 
modulates complement and evaluated the mechanisms. Effects of aHUS-associated TM 
missense mutations on complement activation were assessed by expressing the mutant forms 
of TM in cultured cells. Results: Six different heterozygous missense THBD gene mutations 
were identified in seven unrelated aHUS patients. In vitro, TM binds to factor H (CFH) and 
C3b, and interferes with complement activation by facilitating factor I (CFI)-mediated 
inactivation of C3b to iC3b in the presence of cofactors, C4b binding protein (C4bBP) or 
CFH. By enhancing generation of the plasma carboxypeptidase B, TAFIa, TM also promotes 
inactivation of anaphylatoxins C3a and C5a. Cultured cells expressing aHUS-associated TM 
mutants, were less effective at promoting the inactivation of C3b and in activating TAFI, and 
were therefore less protected from complement hyperactivation. Conclusions: TM is a 
clinically important negative regulator of complement on the endothelium, and mutations that 
impair its function, predispose to aHUS and possibly to other thrombotic microangiopathies. 
The findings establish a molecular link between complement and coagulation, and provide 
insights for novel diagnostic and therapeutic strategies. 
 241 
Session V     Poster V, 6 
 
Adeline Divoux 1,2 , Mayoura Keophiphath1,2,  Joan Tordjman1,2,, Danièle Lacasa 1,2,  and 
Karine Clément 1,2,3 
 
1 - INSERM, U872, Nutriomique (Team 7), Paris, F-75006 France;  
2 - Université Pierre et Marie Curie - Paris6, Centre de Recherche des Cordeliers, 
UMRS 872, Paris, F-75006  France;  
3 - Assistance Publique-Hôpitaux de Paris, APHP, Pitié Salpetrière Hospital, 
Endocrinology and Nutrition department, Paris, F-75013 France. 
 
White adipose tissue (WAT) exhibits a higher cellular heterogeneity than previously thought. 
We recently identified fibrosis areas in human obese WAT where preadipocytes are suggested 
to be a major fibrotic cell. The non-adipocyte fraction contains, many immune cell types such 
as macrophages. Mast cells (MC) were identified as another potentially important cell type, 
since a MC-deficient mouse model (Kit
W-sh/W-sh
) was resistant to diet-induced obesity 
(collaboration with G.P. Shi team, Boston). Importantly, reconstitution with bone marrow MC 
restored the wild-type phenotype. Thus, MC have been positioned as an actor in the 
development of obesity. We first determined the presence of MC in human obese WAT by 
immunohistochemistry with tryptase and chymase. These two proteases specifically contained 
in MC granules were detected also in explants and MC secreted media from obese WAT. 
Second, as observed in other fibrotic pathologies, MC tryptase staining was predominantly 
found in the fibrotic regions and particularly close to vessels. In subcutaneous WAT sections 
from obese subjects, a strong positive correlation was found between the number of MC in 
fibrotic area and the amount of collagen quantified by picrosirius staining (R=0.85 p<10
-4
 
n=29). To determine whether the WAT microenvironment could modify MC activation we 
compared IL-6 secretion, a cytokine previously detected in WAT MC media, in two different 
types of 3D matrices. When cultured in a collagen I matrix supplemented with fibronectin, 
which reproduces fibrosis, MC secreted more IL-6 than in matrigel (a matrix largely 
composed of basement membrane proteins). Finally adipose tissue endothelial cells cultured 
with MC conditioned media exhibited higher secretion of IL-6 and IL-8. Altogether, our data 
suggest a potential major role for MC in fibrosis, by activating endothelial cells and 
maintaining the fibrosis inflammatory state. 
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Toll-like receptors (TLRs) are pattern recognition receptors of the innate immune system and 
binding of microbial ligands or endogenous danger signals leads to a pro-inflammatory 
immune response. We found that human endothelial cells can - except TLR8 in aortic 
endothelial cells - express the whole repertoire of the currently known 10 receptors. We now 
were interested in differences between endothelial cells of aortic and microvascular origin 
regarding the functional TLR expression as a possible explanation for the involvement of 
large vessels in pro-inflammatory processes of atherosclerosis, while small vessels remain 
unaffected. In a first step, we checked TLR gene expression pattern of resting and pro-
inflammatory pre-activated primary human aortic endothelial cells (HAoEC) against primary 
human dermal endothelial cells of microvascular origin (HDMEC). We found only small 
differences comparing both types of endothelial cells that do not explain the selective 
involvement in pathology. Interestingly, challenging resting as well as pre-activated aortic 
and microvascular endothelial cells with a set of specific TLR-ligands and measuring IL-8 
release, we observed a narrow functional receptor repertoire for both endothelial cell types but 
measured a much higher IL-8 release in HAoEC - up to a factor of 10 in resting and up to a 
factor of 20 in pre-activated cells. Thus, chemotactic gradient-directed homing and leukocyte 
infiltration to large vessels is much more likely than to microvasculature and might explain 
why large vessels are predetermined for atherosclerotic lesion formation.  
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Cellular and molecular mechanisms involved in TNF&-mediated inhibition of 
erythropoiesis 
 
Grigorakaki C., Morceau F., Dicato M., Diederich M. 
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Objective: Cancer-related anemia appears to be mediated by pro-inflammatory cytokines 
including tumor necrosis factor (TNF)". This pathology is treated by human recombinant 
erythropoietin (hrEpo), which was recently incriminated to stimulate tumor growth. In order 
to assess the corresponding molecular mechanisms, we investigated the effect of TNF" on 
erythroid progenitor cell maturation mechanisms induced by Epo. Methods: CD34+ cells, 
purified from umbilical cord blood by magnetic cell sorting, were cultured in serum-free 
medium complemented by IL3, SCF and Epo, for cell expansion and differentiation before 
TNF" treatment. Hemoglobinization was assessed by benzidine staining and cellular 
morphology by Giemsa staining. Results: TNF" reduced the ability of EPO to differentiate 
CD34+ cells as shown by a decrease of 36% of hemoglobin-positive cells without any 
detectable erythroid cell maturation. Our results show that TNF" treatment induced a decrease 
of erythrospecific gene expression, such as %-globin, and Epo receptor (EPOR) whose mRNA 
and protein decreased both by 1,8-fold. Moreover, major erythroid-related transcription factor 
GATA1 and its Friend of GATA (FOG)-1 cofactor mRNA were increased (1,7-fold) after 
TNF" treatment. Furthermore, our results show that PU-1, a GATA-1 inhibitor, as well as 
GATA2 protein were also increased (ex GATA2 1,9-fold). Conclusion: Despite the induced 
expression of GATA1, our results show that TNF" blocks erythrospecific gene expression 
under the control of GATA1. Results are correlated with the overexpression of PU-1, an 
inhibitor of GATA-1 transcriptional activity. GATA-2 overexpression is in agreement with an 
inhibition of GATA1 activity. This study provides insight into the molecular mechanisms 
involved in the inhibition of erythropoiesis triggered by increased TNF" expression and will 
thus contribute to the improvement of the cancer anemia therapies.  
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Protective effect of VIP on autoimmune diabetes in NOD mice: balance between 
different T cell subsets. 
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Type 1 diabetes is an autoimmune T-cell mediated disease associated with overexpression of 
inflammatory mediators and the disturbance of different T cell subsets. Vasoactive Intestinal 
Peptide is a pleiotropic peptide, produced in nervous, endocrine and immune systems. It has 
immunoregulatory actions both in innate and acquired immunity, with potent anti-
inflammatory and regulatory effects on activated T cells. Since the equilibrium among 
different T cell subsets participate in the final outcome leading to tolerance or autoimmunity, 
we studied the evolution of markers for these T cells in VIP-treated and non-treated NOD 
mice. The study of different transcription factors, cytokines or cytokine receptors in pancreas 
and spleen, shows that VIP treatment in NOD mice switches the balance between Tregs/Th17 
cells subsets, leading to tolerance. In addition, NOD mice show declining values of Th17/Th1 
balance with the progression of the disease that could be due to an increase of Th1 cell 
subsets or a decrease of Th17 cell subsets. Treatment with VIP reverts this balance, increasing 
Th17 cells relative to the Th1 cell subset. Similarly, in the pancreas of NOD mice, Th1 cell 
subset predominates over Th2 during the development of the autoimmune pathology, however 
the treatment with VIP reverts this balance. The change in the balance between different T 
cell subset induced by VIP during the development of diabetes in NOD mice has a reflex 
upon inflammation and destruction of pancreatic islet cells. In cell transfer experiments the 
transfer of splenocytes from VIP-treated mice delayed the onset of diabetes adoptively 
transferred to NOD-SCID mice. Taken together, these results demonstrate that VIP provides 
significant protection against spontaneous diabetes modulating T cells subsets and 
counterbalancing tolerance and immunity. 
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The immunoregulatory peptide VIP is produced by fibroblast-like synoviocytes from 
osteoarthritis and rheumatoid arthritis patients and is up-regulated after TLR4 stimulation 
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Vasoactive intestinal peptide (VIP) has shown potent anti-inflammatory effects in murine arthritis 
model and ex vivo in human rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and 
peripheral blood lymphocytes (PBL). TLRs are a family of receptors that activates both the innate 
and acquired immunities in response to bacterial and viral compounds, leading to the production 
of proinflammatory and antiviral mediators. FLS from osteoarthritis (OA) and RA patients 
expressed Toll-Like receptor-4 (TLR4) which is the receptor of the exogenous ligand LPS. The 
aim of this study was to investigate the potential participation of the endogenous VIP in the RA 
pathogenesis in FLS, and the significance of TLR4 stimulation in this system. Therefore, we have 
analyzed the expression and regulation of VIP and its functional receptors at basal and LPS-
stimulated condition in FLS from OA and RA patients. VIP expression was detected in FLS at 
mRNA and protein levels, and it was significantly decreased in RA compared to OA-FLS. VPAC1 
receptor was the main AC coupled receptor in OA-FLS, in contrast to RA-FLS where VPAC2 was 
the dominant receptor. LPS stimulation produces an up-regulation in the expression of VIP, 
VPAC1 and VPAC2 receptors in both OA and RA-FLS. On the other hand, our previous data have 
demonstrated that VIP downregulates TLR4 expression and its signal transduction pathway in 
FLS from OA and RA patients, resulting in the decrease of proinflammatory mediators. Thus, 
although LPS-induced TLR4 stimulation increases the endogenous production of VIP and its 
receptors, it is not enough to generate the reduction of proinflammatory mediators. In summary, 
only the exogenous addition of VIP produced the final reduction of proinflammatory mediators 
that ameliorates the pathogenesis of RA. 
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DNA-protein interaction in discoid lupus erythematosus inflammatory disease 
 
E. Keyhani(1), M. Ahadi(2), J. Keyhani(1), Z. Naraghi(2) and S. Shahmohammadi(2) 
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Discoid lupus erythematosus (DLE) is a form of local inflammatory autoimmune disease 
limited to the skin and involving essentially the face, scalp and ear; ultraviolet irradiation is 
believed to be a major factor in the onset of DLE.  Lesions consist of erythematosus raised 
patches with adherent keratotic scaling and follicular plugging; they slowly expand, with 
active inflammation at the periphery, leaving depressed scars, telangiectasia, and 
depigmentation.  Diagnosis is usually made by clinical examination and histopathology; 
additional laboratory tests occasionally performed include anti-nuclear antibodies titers and 
presence of circulating anti-dsDNA antibodies.   DLE patients have about a 10% chance of 
eventually developing systemic lupus erythematosus (SLE), a systemic autoimmune disease 
that results in inflammation and damage to a range of organ systems. 
In this study, we used an electrophoretic mobility shift assay (EMSA) in parallel with an 
enzyme-linked immunosorbent assay (ELISA) for the detection of anti-dsDNA in DLE 
patients.  IgG from the sera of 24 DLE patients and 24 healthy individuals randomly collected 
were isolated by affinity chromatography and tested for the presence of anti-dsDNA.  Routine 
laboratory tests used for the detection of anti-dsDNA antibodies include immunofluorescence, 
radioimmunoassay (RIA) and ELISA; they reveal the presence of anti-dsDNA antibodies in 
20 to 55% of DLE patients.  We previously developed an EMSA which showed a much 
higher sensitivity than the routine tests for the detection of anti-dsDNA in patients with the 
systemic disease, SLE; we used the assay again in this study.  The EMSA gave positive 
results for all DLE patients while the ELISA was positive for only 36% of them.  Both were 
negative for all healthy individuals.  The results presented here suggest that the EMSA is 
much more sensitive than the routine tests used for the detection of anti-dsDNA in DLE.  
They also relate to a number of emerging models that illustrate the activation of autoreactive 
T and B lymphocytes and stress the role of antibodies with specificity for nucleic acids in 
autoimmune inflammatory diseases such as SLE and DLE. 
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Plasma membrane DNA as a tool in the detection of systemic lupus erythematosus 
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Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease in which 
the immune system attacks the patient’s tissues, resulting in inflammation and damage.  
In this report, we show that DNA associated with the plasma membrane of Wil2 lymphocytes 
is a choice antigen for the detection of anti-dsDNA antibodies in the sera of SLE patients.  
Wil2-NS (“Wil2”), a non-immunoglobulin secreting human B lymphocyte line, was cultured 
and used for the detection of immunoglobulins directed against its plasma membrane DNA 
(pmDNA) in the sera of 12 SLE patients as well as 12 healthy individuals.  Freely cultured 
cells were incubated with the sera and then with fluorescein-conjugated anti-IgG for the 
detection of anti-pmDNA IgG at the cell surface by immunofluorescence microscopy.  
Furthermore, pmDNA was isolated from Wil2 plasma membrane, purified, and incubated 
with the IgG fraction of the sera.  Formation of an IgG-pmDNA complex was assessed by an 
electrophoretic mobility shift assay (EMSA).  By immunofluorescence microscopy, all SLE 
patients tested positive for the presence of IgG directed against pmDNA, while healthy 
individuals tested negative.   In addition, for patients responsive to a treatment with 
cyclophosphamide, the sera became negative for the presence of anti-pmDNA IgG; on 
relapse, the sera were positive again for anti-pmDNA IgG.  In comparison, routine anti-DNA 
determination done by ELISA on calf thymus DNA did not give positive results for all SLE 
patients before treatment; furthermore, although the assay would give negative results after 
treatment, these results remained negative even when the patient was in relapse. Thus the test 
for anti-pmDNA as reported here was more sensitive and gave results that paralleled the 
patient’s conditions more reliably than the ELISA. EMSA results showed the formation of a 
complex between pmDNA and IgG from SLE patients but not from healthy individuals.   
Data emphasized the potential role of pmDNA in anti-dsDNA production in SLE and the 
ability of some IgG present in SLE patients’ sera to bind directly to pmDNA.  
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Nrf2 reduces IL-1beta and IL-6 expression in foam cells upon lipopolysaccharide-
stimulation  
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Atherosclerosis is a chronic inflammatory cardiovascular disease, causing high mortality and 
morbidity in industrialized countries. Upon uptake of oxidized low density lipoprotein 
(oxLDL), macrophages differentiate into foam cells in atherosclerotic lesions. To elucidate 
their contribution to chronic inflammation, we mimicked the in vivo situation in vitro by 
pretreating RAW264.7 cells or peritoneal macrophages for 15 h with 40 µg/ml oxLDL. These 
foam cells display a desensitized macrophage phenotype, since they produce significant lower 
amounts of the pro-inflammatory cytokines IL-1beta and IL-6 in response to 
lipopolysaccharide (LPS)-stimulation compared to control macrophages. Considering that the 
uptake of oxLDL activates the anti-inflammatory and anti-oxidative nuclear factor erythroid 
2-related factor (Nrf2), we were interested to define its contribution towards foam cells 
deactivation. Therefore we used foam cells generated from macrophages of Nrf2 knockout 
mice. As expected Nrf2-/- foam cells showed restored expression of pro-inflammatory 
mediators after LPS-treatment compared to wildtype foam cells. Taking into consideration 
that heme oxygenase 1 (HO-1), catalyzing the degradation of heme to biliverdin, iron and 
carbon monoxide (CO), is Nrf2-dependently induced we explored its implication. 
Corroborating this assumption the CO-releasing compound (CORM2) decreased the 
expression of IL-1beta and IL-6 after LPS-treatment. Moreover we noticed transrepression of 
C/EBPbeta and reduced production of reactive oxygen species (ROS) upon LPS-stimulation 
in foam cells. Therefore we suggest that Nrf2 intervenes with LPS signaling by inducing HO-
1 and attenuating ROS production, thus reducing C/EBPbeta transactivation in foam cells and 
consequently inhibiting the expression of pro-inflammatory mediators. 
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Rapid Detection of Pseudomonas aeruginosa in Clinical Samples of Burned Patients by 
Fluorescent in Situ Hybridization (FISH) 
 
Mojtaba Moosavian, Freshteh. Badie 
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Center, Ahvaz Jundishapur University of Medical Sciences, Iran.      
 
Aims of the study : The burn wounds have suitable conditions for colonization of bacteria, 
especially P. aeruginosa as an opportunistic pathogen which could be the cause of septicemia. 
The aim of this study was using of fluorescent in situ hybridization (FISH) as a molecular 
technique that has been developed for detection of pathogenic agents.  
Methods: One hundred of specimens (42 blood positive cultures and 58 wound samples) 
collected from the hospitalized burn patients, were examined. We could identify P.aeruginosa 
by microscopic examination, culturing of samples and standard biochemical tests on isolated 
colonies. Also, a part of each specimen used for FISH technique, after preparation and 
fixation of it.  
Results and discussion: This study detected 39 Pseudomonas isolates (aeruginosa and 
nonaeruginosa) in surveyed specimens by both culture and FISH methods, but the results 
were difference only in 3 blood culture and wound specimens. Sensitivity of FISH for 
detection of P.aeruginosa in blood and wound samples were 94.7% and 100%, respectively. 
Also, specificity of FISH for identification of this bacterium in the same samples was 100 and 
93.3%, respectively. 
This results showed that FISH is a rapid , sensitive and specific test for detection of 
P.aeruginosa and needs to 3 hours of time for doing of all steps of this test. Identification of 
bacterial agents in a short time, is important for treatment and prevention of patient death. 
Key words: FISH, Pseudomonas aeruginosa, burn   
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Transcriptomic profiling and pathway modeling of retinoic acid, Wnt and Hedgehog 
signaling pathways in experimental chronic renal allograft damage 
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Chronic renal allograft damage (CAD) is seen in virtually all transplanted kidneys. CAD is 
manifested by a smoldering inflammation leading to diffuse interstitial fibrosis, glomerular 
changes, tubular atrophy and loss of tubular structures. There are limited therapeutic options 
for the treatment of CAD. Retinoic acid (RA), an important regulator of differentiation during 
vertebrate embryogenesis, can moderate the damage observed in experimental models of 
CAD. Using recently developed methods for enhanced microarray analysis linked to a 
systems biology approach, we show here that Wnt and Hedgehog pathway signaling is 
recapitulated during CAD in a Fischer 344 (RT1lvl) to Lewis (RT1l) rat renal allograft model. 
Subsets of HH/Wnt modules were identified within this experimental system that specifically 
reiterates the emergence of that phenotype in patients and linked to the pathophysiology of 
progressive fibrosis and chronic dysfunction. Treatment with 13cis-retinoic acid selectively 
moderated the dysregulation of gene and protein expression seen in the HH and canonical 
Wnt pathways during CAD. The interplay between these three developmental pathways may 
help explain the therapeutic effects of retinoic acid treatment in CAD and may suggest future 
directions for moderating chronic renal damage. 
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Role of macrophage metalloelastase in inflammatory bowel disease 
 
Sylvia L.F. Pender, Rebecca Walsh, EV Vorobeva, MG Buckley, CK Li , A Di-Sabatino, TT 
MacDonald , SD Shapiro 
 
Matrix metalloproteinases (MMPs) play a major role in many physiological and pathological processes 
such as angiogenesis, wound healing, and inflammation, including that found in inflammatory bowel 
disease (IBD). In our previous studies, we have shown the important role of stromelysin-1 (MMP-3) in 
Inflammatory bowel disease (IBD). In this study, we provide evidence of a potentially role for human 
macrophage metalloelastase (MMP-12) in IBD.  MMP-12 is a macrophage specific enzyme, which could 
play an even more important role in the causation of IBD than MMP-3. Using gene arrays analysis, we 
have shown that MMP-12 stands out among the 23 MMPs we screened (including MMP-3) as being the 
most markedly upregulated in a T cell-mediated model of gut injury and in IBD. MMP-12 expression was 
11.9 and 7.3 fold higher than in controls in the PWM-stimulated explant cultures respectively.  In IBD 
tissues we have shown MMP-12 is increased 7.3 fold in UC and 3.6 fold in Crohn’s disease compared to 
controls. Western blotting has demonstrated that MMP-12 is significantly increased in IBD compared with 
the control subjects, and that UC has the highest expression.  Western blotting was also performed on the 
culture supernatants of explant cultures and it detected high concentrations of both latent and active forms 
of MMP-12 in four independent experiments, suggesting that the production of MMP-12 is directly related 
to T cell or macrophage hypersensitivity as seen in IBD.  When purified MMP-12 (3ug/ml) was used to 
treat tissue explants, we found that in four independent experiments, the epithelium of all the explants was 
completely destroyed after four days of culture.  At a tenth of that dose (0.3ug/ml), the epithelium of the 
explant was partially abolished. Charge staining revealed that glycoaminoglycans were lost from the 
mucosa in a dose response manner.  Immunostaining confirmed the disappearance of the epithelium after 
MMP-12 treatment. The basement membrane and smooth muscle actin of the explant were still intact at 
low doses of MMP-12 treatment; however, they were completely destroyed by high doses.  When TNBS 
was administrated to the colons of MMP-12 knockout mice (n=14) for 7 days, no mucosal damage was 
seen.  However, severe colitis was observed in wild type control mice (C57BL/6, n=29).  Colons of wild 
type mice but not knockout mice were significantly thickened after TNBS treatment.    In another gut 
inflammation model in which sodium dextran sulphate was fed to mice for 7 days, severe wasting and 
bloody diarrhea were observed in wild-type mice.  MMP-3 was upregulated in DSS-treated wild type mice, 
but not in MMP-12 knockout mice is again protected from the treatment. Conclusions: These data indicate 
that local immune responses can increase MMP-12 expression in resident lamina propria macrophages, 
without the need for a blood-borne component, and that MMP-12 could play a significant role in tissue 
inflammation in IBD.  The inhibition of this enzyme could be a future therapeutic application in IBD. 
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Biphasic activation of heat shock system in monocytic cells exposed to live Helicobacter pylori 
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Helicobacter pylori(Hp), curved gram-negative bacterium, can colonize mucous layer of human 
stomach and persists there for many years. This unique Hp feature is possible due to the presence of a 
special enzyme – urease catalyzing the hydrolysis of urea to ammonia and formation the alkaline 
microenvironment. This adaptation have been found to damage the gastric mucosa and to cause 
chronic gastritis, atrophy or even cancer. The immune system takes an active part in the process of 
gastritis due to the infiltration of gastric mucosa with monocytes, neutrophils and lymphocytes in 
response to Hp originated neutrophil activating  proteins or epithelium produced cytokines. For many 
years fact of the direct contact between Hp and immune system phagocytes was being questioned. 
Break through papers of Zu et al. and El-Zimaity showing the in vivo phagocytosis of Hp from the 
lumen of gastrointestinal tract have clarified that problem. The aim of this study was to establish 
weather Hp is responsible for acceleration of monocyte apoptosis. Monomac 6 cell line was used as a 
model for studying bacteria-monocyte interactions. The presence of the live Hp bacteria in Monomac 
6 cell line cultures resulted in the increase of heat shock system activity.  In those cells biphasic – 
early and late – reaction of heat shock system was observed. Translocation of all nuclear heat shock 
proteins to the cytoplasm within the first 6 hours, where its presence could protect cells against toxic 
products of engulfed bacteria, was a general feature of the early phase. At the same time, the activation 
of heat shock genes transcription were noticed. The nuclear factor, HSF-1, was phosphorylated on the 
serine 230 and translocated to the nucleus, what was shown in gel retardation assay. The late phase of 
the shock response started 24 hours after the exposure of Monomac 6 cells to the bacteria. 
Experiments employing blocking the protein synthesis with cycloheximide and fluorescence 
microscopy have confirmed that during that phase, cellular pool of “used/consumed” heat shock 
proteins was regenerated by de novo protein synthesis. Cell exposed to the bacteria for 48 hours did 
not reveal any signs of apoptotic cell death. Therefore we conclude that the biphasic process of 
activation of heat shock system led to the prolongation of phagocytes life. Such reaction in vivo might 
be responsible for the extended contact of phagocyte with pathogen and eventually its efficient 
elimination. 
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Subject of this research were nineteen Landras piglets aged 3 months. After induction of anesthesia piglets 
were randomly divided in to three groups: sham-operation (n=6), total splenectomy (n=6), and splenic 
autotransplantation (n=7) with spleen chips autotransplanted into the greater omentum. The blood samples 
were taken just before the surgery, and on 1st, 5th, 12th, 26th and 40th postoperative day. EDTA blood 
samples were used to determine total white blood cell count and blood smears were made to perform 
differential leukocyte count and morphologic evaluation of the cells. All groups showed leukocytosis 
following the operation but this was not regarded as a change specific for splenectomy or 
autotransplantation, rather than a post-injury inflammatory response due to tissue lesions during operation. 
In addition, up to 12th postoperative day, increase of the absolute differential number of band neutrophils 
and sporadic findings of granulocyte precursors and dividing cells were found, suggesting an increased 
bone marrow activity and release of immature neutrophils and their mobilization from the marginal pool 
into the microvasculature. Increase of the absolute neutrophil number and initial decrease of the 
lymphocyte number was found in all groups, followed by the later recovery of the lymphocyte number. 
But, no unique pattern was determined because these changes had different onset time and intensity in each 
group. Described variation in number of neutrophils and lymphocytes was typical for the physiological 
immune response of the peripheral white blood cells to different stress factors, and correlate with the 
patients’ clinical status. Inflammatory/immune response caused by stress factors can be effectively 
evaluated using a Neutrophil-lymphocyte stress factor (NLSF), and in this research, the highest values were 
found in the group of splenectomized piglets. Postoperative recovery of lymphocyte number was slowest in 
this group, which could indicate a possible lymphopoethic function of the autotransplanted splenic chips. 
Morphological evaluation revealed some reactive, granulated and cytotoxic lymphocytes on peripheral 
blood smears of all groups on the 1st and 5th day after the surgery. On the 12th day granulated lymphocytes 
were frequently found in the group with autotransplantated splenic chips. These morphological changes 
were probably caused by the alarmins release from the destructed and autotransplanted cells, which 
triggered the reaction of humoral and cellular immunity. 
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Introduction. In infectious diseases, hyperinflammation may impair several immune functions. The 
function of phagocytosis and digestion is crucial to overcome sepsis. Using E. coli transfected with a 
pH sensitive fluorescent dye, Eos-FP (Eos-Fluorescent Protein*), the successful fusion of phagosomes 
with lysosomes can be followed by flow cytometry over time. We questioned the influence of sepsis 
on phagocytic function and the kinetics of phagosome-lysosome fusion in leukocytes from patients 
before and after granulocyte colony-stimulating factor (G-CSF, Neupogen)) administration. Methods. 
Heparinized blood (0.5 mL) was diluted 1+4 and incubated  with 107 Eos-P transfected E. coli for 
various time points. Erythrocytes were lysed and leukocytes were fixed before measuring cell-bound 
green and red fluorescence by either flow cytometry or confocal laser scanning microscopy. Results. 
The phagocytic activity was determined by mean fluorescence intensities (MFI) after 30’, 60’, 120’ 
and overnight (o/n) incubation. The healthy donors displayed a fairly homogenous Eos-FP-E. coli-
phagocytosis, with median MFI values of 526(30’), 540(60’), 563(120’), and 549(o/n), respectively. 
The septic patients had a lower activity at 30’ (median MFI 472), but already after 60’, the septic 
patients had a higher median MFI 564(60’), 698(120’), and 1209(o/n), respectively. The phagosome-
lysosome fusion event was determined by a decline of red fluorescent light emission and was 
quantified by calculating the green/red-ratio of median MFI. The majority of the septic patients had a 
faster digestion index : The green/red ratios were 2.3(30’), 3.6(60’), 6.1(120’), and 29.6(o/n), whereas 
the controls and a minority of the sepsis patients ratios were as low as 1.0(30’), 1.4(60’), 2.0(120’) and 
10,3(o/n), respectively. In the G-CSF-treated patients’ group, there was a strong impact of G-CSF 
substitution to up regulate both, phagocytosis and digestion of the Eos-FP E. coli. Conclusions. 
Inflammation induced anti-apoptosis in neutrophils of patients with sepsis is also associated with an 
increased capacity to ingest and degrade bacteria as determined by Eos-FP phagocytosis assays 
established for whole blood analysis. This effect is further stimulated by G-CSF therapy in vivo. The 
minority of patients not upregulating phagocytosis require more detailed analysis of the neutrophil 
function. 
*Wiedenmann, J. et al. Proc Natl Acad Sci U S A 101:15905-15910. 
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Animal Physiology and Biochemistry, Poznan University of Life Sciences,  Poznan, 
Poland.cUniversity of Oulu, Faculty of Medicine, Oulu, Finland. 
 
Recently, chronic, low-grade inflammation is seen as a primary event linking obesity with 
insulin resistance. In the experimental models, mainly murine, it was found that 
overproduction of TNF-" in adipose tissue is an important feature of obesity and causes 
insulin resistance. Moreover, interleukin-6 (IL-6), resistin and visfatin have an immunological 
activity and are produced in adipocytes of visceral and epicardial adipose tissues. To better 
understand the mechanism underlying the interaction of endocrine and immune systems we 
focused our attention on the crosstalk between metabolism and inflammation signals  in 
diabetic piglets. Experiment was carried out on the 8 weeks old piglets treated with 
streptozotocin (STZ) and glucocorticoids. Plasma levels of IL-6, TNF-" and visfatin were 
significantly increased in STZ-treated pigs clearly showing the low-grade systemic  
inflammation paralell with development of diabetes. In contrast, glucocorticoid injections 
caused significant decrease of the IL-6 and increase of resistin plasma levels. Analysis of the 
concentration of all tested peptides in the epicardial adipose tissues showed that STZ caused 
decrease of IL-6 and increase of TNF-". Quantitative PCR showed the modulation of the 
expression of resistin and visfatin mRNAs in epicardial adipose tissue. The obtained results 
clearly showed that TNF-", IL-6, resisistin and visfatin from the epicardial adipose tissue 
participate in the induction and maintenance of the subacute inflammatory state associated 
with insulin resistance and diabetes. The results also indicated that piglets are more useful 
model for the inflammatory and insulin resistance study than rats or mice.  
Supported by Ministry of Science and Higher Education Grants:NR12006406,NN311227138. 
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Cancer immunoediting from immunosurveillance to tumour escape in microvillus-
formed niche. A study of syngeneic orthotopic rat bladder cancer model in comparison 
with human bladder cancer  
Carl-Jørgen Arum1,2, Endre Anderssen1, Trond Viset3, Steinar Lundgren4,5, Duan Chen1 
and Chun-Mei Zhao1* 
1Department of Cancer Research and Molecular Medicine and 5Department of 
Circulation and Medical Imaging, Norwegian University of Science and Technology, 
Trondheim, Norway; 2Department of Urology, 3Department of Pathology and Genetics, 
4Department of Oncology, St. Olav’s University Hospital, Trondheim, Norway 
 
Cancer cells can develop an attenuated immunogenicity and/or create an immunosuppressive 
tumour microenvironment that prevent tumour eradication by the host immune system; the so-
called “cancer immunoediting” hypothesis. We attempted to test this hypothesis by utilising a 
rat bladder cancer model in comparison with human bladder cancer. An orthotopic bladder 
cancer model was induced in Fisher rats by inoculating Fisher rat bladder cancer cell line AY-
27. The cancer cells, rat and human bladder cancer tissues, and publicly available microarray 
data from human bladder cancer were analysed by means of bioinformatics and morphology. 
Results showed that 10 of 23 differentially expressed pathways were concordant in 
connection to cell cycle and proliferation between rats and humans and that 13 of 23 
pathways, including major histocompatibility complex pathways, were related to host 
immunosurveillance with activations of CD8- and CD4-evoked T cells, and KIR-evoked 
natural killer cells in rats. The differentiated pathways and morphogenesis of this rat model 
corresponded more closely with those of human muscle-invasive tumour rather than non-
muscle-invasive tumours. A unique ultrastructure displaying microvillus-formed niche that 
was interconnected with desmosomes between cancer cells and without infiltration of 
lymphocytes was found in small areas within the tumour in both rats and humans. Expression 
of E-cadherin, E-, L- and P-selectins, PGP9.5, VEGF, caspase-3 and BCL2L1 was lower in 
the tumour than in adjacent normal epithelium. In conclusion, a sub-population of the cancer 
cells elude immunosurveillance within microvillus-formed niches.   
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ADAM 12 is highly expressed in, but not restricted to, oligodendrogliomas 
 
Hans-Gert Bernstein1, Dimitrios Kanakis1,2, Uwe Lendeckel3 , Christian Mawrin,4 
Henrik Dobrowolny,1 Johann Steiner1, Gerburg Keilhoff 5, Bernhard Bogerts1 
 
1 Department of Psychiatry, University of Magdeburg, 2 Department of Neuropathology, 
University of Muenster, 3 Department of Medical Biochemistry and Molecular Biology, 
University of Greifswald, 4 Department of Neuropathology, University of Magdeburg, 5 
Institute of Biochemistry and Cell Biology, University of Magdeburg, Germany. 
Correspondence: E-Mail: Hans-Gert. Bernstein@med.ovgu.de 
 
ADAM 12 belongs to a ADAM family of proteases. ADAMs have been implicated in several 
cell physiological processes including cell adhesion, cell fusion, proteolysis and signalling, 
and are considered to play important roles in the immunopathogenesis of immune-mediated 
disorders of the nervous system. In addition, many tumors show elevated expression of 
ADAM 12. In the human CNS ADAM12 is predominantly (but not exclusively) expressed in 
oligodendrocytes. In the present study, the expression of ADAM 12 was investigated in 
various human glial neoplasms by immunohistochemistry and real-time PCR. While 9 of 16 
astrocytomas of different malignancy exhibited moderate expression levels of ADAM 12, all 
(11of 11) oligodendrogliomas showed strong ADAM 12 immunopositivity independently of 
the grading. The percentage of ADAM 12-positive tumor cells was higher in low-grade 
oligodendrogliomas compared to anaplastic oligodendrogliomas. Additionally, invasion 
borders of tumors showed increased immunoexpression. Real-time PCR also detected 
significantly higher amounts of ADAM 12 mRNA in low-grade compared to high-grade 
astrocytomas or oligodendrogliomas. Our data indicate that ADAM12 expression is not 
related to the grade of malignancy in oligodendrogliomas. 
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A mouse model of inflammatory signaling in prostate tumorigenesis 
 
Andreas Birbach1, David Eisenbarth1, Nicolas Kozakowski2, Marc Schmidt-Supprian3, 
Johannes A. Schmid1 
 
1Department of Vascular Biology and Thrombosis Research, Center for Physiology and 
Pharmacology, Schwarzspanierstrasse 17, Medical University of Vienna, Austria 
2Clinical Institute of Pathology, Medical University of Vienna, Austria 
3Max Planck Institute of Biochemistry, Martinsried, Germany  
andreas.birbach@meduniwien.ac.at 
 
Prostate cancer is the second leading cause of death among men in industrialized countries. A 
growing amount of evidence suggests that inflammation and inflammatory signaling are 
involved in the tumorigenic process, but the exact role remains a controversial issue. In the 
current project, we aim to elucidate the role of inflammatory signaling in prostate 
tumorigenesis by developing and analyzing a mouse model of inflammation-induced prostate 
cancer. To this end, three mouse lines are being crossed, one conferring prostate-specificity to 
the model by organ-specific expression of the Cre recombinase, one simulating a genetic 
event by partially deleting a tumor suppressor gene (phosphatase and tensin homologue, 
PTEN), and one imitating signaling during a chronic inflammatory state by expressing a 
constitutively active form of the IkappaB kinase 2 (IKK2ca). Analysis of mice sacrificed at 
different ages indicated that constitutive IKK activity alone is not sufficient to induce changes 
reminiscent of pre-malignant lesions. However, combined activation of IKK signaling and 
partial loss of the tumor suppressor PTEN increased tumor mass compared to partial tumor 
suppressor loss alone. Histologically, these tumors presented as organ-confined intraepithelial 
lesions forming frequent cribriform structures, showing an enhanced stromal response and 
loss of smooth muscle cells encircling the epithelial ducts. Acute inflammation by the 
infiltration of immune cells was observed. Taken together, our results indicate that 
inflammatory signaling can cooperate with genetic lesions to increase tumor mass but not 
enhance invasiveness in prostate tumors.  
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Sox9-associated overexpression of IFIT3 leads to pancreatic cancer progression by activation of 
“pseudoinflammatory” pathways. 
 
Peter Camaj, Ivan Ischenko, Hendrik Seeliger, Andrea Renner, Karl-Walter Jauch, Christiane 
J. Bruns 
 
The understanding of invasion, angiogenesis and metastasis is essential for the development of new 
targeted molecular therapy against cancer. Inflammation plays important role in tumour initiation and 
progression. Here we report the role of the transcription factor Sox9 for regulation of IFIT3 (interferon-
induced protein with tetratricopeptide repeats 3) an inflammation-related and tumour-promoting protein in 
pancreatic cancer. For in vivo and in vitro experiments we utilized the following human pancreatic cancer 
cell lines: low metastatic FG, high metastatic L3.6pl, and the stable transfected cell line FG-IFIT3. To 
demonstrate effects on primary tumor growth and metastases in vivo we orthotopically injected the 
different cell lines in the pancreas of nude mice. To evaluate the VEGF depending angiogenic capacity of 
the different cell lines ELISA technology was used. By One STrEP technology we were able to identify 
IFIT3-binding partners. Chromosomal immunoprecipitation (ChIP) using anti-Sox9 antibody, followed by 
PCR amplifying the IFIT3-promoter was used to identify the interaction of the IFIT3 promoter with the 
transcription factor Sox9. To investigate Sox9-depending expression of IFIT3 (protein and RNA) we used 
stable transfected L3.6pl-Sox9-shRNA cells under control of the Tet-CMV promoter in presence or 
absence of tetracycline, respectively. Analysis of differential gene expression by gene array technology 
demonstrated that the IFIT3 gene is up-regulated in L3.6pl cells as compared to FG cells. Results of animal 
experiment and in vitro experiments clearly demonstrated tumor-promoting, pro-metastatic and pro-
angiogenic features of IFIT3. RT-PCR has revealed that both treatment with IFn" as well as NF!B led to 
up-regulation of IFIT3-RNA expression. One STrEP experiments identified JNK and STAT1 as binding 
partners of IFIT3. ChIP has demonstrated binding of the transcription factor Sox9 to the IFIT3 promoter. 
RT-PCR and immunoblot data demonstrated constitutive up-regulation of Sox9 expression in L3.6pl cells. 
By Western blotting and RT-PCR we could show that diminishing of Sox9 expression in stable transfected 
L3.6pl Sox9-shRNA cells leads to a significant down-regulation of IFIT3-epression on the RNA and 
protein level. The inflammation associated protein IFIT3 is up-regulated in metastatic L3.6pl human 
pancreatic cancer cells and is in part responsible for the aggressive primary pancreatic tumor growth in 
vivo. This gene is up-regulated by IFn" and NF!B. Interestingly Sox9 binds to the IFIT3P and activates its 
expression. Since in L3.6pl cells Sox9 is constitutively over-expressed, IFIT3 is up-regulated independent 
on the presence of the cytokine IFn". Therefore, the pro-inflammatory IFn"-signaling pathway is activated 
even without actual inflammation in absence pro-inflammatory cytokine. The activation of such a “pseudo-
inflammatory pathway” seems to be in part responsible for pancreatic cancer progression. 
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First detection of OXA-60 +-lactamase in Tunisia in clinical strains of Proteus mirabilis  
 
CHOUCHANI Chedly1,2, BELHADJ Omrane2. 
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2 Faculty of Sciences of Tunis, BSB Street, 2092 El-ManarII, Tunisia 
 
Like other countries worldwide, Tunisia has a growing problem with extended-spectrum-#-
lactamases especially with OXA-#-lactamase-producing Enterobacteriaceae species. Six 
major clonally related strains have been identified among OXA producers. We firstly detected 
here the OXA-60 Extended-Spectrum-#-lactamase produces by clinical strain of Proteus 
mirabilis in Tunisia. In order to determine the genetic support of these resistances, plasmids 
were extracted and transformed into E. coli DH5" conjugative mating was attempted on agar. 
MICs were determined by agar dilution. #-Lactamases were typed by isoelectric focusing; 
antibiotic resistance genes were identified by PCR, and sequenced in order to identify these 
resistance gene. OXA-60, have a pI of 5.1, that was expressed only after #-lactam induction. 
After amplification and sequencing, this plasmid-encoded oxacillinase shared 19 percent 
amino acid identity with OXA-22. blaOXA-60, carried by a 70 kb plasmid, was detected in one 
of six strains studied. Conjugative transfer of cefotaxime resistance was only achieved in this 
strain; plasmids from both strains were transferred by transformation. The plasmid from one 
strain additionally carried blaTEM-1 (variably) blaOXA-60; the plasmids from other five strains 
carried blaTEM-1 consistently and blaOXA-22 genes. blaOXA-60 was plasmid-mediated in clinical 
strain of P. mirabilis and was linked to other antibiotic resistance genes. The prevalence of 
OXA production among ceftazidime-resistant P. mirabilis isolates is relatively high in both 
hospitals. Infection control measures have been challenged and further improvements in such 
measures are required to prevent dissemination of these isolates among hospitals. This is the 
first report of OXA-60 ESBL in P. mirabilis in Tunisia. 
 
Key words: Resistance, OXA-60, #-lactamase, Proteus mirabilis. 
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Decreased nuclear expression of Smad4 in uterine cervical carcinogenesis 
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Korea 
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5To whom correspondence should be addressed: E-mail: yssong@snu.ac.kr  
 
Squamous cell carcinoma of the uterine cervix is one of the most frequent gynecologic cancers 
worldwide. Infection with high-risk human papillomavirus types leads to cervical carcinogenesis. 
Escape from growth inhibition by transforming growth factor # (TGF-#) has been demonstrated in 
cervical cancer cell lines. However, little is known about changes in the activity of the intracellular 
Smad downstream of TGF-# signaling during cervical carcinogenesis. We used 
immunohistochemistry to analyze Smad2, nuclear Smad3, nuclear Smad4, and inhibitory Smad7 in 
epithelial cells of normal, intraepithelial neoplasia, and invasive cervical cancer to assess the tendency 
of Smad expression according to the progress of the carcinogenesis. Specimen comprised 20 tissue 
cores of invasive cervical cancer, 36 cases of cervical intraepithelial neoplasia. Immunoreactivities of 
Smad2 and Smad7 were observed exclusively in the cytoplasm of cervical tissues, while Smad3 and 
Smad4 expressions were exclusively localized in the nuclear compartments of cervical cells. Positive 
Smad4 and Smad7 expression was observed in 40 (71.4%) and 19 (33.9%) cases, respectively. In the 
current study, the mean levels of Smad4 nuclear expression were statistically different among early 
CIN group, advanced CIN group and invasive carcinoma group (P = 0.032) while those of Smad7 
cytoplasmic expression were not (P = 0.054). The expressions of Smad4 and Smad7 were inversely 
correlated with each other (P = 0.005) in cases of invasive cervical cancer. These data suggest that 
decreased nuclear Smad4 expression may be associated with the progression to invasive cervical 
cancer, and enhanced expression of the TGF-# signaling inhibitor Smad7 may present one of the 
mechanisms of TGF-# resistance in cervical carcinoma. 
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Upregulation of monocyte chemoattractant protein-1 and macrophage inflammatory 
protein-1#  expression in microglia infiltrating into glioma  
 
Kuan-Min Fang1, Ying-Lan Wang1, Ming-Chao Huang2, Henrich Cheng2, Shun-Fen Tzeng1 
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Glioma is the common primary brain tumor derived from the abnormal proliferation of the glia. 
The infiltration of microglia, brain macrophages, is a characteristic feature of glioma. Several 
studies have addressed that chemotactic factors secreted around glioma may have the regulatory 
role in the induction of microglial activation, which is to modulate gliomal formation. ATP, an 
important intercellular regulator in the immune and nervous systems, is released primarily from 
activated glia and glioma cells. In the study, we used an animal brain tumor model by injecting C6 
glioma cells into the rat cerebral cortex, and found that Iba1+ and ED1+ microglia were infiltrated 
in the tumor center at 1 week after injection (AI). However, Iba1+ cells were the major microglial 
population observed in the tumor center at 2 week AI. The expression of monocyte 
chemoattractant protein-1(MCP-1) and macrophage inflammatory protein-1#(MIP-1#) were also 
observed in Iba1+ or ED1+ microglia situated at the periphery of rat brain tumor at 3 day AI. In 
vitro study showed that the application of ATP increased the release of microglial MCP-1 and 
MIP-1#. Treatment of microglia with BzATP, the agonist of P2X7R, a surface receptor specific 
for ATP, also improved MCP-1 and MIP-1#. Together, based on our in vivo and in vitro results, 
we suggest that injected C6 cells and activated glia around tumor may release a mass amount of 
ATP molecules to induce P2X7R-mediated increase in MCP-1 and MIP expression in microglia 
around glioma tumor. 
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Antitumor activity of in vitro and in vivo treatment with Orbygnia phalerata Mart. 
 
Thiare S. Fortes; Éder M. S. Fialho; Aramys S. Reis; Anne Karine M. Assunção; 
Elizabeth B. S. Barroqueiro, Ana Paula S. Azevedo; Rosane N. M Guerra, Flávia R. F. 
Nascimento. 
 
Federal University of Maranhão- UFMA 
thiarefortes@gmail.com; nascimentofrf@yahoo.com.br 
 
Introduction and aim: Orbignya phalerata Mart is a palm native from North of Brazil where 
cover an area of approximately 10 million hectares. It is  popularly known as babassu and is 
very important to the economy of the region. The mesocarp from babassu fruit is largely used 
in the treatment of various diseases such as inflammations and tumors. Several tests have 
been made in order to test biological activities. The aim of this study was to evaluate the 
antitumor effect of the treatment with aqueous extract of babassu mesocarp (BM) in vitro and 
in vivo of Methodology: To evaluate the antitumor effect the Ehrlich tumor on the forms of 
ascites and solid tumor was used. For the in vitro tests, the tumor cells were adjusted to 
5x106/mL and 100 mL of this suspension  were placed in each well of culture plates 96 well 
flat bottom and cultured in the presence or absence of the extracts at concentrations of 62.5, 
125, 250 and 500 ug/mL, for 24 hours when the quantification and analysis of viability was 
performed. After this procedure, the tumor cells were inoculated in Balb/c and C57Bl/6 mice 
strains (N= 30 per group), by intraperitoneal or subcutaneous routes (ascitic and solid tumors, 
respectively). The solid tumor development was followed by the measurement of paw length 
thickness by 18 days. The ascitic development was evaluated at 10th day by measuring the 
ascitic volume, the tumor cell number and the survival.  Results: The in vitro treatment did 
not induce death in tumor cells. Despite this, the pretreatment in vitro before the inoculation 
of tumor cells induced a significant decrease in the paw’s thickness in both mice strains. 
However, only in the C57Bl/6 strain there was a decrease in the ascite volume, although both 
strains had an increased lifespan. Conclusion: The results indicate that the inoculation of 
tumor cells, pre-treated in vitro with BM induces an increase in anti-tumor immune response, 
which can be related to an immunological deviation of tumor associated macrophages to the 
M1 pattern. However, more investigations are necessary to clarify this mechanism. 
Keywords: Babassu mesocarp; in vitro; in vivo; Ehrlich of tumor. 
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Tamoxifen enhances the anti-proliferative effect of roscovitine (ROSC), a selective 
cyclin-dependent kinase inhibitor on human ER-positive human breast cancer cells 
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We reported recently that roscovitine (ROSC), a selective cyclin-dependent kinase (CDK) 
inhibitor, arrested human ER-ve MCF-7 breast cancer cells in G2 phase of the cell cycle and 
concomitantly induced apoptosis
1 2
. The effect of ROSC was diminished in MCF-7 cells 
maintained in the presence of estrogen-mimicking compounds
3 4
. Therefore, we decided to 
prove whether combining ROSC with anti-estrogen therapy would modulate the efficacy of 
ROSC action. Exposure of MCF-7 cells to tamoxifen (TAM) for 24h decreased the number of 
living cells by approximately 10%. This was associated with an accumulation of G1 cell 
population by approximately 25% and diminution of S-phase cells. Unlike TAM, estrogen 
had a very low effect on cell cycle progression of MCF-7 cells within 24h. The proliferation-
promoting effect of estrogen became evident only after cultivation of cells for 48h or longer. 
Addition of estrogen to MCF-7 cells 1h prior to TAM administration did not alter the anti-
estrogen-induced G1 arrest. Simultaneous treatment of MCF-7 cells with ROSC and TAM 
strongly enhanced the anti-proliferative effect of ROSC. This was potentiated after co-
treatment with estrogen. These results clearly evidence that the efficacy of the therapy of ER-
positive breast cancers by ROSC can be enhanced by combination with anti-estrogens.  
 
1 Wojciechowski J. et al. 2003. Rapid onset of nucleolar disintegration preceding cell cycle 
arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int J Cancer 106: 
486-95. 
2 Wesierska-Gadek J. et al. 2005. Roscovitine-induced up-regulation of p53AIP1 protein 
precedes the onset of apoptosis in human breast cancer cells. Mol Cancer Ther 4: 113-124. 
3 Wesierska-Gadek J. et al. 2006. Phenol red reduces ROSC mediated cell cycle arrest and 
apoptosis in human MCF-7 cells. J Cell Biochem 98: 1369-1379. 
4 Wesierska-Gadek J. et al. 2007. Phenol red in the culture medium strongly affects the 
susceptibility of human MCF-7 cells to anti-cancer drugs. CMBL 12: 280-293. 
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Tumor-associated macrophage is associated with maintenance of glioma cancer stem cell 
populations 
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Recent studies showed a correlation between the numbers of tumor-associated macrophage 
and poor prognosis for diverse human cancers. Tumor-associated macrophage is also 
associated with cancer progression including increasing angiogenenic potential, invasion, and 
metastasis. However, the mechanisms underlying acquisition of malignant properties of 
human cancers associated with macrophage have remained unclear. In this study, we show 
that activated THP-1 macrophage is involved in maintenance of cancer stem cell populations 
in human brain cancer cells. Positive populations for CD133, Nestin and Musashi-1 
possessing tumor-initiating potential in human glioma cells were expanded after treated with 
LPS-activated THP-1 macrophage conditioned media. Cells treated with conditioned media 
have increased anchorage-independent growth on soft agar and tumor formation. LPS-
activated THP-1 macrophage conditioned media also induced a marked activation of both 
PI3K-Akt and PKCdelta signaling pathway. Inhibition of PI3K or PKCdelta with chemical 
inhibitors or specific siRNA resulted in suppression of tumorigenic potential in cells treated 
with THP-1 macrophage conditioned media. Moreover, inhibition of PI3K or PKCdelta led to 
a decrease in expressions of CD133, Nestin and Musashi. The data we elucidated in this study 
indicate that tumor-associated macrophage is associated with maintenance of cancer stem cell 
populations in human brain tumor cells through activation of both PI3K and PKCdelta 
signaling pathways, and may provide pivotal points for therapeutic intervention in brain 
cancer treatment. 
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+-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells via Sp1-
dependent upregulation of DR5 and downregulation of NF-%B activity 
 
Sang-Hycuk Kang, 1 Moon-Soo Heo,1 Yung Hyung Choi,2 and Gi-Young Kim1 
 
1
Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National 
University, Jeju 690-756, Republic of Korea 
2
Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan 614-
052, Republic of Korea 
 
#-Ionone (ION), an end-ring analogue of #-carotenoid, has been known to inhibit tumor cell 
growth and induce apoptosis in various types of cancer cells. Nevertheless, its apoptosis-
related molecular mechanisms remain unclear. Here, we first investigated the molecular 
mechanisms by which ION sensitizes cancer cells to the therapeutic potential of tumor 
necrosis factor-related apoptosis-inducing ligand (TRAIL). Notably, treatment with subtoxic 
concentrations of ION and TRAIL effectively inhibited cell viability in the hepatocellular 
carcinoma cell line Hep3B and other cancer cell lines such as colon carcinoma cell line 
HCT116 and leukemia cell line U937. Combined treatment with ION and TRAIL was also 
more effective in inducing DR5 expression, caspase activities, and apoptosis than treatment 
with either agent alone. ION-mediated sensitization to TRAIL was efficiently reduced by 
treatment with a chimeric blocking antibody or siRNA specific for DR5. EMSA and a 
chromatin immunoprecipitation assay confirmed that ION treatment upregulates the binding 
of transcription factor Sp1 to its putative site within the DR5 promoter region, suggesting that 
Sp1 is an ION-responsive transcription factor. In addition, ION significantly increased 
hepatocellular carcinoma cell sensitivity to TRAIL by abrogating TRAIL-induced NF-!B 
activation and decreasing the expression of antiapoptotic proteins such as XIAP and IAP-1/2. 
Taken together, these data suggest that ION is a useful agent for TRAIL-based cancer 
treatments. 
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Role of Junb in mast cell – mediated tumor angiogenesis 
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The AP-1 transcription factor subunit Junb was recently identified as a critical regulator of 
angiogenesis in vivo
1, 2  
and of mast cell biology
3
 in vitro. Junb-deficient bone-marrow derived 
mast cells (BMMC) display a severe degranulation defect due to impaired expression of 
SWAP-70, SYT-1 and VAMP8 that represent central molecules for Ca
2+
-release (SWAP-70), 
Ca
2+
-sensing (SYT-1) and SNARE complex function (VAMP8). Moreover, reduced 
expression of the cytokines IL-3, IL-4, IL-10 and the growth factors TNF-alpha and, most 
importantly, VEGF-A in BMMC lacking Junb results in a diminished vascular network 
formation of endothelial cells (EC) on matrigel. Since the role of mast cells in tumor growth 
and tumor angiogenesis is currently a subject of increasing interest, we aim to study the 
contribution of Junb to mast cell function in this context in vivo. Therefore, we are generating 
a novel mast-cell specific Junb knockout mouse that will serve as a tool to dissect the putative 
regulatory effects of Junb for mast cell function in vivo. In particular, maturation, migration 
and activity of Junb-deficient MC will be studied applying the murine models of contact 
hypersensitivity and of passive systemic anaphylaxis. The contribution of Junb-deficient mast 
cells to tumor progression will be analyzed by the use of transplantable syngenic tumor 
models injecting B16 melanoma or Lewis lung carcinoma cells into mice. Our experimental 
approach will provide insights into the importance of mast cell recruitment to the tumor site 
with respect to tumor growth or metastasis and reveal whether loss of Junb in mast cells 
affects the angiogenic response to implanted tumors. 
1.  Licht, A.H., Pein, O.T., Florin, L., Hartenstein, B., Reuter, H., Arnold, B., Lichter, P., Angel, P. 
and Schorpp-Kistner, M. (2006). JunB is required for endothelial cell morphogenesis by 
regulating core-binding factor b expression. J. Cell Biol. 175:981-91. 
2.  Schmidt, D., Pein, O., Andrecht, S., Textor, B., Sator-Schmitt, M., Fusenig, N. E., Angel, P. and 
Schorpp-Kistner, M. (2006). Critical role for JunB in VEGF regulation and tumor angiogenesis. 
EMBO J 26, 710-9. 
3.  Textor, B., Licht, A.H., Tuckermann, J.P., Jessberger, R., Razin, E., Angel, P., Schorpp-Kistner, 
M., Hartenstein, B. (2007). JunB is required for IgE-mediated degranulation and cytokine release 
of mast cells. J Immunol. 179:6873-80.  
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Induction of apoptosis in multidrug-resistant human multiple myeloma cells by Roscovitine, a small 
molecule CDK inhibitor: Cooperative action with functional p53 protein improves its therapeutic efficacy 
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Recently, a number of new targeted therapies were developed. Unfortunately, cancer cells develop resistance 
against a wide-range of anti-cancer drugs. Therefore, new therapeutic settings are necessary to overcome the 
failure of many chemotherapeutic protocols. Currently, targeting of cell cycle regulators raised hope for cancer 
cure. Small molecule inhibitors of cyclin-dependent kinases (CDKs) show high therapeutic potential against 
transformed cells. Their high preclinical effectiveness against rapidly dividing cancer cells and malignancies 
characterized by accumulation of transformed cells due to deregulation of apoptosis such as chronic lymphatic 
leukemia or multiple myeloma became evident 1,2. In the present study we raised the question whether 
pharmacological CDK inhibitors like roscovitine (ROSC) would be effective against human multiple myeloma 
cells that acquired drug resistance to doxorubicin. For this purpose we selected an experimental model of human 
multiple myeloma-sensitive (RPMI 8226_S) and doxorubicin-resistant (RPMI-8226_DOX40) cell lines. RPMI-
8226 cells are known to express temperature-sensitive p53 mutant. Exposure of RPMI 8826 cells to ROSC at 
restrictive conditions (37°C) markedly increased the ratio of hypoploid population representing cells undergoing 
apoptosis in both sensitive and resistant cell lines. After 12h the number of sub-G1 RPMI-8226S increased up to 
approximately 40% and RPMI-8226_DOX40 cells up to 27%. Unlike ROSC, DOX at high dosage did not 
elevate the apoptosis rate in RPMI 8226_DOX40 cell line. Remarkably, under permissive conditions (30°C) wt 
p53 induced spontaneous apoptosis in both tested cell lines. However, treatment of multiple myeloma cells 
maintained for 24 h at 30 ˚C with ROSC for another 24 h increased in both cell lines the apoptosis rate by 
approximately 30% or 15%, respectively. Our results show that ROSC has capacity to induce apoptosis in the 
RPMI 8226_DOX40 drug-resistant cell line overexpressing P-gp glycoprotein under restrictive and permissive 
conditions. Moreover, the outcome of ROSC treatment under permissive conditions indicates its cooperative 
action with wt p53 protein. Considering the fact that ROSC inhibits not only cell cycle-related CDKs but also 
negatively regulates kinases involved in the regulation of transcription, its administration to quiescent multidrug-
resistant cells might be of advantage. Inhibition of transcription of pro-survival genes such as BCL-2 or MCL1 as 
well as destabilization of survivin seems to facilitate therapeutic efficacy. 
1 Paprskarova M. et al. 2009. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor rosovitine. J 
Cell Biochem 107: 428. 
2 Rogalinska M. et al. 2009. R-Roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with 
cyclophosphamide: inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. J Cell Biochem (online published on 
Novemebr 12, 2009). 
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Astragalus saponins exhibit anti-angiogenic effect in colon cancer cells via inhibition of 
mTOR signaling and pro-inflammatory mediators 
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Astragalus membranaceus has been demonstrated to induce colonic protection against experimental 
colitis through modulation of cytokines in our previous study [1]. Further studies indicate that total 
Astragalus saponins extract (AST) in the herb, exhibit anti-inflammatory and anti-carcinogenic 
effects using different models[2-3]. In this study, the correlation between inhibiting pro-inflammatory 
mediators and the anti-angiogenic effects of AST in HCT 116 human colon cancer cells under 
hypoxic condition was investigated. The protein and gene expression of angiogenic factors was 
assessed using Western immunoblotting and RT-PCR, respectively. The involvement of mTOR 
signaling in the anti-carcinogenic effect of AST was investigated by using its inhibitor rapamycin. 
Expression of tumor necrosis factor-alpha (TNF-"), heat shock protein 90 (HSP 90), hypoxia-
inducible factor (HIF-1") and vascular endothelial growth factor (VEGF) under hypoxia conditions 
were examined using cobalt chloride (CoCl2) as hypoxia-mimetic agent. AST (80 µg/ml) 
significantly inhibited the protein expression of the key angiogenic growth factors VEGF in 
normoxic condition. Our results showed that the protein expression of PTEN, an upstream regulator 
of PI3K-Akt signaling, was increased. This was followed by reduced Akt phosphorylation (pAkt) 
and downregulation of its downstream target mTOR. Rapamycin alone could decrease the protein 
expression of VEGF, while co-treatment of rapamycin and AST further downregulate these 
proteins. HIF-1 has been considered to be a pivotal transcription factor linking between the 
inflammatory and oncogenic pathways. Under CoCl2 mimicked hypoxia, the induced HIF-1" and 
VEGF expression in HCT 116 cells was suppressed by AST or rapamycin alone. Co-treatment of 
AST and rapamycin could further decrease their protein expression. Preliminary results have shown 
that CoCl2 could induce expression of the pro-inflammatory cytokine TNF-" and of the chaperon 
protein HSP90, which were dropped to control levels after AST treatment. Our data suggest that 
AST could downregulate the angiogenic factors HIF-1" and VEGF through inhibition of mTOR 
signaling and pro-inflammatory mediators in HCT 116 cells under hypoxic condition. 
[1] J.K.S. Ko, et al., Cytokine, 2009, 47(2): p.85-90. [2] K. K.W. Auyeung, et al., Int. J. Cancer, 
2009, 125: p.1082–1091. [3] K. K.W. Auyeung, et al., Int J Mol Med, 2009, 23(2): p.189-96. 
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Objectives: Uterine sarcomas are rare gynecologic malignancies characterized by clinical 
aggressiveness with very limited therapeutic options. Cyclooxygenase-2 (COX-2) is a well 
known enzyme that promotes tumor growth and metastasis. COX-2 is up-regulated in a 
number of human epithelial tumors, but data about its significance in mesenchymal tumors 
are lacking. The purpose of this study was to evaluate COX-2 expression in uterine sarcomas 
and to identify if a relationship exists between COX-2 expression and clinicopathologic 
outcomes. 
Materials and methods: Immunohistochemical staining for COX-2 was performed on 
paraffin-embedded tissue blocks of 32 uterine sarcomas (16 leiomyosarcomas, 14 endometrial 
stromal sarcomas, and 2 malignant mixed müllerian tumors).  
Results: Median age was 41 years (28-65). Of 32 uterine sarcomas analyzed, 4 (12.5%) were 
positive for COX-2 expression (3 leiomyosarcomas and 1 endometrial stromal sarcoma). No 
significant association between COX-2 expression and age, tumor histology, or stage was 
observed. Patients with COX-2 expression showed lower survival rate than those without 
COX-2 expression (P=0.048).  
Conclusion: Our results indicate that immunohistochemically determined COX-2 expression 
has a significant impact on the outcome of patients with uterine sarcoma.  
 
Keywords: cyclooxygenase-2; uterine sarcoma. 
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Implications for inflammation-associated colon carcinogenesis 
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Colorectal cancer is one of the leading causes of cancer-related deaths in the United States and 
many other western societies. Abnormal up-regulation of COX-2 expression has been 
considered as a key oncogenic event in inflammation-associated human colon carcinogenesis. It 
was reported that 15-PGDH, a physiological antagonist of COX-2 in its catabolism, is 
ubiquitously lost in human colon cancer. However, the molecular mechanisms by which 15-
PGDH exerts tumor-suppressing functions in colon carcinogenesis remain largely unresolved. In 
the present study, we have observed that 15-PGDH is negatively regulated by COX-2 in colon 
cancer cell lines. The mRNA levels and protein activity of 15-PGDH were upregulated by 
inhibition of COX-2 using designed siRNA. In line with the in vitro data, 15-PGDH was 
constitutively expressed in mouse colonic mucosa, which was abrogated by treatment with 2.5% 
SDS for 7 days in drinking water. Under the same experimental conditions, expression of COX-
2 was elevated in the DSS-treated mice mucosa, which was not detectable in the normal mice 
colon. To determine whether 15-PGDH is negatively regulated by COX-2, we utilized a 
selective COX-2 inhibitor celecoxib. Thus, oral administration of celecoxib increased the 15-
PGDH expression while the same treatment decreased COX-2 expression in DSS-treated mouse 
colon. Moreover, 15-PGDH expression in colonic mucosa following treatment with AOM plus 
DSS was more prominent in COX-2 knockout mice than that observed in COX-2 wild type 
animals. Likewise, levels of constitutively expressed 15-PGDH were higher in COX-2 knockout 
mice. In patients with colon tumors, the expression of 15-PGDH was markedly reduced in 
adenomas and carcinomas, compared with normal surrounding tissues. These finding suggest 
that expression of 15-PGDH is negatively regulated by COX-2, which may contribute to the 
inflammation-associated colon carcinogenesis. 
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In yeast Saccharomyces cerevisiae, rapamycin an immunosuppressant inhibits the TOR (Target of 
Rpamycin) complex, homologous of mTOP in mammalian cells. It triggers events that mimic the 
effect of nutrient starvation including inhibition of ribosome biogenesis, protein translation and 
inducing autophagy and G0 entry. TOR proteins integrate signals from growth factors nutrients, stress 
and cellular energy levels to control cell growth. Rrd1 is a cis/trans prolyl isomerase that required 
signalling responses to the immunosuppressant rapamycin and mutants devoid of rrd1 display striking 
resistance to the drug. Preliminary data revealed that this effect was blocked by removing the helicase 
Sgs1. Then our objective was to investigate what is the link between Rrd1 and Sgs1. Sgs1 is a nuclear 
DNA helicase of the RecQ family involved in genome integrity maintenance. RecQ family is 
conserved from bacteria to humans; Sgs1 is a homolog of human BLM and WRN proteins implicated 
in Bloom and Werner syndromes. Deletion of SGS1 leads to diverse phenotypes including sensitivity 
to genotoxic agents, hyper-recombination, chromosome missegregation, and meiotic defects. 
Mutations in the SGS1 gene lead to defects similar to those seen in human cells from the RecQ family 
disorders. Sgs1 mutant is sensitive to rapamycin. Significantly, deletion of Sgs1 in the Rrd1 mutant 
causes the mutant to no longer show resistance to rapamycin. Reintroduction of Sgs1 will restore to 
the rrd1 mutant resistance to rapamycin. The sensitivity to Rapamycin remains at the same level even 
if Sgs1 is over expressed in the wild type strain and Rrd1 mutant.Sgs1 may belongs to the pathway 
that signals stress caused by rapamycin. Rapmycin treatment induces rapid degradation of Sgs1 and 
this degradation is dependent on Rrd1 function.  It has recently been demonstrated that Rrd1 is 
required to isomerize the C-terminal domain of RNA polymerase II and caused its release from the 
chromatin for degradation. Based on this observation, Rrd1 could most probably alter the structure of 
Sgs1 then it gets degraded in response to rapamycin. Sgs1 accumulates in Rrd1 mutant after 
rapamycin treatment as detected by immunofluorecent analysis. This finding reveals a lower level 
after rapamycin treatment in parent strain and accumulation in Rrd1 mutant. These observations 
support that Rrd1 is necessary to degrade Sgs1 in the cell, but mechanisms of this degradation are not 
yet known. 
Key words: yeast; Sgs1; Rrd1; rapamycin 
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It has been recognized that conventional anti-cancer drugs exert a variety of adverse side effects 
and, unfortunately, may lead to the generation of a second malignancy. Therefore, development of 
new, more selective and less cytotoxic chemotherapeutics is necessary. Recently, triazoloacridone 
C-1305, a potent topoisomerase II (Topo II) inhibitor, was generated. Although C-1305 shows 
structural similarity to other acridines like m-amsacrine (m-Amsa), it has some unique properties. 
C-1305 is a Topo II poison which leads to the formation of cleavable complexes. It was shown to 
exhibit potent cytostatic activity toward different tumors under in vitro and in vivo conditions. 
Interestingly, mouse cells lacking functional poly(ADP-ribose) polymerase-1 were much more 
sensitive to C-1305 than their normal counterparts1. These observations indicate that the efficacy 
of C-1305 may depend on the cellular context. In the present study we addressed the question 
whether the functional status of p53 in tumor cells might have an impact on the efficiency of C-
1305. Therefore, we performed experiments on human HL-60 promyelocytic leukemia cells 
which are p53-/- and on human MCF-7 breast cancer cells harboring functional p53. Exposure of 
cancer cells to C-1305 reduced the number of viable cells in a time- and concentration-dependent 
manner. Remarkably, HL-60 cells were stronger affected than MCF-7 cells. The measurement of 
DNA concentration in single cells revealed that C-1305 arrested tested cancer cells at the 
transition between G2 and M phases. In concordance with the results of cytotoxicity tests, HL-60 
cells were much stronger affected than MCF-7 cells. The analysis of the cell cycle and apoptosis 
regulators revealed that C-1305 strongly elevated phosphorylation of CDK1 at the inhibitory sites 
(Thr14/Tyr15) in HL-60 cells. Furthermore, C-1305 increased phosphorylation of Rb protein and 
of CDK2 at Thr 160 in HL-60 cells but not in MCF-7 cells. Unlike malignant cells, normal human 
diploid fibroblasts as well as human mononuclear cells isolated from peripheral blood of healthy 
volunteers were only negligibly affected by C-1305. These observations suggest that C-1305 
abrogates the restriction checkpoint and promotes G1/S transition in cells lacking functional p53. 
1 Wesierska-Gadek et al 2004. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to 
antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest. Cancer Res. 64: 4487. 
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Cytokines produced by activated innate immune cells are key players in the functional interaction 
between the inflammatory microenvironment and tumour cells. They stimulate tumour growth 
and progression by activation of transcription factors like AP-1 and NF-kB. The NF-kB signalling 
pathway has been recently shown to participate in inflammation-induced cancer progression. In 
the inflammation-associated liver cancer model of Mdr2 deficient mice, NF-kB plays an 
important role in the development of hepatocellular carcinoma (HCC) as the specific inhibition of 
the NF-"B pathway in hepatocytes due to the expression of an I"B superrepressor (DNIkBhep) 
leads to a significant reduction of tumour incidence and a later onset of tumour development. In 
the present study, we performed a functional genomic approach with HCCs derived from Mdr2-/- 
(KO) and IkB-SR Mdr2-/- mice (DM) and identified a NF-kB-dependent gene regulatory network 
involved in inflammation-associated liver carcinogenesis. These analyses revealed a 
comprehensive list of known and novel putative NF-kB target genes, including S100a8 and 
S100a9. We detected increased co-expression of S100A8 and S100A9 proteins in mouse 
hepatocellular carcinoma cells, in human HCC tissue and in the HCC cell line Hep3B upon 
ectopic RelA expression. Importantly, we identified S100A9 as a direct NF-kB target gene in 
HCC cell lines. Finally, we found a synergistic function for S100A8 and S100A9 in Hep3B cells 
resulting in a significant induction of reactive oxygen species (ROS) and protection from TNF 
induced apoptosis. Furthermore, S100A8 and S100A9 coexpression in epithelial tumour cells 
induce activation of NF-kB-dependent gene transcription. These data imply that S100A8 and 
S100A9 are not only inducers of NF-kB signaling, but also NF-kB-dependent target genes, 
supporting the existence of a feed-forward-loop promoting inflammation and neoplastic 
transformation. 
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In the present study, we demonstrated how the psoralen Bergapten in breast cancer cells is 
able to influence transductional pathways involved in the regulation of cell survival and 
apoptosis. The biological effects induced by this compound were evaluated in MCF-7 and 
SKBR-3 cells where Bergapten increases p53 and p21waf, thus activating p53 gene promoter. 
Site-direct mutagenesis studies showed that the binding sequence of the nuclear factor NF –Y 
on this promoter is necessary for drug-responsiveness. In addition p38 MAPK signalling is 
activated by psoralen treatment and this signaling was required for the Bergapten- induced of 
p53 gene promoter transactivation . The same p38 kinase is required to enhance NF-Y nuclear 
translocation. All these effects were no longer noticeable in the presence of the p38 MAPK 
kinase inhibitor (SB203580). The up-regulation of the p53 oncosuppressor protein induced by 
Bergapten corresponds to the activation of caspase 8 and caspase 9 in the two cell types, even 
though caspase-9 is also activated at lower concentrations of psoralen in SKBR-3 cells 
compared to MCF-7 cells. Moreover, in hormone-dependent MCF-7 cells psoralen is also 
able to antagonize the stimulatory effect of estradiol and IGF-I on phospho-AKT survival 
signal.  
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The Receptor for Advanced Glycation-End products (RAGE) is a multiligand receptor and 
member of the immunoglobulin superfamily of surface receptors mainly involved in chronic 
inflammatory disorders. RAGE engagement by extracellular inflammatory mediators such as 
S100 proteins sustains and prolongs the inflammatory response mainly via activation of NF-
kB signalling. Activated NF-kB promotes not only transcription and overexpression of 
inflammatory mediators but also, in a feed-forward loop, expression of both RAGE and its 
ligands. Besides chronic inflammatory diseases, RAGE and its potential ligand S100A8/A9 
were also shown to be overexpressed in several types of tumor cells, affecting tumor 
progression and metastasis by still unknown mechanisms. Moreover RAGE-deficient mice 
are protected in a model of inflammation-derived skin tumorigenesis. In a murine model of 
inflammation-associated hepatocellular carcinoma (Mdr2-/-), NF-kB activation was shown to 
be essential for tumor development. The inhibition of NF-kB activity resulted in a reduced 
progression and incidence of tumors but did not affect the early transformation phase nor the 
onset of hepatitis. In this model, S100A8/A9, described as novel NF-kB targets, were shown 
to protect cancer cells from apoptosis and induce ROS production. We hypothesize that 
RAGE may play a fundamental role in inflammation-associated tumor progression, sustaining 
the onset and progression of cancer through enhancement of the inflammatory state and 
promotion of chronic NF-kB activation. To unravel the role and molecular mechanisms 
exerted by RAGE, we knocked-out Rage expression in Mdr2 -/- mice. Rage-/- Mrd2-/- mice 
were analyzed through the different stages of inflammation, promotion of chronic hepatitis 
and cancer onset to determine how lack of RAGE may affect the mechanism of inflammation-
dependent tumor formation. 
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The therapeutic/oncolytic effects of Clostridial bacteria are very convincing so far. Both mildly-
pathogenic and non-pathogenic strains have shown their clinical effects in different cancers since 
early 1890s. However, how clostridia interact with the immune system, a clear understanding of 
which would be crucial for the success of this therapy in the clinic. In this study, we have 
evaluated anti-tumor effects and resultant inflammatory cascades of Clostridium spore delivery in 
BALB/c mice bearing synergeic subcutaneous CT26 colorectal cancer.  Mice with or without 
tumors were given 107 C. sordelli spores intravenously and those showing a complete, partial or 
no tumor regression were culled on day 3 and 7 respectively.  In order to establish clinical 
efficacy and inflammatory immune response, tumor volumes were monitored and a Bioplex 
(BioRad) based cytokine assay was conducted using serum harvested from mice. A panel of nine 
different cytokines was examined based on previous studies and their current roles in cancer 
inflammatory networks. Our results showed that there was an increase in the levels of some of the 
cytokines in spore- treated mice without tumor; however, the levels were significantly much 
higher in spore-treated group with tumors. More specifically, the levels of IL-6, IL-17, IFN-
gamma, G-CSF, MIP-2 and KC were up-regulated in spore-treated group with tumor whilst the 
levels remain unchanged for TNF- alpha and IL-4 in all groups. Interestingly, the levels of IL-
1alpha and IL-1beta were detected at lower levels in spore-treated mice (with or without tumor) 
when compared to mice with no spores (with or without tumor). In conclusion, a substantial 
antitumor activity was achieved in response to C. sordelli spore-mediated bacteriolytic therapy (a 
clinical response of 64.28%). Further, a potent immune response was generated, which can be co-
related to the tumor regression in treated mice, though at an expense of increased systemic 
toxicity. It is anticipated that the results from this study may help comprehend the balance 
between favourable (anti-cancer) and un-favourable (against host itself) immune responses to 
achieve the ultimate goal of complete tumor reduction with less toxic effects.  
 279 
Session VI     Poster VI, 23 
 
Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated 
through the inhibition of the cell division cycle 25 phosphatases  
 
Elodie Virya, Awais Anwarb, Gilbert Kirscha, Claus Jacobb, Marc Diederichc and Denyse 
Bagrela 
 
a Laboratoire d’Ingénierie Moléculaire et Biochimie Pharmacologique, EA 3940, FR CNRS 
2843, UFR SciFA, Rue du Général Delestraint, 57070, Metz, France 
b School of Pharmacy, Saarland University (Universität des Saarlandes), PO Box 15 11 50, 
D-66041 Saarbruecken, Germany 
c Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Fondation de Recherche 
Cancer et Sang, Hôpital Kirchberg, L-2540 Luxembourg, Luxembourg 
 
For many centuries, Allium vegetables, such as garlic and onion, have been used to prevent a large 
variety of health disorders. Several epidemiologic studies have supported an inverse correlation 
between dietary intake of Allium vegetables and cancer risk. In addition to these preventive 
effects, recent studies performed in vitro and in vivo, revealed that such vegetables are able to 
suppress the proliferation of various types of cancer cells. These anticarcinogenic properties were 
attributed to biologically active sulfur compounds such as allyl- and propylpolysufides found in 
Allium vegetables. This study reports the inhibitory effect of two tetrasulfides, found in garlic and 
onion, diallyl- (DAS4) and dipropyl-tetrasulfide (DPS4), towards the human cell division cycle 
(Cdc)25 phosphatases. Both compounds have emerged as interesting in vitro irreversible 
inhibitors of the Cdc25 isoforms A and C. These enzymes are important regulators of eukaryotic 
cell cycle progression and play a crucial role in the activation of cyclin-dependent kinases (Cdk) 
by dephosphorylating their phospho-Thr14 and phospho-Tyr15 residues. Furthermore, 
experiments performed on cultured cells have shown that growth of both sensitive (MCF-7) and 
resistant (Vcr-R) human breast carcinoma cells was significantly decreased by these tetrasulfides. 
The observed antiproliferative effect appeared to be associated with a G2-M cell cycle arrest. 
Cdc25s are attractive targets in cancer therapy because their over-expression was reported in 
various types of human malignancies, including breast cancer, and this has been correlated with 
either poor prognosis or tumor aggressiveness. Thus, our results suggest that Cdc25 phosphatases 
as possible targets of naturally occuring polysulfides and contribute to their anticancer properties. 
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Lung cancer arising from a complex series of genetic and epigenetic alterations of proto-
oncogenes and tumor suppressor genes is the leading cause of cancer-related deaths. The 
molecular complexity of lung cancer makes efficient therapy difficult. Currently the first-line 
therapy is based on platinum-derivatives combined with other agents. Despite great curative 
efforts the prognosis for lung cancer patients is poor. Therefore, development of new drugs or 
innovative therapeutic strategies by combining existing agents is needed. In the present study we 
compared the effect of cisplatin (CP)1, a strong DNA damaging compound with that of 
roscovitine (ROSC), a selective inhibitor of cyclin-dependent kinases (CDKs), on wt p53 positive 
human A549 lung adenocarcinoma cells harboring mutated K-RAS gene. Asynchronously 
growing A549 cells are relatively resistant to CP treatment for 24h. After exposure to CP at higher 
dose an accumulation of S-arrested cells was observed. However, after post-incubation of CP-
treated cells in a drug-free medium for a further 48h the number of living cells was markedly 
reduced. Combining CP with L-744,832, a small molecule FPTase inhibitor (FTI)2, enhanced its 
anti-proliferative effect. Interestingly, FTI sensitized A549 cells to CP-induced apoptosis. ROSC 
inhibited A549 cells at the G2/M boarder resulting in a marked decrease of the number of viable 
cells within 24h. The continuous treatment with ROSC for 48h abated the frequency of living 
cells by induction of apoptosis. Unlike CP, ROSC did not benefit from the inhibition of Ras 
protein processing pathway. Our preliminary results indicate that functional p53 contributes to the 
outcome of the therapy in human A549 cells by distinct anti-cancer drugs. 
 
1 Wesierska-Gadek J. et al. 2002. Escape of p53 protein from E6-mediated degradation in HeLa 
cells after cisplatin therapy. Int. J. Cancer. 101: 128-36. 
2 Wesierska-Gadek J. et al. 2007. A combined treatment of HeLa cells with the farnesyl protein 
transferase inhibitor L-744,832 and cisplatin significantly increases the therapeutic effect as 
compared to cisplatin monotherapy. J. Cell. Biochem. 104: 189-201. 
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Oncolytic clostridia have shown significant promise as effective anticancer agents. Culture supernatants 
of oncolytic clostridia reproducibly and effectively kill tumour cells in culture. In experimental tumour 
models in immune competent animals, there exist complicated clostridia-hosts interactions that 
influence oncolytic activities, including immune and inflammatory responses. Clearly, immune and 
inflammatory responses to clostridia, especially the spores, the form of clostridia that we used for 
delivery, be it innate or acquired, may restrict spore penetration, colonisation, germination, and promote 
bacterial clearance, thus limiting the antitumor effect of the therapy. On the other hand, immune and 
inflammatory responses against dead tumour cells (debris) may rcognise them as new antigens, thus 
enhancing tumour destruction, as specific host immunity and inflammatory responses may develop 
against these newly release tumour antigens. In this study, we design an experiment to investigate 
whether the immune and inflammatory response is a welcome friend or a meddlesome foe? Or is it both 
or neither? Two synergeic tumour models, one of subcutaneous colorectal cancer (CT26) and one for 
lung cancer (D122) were established. Mice with or without tumours were administered with once or 
twice 107 of two C. sordelli and two C. bifermantans spores intravenously. Serum from these mice was 
collected 24 hours after spore injection and at the end of the experiments. Mice showing a complete, 
partial or no tumour regression were culled on day 3 and 7 respectively.  A panel of nine different 
cytokines was examined based on previous studies and their current roles in cancer inflammatory 
networks. Our results showed there emerge a significant difference in the pattern of cytokine responses. 
In the group of animals that had experienced complete oncolysis, the levels of proimmune and 
proinflammatory cytokines increased significantly when compared with the partial oncolytic group, 
which in turn were much higher than the non-responsive group. Further experiments are underway to 
establish the exact degree of increases and decreases of each of the nine cytokines.   In conclusion, a 
substantial immune and inflammatory response was generated in response to Clostridial spore-mediated 
bacteriolytic therapy. The mechanisms of these responses will be discussed, and their potential in anti-
cancer therapy will be determined. 
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A rat model of intravesical delivery of small interfering RNA for studying urinary 
bladder cancer  
 
Chun-Mei Zhao, Carl-Jørgen Arum, Yosuke Kodama, Liang Zheng, Natale Rolim, 
Marius Widerøe, Endre Andessen, Trond Viset, Marit Otterlei, Steinar Lundgren, Duan 
Chen 
 
Departments of Cancer Research & Molecular Medicine and Circulation and Medical 
Imaging, Norwegian University of Science and Technology, Trondheim, Norway; 
Departments of Surgery, Oncology, Pathology and Genetics, St. Olav’s University 
Hospital, Trondheim, Norway 
 
The siRNA has been widely used for research in loss-of-function studies in vitro, but not 
successfully for research in vivo and clinical application.  The aims of the present study was 
to establish i) rat models of  in vivo delivery of siRNA into bladder cancer, ii) potential targets 
for siRNA, and iii) methods to evaluate therapeutic effects. The rat model of human bladder 
transitional cell carcinoma (TCC) and its derived cell line (AY27) was induced by the 
tobacco-related chemical carcinogen, either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide 
(FANFT) or N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN).  A syngeneic orthotopic bladder 
cancer model was further established by inoculation of AY27 cells. A fluorescence-labeled 
negative control siRNA with cationic liposomes was tested both in vitro (AY-27 cells) and in 
vivo. The siRNA were highly accumulated in the cancer cells for at least 24 hours after a 
single dose in vivo. Numerous lymphocytes, but not the tumor infiltrating lymphocytes, 
appeared in the tumor area. Bionformatics analysis revealed a list of concordantly highly 
expressed genes, possible siRNA targets, in both the animal models as well as in human TCC. 
Literature search of in vitro bladder cancer provided a list of genes used as siRNA targets. 
The methodology and data presented in the present study provide a number of opportunities 
for basic research of TCC carcinogenesis and translational research for evaluation of new 
therapeutic strategies (including siRNA) for bladder cancer in the native organ, where 
hormonal, neural and immunological processes
 
more closely resemble the clinical situation.  
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Expression and significance of Tumor-associated macrophages(TAMs)and microvessel 
density(MVD) in Human Ameloblastomas 
 
Ming Zhong, Jie Liu, Jing Wang, Meisi Ren. 
 
China Medeical University School of Stomatology-zhongming_oral@yahoo.com.cn 
 
Abstract:This study was to investigate the influence of Tumor-associated macrophages 
(TAMs) infiltration in the human ameloblastomas (ABs), the correlation between TAMs and 
angiogenesis in ABs. Methods: The expression of TAMs and microvascular density (MVD) 
in ABs were investigated by immunohistochemical SP method using specific monoclonal 
antibody to CD68 and CD34. Results: The mean macrophage counts in ABs was significantly 
higher than the counts in normal mucosa (P<0. 05). The mean macrophage counts in primary 
ABs, recurring ABs and canceration ABs were different. The mean microvessel counts in 
ABs were higher than that in normal mucosa (P<0.05). The mean microvessel counts in 
primary ABs, recurring ABs and canceration ABs were not significantly different, but both 
microvessel counts were strongly correlated with TAMs counts in ABs (P<0. 01). Conclusion 
: Tumor associated macrophages may play a major role in the regulation of angiogenesis in 
ABs.  
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Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor on human 
breast cancer cells differing in the expression of ER 
 
Nora Zulehner, Margarita Maurer and Józefa W#sierska-G$dek 
 
Cell Cycle Regulation Group, Division: Institute of Cancer Research, Department of 
Medicine I, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria. E-
mail: Jozefa.Gadek-Wesierski@meduniwien.ac.at 
 
Inhibition of cyclin-dependent kinases (CDKs) by small molecule inhibitors is a very 
effective weapon against malignant cells. Roscovitine (ROSC), a selective CDK inhibitor 
primarily affecting CDK2, CDK1, and CDK7, reduces the number of human cancer cells in a 
concentration-dependent manner. At lower doses ROSC arrests cell cycle progression and at 
higher doses it induces apoptosis. ROSC inhibits efficiently proliferation of human ER+-ve 
MCF-7 breast cancer cells by induction of cell cycle arrest at the G2/M transition
1
 and 
concomitantly initiates apoptosis by a p53-dependent pathway
2
. However, the effect of ROSC 
was much weaker in MCF-7 cells maintained in the presence of estrogen-mimicking 
compounds
3, 4
. Therefore, we decided to examine the action of ROSC on other breast cancer 
cell lines differing in the status of p53 and ER and to prove the impact of selective estrogen 
receptor modulators (SERMs) on the efficacy of a CDK inhibitor. ROSC was effective on all 
tested breast cancer cell lines. It arrested MCF-7 and BT-20 cells at G2/M transition and 
SKBR3 cells in G1 phase and additionally induced apoptosis. The effect of ROSC on distinct 
pro-survival and inflammatory factors was studied. Interestingly, tamoxifen (TAM), a SERM 
of first generation, strongly affected all tested cell lines irrespective of their ER status. Its 
combination with ROSC had a different impact. It enhanced G1 or G2 arrest. Our results 
evidence that ROSC can be combined with anti-estrogen therapy and show that the mode of 
ROSC action depends on the cellular context. The strong effect of TAM on ER-negative 
cancer cells indicates that SERMs crosstalk with other steroid hormone receptors. 
1 Wojciechowski J. et al. 2003. Rapid onset of nucleolar disintegration preceding cell cycle arrest in 
roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int J Cancer 106: 486-95. 
2 Wesierska-Gadek J. et al. 2005. Roscovitine-induced up-regulation of p53AIP1 protein precedes the 
onset of apoptosis in human breast cancer cells. Mol Cancer Ther 4: 113-124. 
3 Wesierska-Gadek J. et al. 2006. Phenol red reduces ROSC mediated cell cycle arrest and apoptosis 
in human MCF-7 cells. J Cell Biochem. 98: 1369-1379. 
4 Wesierska-Gadek J. et al. 2007. Phenol red in the culture medium strongly affects the susceptibility 
of human MCF-7 cells to anti-cancer drugs. CMBL 12: 280-293. 
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Markers of Inflammation and Apoptosis in Chronic Generalized Periodontitis 
 
Nataliya P. Antonova, Irina B. Alchinova 
 
Institute of General Pathology and Pathophysiology RAMS, 8, Baltyiskaya street, 
125315 Moscow, Russia E-mail: labpolys@gmail.com 
 
In is known that chronic generalized periodontitis is accompanied by more or less pronounced 
changes in the concentration of cytokines (interleukin-1#, interleukin-4, tumor necrosis 
factor-", interferon-$) in the saliva. For instance, considerable increase in the concentration of 
interferon-$ and interleukin-8 in the oral fluid maintains the inflammatory process and 
promotes destructive changes in the mucosa. For evaluation of the degree of tissue damage 
we used the method of laser correlation spectroscopy allowing measurement of the percent 
proportion of various particles in biological fluids. It was demonstrated that the contribution 
of particles with diameters of 223-300 nm and >988 nm into light scatter in oropharyngeal 
washout fluid increased in patients with generalized periodontitis (n=31) compared to healthy 
controls (n=35). These large particles can correspond to either lipoproteins or DNP and RNP 
particles. Elevation of cytotoxic activity of inflammatory mediators in periodontitis modifies 
the quality of nuclear material. We counted nuclear abnormalities (karyorrhexis, karyolysis, 
binuclear cells, pyknosis) in buccal epithelial cells. In each preparation, 1000 Giemsa-stained 
cells were analyzed at magnification of 10x90. Preliminary analysis revealed increased 
incidence of cells with karyorrhexis in patients with chronic generalized periodontitis. Thus, 
parallel processes take place in chronic generalized periodontitis: development of 
inflammatory reaction leading to necrosis, on the one side, and apoptosis responsible for 
timely elimination of damaged cells, on the other. Changes in the balance between these two 
processes open new prospects for improving the efficiency of therapy. 
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Organism defence systems status integrated method of estimation using cytotoxicity 
 
Elena N. Arkhipova, Olga A. Ezhova, Irina B. Alchinova, Nadezhda N. Khlebnikova, 
Anton B. Cherepov, Mikhail Yu. Karganov 
 
Institute of General Pathology and Pathophysiology RAMS, 8, Baltyiskaya street, 
125315 Moscow, Russia   E-mail: hippova@gmail.com 
 
Laser correlation spectroscopy (LCS) and analysis of cytotoxicity of patient serum and urine 
for bovine spermatozoa were first used in allergological clinical practice. Test system 
consisting of bovine spermatozoa suspension mobile culture was developed for endotoxicity 
level of biological fluids measurement and, respectively, organism non-specific defense 
system evaluation. We examined 249 patients (34,4 ± 2 years) with documented allergic 
disease of medium severity and 145 healthy individuals ( 38,1 ± 1 years). Significant 
differences were revealed in the functional state of the defense systems in these groups. It was 
found that endogenous intoxication develops in the majority of patients; it is characterized by 
reduced index of blood toxicity and elevated index of urine toxicity (IUT). During therapy we 
observed a decrease in IUT, which attested to correction of the state of humoral defense 
system of the organism, what was confirmed clinically. Method of LCS allows determining 
the dispersion composition of the studied fluid by the relative contribution of particle 
components into light scattering. Investigation of blood serum of patients with bronchial 
asthma showed that with the growth of disease severity increases first contribution to light 
scattering by small immunoglobulins, and then - large immune complexes. In the urine 
samples of patients predominate, as compared with "normal" spectra, large particle size of 
221-1500 nm, which is defined as "allergy similar shifts" according to semiotic classifier. In 
LC-spectra of blood serum increased contribution to light scattering by particles of small size, 
indicating that the accelerated degradation of molecules. Shown that changes in immune 
function induced by the allergen, leads to not only local symptoms, but also to the 
development of chronic endogenous intoxication, manifested by changes in the molecular 
composition of biological fluids. The data produced by the above two methods were in good 
correlation. Our results suggest that new methods are highly informative and safe and should 
be introduced into allergologist’s practics.  
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Resistance to apoptosis mediated by agonist Fas antibody in peripheral T-lymphocytes from 
Crohn’s disease patients at onset. 
 
Belen Beltran1,3, Ines Moret2, Francisco Rausell1,  Marisa Iborra2, Guillermo Bastida1,3,  Julio 
Ponce1,3, Pilar Nos1, 3 
 
1. Gastroenterology Department. Hospital Universitari la Fe-CIBERehd. Valencia. Spain. 2. 
Instituto de Investigación Sanitaria la Fe. Valencia. Spain. 3. Gastroenterology Department. 
Hospital Universitari la Fe. Valencia. Spain 
 
Background: Defective apoptosis has been reported in mononuclear cells from the lamina propria of 
Crohn’s Disease (CD) patients. Few studies have evaluated the apoptotic capacities of peripheral 
lymphocytes and these studies lack homogeneity. Furthermore, the relationship between the two 
compartiments has not been properly characterized. Aims: To study the susceptibility to apoptosis of 
non-activated peripheral lymphocytes from active-CD patients after activation in vitro and after 
addition of an external apoptotic stimulus (agonist Fas antibody). Materials & Methods: Heparinised 
blood samples were obtained from healthy subjects (n=11) and from patients at onset of CD and yet to 
begin any specific medication (n=20). Patients were diagnosed according to Leonard-Jones criteria 
and disease activity was scored based on the Harvey-Bradshaw index. Lymphocytes were isolated by 
Histopaque gradient centrifugation, followed by negative purification of non-activated T cells 
(Depletion Dynabeads®). Isolated cells were cultured for 5 days in the presence (to activate) or 
absence of bounded anti-CD3 and anti-CD28 diluted in X Vivo-15 medium (Lonza). Afterwards, Fas 
antibody (Fas Ab) was added (1'g/mL) and apoptosis was detected by flow-cytometry (Annexin-V) 
after incubation for 5h and overnight, ON (24h). Results: Activation of T-Lymphocytes by 
CD3/CD28 antibodies exposure resulted in a significant increase of apoptosis in both controls and 
active-CD patients (53.8±17.2 vs 8.3± 2.7 and 46.4±18.2 vs 7.8±4.9, respectively, data in % of 
apoptotic cells). There are no differences in apoptosis induced by activation between patients and 
controls. The addition of the Fas Ab significantly increased the percentage of apoptotic cells 
(67.0±10.9 vs 53.8±17.2 in controls and 62..9±17.1 vs 46.4±18.2 in CD patients). Overnight exposure 
to Fas Ab was necessary for showing  a significantly less induced apoptosis in active-CD lymphocytes 
than in controls (56.4±16.7vs 69.6±11.9, respectively). Conclusions: Resistance to apoptosis may be a 
feature of peripheral T-lymphocytes before cells reach the intestinal mucosa. This intrinsic alteration 
in their apoptotic capacities helps to clarify the relationship between adaptative and innate immune 
responses in CD and the physiopathology of the disease. 
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Nanoceria antagonizes apoptosis via ROS scavenging 
 
Ivana Celardo#, Milena De Nicola#, Corrado Mandoli*, Enrico Traversa*^, Lina 
Ghibelli# 
 
#Dipartimento di Biologia, *Dipartimento di Scienze e Tecnologie Chimiche, Universita’ 
di Roma Tor Vergata, Roma (I); ^ World Premier International Research Center for 
Materials Nanoarchitectonics and National Institute for Materials Science, Tsukuba (J) 
 
Cerium oxide, when in form of nanoparticles (nanoceria), contains oxygen vacancies or 
defects in the lattice structure, that cause a change in the local electronic and valence 
arrangement that stabilizes the trivalent oxidation state. Moreover, the mixed Ce3+/Ce4+ 
valence states on the surface of nanoceria confer anti-oxidant ability allowing scavenging free 
radicals. These peculiar features allowed proposing nanoceria as a biologically active agent, 
possibly neutralizing oxygen in O2-donors enzymes such as those involved in the 
inflammatory response on the one side, and on the other, by scavenging excess oxidation in 
biological processes, with the goal of contrasting the many pathologies and disturbances 
caused by deregulated or excessive oxidation. Since apoptosis is a cellular process implicated 
in many of the oxidation-dependent pathologies, and some forms of apoptosis do depend on 
deregulated intracellular oxidative processes, we analyzed the effects of nanoceria on 
apoptosis induced by the chemotherapic agent etoposide on the human leukocytes cell lines 
U937 and Jurkat. The experiments were performed adding cerium oxide nanoparticles, with 
average particles sizes of 5 nm in diameter, to the culture medium. We found that nanoceria 
reduces the extent of etoposide-induced apoptosis by about 30%. Nanoceria also inhibits 
apoptotic rise of ROS and superoxide, demonstrating in vivo anti-oxidant ability. To 
understand whether the anti-apoptotic ability of nanoceria was due to its oxidant scavenger 
ability, we evaluated the effect that nanoceria exerts on each of the two apoptotic subtypes, 
the oxidation-independent budding and the oxidation-dependent cleavage. Nanoceria only and 
strongly affects the ROS-dependent “cleavage” pathway, in the same guise as known anti-
oxidant do, demonstrating that nanoceria antagonizes apoptosis by its radical scavenging 
ability. 
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Pro-inflammatory context mediated by Electroporation as promising approach in DNA 
vaccination protocols against cancer 
 
Pieranna Chiarella1,2, Emanuela Massi1,2, Mariangela De Robertis1,2, Annarita Sibilio3 
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e.massi@unicampus.it; m.derobertis@unicampus.it; fazio@unicampus.it 
2Laboratory of Molecular Pathology and Experimental Oncology, INMM-CNR, Via 
Fosso del Cavaliere 100, 00133 Rome, Italy. emanuela.signori@cnr.it 
3Bio-Ker Srl, Parco Scientifico “Polaris”, Località Piscinamanna, 09010 Pula, Cagliari, 
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Sofferenza", Viale Padre Pio, 71013 S. Giovanni Rotondo (FG), Italy. 
pparrella@operapadrepio.it 
 
Eradication of cancer cells is imperative for a successful treatment of tumors. In addition to 
the existent chemotherapy or radiation therapy, other novel immunotherapeutic strategies are 
currently under investigation. Naked-DNA vaccination has arisen as an approach aimed at 
inducing effective immune responses in the host against defined tumor antigens. Recent 
advances in both the immunological and biotechnological research field, made it possible to 
enhance significantly the DNA vaccine potency and naked-DNA vaccination protocols, 
combined with electroporation (EP), provide a promising approach for cancer 
immunotherapy. We demonstrated that EP induces transient morphological changes in the 
muscle with early production of endogenous cytokines responsible for signaling danger at the 
local level. Moreover, it causes the recruitment of inflammatory cells, independently of the 
DNA injection, and the activation of a danger pro-inflammatory pathway, which results in the 
recruitment and triggering of cells involved in antigen presentation and leads to T-lymphocyte 
migration. Collectively, our data indicate that a moderate tissue injury and the generation of a 
pro-inflammatory context with immediate cytokine release induced by the EP treatment, have 
adjuvant-like properties able to enhance the immune response in vaccination protocols against 
cancer. 
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Reaction to DNA damage caused by ionizing radiation in embryonic fibroblasts WI-38 
 
J. Cmielova1, M. Seifrtova1, R. Havelek1, D. Muthna1, J. Vavrova2, M. Rezacova1 
 
1Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles 
University in Prague and 2Department of Radiobiology, Faculty of Military Health Sciences 
Hradec Kralove, University of Defence Brno, CZECH REPUBLIC 
Contact: cmielovaj@lfhk.cuni.cz 
 
Aim: The aim of the present study was to determine changes in cell cycle distribution, protein 
expression and activity of beta-galactosidase in emryonic fibroblasts WI-38 after irradiation. 
Methods: Cells were irradiated with the doses of 2, 6 and 20 Gy for the determination of changes 
in cell cycle distribution by flow-cytometry. For the determination of senescence and protein 
expression cells were irradiated with the dose 20 Gy. Senescence has been established by analysis 
of activity of beta-galactosidase and by western blotting detection of proteins. Results: Irradiation 
with the dose of 2 Gy has no effect on cell cycle distribution, whereas after the doses of 6 as well 
as 20 Gy 40% of cells are arrested in G2 phase as early as the first day after irradiation. Enhanced 
activity of beta-galactosidase can be observed first day after the irradiation with the dose of 20 Gy 
and this activity is increasing in time. Ionizing radiation caused significant increase in expression 
of p53. Third day after irradiation the level of protein p53 increases and reaches its maximum. 6 
day post irradiation the level is decreased and is rapidly decreasing in time. Phosphorylation of 
p53 at serine 15 occurs already 4 hours after irradiation and its level is decreased compared to 
control in 6 days. Maximal phosphorylation at serine 392 reaches its maximum 4 hours after 
irradiation as well and has the same tendency as phosphorylation at serine 15. The negative 
regulator of the protein p53 mdm2 is activated and follows the tendency of p53. Ionizing radiation 
also induces the expression of p21 protein. Its level is increased 1 and 3 days after irradiation and 
than it goes back to the control level. The expression of p16, which is associated with cellular 
senescence, increases in time since the day 3 post irradiation. Conclusion: Irradiation of 
embryonic fibroblasts with the doses of 6 and 20 Gy causes decrease in 40 % of cells provokes 
arrest in G2 phase of cell cycle. Since the first day after the irradiation with the dose of 20 Gy 
cells enter senesce, which was proved as increased beta-galactosidase activity and elevated 
expression of protein p16. Acknowledgement: This work was supported by the project MSM 
0021620820. 
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Adult Retinal Pigmental Epithelium (ARPE) 19: a model to study cell death evasion and 
inflammation.  
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1IGM-CNR, via Abbiategrasso 207, 27100 Pavia, Italy; 2INSERM U598, Centre de 
Recherches Biomédicales des Cordeliers, rue de l'Ecole de Médecine, 75006 Paris, 
France. 
E-mail: giansanti@igm.cnr.it 
 
Human Adult Retinal Pigmental Epithelium (ARPE) 19 cells, which are located behind the 
photoreceptors, are constantly exposed to various stress conditions (e.g. visible/UV light-
derived ROS). These cells are responsible for photoreceptor homeostasis by degrading and 
allowing the renewal of outer segments, they participate in the visual cycle and are involved 
in the outer hemato-retinal barrier. The importance of these cells in retinal function and their 
position in the most oxidative area of the body make them extremely resistant to various 
apoptotic and pro-inflammatory stimuli, possibly in correlation with a high autophagy rate. In 
this regard, we have investigated the effect of HMA [5-(N,N-hexamethylene)amiloride], an 
inhibitor of Na
+
/H
+
 exchanger that causes intracytosolic acidification, on ARPE19, focusing 
on the correlation between autophagy and apoptosis evasion. We found that a treatment with 
HMA for 8 to 24 h induced the apoptotic process as demonstrated by the activation of 
caspase-3; interestingly, apoptosis was only triggered but never executed, while autophagy 
occurred. It seems that autophagy can face and block cell death through the elimination of 
unwanted pro-apoptotic proteins. The analysis of PARP-1 protein status showed that it is 
initially cleaved and then confined into autophagic vacuoles. This selective elimination of 
PARP-1 is interesting because PARP-1 is an important enzyme involved in inflammation 
regulation; indeed, some PARP-1 inhibitors exert an anti-inflammatory response.   
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PUMA mediates cytokine- and ER stress-induced pancreatic beta cell apoptosis 
 
Esteban N. Gurzov, Carla M. Germano, Daniel A. Cunha, Fernanda Ortis, Jean-Marie 
Vanderwinden, Piero Marchetti, Lin Zhang, Decio L. Eizirik  
 
Laboratory of Experimental Medicine, Université Libre de Bruxelles (ULB), Route de 
Lennik, 808, 1070, Brussels, Belgium  
 
Type 1diabetes (T1D) is an autoimmune disease characterized by chronic inflammation and 
progressive pancreatic #-cell loss. The pro-inflammatory cytokines IL-1# and IFN-$ 
contribute to #-cell apoptosis in T1D, at least in part via induction of endoplasmic reticulum 
(ER) stress, but the ultimate mechanisms leading to #-cell death remain to be clarified. We 
presently demonstrate that IL-1# + IFN-$ induce the expression of the Bcl-2 homology 3 
(BH3)-only activator member PUMA (p53 upregulated modulator of apoptosis) in human and 
rodent #-cells. We observed that cytokine-induced transcriptional activation of PUMA is 
regulated by nuclear factor-!B and endoplasmic reticulum stress but is independent of p53. 
PUMA activation leads to mitochondrial Bax translocation, cytochrome c release and 
caspase-3 cleavage, ultimately resulting in #-cell apoptosis. The anti-apoptotic Bcl-XL protein 
is localized at the mitochondria of the #-cells and antagonizes PUMA action, but our data 
indicate that Bcl-XL is inactivated by the BH3-only sensitizer DP5/Hrk, previously shown by 
our group to contribute to cytokine-induced #-cell death.  Interestingly, siRNAs targeting 
PUMA or DP5/Hrk prevented at least in part cytokine- or ER stress-induced #-cell death, but 
there was no additive protection by blocking both proteins.  The present data support a 
hierarchical activation of the BH3-only members DP5/Hrk and PUMA controlling the 
intrinsic pathway of #-cell apoptosis downstream of cytokine- and ER stress-induced 
signaling.  
 
References 
Gurzov EN et al. PLoS ONE 3:e3030 (2008). 
Gurzov EN et al. Cell Death Diff 16:1539-1550 (2009). 
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Curcumin induces apoptosis in cervical cancer cells through the activation of GADD153 
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Curcumin, a major yellow pigment of tumeric derived from Curcuma longa plant, is known to 
have anticancer and antioxidant effects. Recently, many studies have shown that curcumin 
induces apoptosis by a different mechanism depends on the cell type. Here, we examined the 
apoptotic effect of curcumin on cervical cancer cells and its mechanism. Cell growth was 
inhibited by curcumin treatment in a dose and time dependent manner. The decreased cell 
viability by curcumin was associated with cleavage of caspases-3 and PARP. The event was 
resulted from the activation of caspase-8 and caspase-9 with Bid cleavage. The anti-apoptotic 
Bcl-2 expression was decreased in a time dependent manner, whereas the pro-apoptotic Bax 
expression was not changed. We also showed that GADD153, a growth arrest and DNA 
damage inducible gene, was increased at mRNA and protein level. Taken together, we 
demonstrate that curcumin suppresses the growth of cervical cancer cell via apoptosis. In 
addition, this event is induced by the activation of caspase-8 and -9, which could involve 
GADD153 activation. 
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Monensin-induced growth inhibition of PC-3 human prostate cancer cells via cell cycle 
arrest and apoptosis 
 
Dong-Min Kang, Kwang-Youn Kim, Sun-Nyoung Yu, Young-Rang Jin, Hyun-Joo Jeon,  
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*Corresponding Author E-mail: ahnsc@pusan.ac.kr 
 
Monensin is a carboxyl polyether ionophore that potently inhibited the growth of various 
cancer cell lines. But, the mechanism by which monensin acts remains unknown, especially in 
human prostate cancer cells. Here, we demonstrate that monensin inhibited the proliferation 
of prostate cancer cells. Particularly, monensin induced a G1 cell cycel arrest in PC-3 cells. 
Showing that monensin decreased the levels of CDK2, CDK4, CDK6, cyclin A, cyclin D1 
and cyclin E proteins. Monensin also induced the apoptosis in PC-3 cells through ROS 
production and a loss of mitochondrial membrane potential. It suggested that apoptotic 
process of PC-3 cells was associated with changes of Bax, Bcl-2, caspase-3 and PARP. In 
conclusion, this is the first report that monensin potently inhibits the proliferation of human 
prostate cancer PC-3 cells. 
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Salinomycin induces reactive oxygen species-mediated apoptosis in human prostate 
cancer PC-3 cells  
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Salinomycin is an anionic polyether that has been used extensively as a microbial 
antibiotic. There is limited information on the cytotoxicity effect of salinomycin on human 
prostate cancer cells. To decipher the mechanism of this effect, we studied the sequence of 
signaling events leading to cell growths inhibition in PC-3 human prostate cancer cells. We 
found the production of reactive oxygen species (ROS) to be a critical mediator in 
salinomycin-induced inhibiton of cell growth. The event was reversed by N-acetyl-L- cysteine 
(NAC), inhibitor of ROS. Further investigation revealed that salinomycin triggered the 
mitochondrial apoptotic pathway, as indicated by differential regulation of Bax/Bcl-2 
proteins, resulting in a loss of mitochondrial membrane potential, release of cytochrome c, 
activation of caspase-3 and cleavage of PARP. Our data suggest that salinomycin should be 
considered as an effective anticancer agent that modulates ROS-induced cell death via a 
mitochondrial death pathway in PC-3 cells. 
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Apoptosis of immortalized keratinocyte HaCaT cells  
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School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong 
Kong, Shatin, Hong Kong 
 
Camptothecin (CPT) is the first line chemotherapeutic agent for colon cancer because of its 
potent antiproliferative and apoptotic properties, but it is also used to treat psoriasis, an 
epidermal hyperproliferation skin disease, in China. A comparative study showed that the 
human epidermal immortalized HaCaT keratinocytes were more sensitive to the cytotoxicity 
of CPT than the human colon cancer HT29 cells, with a stronger expression of apoptotic BAX 
protein and active caspase 3 in HaCaT cells as demonstrated by western blotting and 
immunofluorescence analysis. In addition, the transcription of coiled-coil alpha helical rod 
protein 1 (CCHCR1), a marker protein for psoriasis, was also up-regulated in HaCaT cells. 
When the cells were depleted with CCHCR1 protein by small interfering RNA (siRNA), the 
CPT-induced expression of active caspase 3 and cell apoptosis were altered, implicating a 
possible role of this protein with apoptotic changes in keratinocytes. 
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The caspase-cleaved form of lyn médiates a psoriasis-like inflammatory syndrome in 
mice 
 
Marchetti S1,9, Gamas P1,9, Belhacène N1,9, Grosso S1,9, Pradelli LA2,9, Colosetti P1,9, 
Johansen C5, Iversen L5, Deckert M4,9, Luciano F1,9, Hofman P6,9,10, Ortonne N7, Khemis 
A3, Mari B8, Ortonne J-P3, Ricci J-E2,9 and Auberger P1,9. 
 
1 Inserm, U895, Centre Méditerranéen de Médecine Moléculaire (C3M), team 2, Nice, F-
06204, France; 2 Inserm, U895, Centre Méditerranéen de Médecine Moléculaire (C3M), 
team 3, Nice, F-06204, France; 3 CHU de NICE, Department of dermatology, Nice, F-06202, 
France; 4 Inserm, U576, Nice, F-06200, France; 5 Department of Dermatology, Aarhus 
University Hospital, 8000 Aarhus C, Denmark; 6 Inserm ERI-21/EA4319, Nice, F-06107, 
France; 7 Department of pathology, AP-HP, groupe hospitalier Henri Mondor-Albert 
Chenevier, Creteil, France; 8 CNRS, UMR6097, Institut de Pharmacologie Moléculaire et 
Cellulaire, Université de Nice-Sophia Antipolis, F-06560 Valbonne, France; 9 Université de 
Nice Sophia-Antipolis, Faculté de Médecine, Signalisation et pathologies (IFR50), Nice, F-
06107, France; 10 CHU de Nice, Laboratory of clinical and experimental pathology, Nice, F-
06107, France. 
 
We showed previously that Lyn is a substrate of caspases, a family of cysteine proteases 
involved in the regulation of apoptosis and inflammation. Here, we report that expression of 
the caspase-cleaved form of Lyn (LynDN) in mice mediates a chronic inflammatory 
syndrome resembling human psoriasis. Genetic ablation of TNF Receptor 1 in a LynDN 
background rescues a normal phenotype indicating that LynDN mice phenotype is TNF-a-
dependent. The predominant role of  T cells in the disease developped by LynDN mice was 
highlighted by the distinct improvement of LynDN mice phenotype in a Rag1 deficient 
background. We also established by pangenomic profiling that LynDN mice exhibit increased 
expression of STAT-3 and inhibitory members of the NFkB pathway. Accordingly, LynDN 
alters NFkB activity underlying a link between inhibition of NFkB and LynDN mice 
phenotype. Finally, analysis of Lyn expression in human skin biopsies of psoriatic patients 
detected Lyn cleavage product whose expression correlates with activation of caspase 1. Our 
data identify a new role for Lyn as a regulator of psoriasis through its cleavage by caspases.  
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Involvement of NF-kB activation in tipping the balance in favor of survival or apoptosis 
in 3’-azido-3’-deoxythymidine (AZT) treated cells 
 
Claudia Matteucci1, Antonella Minutolo1, Emanuela Balestrieri1, Sandro Grelli1, 
Francesca Marino-Merlo3, Placido Bramanti4, Beatrice Macchi2,5, Antonio Mastino3,4 
 
1Department of Experimental Medicine and Biochemical Sciences, e-mail: 
grelli@med.uniroma2.it, and 2Department of Neuroscience, University of Rome “Tor 
Vergata” Rome, Italy; 3Department of Life Sciences, University of Messina, Messina, 
Italy, e-mail:antonio.mastino@unime.it; 4IRCCS Centro Neurolesi “Bonino-Pulejo”, 
Messina, Italy; 5IRCCS, S. Lucia, Rome, Italy.  
 
In this study we investigated the role of NF-kB activation in molecular mechanisms 
underlying susceptibility/resistance to apoptosis induced by AZT. To this purpose, we firstly 
evaluated induction of apoptosis by AZT in a panel of different cell lines, observing a higher 
susceptibility of the U937 cell line to AZT-induced apoptosis, in comparison with other cell 
lines. Then, the transcriptional activity of apoptosis-, cell cycle- and DNA-damage-related 
genes was detected in AZT-treated U937 cells by SuperArray analysis and confirmed, in 
selected cases, at protein level, by flow cytometry and western blotting analysis. Surprisingly, 
AZT induced the transcriptional activity of both pro- and anti-apoptotic genes. Interestingly, 
several genes, whose transcription was up-regulated by AZT were NF-kB related. In fact, 
AZT, at a pro-apoptotic concentration, after an initial inhibition of NF-kB activation with 
respect to control, induced a transient, but consistent, increase of NF-kB binding activity. As a 
consequence, the effects of AZT on apoptosis in cells in which NF-kB activation was 
impaired by stable transfection with a dominant-negative IkB-alpha or by pharmacological 
treatment, were ascertained, showing that inhibition of NF-kB activation increased apoptosis 
in AZT treated cells and impaired the up-regulation of antiapoptotic genes in response to AZT 
treatment, with respect to control cells. These results indicate that NF-kB activation by AZT 
plays an important role in protecting target cells from apoptotic cell death, improving our 
understanding of the toxicology and the therapeutic usage of this drug. Given basic 
knowledge concerning the biology of both viral infections and tumours, modulation of NF-kB 
activation could be a critical step in determining the adverse or desired effects of AZT.  
 300 
Session VII     Poster VII, 15 
 
Histopathologic study of apoptosis and angiogenic factors in large bowel wall in patients with 
inflammatory bowel disease. 
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2.Department of Pathology, Witold Orlowski Clinical Hospital, The Medical Centre of 
Postgraduate Education, Czerniakowska 231, 00-416 Warsaw, Poland. E-mail: 
zakl.patomorfologii@szpital-orlowskiego.pl. 3.Department of Oncologic Gynecology, M. 
Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Wawelska 15, 02-034 
Warsaw, Poland. E-mail: gszewczy@wp.pl. 4.Department of Experimental and Clinical 
Neuropathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 
Pawinskiego 5, 02-106, Warsaw, Poland. 
 
Current researches strongly suggest, that angiogenesis and apoptosis play important role in 
pathogenesis of inflammatory bowel disease (IBD). Investigations on animal models show that extent 
and intensity of inflammation correlate with increased angiogenesis. Several factors increase 
angiogenesis in the course of IBD, including vascular endothelial growth factor (VEGF) and its 
receptors (VEGFR). There are also anti-angiogenic factors like thrombospondin. Their interactions 
seem to promote changes in the microvascular density (MVD) of bowel wall. Apoptosis – a 
programmed cell death, correlates with inflammation in IBD. It’s been shown that decreased apoptosis 
in the population of lymphocytes may be a key factor in pathogenesis of IBD. Several studies have 
demonstrated that increased epithelial apoptosis may be responsible for epithelial barrier dysfunction 
occurring in the course of IBD particularly in Crohn’s disease. The purpose of our study was to 
demonstrate the correlation between angiogenic factors and apoptotic activity of cells in IBD. For our 
investigation full thickness tissue sections of the large bowel wall were used. Sections were taken 
from specimens after surgical resection in patients with Crohn’s disease (CD) and ulcerative colitis 
(CU). We performed morphometrical analysis of all tissue samples. Immunohistochemical expression 
of VEGFR and anti-angionic factors was demonstrated with antibodies against Flt-1 [Sigma-Aldrich] 
and thrombospondin [Sigma-Aldrich]. Epithelial apoptotic activity was assessed with antibodies 
against caspase-cleaved cytokeratin 18 - M30 CytoDEATH [Roche]. Our research showed correlation 
between angiogenic and anti-angiogenic activity in IBD, with no significant differences between CU 
and CD. We also demonstrated increased apoptotic activity in epithelial cells of intestinal mucosa 
notably in inflammatory polyps (CU) and in proximity of ulcerations (CD). 
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On the mechanisms of cell death mediated by a lysosomal protease: the cathepsin D. 
 
Gloria Villalpando Rodriguez 1, Sabine Chahory 2, Alicia Torriglia 1 
 
1Centre de Recherches des Cordeliers, INSERM U 872 eq. 17, 15, rue de L’école de 
Médecine, 75006. Paris. Université Paris Descartes; 2Ecole Nationale vétérinaire 
d’Alfort. 
 
It is widely accepted that classical caspase-dependent apoptosis occurs almost in the absence 
of inflammatory response. However, studies have shown the induction of caspases- 
independent cell death describing other proteases effectors like calpains or cathepsins. This 
occurs mostly in differentiated cells and in neurons. The pro-inflammatory effects of these 
alternative pathways have not been studied. It has been shown that, in a Light Induced Retinal 
Degeneration model of photoreceptor demise, the LEI/L-DNase II pathway is activated. This 
is a caspases independent cell death pathway and recent results indicate that it is activated by 
cathepsin D in this paradigm. As LEI, the precursor of L-DNase II is a cytoplasmic protein, 
the main fact in its activation is the release of cathepsin D from the lysosome. In this work we 
study the mechanism and the pro-apoptotic activities of lysosome permeabilization. We 
mainly focus on the effects of cathepsin D translocation to the cytoplasm and the molecular 
pathways activated. To do that we use two different cell lines treated with ciprofloxacin  an 
antibiotic which has been previously shown to permeabilze the lysosomes. The kinetics of 
cathepsin D release and of L-DNase II activation is described. The description of alternative 
pathways of cell death is essential in the understanding of cellular reactions involved in 
inflammatory processes. 
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Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth 
muscle cells via epidermal growth factor receptor signalling 
 
Gemma E. White1, Thomas C.C. Tan1, Ivy Christou1, Carl Whatling2, William L. 
McPheat2 and David R. Greaves1 
 
1Sir William Dunn School of Pathology, University of Oxford, UK. 2Bioscience 
Department, CVGI, AstraZeneca R&D Mölndal, Sweden.  
 
Aims: Fractalkine (CX3CL1) is a membrane-bound chemokine that signals
 
through the G 
protein-coupled receptor CX3CR1 that is implicated
 
in the development of atherosclerosis. We 
have previously reported
 
that CX3CR1 is expressed by primary human coronary artery smooth
 
muscle cells (CASMC), where it mediates chemotaxis towards CX3CL1.
 
We sought to 
determine the effect of CX3CL1 on CASMC survival
 
and proliferation and elucidate the 
signalling mechanisms involved.
 Methods and results: CX3CL1 significantly reduces 
staurosporine-induced apoptosis
 
of CASMC, as quantified by caspase 3 immunostaining and 
Annexin-V
 
flow cytometry. Furthermore, CX3CL1 is a potent mitogen for
 
primary CASMC and 
induces phosphorylation of ERK and Akt, measured by western blotting. Inhibition
 
of either 
ERK or PI3K signalling
 
abrogates proliferation, while only PI3K signalling is involved
 
in the 
anti-apoptotic effects of CX3CL1. We describe a novel
 
and specific small molecule antagonist 
of CX3CR1 (AZ12201182)
 
which abrogates the mitogenic and anti-apoptotic effects of
 
CX3CL1 
on CASMC. Pharmacological inhibition of the EGFR blocks CASMC survival and DNA
 
synthesis, indicating a previously undocumented role for EGFR
 
signalling in response to 
CX3CL1 involving release of a soluble
 
EGFR ligand. Specifically, CX3CL1 induces shedding of 
epiregulin
 
and increases epiregulin mRNA expression 20-fold within 2 h.
 
Finally, antibody 
neutralization of epiregulin abrogates the
 
mitogenic effect of CX3CL1. Conclusion: We have 
demonstrated two novel and important functions of CX3CL1
 
on primary human SMCs: anti-
apoptosis and proliferation, both
 
mediated via epiregulin-induced EGFR signalling. Our data 
have
 
important implications in vascular pathologies including atherosclerosis,
 
restenosis, and 
transplant accelerated arteriosclerosis, where
 
the balance of SMC proliferation and apoptosis 
critically determines
 
both plaque stability and vessel stenosis.
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Evaluation of pro-apoptotic effect of purine analogs combined with alkylating agent on CLL 
cells after in vivo and ex vivo treatment 
 
Jolanta D. )o!nierczyk1,3, Arleta Ka(mierczuk1, Jerzy Z.B!o"ski2, Ma!gorzata Rogali"ska1,3, 
Tadeusz Robak2, Zofia M.Kilia"ska1, Józefa W#sierska-G$dek3 
 
1 University of Lodz, Dept. of Cytobiochemistry, Poland; 2 Medical University of Lodz, Dept. of 
Hematology, Poland; 3 Medical University of Vienna, Dept. of Medicine 1, Div.: Inst. of Cancer 
Research, Cell Cycle Regulation Group, Austria, Borschkegasse 8a, 1090 Vienna, Austria. E-
mail: Jozefa.Gadek-Wesierski@meduniwien.ac.at 
 
Chronic lymphocytic leukemia (CLL) is considered as a cancer-involving, mainly deregulated apoptosis. 
However, apart from a population consisting of long-lived resting malignant lymphocytes, a small 
subpopulation, representing rapidly dividing cells, also occurs. Despite advances in the medication of CLL this 
hematological cancer still remains incurable with standard therapies. Thus, elaboration of more effective 
treatment protocols slowing the disease progression and impeding relapsing is needed. Recently, besides 
conventional chemotherapy or chemoimmunotherapy a new approach based on agents which broadly inhibit 
cyclin dependent kinases was developed. In the present study, the in vivo response of CLL cells obtained from 
peripheral blood of patients cured with cladribine or fludarabine, combined with cyclophosphamide (CC or FC), 
was compared with that under ex vivo conditions. Moreover, in ex vivo experiments the impact of R-roscovitine, 
a tri-substituted purine analog inhibiting cyclin-dependent kinases, was additionally determined. R-roscovitine 
was administered alone as well as in combination with alkylator-mafosfamide. Leukemic cell samples were 
isolated from blood of untreated CLL patients prior to the onset of therapy (day 0.) and during administration, 
i.e. on day 1 and 3 of CC and FC regimen as well as 14 days after termination of the first treatment cycle. For 
control, mononuclear cells isolated from blood of healthy volunteers (PBMNC) were tested. The effect of the 
examined agent(s) applied alone or in combinations on human cells was evaluated by two independent methods. 
Reduction of the number of living cells and apoptosis rate was determined by Vybrant apoptosis assay #4 using 
flow cytometric measurement of stained cells. Cellular levels and functional status of chosen apoptosis-related 
proteins (Mcl-1, Bax, caspase-9, caspase-3, PARP-1, and lamin B) were examined by immunoblotting. 
Evaluation of our results revealed that the apoptosis rate of leukemic cells assessed by Vybrant assay and 
confirmed by DNA fragmentation differed between in vivo and ex vivo treatment. In leukemic cells obtained 
from some in vivo treated patients a translocation of histone H1.2 from the nucleus into the cytosol was 
observed. Furthermore, experiments performed under ex vivo conditions revealed that R-roscovitine is much 
more effective than other purine analogs and induces fast apoptosis of CLL cells at high rate. Our results suggest 
that R-roscovitine emerges as a powerful agent for improvement of CLL therapy outcome. 
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Astragalus saponins exhibit anti-angiogenic effect in colon cancer cells via inhibition of mTOR 
signaling and pro-inflammatory mediators 
 
PC Law, KKW Au Yeung and JKS Ko. 
 
Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist 
University, Hong Kong SAR, China -E-mail address: jksko@hkbu.edu.hk (J.K.S. Ko). 
 
Astragalus membranaceus has been demonstrated to induce colonic protection against experimental 
colitis through modulation of cytokines in our previous study [1]. Further studies indicate that total 
Astragalus saponins extract (AST) in the herb, exhibit anti-inflammatory and anti-carcinogenic effects 
using different models[2-3]. In this study, the correlation between inhibiting pro-inflammatory mediators 
and the anti-angiogenic effects of AST in HCT 116 human colon cancer cells under hypoxic condition 
was investigated. The protein and gene expression of angiogenic factors was assessed using Western 
immunoblotting and RT-PCR, respectively. The involvement of mTOR signaling in the anti-
carcinogenic effect of AST was investigated by using its inhibitor rapamycin. Expression of tumor 
necrosis factor-alpha (TNF-"), heat shock protein 90 (HSP 90),   hypoxia-inducible factor (HIF-1") 
and vascular endothelial growth factor (VEGF) under hypoxia conditions were examined using cobalt 
chloride (CoCl2) as hypoxia-mimetic agent. AST (80 %g/ml) significantly inhibited the protein 
expression of the key angiogenic growth factors VEGF in normoxic condition. Our results showed that 
the protein expression of PTEN, an upstream regulator of PI3K-Akt signaling, was increased. This 
was followed by reduced Akt phosphorylation (pAkt) and downregulation of its downstream target 
mTOR. Rapamycin alone could decrease the protein expression of VEGF, while co-treatment of 
rapamycin and AST further downregulate these proteins. HIF-1 has been considered to be a pivotal 
transcription factor linking between the inflammatory and oncogenic pathways. Under CoCl2 
mimicked hypoxia, the induced HIF-1" and VEGF expression in HCT 116 cells was suppressed by 
AST or rapamycin alone. Co-treatment of AST and rapamycin could further decrease their protein 
expression. Preliminary results have shown that CoCl2 could induce expression of the pro-
inflammatory cytokine TNF-" and of the chaperon protein HSP90, which were dropped to control 
levels after AST treatment. Our data suggest that AST could downregulate the angiogenic factors HIF-
1" and VEGF through inhibition of mTOR signaling and pro-inflammatory mediators in HCT 116 
cells under hypoxic condition.  
[1] J.K.S. Ko, et al., Cytokine, 2009, 47(2): p.85-90. [2] K. K.W. Auyeung, et al., Int. J. Cancer, 2009, 
125: p.1082–1091. [3] K. K.W. Auyeung, et al., Int J Mol Med, 2009, 23(2): p.189-96. 
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Wednesday, January 27th 
Keynote session: 
9h30 – 10h30: Jurg Tschopp  
10h30 – 11h00: Coffee break 
Session 1: Cell signaling pathways I 
11h00 – 11h30: Young-Joon Surh 
11h30 – 12h00: Massimo Locati  
12h00 – 12h30: Matthias Gaestel 
12h30 – 13h00: Thad Stappenbeck 
13h00: Lunch, workshops, posters 
14h00 – 15h00: Becton Dickinson 
15h00 – 16h00: Promega 
Session 2: Cell signaling pathways II 
16h00 – 16h30: Véronique Baud 
16h30 – 17h00: Rudi Beyaert 
17h00 – 17h30: Hye-Kyung Na 
17h30 – 18h00: Wouter de Jonge 
18h00 – 18h20: Roberto Gambari 
18h20 – 18h40: Emmanuel Dejardin  
18h40 – 19h00: Hyeyoung Kim 
 
Thursday, January 28th 
Session 3: Inflammatory mediators 
8h30 – 9h00: Bharat B. Aggarwal 
9h00 – 9h30: Sankar Ghosh 
9h30 – 10h00: Edward A. Dennis 
10h00 – 10h30: Zigang Dong 
10h30 – 11h00: Coffee break 
Session 4: Epigenetics and transcription 
11h00 – 11h30: Ajay Goel  
11h30 – 12h00: Guy Haegeman 
12h00 – 12h20: Jonathan Turner  
12h20 – 12h40: Oliver H. Krämer  
12h40 – 13h00: Alexander Remels  
13h00: Lunch, workshops, posters 
13h00 – 14h00: IBA 
14h00 – 15h00: Polyplus-Transfection 
15h00 – 16h00: AMS Biotechnology 
Session 5: Virus and immunity 
16h00 – 16h30: Jacques Piette 
16h30 – 17h00: Andrew Bowie  
17h00 – 17h30: Christian Münz 
17h30 – 18h00: Johannes Bode 
18h00 – 18h30: Yong Sang Song 
18h30 – 19h00: Stephen J. Galli 
Friday, January 29th 
Session 6: Pathologies – Part I 
8h30 – 9h00: Seth Masters 
9h00 – 9h30: Decio L. Eizirik  
9h30 – 10h00: Sushovan Guha 
10h00 – 10h30: Kapil Mehta 
10h30 – 11h00: Coffee break 
Session 7: Pathologies – Part II 
11h00 – 11h30: Sunil Krishnan 
11h30 – 11h50: Franck Morceau  
11h50 – 12h10: Ma!gorzata Rogali"ska 
12h10 – 12h30: Jenny E. Gumperz  
12h30 – 12h50: George Hajishengallis 
12h50 – 13h10: Salahaddin Mahmudi-Azer 
13h10 – 13h30: Alfonso Pompella  
13h30: Lunch, workshops, posters 
14h00 – 15h00: Bio-Rad 
15h00 – 16h00: GE Healthcare 
Session 8: Cell signaling pathways III 
16h00 – 16h30: Varsha Gandhi 
16h30 – 17h00: Peter Friedl 
17h00 – 17h30: Ivana Scovassi  
17h30 – 17h50: Claudia Cerella 
17h50 – 18h10: Alicia Torriglia 
18h10 – 18h30: Béatrice Charreau  
18h30 – 18h50: Thomas Luft 
18h50 – 19h10: Iris Behrmann  
 
Saturday, January 30th 
Session 9: Natural compounds I 
8h30 – 9h00: Lina Ghibelli  
9h00 – 9h30: De-Xing Hou 
9h30 - 9h50: Norbert Latruffe  
9h50 – 10h10: Francesco Peri 
10h10 – 10h30: Flavia Radogna 
10h30 – 11h00: Coffee break 
Session 10: Natural compounds II 
11h00 – 11h20: Assam El-Osta 
11h20 – 11h40: Marc Schumacher  
11h40 – 12h00: Veera R. Konda 
12h00 – 12h20: Józefa W#sierska-G$dek  
12h20 – 12h40: Dietmar Fuchs  
12h40 – 13h00: Stephan Immenschuh  
13h00: Lunch and end of the meeting 
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Astragalus saponins exhibit anti-angiogenic effect in colon cancer cells via inhibition of mTOR 
signaling and pro-inflammatory mediators 
 
PC Law, KKW Au Yeung and JKS Ko. 
 
Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist 
University, Hong Kong SAR, China -E-mail address: jksko@hkbu.edu.hk (J.K.S. Ko). 
 
Astragalus membranaceus has been demonstrated to induce colonic protection against experimental 
colitis through modulation of cytokines in our previous study [1]. Further studies indicate that total 
Astragalus saponins extract (AST) in the herb, exhibit anti-inflammatory and anti-carcinogenic effects 
using different models[2-3]. In this study, the correlation between inhibiting pro-inflammatory mediators 
and the anti-angiogenic effects of AST in HCT 116 human colon cancer cells under hypoxic condition 
was investigated. The protein and gene expression of angiogenic factors was assessed using Western 
immunoblotting and RT-PCR, respectively. The involvement of mTOR signaling in the anti-
carcinogenic effect of AST was investigated by using its inhibitor rapamycin. Expression of tumor 
necrosis factor-alpha (TNF-!), heat shock protein 90 (HSP 90),   hypoxia-inducible factor (HIF-1!) 
and vascular endothelial growth factor (VEGF) under hypoxia conditions were examined using cobalt 
chloride (CoCl2) as hypoxia-mimetic agent. AST (80 "g/ml) significantly inhibited the protein 
expression of the key angiogenic growth factors VEGF in normoxic condition. Our results showed that 
the protein expression of PTEN, an upstream regulator of PI3K-Akt signaling, was increased. This 
was followed by reduced Akt phosphorylation (pAkt) and downregulation of its downstream target 
mTOR. Rapamycin alone could decrease the protein expression of VEGF, while co-treatment of 
rapamycin and AST further downregulate these proteins. HIF-1 has been considered to be a pivotal 
transcription factor linking between the inflammatory and oncogenic pathways. Under CoCl2 
mimicked hypoxia, the induced HIF-1! and VEGF expression in HCT 116 cells was suppressed by 
AST or rapamycin alone. Co-treatment of AST and rapamycin could further decrease their protein 
expression. Preliminary results have shown that CoCl2 could induce expression of the pro-
inflammatory cytokine TNF-! and of the chaperon protein HSP90, which were dropped to control 
levels after AST treatment. Our data suggest that AST could downregulate the angiogenic factors HIF-
1! and VEGF through inhibition of mTOR signaling and pro-inflammatory mediators in HCT 116 
cells under hypoxic condition.  
[1] J.K.S. Ko, et al., Cytokine, 2009, 47(2): p.85-90. [2] K. K.W. Auyeung, et al., Int. J. Cancer, 2009, 
125: p.1082–1091. [3] K. K.W. Auyeung, et al., Int J Mol Med, 2009, 23(2): p.189-96. 
